CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: antipsychotic agent
Accession: CHEBI:35476
browse the term
Definition: Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
Synonyms: related_synonym: Neuroleptikum; antipsychotic agents; antipsychotic drug; antipsychotic drugs; antipsychotics; antipsychotiques; grosser Tranquilizer; major tranquilizers; major tranquilizing agents; neuroleptic; neuroleptic agents; neuroleptics; neuroleptique; neuroleptiques
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO
Chlorprothixene inhibits the reaction [(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane binds to HTR1A protein]
CTD
PMID:2891550
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Chlorprothixene results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Prl
prolactin
increases secretion
ISO
Chlorprothixene results in increased secretion of PRL protein
CTD
PMID:10525070
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ache
acetylcholinesterase
increases activity
ISO
Acepromazine results in increased activity of ACHE protein
CTD
PMID:29614332
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ar
androgen receptor
multiple interactions
ISO
acetophenazine binds to and results in decreased activity of AR protein
CTD
PMID:17606915
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Ache
acetylcholinesterase
decreases activity
ISO
Amisulpride results in decreased activity of ACHE protein
CTD
PMID:33844597
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Drd2
dopamine receptor D2
affects binding
EXP
Amisulpride binds to DRD2 protein
CTD
PMID:12191584
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Prl
prolactin
increases secretion increases expression multiple interactions
ISO EXP
Amisulpride results in increased secretion of PRL protein Amisulpride results in increased expression of PRL protein Bromocriptine inhibits the reaction [Amisulpride results in increased secretion of PRL protein]; carmoxirole inhibits the reaction [Amisulpride results in increased secretion of PRL protein]
CTD
PMID:12106810 PMID:14966260 PMID:14997280 PMID:15665803 PMID:16938372 PMID:18063941 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Vipr2
vasoactive intestinal peptide receptor 2
decreases expression
ISO
Amisulpride results in decreased expression of VIPR2 mRNA
CTD
PMID:27900577
NCBI chr 6:136,996,664...137,070,599
Ensembl chr 6:137,001,511...137,070,597
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
amperozide inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:19583963
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Acadl
acyl-CoA dehydrogenase, long chain
decreases expression
EXP
Aripiprazole results in decreased expression of ACADL mRNA
CTD
PMID:17868501
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
G
Adora2a
adenosine A2a receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ADORA2A mRNA
CTD
PMID:31476115
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
decreases expression
EXP
Aripiprazole results in decreased expression of ARPC1B mRNA
CTD
PMID:17868501
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
G
Bcl10
BCL10, immune signaling adaptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of BCL10 mRNA
CTD
PMID:31476115
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of BCL2L1 mRNA
CTD
PMID:31476115
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl6
BCL6, transcription repressor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of BCL6 mRNA
CTD
PMID:31476115
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of BID mRNA
CTD
PMID:31476115
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
C1r
complement C1r
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in decreased expression of C1R mRNA]
CTD
PMID:31476115
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C2
complement C2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of C2 mRNA
CTD
PMID:31476115
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
G
Cbx7
chromobox 7
decreases expression increases expression
EXP
Aripiprazole results in decreased expression of CBX7 mRNA Aripiprazole results in increased expression of CBX7 mRNA
CTD
PMID:17868501
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Ccl19
C-C motif chemokine ligand 19
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL19 mRNA
CTD
PMID:31476115
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL2 mRNA
CTD
PMID:31476115
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL20 mRNA
CTD
PMID:31476115
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of CCL22 mRNA]
CTD
PMID:31476115
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL3 mRNA
CTD
PMID:31476115
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL4 mRNA
CTD
PMID:31476115
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCL5 mRNA
CTD
PMID:31476115
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr3
C-C motif chemokine receptor 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CCR3 mRNA
CTD
PMID:31476115
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Cd274
CD274 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD274 mRNA
CTD
PMID:31476115
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd33
CD33 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD33 mRNA
CTD
PMID:31476115
NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149
G
Cd44
CD44 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD44 mRNA
CTD
PMID:31476115
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd70
Cd70 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD70 mRNA
CTD
PMID:31476115
NCBI chr 9:2,006,563...2,009,715
Ensembl chr 9:2,006,563...2,009,715
G
Cd83
CD83 molecule
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CD83 mRNA
CTD
PMID:31476115
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cdh5
cadherin 5
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of CDH5 mRNA]
CTD
PMID:31476115
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CDKN1A mRNA
CTD
PMID:31476115
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cebpb
CCAAT/enhancer binding protein beta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CEBPB mRNA
CTD
PMID:31476115
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
Aripiprazole inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Aripiprazole inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]
CTD
PMID:20097249
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cfb
complement factor B
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CFB mRNA
CTD
PMID:31476115
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cldn5
claudin 5
decreases expression
EXP
Aripiprazole results in decreased expression of CLDN5 mRNA
CTD
PMID:17868501
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Cnr1
cannabinoid receptor 1
increases expression
EXP
Aripiprazole results in increased expression of CNR1 mRNA
CTD
PMID:17868501
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
increases expression
EXP
Aripiprazole results in increased expression of COMT mRNA
CTD
PMID:17868501
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Creb5
cAMP responsive element binding protein 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CREB5 mRNA
CTD
PMID:31476115
NCBI chr 4:82,393,091...82,794,320
Ensembl chr 4:82,393,730...82,790,325
G
Crebbp
CREB binding protein
decreases expression
EXP
Aripiprazole results in decreased expression of CREBBP mRNA
CTD
PMID:17868501
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crmp1
collapsin response mediator protein 1
increases expression
EXP
Aripiprazole results in increased expression of CRMP1 mRNA
CTD
PMID:17868501
NCBI chr14:73,509,933...73,556,192
Ensembl chr14:73,509,933...73,556,177
G
Csf1
colony stimulating factor 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CSF1 mRNA
CTD
PMID:31476115
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CSF2 mRNA
CTD
PMID:31476115
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CSF3 mRNA
CTD
PMID:31476115
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cx3cl1
C-X3-C motif chemokine ligand 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CX3CL1 mRNA
CTD
PMID:31476115
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCL1 mRNA
CTD
PMID:31476115
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCL2 mRNA
CTD
PMID:31476115
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCL1 mRNA
CTD
PMID:31476115
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr5
C-X-C motif chemokine receptor 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCR5 mRNA
CTD
PMID:31476115
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
G
Cxcr6
C-X-C motif chemokine receptor 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CXCR6 mRNA
CTD
PMID:31476115
NCBI chr 8:123,434,417...123,439,568
Ensembl chr 8:123,416,325...123,439,526
G
Cybb
cytochrome b-245 beta chain
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CYBB mRNA
CTD
PMID:31476115
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cyld
CYLD lysine 63 deubiquitinase
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of CYLD mRNA
CTD
PMID:31476115
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
G
Ddr2
discoidin domain receptor tyrosine kinase 2
decreases expression
EXP
Aripiprazole results in decreased expression of DDR2 mRNA
CTD
PMID:17868501
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Ddx50
DExD-box helicase 50
increases expression
EXP
Aripiprazole results in increased expression of DDX50 mRNA
CTD
PMID:17868501
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
G
Dnal4
dynein, axonemal, light chain 4
decreases expression
EXP
Aripiprazole results in decreased expression of DNAL4 mRNA
CTD
PMID:17868501
NCBI chr 7:111,312,424...111,325,283
Ensembl chr 7:111,312,427...111,325,283
G
Dnmt3a
DNA methyltransferase 3 alpha
increases expression
EXP
Aripiprazole results in increased expression of DNMT3A mRNA
CTD
PMID:17868501
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Drd2
dopamine receptor D2
multiple interactions
EXP ISO
[Aripiprazole binds to and results in increased activity of DRD2 protein] which results in increased susceptibility to Methamphetamine
CTD
PMID:17069544 PMID:17327886
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dusp4
dual specificity phosphatase 4
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of DUSP4 mRNA
CTD
PMID:31476115
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dusp6
dual specificity phosphatase 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of DUSP6 mRNA
CTD
PMID:31476115
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Ebi3
Epstein-Barr virus induced 3
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of EBI3 mRNA]
CTD
PMID:31476115
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
G
Egr1
early growth response 1
increases expression
EXP
Aripiprazole results in increased expression of EGR1 mRNA; Aripiprazole results in increased expression of EGR1 protein
CTD
PMID:17868501
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
increases expression
EXP
Aripiprazole results in increased expression of EGR2 mRNA
CTD
PMID:17868501
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Egr4
early growth response 4
increases expression
EXP
Aripiprazole results in increased expression of EGR4 mRNA
CTD
PMID:17868501
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
G
Elane
elastase, neutrophil expressed
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ELANE mRNA
CTD
PMID:31476115
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
G
Elavl2
ELAV like RNA binding protein 2
increases expression
EXP
Aripiprazole results in increased expression of ELAVL2 mRNA
CTD
PMID:17868501
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
G
Ets1
ETS proto-oncogene 1, transcription factor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ETS1 mRNA
CTD
PMID:31476115
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Exoc2
exocyst complex component 2
increases expression
EXP
Aripiprazole results in increased expression of EXOC2 mRNA
CTD
PMID:17868501
NCBI chr17:33,506,289...33,698,246
Ensembl chr17:33,506,338...33,693,289
G
F2rl1
F2R like trypsin receptor 1
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of F2RL1 mRNA]
CTD
PMID:31476115
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
Fez1
fasciculation and elongation protein zeta 1
multiple interactions increases expression
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of FEZ1 mRNA Aripiprazole results in increased expression of FEZ1 mRNA
CTD
PMID:31476115
NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683
G
Fn1
fibronectin 1
decreases expression
ISO
Aripiprazole results in decreased expression of FN1 mRNA
CTD
PMID:31476115
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
EXP
Aripiprazole results in decreased expression of HBEGF mRNA
CTD
PMID:17868501
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO
Aripiprazole binds to and affects the activity of HTR1A protein; Aripiprazole binds to and results in increased activity of HTR1A protein
CTD
PMID:17069544 PMID:21823597
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions decreases response to substance affects response to substance
ISO
Aripiprazole binds to and results in decreased activity of HTR2A protein; Aripiprazole binds to and results in increased activity of HTR2A protein; Aripiprazole inhibits the reaction [Ketanserin binds to HTR2A protein] HTR2A gene SNP results in decreased susceptibility to Aripiprazole HTR2A protein affects the susceptibility to Aripiprazole
CTD
PMID:16314884 PMID:21823597
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
multiple interactions
ISO
Aripiprazole binds to and affects the activity of HTR2C protein
CTD
PMID:21823597
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ICAM1 mRNA
CTD
PMID:31476115
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icam4
intercellular adhesion molecule 4, Landsteiner-Wiener blood group
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ICAM4 mRNA
CTD
PMID:31476115
NCBI chr 8:19,566,075...19,567,171
Ensembl chr 8:19,566,075...19,567,171
G
Icoslg
inducible T-cell co-stimulator ligand
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ICOSLG mRNA
CTD
PMID:31476115
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
G
Ifnb1
interferon beta 1
increases expression multiple interactions
ISO
Aripiprazole results in increased expression of IFNB1 mRNA Aripiprazole promotes the reaction [Ozone results in increased expression of IFNB1 mRNA]
CTD
PMID:31476115
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of IFNG mRNA
CTD
PMID:31476115
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IFNGR1 mRNA
CTD
PMID:31476115
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IKBKE mRNA
CTD
PMID:31476115
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Il11
interleukin 11
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL11 mRNA
CTD
PMID:31476115
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1A mRNA
CTD
PMID:31476115
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1B mRNA
CTD
PMID:31476115
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1R2 mRNA
CTD
PMID:31476115
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rap
interleukin 1 receptor accessory protein
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1RAP mRNA
CTD
PMID:31476115
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
G
Il1rapl2
interleukin 1 receptor accessory protein-like 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1RAPL2 mRNA
CTD
PMID:31476115
NCBI chr X:100,961,509...102,271,753
Ensembl chr X:100,961,812...102,271,753
G
Il1rl1
interleukin 1 receptor-like 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL1RL1 mRNA
CTD
PMID:31476115
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il23a
interleukin 23 subunit alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL23A mRNA
CTD
PMID:31476115
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il24
interleukin 24
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL24 mRNA
CTD
PMID:31476115
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il2rg
interleukin 2 receptor subunit gamma
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of IL2RG mRNA
CTD
PMID:31476115
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
G
Il4r
interleukin 4 receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL4R mRNA
CTD
PMID:31476115
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL5 mRNA
CTD
PMID:31476115
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL6 mRNA; Aripiprazole promotes the reaction [Ozone results in increased expression of IL6 mRNA]
CTD
PMID:31476115
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of IL7R mRNA
CTD
PMID:31476115
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Inpp5d
inositol polyphosphate-5-phosphatase D
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of INPP5D mRNA
CTD
PMID:31476115
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Irak2
interleukin-1 receptor-associated kinase 2
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of IRAK2 mRNA]
CTD
PMID:31476115
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Irf8
interferon regulatory factor 8
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of IRF8 mRNA
CTD
PMID:31476115
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Isg20
interferon stimulated exonuclease gene 20
increases expression multiple interactions
ISO
Aripiprazole results in increased expression of ISG20 mRNA [Aripiprazole co-treated with Ozone] results in increased expression of ISG20 mRNA
CTD
PMID:31476115
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itga2
integrin subunit alpha 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ITGA2 mRNA
CTD
PMID:31476115
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga5
integrin subunit alpha 5
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of ITGA5 mRNA
CTD
PMID:31476115
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Aripiprazole inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Aripiprazole results in decreased activity of KCNH2 protein
CTD
PMID:21158687 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
increases expression
EXP
Aripiprazole results in increased expression of KCNJ3 mRNA
CTD
PMID:17868501
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
G
Lif
LIF, interleukin 6 family cytokine
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LIF mRNA
CTD
PMID:31476115
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lrrn3
leucine rich repeat neuronal 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LRRN3 mRNA
CTD
PMID:31476115
NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330
G
Lta
lymphotoxin alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LTA mRNA
CTD
PMID:31476115
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Ltb
lymphotoxin beta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LTB mRNA
CTD
PMID:31476115
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of LYN mRNA
CTD
PMID:31476115
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Maob
monoamine oxidase B
increases expression
EXP
Aripiprazole results in increased expression of MAOB mRNA
CTD
PMID:17868501
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Mapk6
mitogen-activated protein kinase 6
increases expression
EXP
Aripiprazole results in increased expression of MAPK6 mRNA
CTD
PMID:17868501
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
G
Mapkapk2
MAPK activated protein kinase 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of MAPKAPK2 mRNA
CTD
PMID:31476115
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NFKB1 mRNA
CTD
PMID:31476115
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkb2
nuclear factor kappa B subunit 2
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of NFKB2 mRNA]
CTD
PMID:31476115
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NFKBIA mRNA
CTD
PMID:31476115
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NLRP3 mRNA
CTD
PMID:31476115
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nod2
nucleotide-binding oligomerization domain containing 2
multiple interactions increases expression
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NOD2 mRNA Aripiprazole results in increased expression of NOD2 mRNA
CTD
PMID:31476115
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Npdc1
neural proliferation, differentiation and control, 1
decreases expression
EXP
Aripiprazole results in decreased expression of NPDC1 mRNA
CTD
PMID:17868501
NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866
G
Nt5e
5' nucleotidase, ecto
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of NT5E mRNA
CTD
PMID:31476115
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Ntm
neurotrimin
decreases expression
EXP
Aripiprazole results in decreased expression of NTM mRNA
CTD
PMID:17868501
NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
G
Pdcd1lg2
programmed cell death 1 ligand 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PDCD1LG2 mRNA
CTD
PMID:31476115
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
G
Pdgfc
platelet derived growth factor C
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of PDGFC mRNA
CTD
PMID:31476115
NCBI chr 2:166,316,870...166,493,449
Ensembl chr 2:166,316,803...166,493,433
G
Pdp1
pyruvate dehydrogenase phosphatase catalytic subunit 1
increases expression
EXP
Aripiprazole results in increased expression of PDP1 mRNA
CTD
PMID:17868501
NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
G
Plau
plasminogen activator, urokinase
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PLAU mRNA
CTD
PMID:31476115
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PLAUR mRNA
CTD
PMID:31476115
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Pou2f2
POU class 2 homeobox 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of POU2F2 mRNA
CTD
PMID:31476115
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PRG2 mRNA
CTD
PMID:31476115
NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
G
Prkcd
protein kinase C, delta
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PRKCD mRNA
CTD
PMID:31476115
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prl
prolactin
multiple interactions increases secretion decreases secretion decreases expression
ISO EXP
Aripiprazole inhibits the reaction [haloperidol decanoate results in increased expression of PRL protein]; Aripiprazole inhibits the reaction [Risperidone results in increased secretion of PRL protein] Aripiprazole results in increased secretion of PRL protein Aripiprazole results in decreased secretion of PRL protein Aripiprazole inhibits the reaction [talipexole results in decreased secretion of PRL protein]; Haloperidol inhibits the reaction [Aripiprazole results in decreased secretion of PRL protein] Aripiprazole results in decreased expression of PRL protein
CTD
PMID:8613910 PMID:17873694 PMID:19230981 PMID:19519261 PMID:19653986 PMID:19906340 PMID:20814333 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prodh
proline dehydrogenase
decreases expression
EXP
Aripiprazole results in decreased expression of PRODH mRNA
CTD
PMID:17868501
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Psmc6
proteasome 26S subunit, ATPase 6
increases expression
EXP
Aripiprazole results in increased expression of PSMC6 mRNA
CTD
PMID:17868501
NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of PTGS2 mRNA
CTD
PMID:31476115
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pycard
PYD and CARD domain containing
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of PYCARD mRNA
CTD
PMID:31476115
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Rab3a
RAB3A, member RAS oncogene family
increases expression
EXP
Aripiprazole results in increased expression of RAB3A mRNA
CTD
PMID:17868501
NCBI chr16:18,684,185...18,688,297
Ensembl chr16:18,684,188...18,688,336
G
Rasd1
ras related dexamethasone induced 1
increases expression
EXP
Aripiprazole results in increased expression of RASD1 mRNA
CTD
PMID:17868501
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Relb
RELB proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of RELB mRNA
CTD
PMID:31476115
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rig1
RNA sensor RIG-1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of RIGI mRNA
CTD
PMID:31476115
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Sae1
SUMO1 activating enzyme subunit 1
increases expression
EXP
Aripiprazole results in increased expression of SAE1 mRNA
CTD
PMID:17868501
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
G
Sbno2
strawberry notch homolog 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SBNO2 mRNA
CTD
PMID:31476115
NCBI chr 7:9,605,572...9,649,529
Ensembl chr 7:9,605,627...9,649,527
G
Serpinb2
serpin family B member 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SERPINB2 mRNA
CTD
PMID:31476115
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Sh2b2
SH2B adaptor protein 2
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of SH2B2 mRNA
CTD
PMID:31476115
NCBI chr12:20,427,057...20,456,845
Ensembl chr12:20,429,043...20,456,844
G
Slamf6
SLAM family member 6
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SLAMF6 mRNA
CTD
PMID:31476115
NCBI chr13:84,384,561...84,405,300
Ensembl chr13:84,383,742...84,405,300
G
Slc6a4
solute carrier family 6 member 4
affects binding
ISO
Aripiprazole binds to SLC6A4 protein
CTD
PMID:21823597
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
EXP
Aripiprazole results in decreased expression of SLCO2B1 mRNA
CTD
PMID:17868501
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Slit3
slit guidance ligand 3
increases expression
EXP
Aripiprazole results in increased expression of SLIT3 mRNA
CTD
PMID:17868501
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
G
Smad3
SMAD family member 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SMAD3 mRNA
CTD
PMID:31476115
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Socs1
suppressor of cytokine signaling 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of SOCS1 mRNA
CTD
PMID:31476115
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Syt17
synaptotagmin 17
decreases expression multiple interactions
ISO
Aripiprazole results in decreased expression of SYT17 mRNA [Aripiprazole co-treated with Ozone] results in decreased expression of SYT17 mRNA
CTD
PMID:31476115
NCBI chr 1:172,695,275...172,761,906
Ensembl chr 1:172,696,120...172,761,960
G
Tab1
TGF-beta activated kinase 1/MAP3K7 binding protein 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TAB1 mRNA
CTD
PMID:31476115
NCBI chr 7:111,675,829...111,707,058
Ensembl chr 7:111,686,371...111,707,058
G
Tacr3
tachykinin receptor 3
decreases expression increases expression
EXP
Aripiprazole results in decreased expression of TACR3 mRNA Aripiprazole results in increased expression of TACR3 mRNA
CTD
PMID:17868501
NCBI chr 2:223,266,536...223,363,791
Ensembl chr 2:223,266,536...223,363,791
G
Thbd
thrombomodulin
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of THBD mRNA
CTD
PMID:31476115
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of THBS1 mRNA]
CTD
PMID:31476115
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Ticam1
TIR domain containing adaptor molecule 1
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TICAM1 mRNA
CTD
PMID:31476115
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
G
Tlr3
toll-like receptor 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TLR3 mRNA
CTD
PMID:31476115
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tlr5
toll-like receptor 5
increases expression multiple interactions
ISO
Aripiprazole results in increased expression of TLR5 mRNA [Aripiprazole co-treated with Ozone] results in decreased expression of TLR5 mRNA
CTD
PMID:31476115
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of TNF mRNA]
CTD
PMID:31476115
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFAIP3 mRNA
CTD
PMID:31476115
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf11b
TNF receptor superfamily member 11B
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in increased expression of TNFRSF11B mRNA]
CTD
PMID:31476115
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf12a
TNF receptor superfamily member 12A
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF12A mRNA
CTD
PMID:31476115
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf14
TNF receptor superfamily member 14
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TNFRSF14 mRNA
CTD
PMID:31476115
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfrsf1b
TNF receptor superfamily member 1B
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF1B mRNA
CTD
PMID:31476115
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tnfrsf22
tumor necrosis factor receptor superfamily, member 22
multiple interactions
ISO
Aripiprazole inhibits the reaction [Ozone results in decreased expression of TNFRSF10C mRNA]
CTD
PMID:31476115
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
G
Tnfrsf8
TNF receptor superfamily member 8
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF8 mRNA
CTD
PMID:31476115
NCBI chr 5:157,123,183...157,168,421
Ensembl chr 5:157,123,185...157,168,421
G
Tnfrsf9
TNF receptor superfamily member 9
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF9 mRNA
CTD
PMID:31476115
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TNFSF10 mRNA
CTD
PMID:31476115
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf12
TNF superfamily member 12
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in decreased expression of TNFSF12 mRNA
CTD
PMID:31476115
NCBI chr10:54,403,870...54,413,213
Ensembl chr10:54,403,870...54,413,213
G
Tnfsf15
TNF superfamily member 15
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF15 mRNA
CTD
PMID:31476115
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnfsf18
TNF superfamily member 18
multiple interactions
ISO
[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF18 mRNA
CTD
PMID:31476115
NCBI chr13:73,833,478...73,907,249
Ensembl chr13:73,831,252...73,843,169
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
EXP
Aripiprazole results in decreased expression of TUBB2A mRNA
CTD
PMID:17868501
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
Aripiprazole promotes the reaction [Ozone results in increased expression of VEGFA mRNA]
CTD
PMID:31476115
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Wee1
WEE1 G2 checkpoint kinase
increases expression
EXP
Aripiprazole results in increased expression of WEE1 mRNA
CTD
PMID:17868501
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Zfp354c
zinc finger protein 354C
increases expression
EXP
Aripiprazole results in increased expression of ZNF354C mRNA
CTD
PMID:17868501
NCBI chr10:35,129,720...35,145,717
Ensembl chr10:35,132,959...35,145,661
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity decreases expression
ISO
Asenapine results in decreased activity of CYP1A2 protein Asenapine results in decreased expression of CYP1A2 mRNA
CTD
PMID:32941854
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Azaperone results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Dhcr7
7-dehydrocholesterol reductase
decreases activity
ISO
cariprazine results in decreased activity of DHCR7 protein
CTD
PMID:29698737
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases expression
ISO EXP
[Chlorpromazine co-treated with Cholic Acids] affects the expression of ABCB11 mRNA Chlorpromazine results in decreased expression of ABCB11 mRNA; Chlorpromazine results in decreased expression of ABCB11 protein
CTD
PMID:27344345 PMID:27765674 PMID:28391356 PMID:35708773
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression decreases activity
ISO
Chlorpromazine analog results in increased expression of ABCB1 mRNA Chlorpromazine results in decreased activity of ABCB1 protein
CTD
PMID:15924885 PMID:16810505
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects activity
EXP
Chlorpromazine affects the activity of ABCB1B protein
CTD
PMID:12626638
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of ABCB4 mRNA
CTD
PMID:27344345
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcb6
ATP binding cassette subfamily B member 6
decreases expression
EXP
Chlorpromazine results in decreased expression of ABCB6 mRNA
CTD
PMID:25596134
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
G
Abcb9
ATP binding cassette subfamily B member 9
increases expression
EXP
Chlorpromazine results in increased expression of ABCB9 mRNA
CTD
PMID:25596134
NCBI chr12:32,499,213...32,531,932
Ensembl chr12:32,499,225...32,531,931
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression multiple interactions
EXP ISO
Chlorpromazine results in increased expression of ABCC2 mRNA [Bile Acids and Salts co-treated with Chlorpromazine] results in decreased expression of ABCC2 mRNA
CTD
PMID:27765674 PMID:35708773
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression multiple interactions decreases expression
ISO EXP
Chlorpromazine analog results in increased expression of ABCC3 mRNA [Bile Acids and Salts co-treated with Chlorpromazine] results in decreased expression of ABCC3 mRNA Chlorpromazine results in decreased expression of ABCC3 mRNA
CTD
PMID:15924885 PMID:25596134 PMID:35708773
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
increases expression
ISO
Chlorpromazine results in increased expression of ABCC4 mRNA
CTD
PMID:35708773
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Chlorpromazine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of ABCG8 mRNA
CTD
PMID:27344345
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Acaca
acetyl-CoA carboxylase alpha
decreases phosphorylation
EXP
Chlorpromazine results in decreased phosphorylation of ACACA protein
CTD
PMID:17512020
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Ace2
angiotensin converting enzyme 2
decreases expression
ISO
Chlorpromazine results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ache
acetylcholinesterase
decreases activity increases activity multiple interactions
ISO
Chlorpromazine results in decreased activity of ACHE protein Chlorpromazine results in increased activity of ACHE protein Dichlorvos promotes the reaction [Chlorpromazine results in decreased activity of ACHE protein]
CTD
PMID:4859365 PMID:29614332
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acp5
acid phosphatase 5, tartrate resistant
multiple interactions
ISO
Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]
CTD
PMID:21869564
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Adra1a
adrenoceptor alpha 1A
decreases activity
EXP
Chlorpromazine results in decreased activity of ADRA1A protein
CTD
PMID:23611293
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Adra1b
adrenoceptor alpha 1B
decreases activity
EXP
Chlorpromazine results in decreased activity of ADRA1B protein
CTD
PMID:23611293
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
G
Afp
alpha-fetoprotein
decreases expression
ISO
Chlorpromazine analog results in decreased expression of AFP mRNA
CTD
PMID:15924885
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agrn
agrin
decreases expression
EXP
Chlorpromazine results in decreased expression of AGRN mRNA
CTD
PMID:25596134
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
G
Ahr
aryl hydrocarbon receptor
affects activity
EXP
Chlorpromazine affects the activity of AHR protein
CTD
PMID:25596134
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ak3
adenylate kinase 3
decreases expression
EXP
Chlorpromazine results in decreased expression of AK3 mRNA
CTD
PMID:25596134
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation
EXP
Chlorpromazine results in decreased phosphorylation of AKT1 protein
CTD
PMID:17512020
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of ALDH1A1 mRNA
CTD
PMID:27344345
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
Chlorpromazine results in increased expression of ALDOA mRNA
CTD
PMID:25596134
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Alpp
alkaline phosphatase, placental
multiple interactions
ISO
Chlorpromazine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Chlorpromazine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]
CTD
PMID:16036225
NCBI chr 9:87,765,846...87,768,606
Ensembl chr 9:87,765,860...87,768,606
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
ISO
Chlorpromazine results in decreased expression of AP1S1 mRNA
CTD
PMID:17175557
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
G
Apoc4
apolipoprotein C4
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of APOC4 mRNA
CTD
PMID:27344345
NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
G
Apof
apolipoprotein F
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of APOF mRNA
CTD
PMID:27344345
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
G
Areg
amphiregulin
decreases expression
ISO
Chlorpromazine results in decreased expression of AREG mRNA
CTD
PMID:15924885 PMID:30703373
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arfgef2
ADP ribosylation factor guanine nucleotide exchange factor 2
increases expression
EXP
Chlorpromazine results in increased expression of ARFGEF2 mRNA
CTD
PMID:25596134
NCBI chr 3:155,547,504...155,633,652
Ensembl chr 3:155,547,538...155,630,856
G
Arhgef10
Rho guanine nucleotide exchange factor 10
decreases expression
EXP
Chlorpromazine results in decreased expression of ARHGEF10 mRNA
CTD
PMID:25596134
NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Chlorpromazine results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Chlorpromazine results in increased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atf4
activating transcription factor 4
affects activity multiple interactions
EXP ISO
Chlorpromazine affects the activity of ATF4 protein [Chlorpromazine co-treated with Cholic Acids] affects the expression of ATF4 mRNA
CTD
PMID:25596134 PMID:27344345
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atp6v1b2
ATPase H+ transporting V1 subunit B2
decreases expression
EXP
Chlorpromazine results in decreased expression of ATP6V1B2 protein
CTD
PMID:19441803
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
G
Avp
arginine vasopressin
increases expression multiple interactions
ISO EXP
Chlorpromazine results in increased expression of AVP protein Chlorpromazine inhibits the reaction [Lithium results in increased expression of AVP protein]
CTD
PMID:3567260 PMID:3976404
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
G
Bag4
BAG cochaperone 4
decreases expression
ISO
Chlorpromazine analog results in decreased expression of BAG4 mRNA
CTD
PMID:15924885
NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663
G
Bcl2l1
Bcl2-like 1
increases expression
ISO
Chlorpromazine results in increased expression of BCL2L1 mRNA
CTD
PMID:21683644
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
affects response to substance affects expression
ISO EXP
BDNF affects the susceptibility to Chlorpromazine Chlorpromazine affects the expression of BDNF mRNA
CTD
PMID:18408624 PMID:31324950
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bhlhe40
basic helix-loop-helix family, member e40
increases expression
ISO
Chlorpromazine analog results in increased expression of BHLHE40 mRNA
CTD
PMID:15924885
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression
ISO
Chlorpromazine results in decreased expression of BIRC2 mRNA
CTD
PMID:30703373
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
Chlorpromazine analog results in decreased expression of BIRC5 mRNA; Chlorpromazine results in decreased expression of BIRC5 mRNA
CTD
PMID:15924885 PMID:30703373
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bnip3
BCL2 interacting protein 3
increases expression
EXP
Chlorpromazine results in increased expression of BNIP3 mRNA
CTD
PMID:25596134
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Chlorpromazine analog results in increased expression of BTG2 mRNA
CTD
PMID:15924885
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btg3
BTG anti-proliferation factor 3
increases expression
ISO
Chlorpromazine analog results in increased expression of BTG3 mRNA
CTD
PMID:15924885
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
C3
complement C3
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of C3 mRNA
CTD
PMID:27344345
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C6
complement C6
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of C6 mRNA
CTD
PMID:27344345
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
Calcr
calcitonin receptor
multiple interactions
ISO
Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]
CTD
PMID:21869564
NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392
G
Calr
calreticulin
decreases expression
EXP
Chlorpromazine results in decreased expression of CALR mRNA
CTD
PMID:18246545
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Car2
carbonic anhydrase 2
multiple interactions
ISO
Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]
CTD
PMID:21869564
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Cat
catalase
multiple interactions decreases expression decreases activity
EXP ISO
carvedilol inhibits the reaction [Chlorpromazine results in decreased expression of CAT protein]; zolpidem inhibits the reaction [Chlorpromazine results in decreased activity of CAT]
CTD
PMID:12010767 PMID:17513028 PMID:25449126
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
Chlorpromazine results in decreased expression of CCN2 mRNA; Chlorpromazine results in decreased expression of CCN2 protein
CTD
PMID:30703373
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccn3
cellular communication network factor 3
affects expression
EXP
Chlorpromazine affects the expression of CCN3 mRNA
CTD
PMID:31324950
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
G
Ccnb2
cyclin B2
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CCNB2 mRNA; Chlorpromazine results in decreased expression of CCNB2 mRNA
CTD
PMID:15924885
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
decreases expression
EXP
Chlorpromazine results in decreased expression of CCND1 mRNA
CTD
PMID:17202759
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CCND3 mRNA
CTD
PMID:15924885
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccnf
cyclin F
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CCNF mRNA
CTD
PMID:15924885
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
G
Cd274
CD274 molecule
multiple interactions
ISO
Chlorpromazine inhibits the reaction [platycodin D results in decreased expression of and results in increased secretion of CD274 protein]
CTD
PMID:31150782
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd44
CD44 molecule
multiple interactions decreases expression
ISO
Chlorpromazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] Chlorpromazine results in decreased expression of CD44 protein
CTD
PMID:9929743 PMID:30703373
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd86
CD86 molecule
increases expression
ISO
Chlorpromazine results in increased expression of CD86 protein
CTD
PMID:19665512
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdk5
cyclin-dependent kinase 5
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CDK5 mRNA
CTD
PMID:15924885
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdk7
cyclin-dependent kinase 7
increases expression
ISO
Chlorpromazine analog results in increased expression of CDK7 mRNA
CTD
PMID:15924885
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
EXP
[EGR1 binds to CDKN1A promoter] promotes the reaction [Chlorpromazine results in increased expression of CDKN1A mRNA]; EGR1 promotes the reaction [Chlorpromazine results in increased expression of CDKN1A mRNA]
CTD
PMID:20368687
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CDKN2C mRNA
CTD
PMID:15924885
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Ces2h
carboxylesterase 2H
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of CES2 mRNA
CTD
PMID:27344345
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cfh
complement factor H
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of CFH mRNA
CTD
PMID:27344345
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cgref1
cell growth regulator with EF hand domain 1
decreases expression
EXP
Chlorpromazine results in decreased expression of CGREF1 mRNA
CTD
PMID:17202759
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
G
Chtf18
chromosome transmission fidelity factor 18
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CHTF18 mRNA
CTD
PMID:15924885
NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
EXP
Chlorpromazine results in decreased expression of CITED2 mRNA
CTD
PMID:18246545
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
ISO
Chlorpromazine analog results in decreased expression of CKS2 mRNA
CTD
PMID:15924885
NCBI chr17:13,570,611...13,575,770
G
Clcf1
cardiotrophin-like cytokine factor 1
increases expression
ISO
Chlorpromazine results in increased expression of CLCF1 mRNA
CTD
PMID:21683644
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
G
Col18a1
collagen type XVIII alpha 1 chain
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of COL18A1 mRNA
CTD
PMID:27344345
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Chlorpromazine results in increased expression of COL1A1 mRNA
CTD
PMID:35708773
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
EXP
Chlorpromazine results in decreased expression of COL4A1 mRNA
CTD
PMID:25596134
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Cort
cortistatin
affects expression
EXP
Chlorpromazine affects the expression of CORT mRNA
CTD
PMID:31324950
NCBI chr 5:159,560,591...159,562,032
G
Cox8a
cytochrome c oxidase subunit 8A
affects expression increases expression
EXP
Chlorpromazine affects the expression of COX8A mRNA Chlorpromazine results in increased expression of COX8A mRNA
CTD
PMID:18246545
NCBI chr 1:204,402,118...204,404,439
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Chlorpromazine results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cth
cystathionine gamma-lyase
decreases expression
EXP
Chlorpromazine results in decreased expression of CTH mRNA
CTD
PMID:25596134
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctsk
cathepsin K
multiple interactions
ISO
Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]
CTD
PMID:21869564
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity decreases response to substance increases expression
ISO EXP
[Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Chlorpromazine results in decreased activity of CYP1A1 protein CYP1A1 protein results in decreased susceptibility to Chlorpromazine Chlorpromazine results in increased expression of CYP1A1 mRNA
CTD
PMID:17202759 PMID:18246545 PMID:18493746 PMID:25596134 PMID:26477383 PMID:29724254 PMID:33814510 More...
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions decreases response to substance increases expression increases oxidation affects expression decreases methylation
ISO EXP
[Chlorpromazine co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine; Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; CYP1A2 protein results in increased metabolism of and results in increased activity of Chlorpromazine CYP1A2 protein results in decreased susceptibility to Chlorpromazine Chlorpromazine results in increased expression of CYP1A2 mRNA CYP1A2 protein results in increased oxidation of Chlorpromazine Chlorpromazine affects the expression of CYP1A2 mRNA CYP1A2 protein results in decreased methylation of Chlorpromazine
CTD
PMID:18246545 PMID:18493746 PMID:19482014 PMID:20615392 PMID:23397584 PMID:25596134 PMID:26477383 PMID:27344345 More...
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases response to substance decreases activity multiple interactions
ISO
CYP1B1 protein results in decreased susceptibility to Chlorpromazine Chlorpromazine results in decreased activity of CYP1B1 protein [Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA]
CTD
PMID:26477383 PMID:29724254 PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions decreases response to substance
ISO
[Chlorpromazine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; Chlorpromazine inhibits the reaction [Androstenols inhibits the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]] NR1I3 protein affects the reaction [Chlorpromazine results in increased expression of CYP2B10 mRNA] CYP2B6 protein results in decreased susceptibility to Chlorpromazine
CTD
PMID:10037683 PMID:12049174 PMID:17041008 PMID:26477383
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression decreases response to substance
EXP ISO
Chlorpromazine results in decreased expression of CYP2C mRNA; Chlorpromazine results in decreased expression of CYP2C11 mRNA CYP2C18 protein results in decreased susceptibility to Chlorpromazine
CTD
PMID:18246545 PMID:26477383
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions decreases response to substance decreases activity affects methylation
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine CYP2C19 protein results in decreased susceptibility to Chlorpromazine Chlorpromazine results in decreased activity of CYP2C19 protein CYP2C19 protein affects the methylation of Chlorpromazine
CTD
PMID:15135088 PMID:20615392 PMID:23397584 PMID:26477383
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases response to substance
ISO
CYP2C8 protein results in decreased susceptibility to Chlorpromazine
CTD
PMID:26477383
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions decreases response to substance
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine; CYP2D6 protein results in increased metabolism of and results in increased activity of Chlorpromazine CYP2D6 protein results in decreased susceptibility to Chlorpromazine
CTD
PMID:19482014 PMID:23397584 PMID:26477383
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity decreases response to substance
ISO
Chlorpromazine results in decreased activity of CYP2E1 protein CYP2E1 protein results in decreased susceptibility to Chlorpromazine
CTD
PMID:15135088 PMID:26477383
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
affects methylation affects oxidation multiple interactions decreases response to substance decreases activity
ISO
CYP3A4 protein affects the methylation of Chlorpromazine CYP3A4 protein affects the oxidation of Chlorpromazine [Chlorpromazine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine CYP3A4 protein results in decreased susceptibility to Chlorpromazine Chlorpromazine results in decreased activity of CYP3A4 protein
CTD
PMID:15135088 PMID:17041008 PMID:20615392 PMID:23397584 PMID:26477383
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases response to substance
ISO
CYP3A5 protein results in decreased susceptibility to Chlorpromazine
CTD
PMID:26477383
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of CYP8B1 mRNA
CTD
PMID:27344345
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dao
D-amino-acid oxidase
decreases activity
ISO
Chlorpromazine results in decreased activity of DAO protein
CTD
PMID:18615285
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
G
Dcstamp
dendrocyte expressed seven transmembrane protein
multiple interactions
ISO
Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]
CTD
PMID:21869564
NCBI chr 7:70,807,455...70,822,067
Ensembl chr 7:70,807,581...70,822,078
G
Ddit3
DNA-damage inducible transcript 3
increases expression
EXP
Chlorpromazine results in increased expression of DDIT3 mRNA
CTD
PMID:25596134
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Chlorpromazine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Drd1
dopamine receptor D1
decreases activity
ISO
Chlorpromazine results in decreased activity of DRD1 protein
CTD
PMID:23611293
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
decreases response to substance decreases activity
ISO
DRD2 polymorphism results in decreased susceptibility to Chlorpromazine Chlorpromazine results in decreased activity of DRD2 protein
CTD
PMID:15694263 PMID:23611293
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dusp1
dual specificity phosphatase 1
increases expression affects expression
ISO
Chlorpromazine analog results in increased expression of DUSP1 mRNA Chlorpromazine affects the expression of DUSP1 mRNA
CTD
PMID:15924885 PMID:20843724
NCBI chr10:16,680,478...16,683,275
G
Dusp9
dual specificity phosphatase 9
decreases expression
ISO
Chlorpromazine analog results in decreased expression of DUSP9 mRNA
CTD
PMID:15924885
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
E2f1
E2F transcription factor 1
decreases expression
ISO
Chlorpromazine analog results in decreased expression of E2F1 mRNA
CTD
PMID:15924885
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Egr1
early growth response 1
increases expression multiple interactions
EXP
Chlorpromazine results in increased expression of EGR1 [EGR1 binds to CDKN1A promoter] promotes the reaction [Chlorpromazine results in increased expression of CDKN1A mRNA]; EGR1 promotes the reaction [Chlorpromazine results in increased expression of CDKN1A mRNA]; MAPK1 affects the reaction [Chlorpromazine results in increased expression of EGR1]; MAPK3 affects the reaction [Chlorpromazine results in increased expression of EGR1]
CTD
PMID:20368687
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif1
eukaryotic translation initiation factor 1
increases expression
EXP
Chlorpromazine results in increased expression of EIF1 mRNA
CTD
PMID:25596134
NCBI chr10:85,246,751...85,248,842
Ensembl chr10:85,246,764...85,427,327
G
Eno2
enolase 2
increases expression
EXP
Chlorpromazine results in increased expression of ENO2 mRNA
CTD
PMID:25596134
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
EXP
Chlorpromazine results in increased expression of ERO1A mRNA
CTD
PMID:25596134
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
F2
coagulation factor II, thrombin
decreases expression
ISO
Chlorpromazine analog results in decreased expression of F2 mRNA
CTD
PMID:15924885
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
Chlorpromazine results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fas
Fas cell surface death receptor
increases expression
ISO
Chlorpromazine analog results in increased expression of FAS mRNA
CTD
PMID:15924885
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbp1
fructose-bisphosphatase 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of FBP1 mRNA
CTD
PMID:27344345
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fbxo22
F-box protein 22
decreases expression
EXP
Chlorpromazine results in decreased expression of FBXO22 mRNA
CTD
PMID:25596134
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
G
Fech
ferrochelatase
decreases expression
EXP
Chlorpromazine results in decreased expression of FECH mRNA
CTD
PMID:25596134
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
G
Fetub
fetuin B
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of FETUB mRNA
CTD
PMID:27344345
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
G
Fga
fibrinogen alpha chain
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of FGA mRNA
CTD
PMID:27344345
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of FGF2 mRNA
CTD
PMID:27344345
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgfr1
Fibroblast growth factor receptor 1
decreases expression
ISO
Chlorpromazine analog results in decreased expression of FGFR1 mRNA
CTD
PMID:15924885
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
decreases expression
EXP
Chlorpromazine results in decreased expression of FGR mRNA
CTD
PMID:25596134
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Fkbp5
FKBP prolyl isomerase 5
multiple interactions
ISO
Chlorpromazine inhibits the reaction [Lipopolysaccharides results in decreased expression of FKBP5 protein]
CTD
PMID:21034739
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Chlorpromazine results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
Chlorpromazine affects the expression of FOS mRNA
CTD
PMID:20843724
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
affects expression
ISO
Chlorpromazine affects the expression of FOSB mRNA
CTD
PMID:20843724
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression affects expression
ISO
Chlorpromazine analog results in increased expression of FOSL1 mRNA Chlorpromazine affects the expression of FOSL1 mRNA
CTD
PMID:15924885 PMID:20843724
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
affects expression
ISO
Chlorpromazine affects the expression of FOSL2 mRNA
CTD
PMID:20843724
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Fth1
ferritin heavy chain 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of FTH1 mRNA
CTD
PMID:27344345
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression decreases activity multiple interactions
ISO EXP
Chlorpromazine analog results in decreased expression of G6PD mRNA Chlorpromazine results in decreased activity of G6PD protein [Taurine co-treated with coenzyme Q10] inhibits the reaction [Chlorpromazine results in decreased activity of G6PD protein]; coenzyme Q10 inhibits the reaction [Chlorpromazine results in decreased activity of G6PD protein]; Taurine inhibits the reaction [Chlorpromazine results in decreased activity of G6PD protein]
CTD
PMID:15924885 PMID:33548410
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gad1
glutamate decarboxylase 1
decreases methylation multiple interactions
ISO
Chlorpromazine results in decreased methylation of GAD1 promoter Valproic Acid promotes the reaction [Chlorpromazine results in decreased methylation of GAD1 promoter]
CTD
PMID:19110320
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gcgr
glucagon receptor
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of GCGR mRNA
CTD
PMID:27344345
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
Chlorpromazine results in decreased expression of GCLC mRNA
CTD
PMID:25596134
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gdf15
growth differentiation factor 15
increases expression
EXP
Chlorpromazine results in increased expression of GDF15 mRNA
CTD
PMID:25596134
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Chlorpromazine results in increased expression of GDPD3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
G
Gfap
glial fibrillary acidic protein
affects expression
EXP
Chlorpromazine affects the expression of GFAP mRNA
CTD
PMID:31324950
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gpnmb
glycoprotein nmb
increases expression
EXP
Chlorpromazine results in increased expression of GPNMB mRNA
CTD
PMID:25596134
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpt
glutamic--pyruvic transaminase
increases expression
EXP
Chlorpromazine results in increased expression of GPT protein
CTD
PMID:35722787
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsr
glutathione-disulfide reductase
decreases activity
EXP
Chlorpromazine results in decreased activity of GSR protein
CTD
PMID:6693892
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of GSTA1 mRNA
CTD
PMID:27344345
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Hif1a
hypoxia inducible factor 1 subunit alpha
affects activity
EXP
Chlorpromazine affects the activity of HIF1A protein
CTD
PMID:25596134
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
Chlorpromazine results in increased expression of HMGCR mRNA
CTD
PMID:17052361
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
Chlorpromazine results in increased expression of HMGCS1 mRNA
CTD
PMID:17052361
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
increases expression affects expression
ISO EXP
Chlorpromazine results in increased expression of HMOX1 mRNA Chlorpromazine affects the expression of HMOX1 mRNA
CTD
PMID:15924885 PMID:25596134 PMID:31324950
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpn
hepsin
increases expression
ISO
Chlorpromazine results in increased expression of HPN mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
G
Hspa2
heat shock protein family A (Hsp70) member 2
increases expression decreases expression
EXP
Chlorpromazine results in increased expression of HSPA2 mRNA Chlorpromazine results in decreased expression of HSPA2 mRNA; Chlorpromazine results in decreased expression of HSPA2 protein
CTD
PMID:36751017
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspb1
heat shock protein family B (small) member 1
increases expression decreases expression
EXP
Chlorpromazine results in increased expression of HSPB1 mRNA Chlorpromazine results in decreased expression of HSPB1 mRNA
CTD
PMID:36751017
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
EXP
Chlorpromazine results in increased expression of HSPD1 mRNA
CTD
PMID:36751017
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hspe1
heat shock protein family E (Hsp10) member 1
increases expression
EXP
Chlorpromazine results in increased expression of HSPE1 mRNA
CTD
PMID:36751017
NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
G
Ibsp
integrin-binding sialoprotein
decreases expression multiple interactions
EXP
Chlorpromazine results in decreased expression of IBSP mRNA herbimycin inhibits the reaction [Chlorpromazine results in decreased expression of IBSP mRNA]; U 0126 inhibits the reaction [Chlorpromazine results in decreased expression of IBSP mRNA]
CTD
PMID:16294319
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
G
Ifnb1
interferon beta 1
multiple interactions
ISO
Chlorpromazine promotes the reaction [PAM2-CSK4 results in increased expression of IFNB1 mRNA]
CTD
PMID:32796029
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
multiple interactions
ISO
[Chlorpromazine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA
CTD
PMID:29594315
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifnlr1
interferon, lambda receptor 1
increases expression
ISO
Chlorpromazine results in increased expression of IFNLR1 mRNA
CTD
PMID:21683644
NCBI chr 5:147,919,547...147,942,328
Ensembl chr 5:147,919,908...147,942,332
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
ISO
Chlorpromazine results in increased expression of IGFBP1 mRNA
CTD
PMID:15924885
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
increases expression
ISO
Chlorpromazine analog results in increased expression of IKBKG mRNA
CTD
PMID:15924885
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Chlorpromazine
CTD
PMID:19362101
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
decreases expression
ISO
Chlorpromazine results in decreased expression of IL1B mRNA
CTD
PMID:29594315
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
ISO
[Chlorpromazine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Chlorpromazine inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein]; Chlorpromazine inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11014349 PMID:29594315
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Chlorpromazine
CTD
PMID:19362101
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Chlorpromazine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Ins1
insulin 1
decreases secretion
EXP
Chlorpromazine results in decreased secretion of INS1 protein
CTD
PMID:18308779
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Insig2
insulin induced gene 2
decreases expression
EXP
Chlorpromazine results in decreased expression of INSIG2 mRNA
CTD
PMID:25596134
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Irs2
insulin receptor substrate 2
multiple interactions
EXP
Chlorpromazine results in decreased expression of and results in decreased phosphorylation of IRS2 protein; Chlorpromazine results in decreased expression of and results in increased degradation of IRS2 protein
CTD
PMID:17512020 PMID:18308779
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Chlorpromazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Chlorpromazine results in decreased activity of KCNH2 protein
CTD
PMID:15071359 PMID:21158687 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
decreases activity
EXP
Chlorpromazine results in decreased activity of KCNN2 protein
CTD
PMID:10915830
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Klf4
KLF transcription factor 4
multiple interactions decreases expression
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of KLF4 mRNA Chlorpromazine results in decreased expression of KLF4 mRNA
CTD
PMID:27344345 PMID:30703373
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klkb1
kallikrein B1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of KLKB1 mRNA
CTD
PMID:27344345
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
G
Kng1
kininogen 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of KNG1 mRNA
CTD
PMID:27344345
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Lats1
large tumor suppressor kinase 1
increases phosphorylation
ISO
Chlorpromazine results in increased phosphorylation of LATS1 protein
CTD
PMID:30703373
NCBI chr 1:2,160,411...2,193,640
Ensembl chr 1:2,160,411...2,193,640
G
Ldhc
lactate dehydrogenase C
decreases activity multiple interactions
EXP
Chlorpromazine results in decreased activity of LDHC protein [Taurine co-treated with coenzyme Q10] inhibits the reaction [Chlorpromazine results in decreased activity of LDHC protein]; coenzyme Q10 inhibits the reaction [Chlorpromazine results in decreased activity of LDHC protein]; Taurine inhibits the reaction [Chlorpromazine results in decreased activity of LDHC protein]
CTD
PMID:33548410
NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Chlorpromazine results in increased expression of LDLR mRNA
CTD
PMID:17052361
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
increases expression
EXP
Chlorpromazine results in increased expression of LEP protein
CTD
PMID:17512020
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lss
lanosterol synthase
increases expression
ISO
Chlorpromazine results in increased expression of LSS mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Map2
microtubule-associated protein 2
increases expression
EXP
Chlorpromazine results in increased expression of MAP2 mRNA
CTD
PMID:15079866
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO EXP
Chlorpromazine inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK1 protein] MAPK1 affects the reaction [Chlorpromazine results in increased expression of EGR1]
CTD
PMID:11014349 PMID:20368687
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
decreases expression
ISO
Chlorpromazine analog results in decreased expression of MAPK14 mRNA
CTD
PMID:15924885
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
decreases expression multiple interactions
ISO EXP
Chlorpromazine analog results in decreased expression of MAPK3 mRNA MAPK3 affects the reaction [Chlorpromazine results in increased expression of EGR1] Chlorpromazine inhibits the reaction [IL2 protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11014349 PMID:15924885 PMID:20368687
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
[Chlorpromazine co-treated with lipoteichoic acid] results in increased phosphorylation of MAPK8 protein; Chlorpromazine promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased phosphorylation of MAPK8 protein]; TIRAP gene mutant form inhibits the reaction [Chlorpromazine promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]]
CTD
PMID:23238562
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapkapk2
MAPK activated protein kinase 2
increases expression
EXP
Chlorpromazine results in increased expression of MAPKAPK2 mRNA
CTD
PMID:19441803
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
Chlorpromazine analog results in decreased expression of MCM3 mRNA
CTD
PMID:15924885
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
Chlorpromazine analog results in decreased expression of MCM5 mRNA
CTD
PMID:15924885
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mdm2
MDM2 proto-oncogene
increases expression
EXP
Chlorpromazine results in increased expression of MDM2 mRNA
CTD
PMID:25596134
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mitf
melanocyte inducing transcription factor
increases expression
ISO
Chlorpromazine results in increased expression of MITF protein
CTD
PMID:25449126
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
Chlorpromazine analog results in decreased expression of MKI67 mRNA
CTD
PMID:15924885
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]; Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]
CTD
PMID:25200491
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Msc
musculin
decreases expression
EXP
Chlorpromazine results in decreased expression of MSC mRNA
CTD
PMID:25596134
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
G
Msh2
mutS homolog 2
decreases expression
ISO
Chlorpromazine results in decreased expression of MSH2 mRNA
CTD
PMID:15924885
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
G
Mst1
macrophage stimulating 1
increases phosphorylation
ISO
Chlorpromazine results in increased phosphorylation of MST1 protein
CTD
PMID:30703373
NCBI chr 8:108,767,886...108,773,425
Ensembl chr 8:108,768,839...108,773,416
G
Mt1
metallothionein 1
increases expression
EXP
Chlorpromazine results in increased expression of MT1A mRNA
CTD
PMID:8128501
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mybl2
MYB proto-oncogene like 2
decreases expression
ISO
Chlorpromazine analog results in decreased expression of MYBL2 mRNA
CTD
PMID:15924885
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
Chlorpromazine results in decreased expression of MYC mRNA
CTD
PMID:30703373
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
EXP
Chlorpromazine results in increased expression of NAMPT mRNA
CTD
PMID:25596134
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nanog
Nanog homeobox
decreases expression
ISO
Chlorpromazine results in decreased expression of NANOG mRNA
CTD
PMID:30703373
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
decreases expression
EXP
Chlorpromazine results in decreased expression of NDUFS3 protein
CTD
PMID:19441803
NCBI chr 3:76,876,646...76,883,824
Ensembl chr 3:76,876,646...76,883,824
G
Nectin2
nectin cell adhesion molecule 2
multiple interactions
ISO
Chlorpromazine inhibits the reaction [Cadmium Chloride results in decreased expression of and affects the localization of NECTIN2 protein]
CTD
PMID:25046863
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
decreases expression
EXP
Chlorpromazine results in decreased expression of NEDD9 mRNA
CTD
PMID:25596134
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Nefh
neurofilament heavy chain
affects expression
EXP
Chlorpromazine affects the expression of NEFH mRNA
CTD
PMID:31324950
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions
ISO
Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]
CTD
PMID:21869564
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression affects activity
EXP
Chlorpromazine results in decreased expression of NFE2L2 mRNA Chlorpromazine affects the activity of NFE2L2 protein
CTD
PMID:25596134
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ninj1
ninjurin 1
increases expression
EXP
Chlorpromazine results in increased expression of NINJ1 mRNA
CTD
PMID:25596134
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nppb
natriuretic peptide B
increases expression
EXP
Chlorpromazine results in increased expression of NPPB protein
CTD
PMID:36751017
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Chlorpromazine results in increased expression of NR0B2 mRNA
CTD
PMID:17175557
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression
EXP
Chlorpromazine results in decreased expression of NR1H4 mRNA
CTD
PMID:27765674 PMID:28391356
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression multiple interactions
ISO
Chlorpromazine analog results in increased expression of NR1I2 mRNA [Chlorpromazine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD
PMID:15924885 PMID:17041008
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases activity increases expression multiple interactions
ISO
Chlorpromazine results in increased activity of NR1I3 protein Chlorpromazine results in increased expression of NR1I3 mRNA [Chlorpromazine co-treated with Cholic Acids] affects the expression of NR1I3 mRNA; [Chlorpromazine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; Chlorpromazine inhibits the reaction [Androstenols inhibits the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA]] NR1I3 protein affects the reaction [Chlorpromazine results in increased expression of CYP2B10 mRNA]; NR1I3 protein affects the reaction [Chlorpromazine results in increased expression of CYP3A11 mRNA]
CTD
PMID:10037683 PMID:12049174 PMID:12948398 PMID:17041008 PMID:22310298 PMID:27344345 More...
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
Chlorpromazine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]
CTD
PMID:16581232
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Chlorpromazine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Orc1
origin recognition complex, subunit 1
decreases expression
ISO
Chlorpromazine analog results in decreased expression of ORC1 mRNA
CTD
PMID:15924885
NCBI chr 5:123,324,273...123,348,375
Ensembl chr 5:123,324,315...123,348,375
G
Orm1
orosomucoid 1
affects binding multiple interactions
ISO
Chlorpromazine binds to ORM1 protein alternative form Chlorpromazine inhibits the reaction [Warfarin binds to ORM1 protein alternative form]
CTD
PMID:8946472
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Pdia2
protein disulfide isomerase family A, member 2
increases expression
ISO
Chlorpromazine analog results in increased expression of PDIA2 mRNA
CTD
PMID:15924885
NCBI chr10:15,215,824...15,218,937
Ensembl chr10:15,215,824...15,220,931
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
EXP
Chlorpromazine results in decreased expression of PDIA5 mRNA
CTD
PMID:25596134
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdk1
pyruvate dehydrogenase kinase 1
increases expression
EXP
Chlorpromazine results in increased expression of PDK1 mRNA
CTD
PMID:25596134
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pdk4
pyruvate dehydrogenase kinase 4
increases expression
EXP
Chlorpromazine results in increased expression of PDK4 mRNA
CTD
PMID:25596134
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Phyh
phytanoyl-CoA 2-hydroxylase
increases expression
ISO
Chlorpromazine results in increased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Pias1
protein inhibitor of activated STAT, 1
increases expression
ISO
Chlorpromazine results in increased expression of PIAS1 mRNA
CTD
PMID:21683644
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
increases expression
ISO
Chlorpromazine analog results in increased expression of PIM1 mRNA
CTD
PMID:15924885
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
G
Pir
pirin
decreases expression
EXP
Chlorpromazine results in decreased expression of PIR mRNA
CTD
PMID:25596134
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Plin2
perilipin 2
increases expression
EXP
Chlorpromazine results in increased expression of PLIN2 mRNA
CTD
PMID:25596134
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Pmepa1
prostate transmembrane protein, androgen induced 1
decreases expression
EXP
Chlorpromazine results in decreased expression of PMEPA1 mRNA
CTD
PMID:25596134
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pola1
DNA polymerase alpha 1, catalytic subunit
decreases expression
ISO
Chlorpromazine analog results in decreased expression of POLA1 mRNA
CTD
PMID:15924885
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
G
Pold4
DNA polymerase delta 4, accessory subunit
increases expression
ISO
Chlorpromazine analog results in increased expression of POLD4 mRNA
CTD
PMID:15924885
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
G
Pou5f1
POU class 5 homeobox 1
decreases expression
ISO
Chlorpromazine results in decreased expression of POU5F1 mRNA
CTD
PMID:30703373
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Pparg
peroxisome proliferator-activated receptor gamma
affects activity
EXP
Chlorpromazine affects the activity of PPARG protein
CTD
PMID:25596134
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
EXP
Chlorpromazine results in increased expression of PPP1R15A mRNA
CTD
PMID:25596134
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
decreases phosphorylation
EXP
Chlorpromazine results in decreased phosphorylation of PRKAA1 protein
CTD
PMID:17512020
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Prl
prolactin
increases expression
ISO
Chlorpromazine results in increased expression of PRL protein
CTD
PMID:718334 PMID:996201
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Rara
retinoic acid receptor, alpha
decreases expression
EXP
Chlorpromazine results in decreased expression of RARA mRNA
CTD
PMID:18246545
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rnd1
Rho family GTPase 1
decreases expression
EXP
Chlorpromazine results in decreased expression of RND1 mRNA
CTD
PMID:25596134
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnd3
Rho family GTPase 3
decreases expression
EXP
Chlorpromazine results in decreased expression of RND3 mRNA
CTD
PMID:25596134
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rnf121
ring finger protein 121
decreases expression
EXP
Chlorpromazine results in decreased expression of RNF121 mRNA
CTD
PMID:25596134
NCBI chr 1:156,377,368...156,439,936
Ensembl chr 1:156,377,364...156,446,826
G
Runx1
RUNX family transcription factor 1
increases expression
EXP
Chlorpromazine results in increased expression of RUNX1 mRNA
CTD
PMID:25596134
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Rxrg
retinoid X receptor gamma
affects response to substance
ISO
RXRG protein affects the susceptibility to Chlorpromazine
CTD
PMID:10336693
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
EXP
Chlorpromazine results in increased expression of SAT1 mRNA
CTD
PMID:25596134
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
Chlorpromazine results in increased expression of SC5D mRNA
CTD
PMID:17052361
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
Chlorpromazine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpinh1
serpin family H member 1
increases expression
ISO
Chlorpromazine results in increased expression of SERPINH1 mRNA
CTD
PMID:35708773
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Sesn1
sestrin 1
decreases expression
EXP
Chlorpromazine results in decreased expression of SESN1 mRNA
CTD
PMID:25596134
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sik1
salt-inducible kinase 1
decreases expression
EXP
Chlorpromazine results in decreased expression of SIK1 mRNA
CTD
PMID:25596134
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Slc10a1
solute carrier family 10 member 1
decreases expression increases expression
EXP ISO
Chlorpromazine results in decreased expression of SLC10A1 mRNA Chlorpromazine results in increased expression of SLC10A1 mRNA
CTD
PMID:27765674 PMID:28391356 PMID:35708773
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc12a8
solute carrier family 12, member 8
increases expression
EXP
Chlorpromazine results in increased expression of SLC12A8 mRNA
CTD
PMID:25596134
NCBI chr11:67,116,876...67,266,548
Ensembl chr11:67,116,877...67,266,834
G
Slc19a1
solute carrier family 19 member 1
multiple interactions decreases activity
EXP
Chlorpromazine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] Chlorpromazine results in decreased activity of SLC19A1 protein
CTD
PMID:17482559
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
G
Slc1a5
solute carrier family 1 member 5
increases expression
EXP
Chlorpromazine results in increased expression of SLC1A5 mRNA
CTD
PMID:25596134
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Chlorpromazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of SLC22A7 mRNA
CTD
PMID:27344345
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Chlorpromazine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc31a1
solute carrier family 31 member 1
multiple interactions
ISO
Chlorpromazine inhibits the reaction [Copper affects the localization of SLC31A1 protein]
CTD
PMID:12501239
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc3a2
solute carrier family 3 member 2
increases expression
EXP
Chlorpromazine results in increased expression of SLC3A2 mRNA
CTD
PMID:25596134
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc51b
SLC51 subunit beta
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of SLC51B mRNA
CTD
PMID:27344345
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slc6a6
solute carrier family 6 member 6
increases expression
EXP
Chlorpromazine results in increased expression of SLC6A6 mRNA
CTD
PMID:25596134
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
decreases expression
EXP
Chlorpromazine results in decreased expression of SLCO2B1 mRNA
CTD
PMID:25596134
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Sod1
superoxide dismutase 1
multiple interactions
EXP
Chlorpromazine inhibits the reaction [Copper inhibits the reaction [Trientine results in decreased activity of SOD1 protein]]
CTD
PMID:22362149
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sox2
SRY-box transcription factor 2
decreases expression
ISO
Chlorpromazine results in decreased expression of SOX2 mRNA
CTD
PMID:30703373
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
G
Spp1
secreted phosphoprotein 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of SPP1 mRNA
CTD
PMID:27344345
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spsb1
splA/ryanodine receptor domain and SOCS box containing 1
increases expression
EXP
Chlorpromazine results in increased expression of SPSB1 mRNA
CTD
PMID:25596134
NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
EXP
Chlorpromazine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of SRC protein]
CTD
PMID:29702141
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
Chlorpromazine results in increased cleavage of and results in increased activity of SREBF2 protein
CTD
PMID:17052361
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Strbp
spermatid perinuclear RNA binding protein
increases expression
EXP
Chlorpromazine results in increased expression of STRBP mRNA
CTD
PMID:25596134
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
G
Sts
steroid sulfatase
multiple interactions
ISO
Chlorpromazine inhibits the reaction [Tretinoin results in increased activity of STS protein]
CTD
PMID:16178010
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Tagln
transgelin
decreases expression
ISO
Chlorpromazine results in decreased expression of TAGLN mRNA
CTD
PMID:17175557
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tf
transferrin
affects localization
ISO
Chlorpromazine affects the localization of TF protein
CTD
PMID:12501239
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tfdp1
transcription factor Dp-1
decreases expression
ISO
Chlorpromazine analog results in decreased expression of TFDP1 mRNA
CTD
PMID:15924885
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
EXP
Chlorpromazine results in increased expression of TIPARP mRNA
CTD
PMID:25596134
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tirap
TIR domain containing adaptor protein
multiple interactions
ISO
TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased expression of TNF protein]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased phosphorylation of MAPK8 protein]; TIRAP gene mutant form inhibits the reaction [Chlorpromazine promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]]; TIRAP protein results in increased susceptibility to [Chlorpromazine co-treated with lipopolysaccharide, Escherichia coli O111 B4]; TIRAP protein results in increased susceptibility to [Chlorpromazine co-treated with lipoteichoic acid]
CTD
PMID:23238562
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
G
Tnf
tumor necrosis factor
decreases expression increases response to substance multiple interactions
ISO
Chlorpromazine analog results in decreased expression of TNF protein; Chlorpromazine results in decreased expression of TNF mRNA TNF protein results in increased susceptibility to Chlorpromazine [Chlorpromazine co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein; [Chlorpromazine co-treated with lipoteichoic acid] results in increased expression of TNF protein; Chlorpromazine inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride]; Chlorpromazine inhibits the reaction [hydroquinone results in increased expression of TNF protein]; pyrazolanthrone inhibits the reaction [TNF protein results in increased susceptibility to Chlorpromazine]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein]; TIRAP gene mutant form inhibits the reaction [[Chlorpromazine co-treated with lipoteichoic acid] results in increased expression of TNF protein] [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Chlorpromazine; Chlorpromazine results in decreased expression of and results in decreased activity of TNF protein
CTD
PMID:8550079 PMID:15052360 PMID:19362101 PMID:20371967 PMID:22414385 PMID:23238562 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip8
TNF alpha induced protein 8
increases expression
EXP
Chlorpromazine results in increased expression of TNFAIP8 mRNA
CTD
PMID:25596134
NCBI chr18:43,183,854...43,299,512
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf14
TNF receptor superfamily member 14
increases expression
ISO
Chlorpromazine analog results in increased expression of TNFRSF14 mRNA
CTD
PMID:15924885
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfsf11
TNF superfamily member 11
decreases activity multiple interactions
ISO
Chlorpromazine results in decreased activity of TNFSF11; Chlorpromazine results in decreased activity of TNFSF11 protein Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]; Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]; Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]
CTD
PMID:21869564
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Tp53
tumor protein p53
affects activity
EXP
Chlorpromazine affects the activity of TP53 protein
CTD
PMID:25596134
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trafd1
TRAF type zinc finger domain containing 1
decreases expression
EXP
Chlorpromazine results in decreased expression of TRAFD1 mRNA
CTD
PMID:25596134
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
Chlorpromazine results in decreased expression of TUBA1A mRNA
CTD
PMID:27015953
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Txn1
thioredoxin 1
decreases expression
EXP
Chlorpromazine results in decreased expression of TXN1 mRNA
CTD
PMID:25596134
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
multiple interactions
ISO
[Chlorpromazine co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA
CTD
PMID:27344345
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tyr
tyrosinase
increases expression
ISO
Chlorpromazine results in increased expression of TYR protein
CTD
PMID:25449126
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
Chlorpromazine analog results in decreased expression of UNG mRNA
CTD
PMID:15924885
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Unkl
unk like zinc finger
decreases expression
EXP
Chlorpromazine results in decreased expression of UNKL mRNA
CTD
PMID:25596134
NCBI chr10:14,206,125...14,252,226
Ensembl chr10:14,206,189...14,252,225
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
Chlorpromazine analog results in increased expression of VEGFA mRNA
CTD
PMID:15924885
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
increases expression
EXP
Chlorpromazine results in increased expression of VEGFB mRNA
CTD
PMID:25596134
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
G
Wars1
tryptophanyl-tRNA synthetase 1
increases expression
EXP
Chlorpromazine results in increased expression of WARS1 mRNA
CTD
PMID:25596134
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Chlorpromazine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Xbp1
X-box binding protein 1
affects activity decreases expression
EXP
Chlorpromazine affects the activity of XBP1 protein Chlorpromazine results in decreased expression of XBP1 mRNA
CTD
PMID:25596134
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
Chlorpromazine results in decreased expression of XPC mRNA
CTD
PMID:25596134
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
G
Xrcc4
X-ray repair cross complementing 4
decreases expression
ISO
Chlorpromazine results in decreased expression of XRCC4 mRNA
CTD
PMID:15924885
NCBI chr 2:20,948,464...21,197,705
Ensembl chr 2:20,951,200...21,197,808
G
Yap1
Yes1 associated transcriptional regulator
multiple interactions
ISO
Chlorpromazine results in decreased expression of and results in increased phosphorylation of and affects the localization of YAP1 protein
CTD
PMID:30703373
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Clopenthixol results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Aars1
alanyl-tRNA synthetase 1
increases expression
ISO
Clozapine results in increased expression of AARS1 protein
CTD
PMID:34122009
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Clozapine results in decreased activity of ABCB11 protein
CTD
PMID:22646477
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions decreases activity
EXP ISO
Clozapine inhibits the reaction [Bromocriptine results in increased expression of ABCB1 protein]; Clozapine inhibits the reaction [N-n-propylnorapomorphine results in increased expression of ABCB1 protein]; Clozapine inhibits the reaction [Quinpirole results in increased expression of ABCB1 protein] Clozapine results in decreased activity of ABCB1 protein
CTD
PMID:9111066 PMID:16810505
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
multiple interactions
EXP
Clozapine inhibits the reaction [Bromocriptine results in increased activity of ABCB1B promoter]; Clozapine inhibits the reaction [N-n-propylnorapomorphine results in increased activity of ABCB1B promoter]; Clozapine inhibits the reaction [Quinpirole results in increased activity of ABCB1B promoter]
CTD
PMID:9111066
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abce1
ATP binding cassette subfamily E member 1
increases expression
ISO
Clozapine results in increased expression of ABCE1 protein
CTD
PMID:34122009
NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
G
Abcg1
ATP binding cassette subfamily G member 1
increases expression
ISO
Clozapine results in increased expression of ABCG1 mRNA
CTD
PMID:17346280
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Clozapine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ablim2
actin binding LIM protein family, member 2
increases expression
ISO
Clozapine results in increased expression of ABLIM2 mRNA
CTD
PMID:17346280
NCBI chr14:74,865,409...74,990,334
Ensembl chr14:74,866,281...74,990,334
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
ISO
Clozapine results in increased expression of ACAT2 mRNA
CTD
PMID:17052361
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acot2
acyl-CoA thioesterase 2
increases expression
ISO
Clozapine results in increased expression of ACOT2 protein
CTD
PMID:34122009
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
G
Acot7
acyl-CoA thioesterase 7
decreases expression
ISO
Clozapine results in decreased expression of ACOT7 protein
CTD
PMID:34122009
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
G
Acox1
acyl-CoA oxidase 1
multiple interactions
EXP
[Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased activity of ACOX1 protein; [Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased expression of ACOX1 mRNA
CTD
PMID:23226405
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Actb
actin, beta
decreases expression
ISO
Clozapine results in decreased expression of ACTB protein
CTD
PMID:34122009
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actbl2
actin, beta-like 2
increases expression
ISO
Clozapine results in increased expression of ACTBL2 protein
CTD
PMID:34122009
NCBI chr 2:42,858,020...42,860,767
Ensembl chr 2:42,858,020...42,860,767
G
Actr3
actin related protein 3
decreases expression
ISO
Clozapine results in decreased expression of ACTR3 protein
CTD
PMID:34122009
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
G
Actr5
actin related protein 5
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of ACTR5 protein
CTD
PMID:34122009
NCBI chr 3:147,282,461...147,295,870
Ensembl chr 3:147,282,624...147,296,110
G
Adam1a
ADAM metallopeptidase domain 1a
decreases expression
EXP
Clozapine results in decreased expression of ADAM1A mRNA
CTD
PMID:16715494
NCBI chr12:35,017,433...35,020,300
Ensembl chr12:35,017,315...35,020,311
G
Adamts12
ADAM metallopeptidase with thrombospondin type 1 motif, 12
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of ADAMTS12 protein
CTD
PMID:34122009
NCBI chr 2:60,032,873...60,327,629
Ensembl chr 2:60,032,873...60,327,629
G
Adcy5
adenylate cyclase 5
affects response to substance multiple interactions
ISO
ADCY5 protein affects the susceptibility to Clozapine SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Clozapine]
CTD
PMID:12223546
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of ADH5 protein
CTD
PMID:34122009
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
G
Adipoq
adiponectin, C1Q and collagen domain containing
decreases expression increases expression multiple interactions
ISO EXP
Clozapine results in decreased expression of ADIPOQ protein Clozapine results in increased expression of ADIPOQ protein Clozapine results in increased expression of ADIPOQ mRNA Berberine inhibits the reaction [Clozapine results in increased expression of ADIPOQ mRNA]
CTD
PMID:17933447 PMID:18162013 PMID:20564506
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adora2a
adenosine A2a receptor
decreases expression
ISO
Clozapine results in decreased expression of ADORA2A mRNA
CTD
PMID:17266109
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Clozapine binds to and results in decreased activity of ADRA1A protein
CTD
PMID:16545797
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Agpat1
1-acylglycerol-3-phosphate O-acyltransferase 1
decreases expression
ISO
Clozapine results in decreased expression of AGPAT1 mRNA
CTD
PMID:14647396
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
G
Agt
angiotensinogen
multiple interactions
ISO
Clozapine inhibits the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]; Clozapine promotes the reaction [Raclopride promotes the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]]
CTD
PMID:11549694
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Aimp1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
increases expression
ISO
Clozapine results in increased expression of AIMP1 protein
CTD
PMID:34122009
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
G
Ak1
adenylate kinase 1
decreases expression
ISO
Clozapine results in decreased expression of AK1 protein
CTD
PMID:34122009
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
G
Akt1
AKT serine/threonine kinase 1
increases expression decreases expression increases phosphorylation
ISO EXP
Clozapine results in increased expression of AKT1 mRNA; Clozapine results in increased expression of AKT1 protein Clozapine results in decreased expression of AKT1 mRNA Clozapine results in increased phosphorylation of AKT1 protein
CTD
PMID:15860345 PMID:19440698
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
increases expression
EXP
Clozapine results in increased expression of AKT2 mRNA
CTD
PMID:15860345
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alb
albumin
multiple interactions affects binding
EXP ISO
Clozapine results in decreased expression of and results in decreased reduction of ALB protein Clozapine binds to ALB protein [[[stearic acid binds to ALB protein] which affects the susceptibility to Clozapine] which affects the reduction of Cysteine] which affects the activity of ALB protein; [[stearic acid binds to ALB protein] which affects the susceptibility to Clozapine] which affects the reduction of Cysteine; [stearic acid binds to ALB protein] which affects the susceptibility to Clozapine; stearic acid inhibits the reaction [Clozapine binds to ALB protein]
CTD
PMID:31400341
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
ISO
Clozapine results in increased expression of ALDH1A1 mRNA
CTD
PMID:17266109
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
Clozapine results in increased expression of ALDOA mRNA
CTD
PMID:15860345
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldob
aldolase, fructose-bisphosphate B
increases expression decreases expression
ISO
Clozapine results in increased expression of ALDOB protein Clozapine results in decreased expression of ALDOB protein
CTD
PMID:34122009 PMID:36482696
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Aldoc
aldolase, fructose-bisphosphate C
decreases expression increases expression
ISO EXP
Clozapine results in decreased expression of ALDOC mRNA Clozapine results in increased expression of ALDOC mRNA
CTD
PMID:15860345 PMID:16465460
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alpp
alkaline phosphatase, placental
multiple interactions
ISO
Clozapine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Clozapine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]
CTD
PMID:16036225
NCBI chr 9:87,765,846...87,768,606
Ensembl chr 9:87,765,860...87,768,606
G
Alyref
Aly/REF export factor
decreases expression
ISO
Clozapine results in decreased expression of ALYREF protein
CTD
PMID:34122009
NCBI chr10:105,871,424...105,875,076
Ensembl chr10:105,871,306...105,875,069
G
Anxa1
annexin A1
decreases expression
ISO
Clozapine results in decreased expression of ANXA1 protein
CTD
PMID:34122009
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa5
annexin A5
decreases expression
ISO
Clozapine results in decreased expression of ANXA5 protein
CTD
PMID:34122009
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Anxa6
annexin A6
decreases expression
ISO
Clozapine results in decreased expression of ANXA6 protein
CTD
PMID:34122009
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
ISO
Clozapine results in decreased expression of AP1S1 mRNA
CTD
PMID:17175557
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
G
Ap2b1
adaptor related protein complex 2 subunit beta 1
increases expression
EXP
Clozapine results in increased expression of AP2B1 mRNA
CTD
PMID:15860345
NCBI chr10:68,099,397...68,205,023
Ensembl chr10:68,099,547...68,205,013
G
Ap3b1
adaptor related protein complex 3 subunit beta 1
increases expression
ISO
Clozapine results in increased expression of AP3B1 protein
CTD
PMID:34122009
NCBI chr 2:25,600,069...25,800,937
Ensembl chr 2:25,600,040...25,800,935
G
Apoa5
apolipoprotein A5
affects response to substance
EXP
APOA5 gene polymorphism affects the susceptibility to Clozapine
CTD
PMID:17726453
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apod
apolipoprotein D
increases expression
ISO
Clozapine results in increased expression of APOD mRNA; Clozapine results in increased expression of APOD protein
CTD
PMID:11158250 PMID:14647396 PMID:17266109
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
App
amyloid beta precursor protein
increases expression
ISO
Clozapine results in increased expression of APP protein
CTD
PMID:36482696
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Arc
activity-regulated cytoskeleton-associated protein
decreases expression
EXP
Clozapine results in decreased expression of ARC mRNA
CTD
PMID:18208916
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Arhgef9
Cdc42 guanine nucleotide exchange factor 9
decreases expression
ISO
Clozapine results in decreased expression of ARHGEF9 mRNA
CTD
PMID:17266109
NCBI chr X:59,919,560...60,077,538
Ensembl chr X:59,920,870...60,077,513
G
Arl8a
ADP-ribosylation factor like GTPase 8A
decreases expression
ISO
Clozapine results in decreased expression of ARL8A protein
CTD
PMID:34122009
NCBI chr13:46,585,845...46,594,851
Ensembl chr13:46,585,845...46,594,851
G
Armt1
acidic residue methyltransferase 1
increases expression
ISO
Clozapine results in increased expression of ARMT1 protein
CTD
PMID:34122009
NCBI chr 1:40,894,558...40,918,302
Ensembl chr 1:40,894,550...40,918,302
G
Arpc4
actin related protein 2/3 complex, subunit 4
affects expression
ISO
Clozapine affects the expression of ARPC4 mRNA
CTD
PMID:14647396
NCBI chr 4:146,522,255...146,532,784
Ensembl chr 4:146,522,176...146,532,785
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Clozapine results in increased expression of ASAH1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Clozapine results in increased expression of ASNS mRNA; Clozapine results in increased expression of ASNS protein
CTD
PMID:15342952 PMID:17175557 PMID:36482696
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Asph
aspartate-beta-hydroxylase
increases expression
ISO
Clozapine results in increased expression of ASPH protein
CTD
PMID:34122009
NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876
G
Ass1
argininosuccinate synthase 1
increases expression
ISO
Clozapine results in increased expression of ASS1 protein
CTD
PMID:34122009
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atad3a
ATPase family, AAA domain containing 3A
decreases expression
ISO
Clozapine results in decreased expression of ATAD3A protein
CTD
PMID:34122009
NCBI chr 5:166,350,302...166,370,492
Ensembl chr 5:166,350,304...166,370,482
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
increases expression
ISO
Clozapine results in increased expression of ATP2A3 protein
CTD
PMID:34122009
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp5f1b
ATP synthase F1 subunit beta
decreases expression
EXP
Clozapine results in decreased expression of ATP5F1B protein
CTD
PMID:19441803
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
G
Atp5pb
ATP synthase peripheral stalk-membrane subunit b
increases expression
ISO
Clozapine results in increased expression of ATP5F1 protein
CTD
PMID:34122009
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
G
Atp6v1a
ATPase H+ transporting V1 subunit A
decreases expression
ISO
Clozapine results in decreased expression of ATP6V1A protein
CTD
PMID:34122009
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
G
Atp6v1b1
ATPase H+ transporting V1 subunit B1
decreases expression
ISO
Clozapine results in decreased expression of ATP6V1B1 protein
CTD
PMID:34122009
NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475
G
Atp6v1b2
ATPase H+ transporting V1 subunit B2
decreases expression
EXP ISO
Clozapine results in decreased expression of ATP6V1B2 protein
CTD
PMID:19441803 PMID:34122009
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
G
Atxn10
ataxin 10
increases expression
ISO
Clozapine results in increased expression of ATXN10 protein
CTD
PMID:34122009
NCBI chr 7:116,441,768...116,565,093
Ensembl chr 7:116,441,613...116,565,087
G
Axin2
axin 2
decreases expression
EXP
Clozapine results in decreased expression of AXIN2 mRNA
CTD
PMID:16715494
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bace2
beta-secretase 2
increases expression
ISO
Clozapine results in increased expression of BACE2 protein
CTD
PMID:36482696
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions decreases expression
ISO EXP
Clozapine results in increased expression of BAX mRNA; Clozapine results in increased expression of BAX protein CSF3 protein inhibits the reaction [Clozapine results in increased expression of BAX mRNA] Clozapine results in decreased expression of BAX protein
CTD
PMID:16160616 PMID:17069804
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of BAZ1B protein
CTD
PMID:34122009
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
G
Bcar1
BCAR1 scaffold protein, Cas family member
decreases expression
ISO
Clozapine results in decreased expression of BCAR1 protein
CTD
PMID:34122009
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
G
Bcl2
BCL2, apoptosis regulator
increases expression
EXP
Clozapine results in increased expression of BCL2 mRNA; Clozapine results in increased expression of BCL2 protein
CTD
PMID:15126120
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l14
Bcl2-like 14
decreases expression
ISO
Clozapine results in decreased expression of BCL2L14 protein
CTD
PMID:34122009
NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086
G
Bdnf
brain-derived neurotrophic factor
decreases expression increases expression
EXP
Clozapine results in decreased expression of BDNF mRNA Clozapine results in increased expression of BDNF mRNA; Clozapine results in increased expression of BDNF protein
CTD
PMID:11488957 PMID:12478621 PMID:17442489
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
decreases expression
EXP
Clozapine results in decreased expression of BET1L mRNA
CTD
PMID:15860345
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
G
Bik
BCL2-interacting killer
multiple interactions increases expression
ISO
CSF3 protein inhibits the reaction [Clozapine results in increased expression of BIK mRNA]
CTD
PMID:16160616
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Bptf
bromodomain PHD finger transcription factor
decreases expression
ISO
Clozapine results in decreased expression of BPTF mRNA
CTD
PMID:14647396
NCBI chr10:91,980,279...92,082,731
Ensembl chr10:91,982,758...92,082,769
G
Bzw1
basic leucine zipper and W2 domains 1
increases expression
ISO
Clozapine results in increased expression of BZW1 protein
CTD
PMID:34122009
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
decreases expression
ISO EXP
Clozapine results in decreased expression of CACNA1A mRNA
CTD
PMID:14647396 PMID:16715494
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
G
Calcoco1
calcium binding and coiled coil domain 1
increases expression
ISO
Clozapine results in increased expression of CALCOCO1 protein
CTD
PMID:36482696
NCBI chr 7:133,834,705...133,849,515
Ensembl chr 7:133,834,707...133,849,422
G
Calm2
calmodulin 2
increases expression
EXP
Clozapine results in increased expression of CALM2 mRNA
CTD
PMID:19289156
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Calr
calreticulin
decreases expression
ISO
Clozapine results in decreased expression of CALR protein
CTD
PMID:34122009
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
decreases expression
ISO
Clozapine results in decreased expression of CALU protein
CTD
PMID:34122009
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
decreases expression increases expression
ISO EXP
Clozapine results in decreased expression of CAMK2A mRNA Clozapine results in increased expression of CAMK2A mRNA Clozapine results in decreased expression of CAMK2A protein
CTD
PMID:15860345 PMID:17266109 PMID:19289156
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
decreases expression
EXP
Clozapine results in decreased expression of CAMK2B mRNA
CTD
PMID:15860345
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
decreases expression
EXP
Clozapine results in decreased expression of CAMK2D mRNA
CTD
PMID:15860345
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Camk4
calcium/calmodulin-dependent protein kinase IV
increases expression decreases expression
EXP
Clozapine results in increased expression of CAMK4 mRNA Clozapine results in decreased expression of CAMK4 protein
CTD
PMID:15860345 PMID:19289156
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
G
Camkk1
calcium/calmodulin-dependent protein kinase kinase 1
decreases expression
EXP
Clozapine results in decreased expression of CAMKK1 protein
CTD
PMID:19289156
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
decreases expression
EXP
Clozapine results in decreased expression of CAMKK2 protein
CTD
PMID:19289156
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
G
Canx
calnexin
decreases expression
ISO
Clozapine results in decreased expression of CANX protein
CTD
PMID:34122009
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
Clozapine results in increased expression of CARS1 protein
CTD
PMID:34122009
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Cartpt
CART prepropeptide
decreases expression
EXP
Clozapine results in decreased expression of CARTPT mRNA
CTD
PMID:14696011
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
G
Casp1
caspase 1
increases activity
ISO
Clozapine results in increased activity of CASP1 protein
CTD
PMID:34935985
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases activity multiple interactions
ISO EXP
Clozapine results in increased activity of CASP3 protein Palmitic Acid promotes the reaction [Clozapine results in increased activity of CASP3 protein]
CTD
PMID:22700542 PMID:24709159
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity multiple interactions
ISO
Clozapine results in increased activity of CASP7 protein Palmitic Acid promotes the reaction [Clozapine results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cat
catalase
multiple interactions
ISO
Clozapine inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Clozapine inhibits the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]]
CTD
PMID:14730115
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccar1
cell division cycle and apoptosis regulator 1
increases expression
ISO
Clozapine results in increased expression of CCAR1 protein
CTD
PMID:34122009
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
G
Ccdc47
coiled-coil domain containing 47
increases expression multiple interactions
ISO
Clozapine results in increased expression of CCDC47 protein [Cuprizone co-treated with Clozapine] results in increased expression of CCDC47 protein
CTD
PMID:34122009
NCBI chr10:91,130,303...91,148,829
Ensembl chr10:91,130,303...91,148,881
G
Cck
cholecystokinin
multiple interactions increases expression
EXP
Clozapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CCK mRNA]; Clozapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CCK protein] Clozapine results in increased expression of CCK mRNA
CTD
PMID:10974607 PMID:16567023
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Cckbr
cholecystokinin B receptor
increases expression
ISO
Clozapine results in increased expression of CCKBR mRNA
CTD
PMID:17266109
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Ccl1
C-C motif chemokine ligand 1
decreases expression
ISO
Clozapine results in decreased expression of CCL1 mRNA
CTD
PMID:17346280
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
Ccnd1
cyclin D1
decreases expression
EXP
Clozapine results in decreased expression of CCND1 mRNA
CTD
PMID:15860345
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
increases expression
EXP
Clozapine results in increased expression of CCND3 mRNA
CTD
PMID:15860345
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccnl1
cyclin L1
increases expression
EXP
Clozapine results in increased expression of CCNL1 mRNA
CTD
PMID:15860345
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Cct7
chaperonin containing TCP1 subunit 7
decreases expression
ISO
Clozapine results in decreased expression of CCT7 protein
CTD
PMID:34122009
NCBI chr 4:117,989,232...118,006,478
Ensembl chr 4:117,989,232...118,006,580
G
Cd276
Cd276 molecule
decreases expression
ISO
Clozapine results in decreased expression of CD276 protein
CTD
PMID:34122009
NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
G
Cd63
Cd63 molecule
increases expression
ISO
Clozapine results in increased expression of CD63 protein
CTD
PMID:36482696
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
G
Cdipt
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
increases expression
ISO
Clozapine results in increased expression of CDIPT protein
CTD
PMID:34122009
NCBI chr 1:181,583,098...181,587,409
Ensembl chr 1:181,583,141...181,587,408
G
Cdk4
cyclin-dependent kinase 4
increases expression
EXP
Clozapine results in increased expression of CDK4 mRNA
CTD
PMID:15860345
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk5
cyclin-dependent kinase 5
increases expression
EXP
Clozapine results in increased expression of CDK5 mRNA
CTD
PMID:15860345
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
Clozapine results in increased expression of CDK5R1 mRNA
CTD
PMID:17266109
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA]; Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein] Clozapine results in increased expression of CEBPA mRNA; Clozapine results in increased expression of CEBPA protein
CTD
PMID:20564506
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cenpv
centromere protein V
increases expression
ISO
Clozapine results in increased expression of CENPV protein
CTD
PMID:34122009
NCBI chr10:47,214,479...47,228,552
Ensembl chr10:47,214,490...47,228,761
G
Cfap210
cilia and flagella associated protein 210
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of CFAP210 protein
CTD
PMID:34122009
NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607
G
Chchd2
coiled-coil-helix-coiled-coil-helix domain containing 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of CHCHD2 protein
CTD
PMID:34122009
NCBI chr12:26,828,738...26,834,762
Ensembl chr12:26,828,736...26,834,755
G
Chd4
chromodomain helicase DNA binding protein 4
decreases expression
ISO
Clozapine results in decreased expression of CHD4 protein
CTD
PMID:34122009
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
G
Chga
chromogranin A
decreases expression increases expression
EXP
Clozapine results in decreased expression of CHGA mRNA Clozapine results in increased expression of CHGA mRNA
CTD
PMID:12437575
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Chl1
cell adhesion molecule L1-like
decreases expression
ISO
Clozapine results in decreased expression of CHL1 mRNA
CTD
PMID:14647396
NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265
G
Chn1
chimerin 1
decreases expression
ISO
Clozapine results in decreased expression of CHN1 mRNA
CTD
PMID:14647396
NCBI chr 3:58,509,822...58,676,462
Ensembl chr 3:58,510,536...58,676,490
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
ISO
Clozapine results in increased expression of CHORDC1 protein
CTD
PMID:34122009
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
G
Chrm1
cholinergic receptor, muscarinic 1
affects binding increases expression multiple interactions
ISO EXP
Clozapine analog binds to CHRM1 protein; Clozapine binds to CHRM1 protein Clozapine results in increased expression of CHRM1 protein Clozapine inhibits the reaction [Dextroamphetamine results in decreased expression of CHRM1 protein]
CTD
PMID:11997696 PMID:16983399 PMID:18806925
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Ckap4
cytoskeleton-associated protein 4
increases expression
ISO
Clozapine results in increased expression of CKAP4 protein
CTD
PMID:34122009
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
G
Clic1
chloride intracellular channel 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of CLIC1 protein
CTD
PMID:34122009
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Clic4
chloride intracellular channel 4
increases expression
ISO
Clozapine results in increased expression of CLIC4 protein
CTD
PMID:34122009
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
G
Clock
clock circadian regulator
affects response to substance
ISO
CLOCK gene SNP affects the susceptibility to Clozapine
CTD
PMID:15331141
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
G
Clta
clathrin, light chain A
decreases expression
EXP
Clozapine results in decreased expression of CLTA mRNA
CTD
PMID:15860345
NCBI chr 5:58,244,253...58,263,480
Ensembl chr 5:58,245,442...58,263,472
G
Cltb
clathrin, light chain B
decreases expression
EXP
Clozapine results in decreased expression of CLTB mRNA
CTD
PMID:15860345
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
decreases expression increases expression
ISO
Clozapine results in decreased expression of CNP mRNA Clozapine results in decreased expression of CNP protein Clozapine results in increased expression of CNP mRNA
CTD
PMID:17266109 PMID:34122009
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Coil
coilin
increases expression
EXP
Clozapine results in increased expression of COIL mRNA
CTD
PMID:16715494
NCBI chr10:73,789,077...73,810,378
Ensembl chr10:73,789,488...73,810,393
G
Col5a2
collagen type V alpha 2 chain
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of COL5A2 protein
CTD
PMID:34122009
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Comt
catechol-O-methyltransferase
multiple interactions affects response to substance increases response to substance
EXP ISO
[tolcapone results in decreased activity of COMT protein] promotes the reaction [Clozapine results in increased abundance of Dopamine] COMT protein affects the susceptibility to Clozapine COMT gene polymorphism results in increased susceptibility to Clozapine
CTD
PMID:15190105 PMID:17123785
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cops3
COP9 signalosome subunit 3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of COPS3 protein
CTD
PMID:34122009
NCBI chr10:44,618,115...44,652,807
Ensembl chr10:44,618,115...44,641,597
G
Coro1b
coronin 1B
decreases expression
ISO
Clozapine results in decreased expression of CORO1B protein
CTD
PMID:34122009
NCBI chr 1:201,442,977...201,448,416
Ensembl chr 1:201,443,014...201,448,416
G
Cplx2
complexin 2
decreases expression
ISO
Clozapine results in decreased expression of CPLX2 mRNA
CTD
PMID:17266109
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
G
Cpn1
carboxypeptidase N subunit 1
increases expression
EXP
Clozapine results in increased expression of CPN1 mRNA
CTD
PMID:16715494
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
G
Cpne1
copine 1
decreases expression
ISO
Clozapine results in decreased expression of CPNE1 protein
CTD
PMID:34122009
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
G
Cpt2
carnitine palmitoyltransferase 2
multiple interactions
EXP
[Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased activity of CPT2 protein; [Clozapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased expression of CPT2 mRNA
CTD
PMID:23226405
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Creb1
cAMP responsive element binding protein 1
multiple interactions decreases phosphorylation
ISO
Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of CREB1 protein] Clozapine results in decreased phosphorylation of CREB1 protein
CTD
PMID:12871586
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Clozapine results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crhbp
corticotropin releasing hormone binding protein
decreases expression
EXP
Clozapine results in decreased expression of CRHBP mRNA
CTD
PMID:16715494
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
G
Crp
C-reactive protein
increases expression
ISO
Clozapine results in increased expression of CRP protein
CTD
PMID:17685758
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
CSF3 protein inhibits the reaction [Clozapine results in increased expression of BAX mRNA]; CSF3 protein inhibits the reaction [Clozapine results in increased expression of BIK mRNA]; CSF3 protein inhibits the reaction [Clozapine results in increased expression of TP53 mRNA]
CTD
PMID:16160616
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csnk2a1
casein kinase 2 alpha 1
decreases expression
EXP
Clozapine results in decreased expression of CSNK2A1 mRNA
CTD
PMID:16715494
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
G
Cst3
cystatin C
increases expression
ISO
Clozapine results in increased expression of CST3 mRNA
CTD
PMID:14647396
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cstf1
cleavage stimulation factor subunit 1
decreases expression
ISO
Clozapine results in decreased expression of CSTF1 protein
CTD
PMID:34122009
NCBI chr 3:161,144,522...161,156,294
Ensembl chr 3:161,144,548...161,156,300
G
Cstf2
cleavage stimulation factor subunit 2
decreases expression
ISO
Clozapine results in decreased expression of CSTF2 protein
CTD
PMID:34122009
NCBI chr X:97,253,559...97,279,476
Ensembl chr X:97,253,586...97,279,476
G
Ctbp1
C-terminal binding protein 1
increases expression
ISO
Clozapine results in increased expression of CTBP1 protein
CTD
PMID:34122009
NCBI chr14:77,455,580...77,482,821
Ensembl chr14:77,455,696...77,482,821
G
Ctnnb1
catenin beta 1
increases expression multiple interactions
EXP
Clozapine results in increased expression of CTNNB1 protein DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein]
CTD
PMID:16144542
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctrl
chymotrypsin-like
increases expression
EXP
Clozapine results in increased expression of CTRL mRNA
CTD
PMID:16715494
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
G
Ctsk
cathepsin K
increases expression
EXP
Clozapine results in increased expression of CTSK mRNA
CTD
PMID:16715494
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cttn
cortactin
increases expression
ISO
Clozapine results in increased expression of CTTN protein
CTD
PMID:34122009
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cul2
cullin 2
increases expression
ISO
Clozapine results in increased expression of CUL2 protein
CTD
PMID:34122009
NCBI chr17:54,169,093...54,210,197
Ensembl chr17:54,169,086...54,209,968
G
Cul3
cullin 3
increases expression
ISO
Clozapine results in increased expression of CUL3 protein
CTD
PMID:34122009
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
G
Cxcl1
C-X-C motif chemokine ligand 1
decreases expression decreases secretion multiple interactions increases secretion
ISO EXP
Clozapine results in decreased expression of CXCL1 mRNA Clozapine results in decreased secretion of CXCL1 protein belnacasan inhibits the reaction [Clozapine results in increased secretion of CXCL1 protein]
CTD
PMID:17346280 PMID:34935985 PMID:36482696
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
decreases secretion
ISO
Clozapine results in decreased secretion of CXCL10 protein
CTD
PMID:36482696
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression decreases secretion
ISO
Clozapine results in decreased expression of CXCL1 mRNA Clozapine results in decreased secretion of CXCL1 protein
CTD
PMID:17346280 PMID:36482696
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxhxorf49
similar to human chromosome X open reading frame 49
increases expression
ISO
Clozapine results in increased expression of CXORF49 protein
CTD
PMID:34122009
NCBI chr X:66,911,430...66,915,407
Ensembl chr X:66,911,431...66,915,293
G
Cyb5b
cytochrome b5 type B
increases expression
EXP
Clozapine results in increased expression of CYB5B mRNA
CTD
PMID:19441803
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
G
Cyb5r1
cytochrome b5 reductase 1
increases expression
ISO
Clozapine results in increased expression of CYB5R1 protein
CTD
PMID:34122009
NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity increases metabolic processing
EXP ISO
Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Clozapine results in decreased activity of CYP1A1 protein CYP1A1 protein results in increased metabolism of Clozapine
CTD
PMID:18493746 PMID:18809730 PMID:33814510
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases response to substance multiple interactions increases metabolic processing increases expression affects metabolic processing affects response to substance decreases metabolic processing
ISO EXP
CYP1A2 gene SNP results in decreased susceptibility to Clozapine Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CYP1A2 protein results in increased metabolism of Clozapine Clozapine results in increased expression of CYP1A2 mRNA CYP1A2 gene polymorphism affects the metabolism of Clozapine; CYP1A2 protein affects the metabolism of Clozapine; CYP1A2 protein polymorphism affects the metabolism of Clozapine [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine; [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine; Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; Smoke affects the reaction [CYP1A2 gene polymorphism affects the metabolism of Clozapine]; Smoke promotes the reaction [CYP1A2 protein results in increased metabolism of Clozapine] CYP1A2 gene SNP affects the susceptibility to Clozapine; CYP1A2 protein affects the susceptibility to Clozapine CYP1A2 gene SNP results in increased metabolism of Clozapine; CYP1A2 protein results in increased metabolism of Clozapine CYP1A2 gene SNP results in decreased metabolism of Clozapine
CTD
PMID:11151749 PMID:11763009 PMID:12919186 PMID:12969762 PMID:15206669 PMID:15286053 PMID:15883149 PMID:15949157 PMID:16044115 PMID:18493746 PMID:18809730 PMID:23397584 PMID:27320963 More...
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases metabolic processing decreases activity
ISO
CYP1B1 protein results in increased metabolism of Clozapine Clozapine results in decreased activity of CYP1B1 protein
CTD
PMID:18809730 PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions increases metabolic processing
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine CYP2C19 protein results in increased metabolism of Clozapine
CTD
PMID:18809730 PMID:23397584 PMID:27320963
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases metabolic processing
ISO
CYP2C8 protein results in increased metabolism of Clozapine
CTD
PMID:18809730 PMID:27320963
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing increases metabolic processing multiple interactions
ISO
CYP2D6 protein affects the metabolism of Clozapine CYP2D6 protein results in increased metabolism of Clozapine [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine
CTD
PMID:15286053 PMID:18809730 PMID:23397584 PMID:27320963
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
increases metabolic processing
ISO
CYP2J2 protein results in increased metabolism of Clozapine
CTD
PMID:18809730
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases metabolic processing affects metabolic processing multiple interactions
ISO
CYP3A4 protein results in increased metabolism of Clozapine CYP3A4 protein affects the metabolism of Clozapine [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine; Clozapine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Clozapine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]
CTD
PMID:15286053 PMID:18809730 PMID:21402137 PMID:23397584 PMID:27320963
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases metabolic processing
ISO
CYP3A5 protein results in increased metabolism of Clozapine
CTD
PMID:18809730
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Dab1
DAB adaptor protein 1
increases expression
EXP
Clozapine results in increased expression of DAB1 mRNA
CTD
PMID:19359144
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
G
Dab2
DAB adaptor protein 2
increases expression
ISO
Clozapine results in increased expression of DAB2 protein
CTD
PMID:36482696
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
G
Daglb
diacylglycerol lipase, beta
increases expression
ISO
Clozapine results in increased expression of DAGLB protein
CTD
PMID:36482696
NCBI chr12:11,059,732...11,102,170
Ensembl chr12:11,059,732...11,102,154
G
Dcaf6
DDB1 and CUL4 associated factor 6
decreases expression
ISO
Clozapine results in decreased expression of DCAF6 mRNA
CTD
PMID:14647396
NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512
G
Dclk1
doublecortin-like kinase 1
increases expression
ISO EXP
Clozapine results in increased expression of DCLK1 mRNA
CTD
PMID:15860345 PMID:18797397
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Ddc
dopa decarboxylase
multiple interactions increases expression
ISO
Clozapine results in increased expression of and results in increased activity of DDC protein Clozapine results in increased expression of DDC mRNA
CTD
PMID:16415089
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddx46
DEAD-box helicase 46
increases expression
ISO
Clozapine results in increased expression of DDX46 protein
CTD
PMID:34122009
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
G
Dennd10
DENN domain containing 10
increases expression
EXP
Clozapine results in increased expression of DENND10 mRNA
CTD
PMID:16715494
NCBI chr 1:259,950,955...259,974,459
Ensembl chr 1:259,950,866...259,974,455
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Clozapine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Dgcr6
DiGeorge syndrome critical region gene 6
decreases expression
ISO
Clozapine results in decreased expression of DGCR6 protein
CTD
PMID:34122009
NCBI chr11:82,927,725...82,932,823
Ensembl chr11:82,927,725...82,932,823
G
Dgka
diacylglycerol kinase, alpha
decreases expression
EXP
Clozapine results in decreased expression of DGKA mRNA
CTD
PMID:15860345
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
ISO
Clozapine results in increased expression of DHCR24 protein
CTD
PMID:34122009
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
increases expression
ISO
Clozapine results in increased expression of DHCR7 mRNA
CTD
PMID:17052361
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dhx30
DExH-box helicase 30
increases expression
ISO
Clozapine results in increased expression of DHX30 protein
CTD
PMID:34122009
NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381
G
Dhx38
DEAH-box helicase 38
decreases expression
ISO
Clozapine results in decreased expression of DHX38 protein
CTD
PMID:34122009
NCBI chr19:37,512,893...37,530,135
Ensembl chr19:37,512,891...37,530,140
G
Disc1
DISC1 scaffold protein
decreases response to substance affects response to substance
ISO
DISC1 gene mutant form results in decreased susceptibility to Clozapine DISC1 protein affects the susceptibility to Clozapine
CTD
PMID:20531374
NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778
G
Dlat
dihydrolipoamide S-acetyltransferase
decreases expression increases expression
EXP ISO
Clozapine results in decreased expression of DLAT mRNA Clozapine results in increased expression of DLAT protein
CTD
PMID:15860345 PMID:34122009
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
G
Dlg2
discs large MAGUK scaffold protein 2
increases expression
ISO
Clozapine results in increased expression of DLG2 protein
CTD
PMID:34122009
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
G
Dlst
dihydrolipoamide S-succinyltransferase
decreases expression
ISO
Clozapine results in decreased expression of DLST protein
CTD
PMID:34122009
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
G
Dnah11
dynein, axonemal, heavy chain 11
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of DNAH11 protein
CTD
PMID:34122009
NCBI chr 6:138,839,175...139,155,554
Ensembl chr 6:138,839,177...139,155,536
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of DNAJA3 protein
CTD
PMID:34122009
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
increases expression
ISO
Clozapine results in increased expression of DNAJB11 protein
CTD
PMID:34122009
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dpf1
double PHD fingers 1
affects expression
ISO
Clozapine affects the expression of DPF1 mRNA
CTD
PMID:14647396
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Dpp3
dipeptidylpeptidase 3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of DPP3 protein
CTD
PMID:34122009
NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541
G
Dpysl3
dihydropyrimidinase-like 3
decreases expression
ISO
Clozapine results in decreased expression of DPYSL3 protein
CTD
PMID:34122009
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
G
Dpysl4
dihydropyrimidinase-like 4
decreases expression
ISO
Clozapine results in decreased expression of DPYSL4 protein
CTD
PMID:34122009
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
G
Dr1
down-regulator of transcription 1
decreases expression
ISO
Clozapine results in decreased expression of DR1 protein
CTD
PMID:34122009
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
G
Drd1
dopamine receptor D1
affects binding decreases expression affects response to substance
ISO EXP
Clozapine binds to DRD1 protein Clozapine results in decreased expression of DRD1 mRNA Clozapine analog binds to DRD1 protein DRD1 gene polymorphism affects the susceptibility to Clozapine; DRD1 protein affects the susceptibility to Clozapine
CTD
PMID:1352677 PMID:9723970 PMID:11997696 PMID:17092969 PMID:17266109
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions affects binding affects response to substance decreases expression increases response to substance
ISO EXP
[Clozapine co-treated with DRD2 gene polymorphism] results in increased secretion of PRL protein Clozapine binds to DRD2 protein DRD2 protein affects the susceptibility to Clozapine Clozapine results in decreased expression of DRD2 mRNA Clozapine analog binds to DRD2 protein; Clozapine binds to DRD2 protein [Clozapine binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein; Bromocriptine promotes the reaction [Clozapine results in decreased expression of DRD2 mRNA]; Clozapine binds to and results in decreased activity of DRD2 protein; Clozapine promotes the reaction [Dopamine binds to DRD2 protein]; DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein]; DRD2 protein affects the reaction [Clozapine results in increased expression of DVL3 protein]; DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3A protein]; DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3B protein] [Clozapine co-treated with Bromocriptine] results in decreased expression of DRD2 mRNA Clozapine binds to DRD2 protein alternative form DRD2 gene SNP results in increased susceptibility to Clozapine DRD2 gene affects the susceptibility to Clozapine; DRD2 gene polymorphism affects the susceptibility to Clozapine
CTD
PMID:1352677 PMID:9723970 PMID:11997696 PMID:12476322 PMID:15286066 PMID:15716360 PMID:15781964 PMID:15830237 PMID:16033416 PMID:16144542 PMID:16278074 PMID:17266109 PMID:20375926 More...
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
affects response to substance multiple interactions decreases response to substance
ISO
DRD3 protein affects the susceptibility to Clozapine DRD3 protein affects the reaction [Clozapine results in increased expression of FOSB protein alternative form] DRD3 gene polymorphism results in decreased susceptibility to Clozapine
CTD
PMID:15579174 PMID:20029384
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Drd4
dopamine receptor D4
affects binding multiple interactions affects response to substance
ISO EXP
Clozapine binds to DRD4 protein Clozapine binds to Drd4 protein Clozapine inhibits the reaction [Dopamine results in increased activity of DRD4 protein] Clozapine analog binds to DRD4 protein DRD4 gene polymorphism affects the susceptibility to Clozapine
CTD RGD
PMID:11997696 PMID:16223700 PMID:31323226 PMID:8078498
RGD:7248459
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
G
Drp2
dystrophin related protein 2
increases expression
EXP
Clozapine results in increased expression of DRP2 mRNA alternative form
CTD
PMID:16715494
NCBI chr X:97,607,577...97,658,117
Ensembl chr X:97,607,719...97,655,684
G
Dtnbp1
dystrobrevin binding protein 1
increases response to substance affects response to substance
ISO
DTNBP1 gene polymorphism results in increased susceptibility to Clozapine DTNBP1 protein affects the susceptibility to Clozapine
CTD
PMID:19369910
NCBI chr17:19,685,218...19,776,668
Ensembl chr17:19,685,215...19,776,661
G
Dusp1
dual specificity phosphatase 1
decreases expression
EXP
Clozapine results in decreased expression of DUSP1 mRNA
CTD
PMID:15860345
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
decreases expression
EXP
Clozapine results in decreased expression of DUSP6 mRNA
CTD
PMID:15860345
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dvl3
dishevelled segment polarity protein 3
increases expression multiple interactions
EXP
Clozapine results in increased expression of DVL3 protein DRD2 protein affects the reaction [Clozapine results in increased expression of DVL3 protein]
CTD
PMID:16144542
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
G
Dync1li1
dynein cytoplasmic 1 light intermediate chain 1
decreases expression
ISO
Clozapine results in decreased expression of DYNC1LI1 protein
CTD
PMID:34122009
NCBI chr 8:114,376,649...114,410,297
Ensembl chr 8:114,376,662...114,410,934
G
Dync1li2
dynein, cytoplasmic 1 light intermediate chain 2
decreases expression
ISO
Clozapine results in decreased expression of DYNC1LI2 protein
CTD
PMID:34122009
NCBI chr19:531,783...554,670
Ensembl chr19:531,812...554,670
G
Edc4
enhancer of mRNA decapping 4
increases expression
ISO
Clozapine results in increased expression of EDC4 protein
CTD
PMID:34122009
NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
increases expression
ISO
Clozapine results in increased expression of EEF1A2 protein
CTD
PMID:34122009
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
G
Eef1d
eukaryotic translation elongation factor 1 delta
decreases expression
ISO
Clozapine results in decreased expression of EEF1D protein
CTD
PMID:34122009
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
G
Egr1
early growth response 1
decreases expression
EXP
Clozapine results in decreased expression of EGR1 mRNA; Clozapine results in decreased expression of EGR1 protein
CTD
PMID:17028028 PMID:18208916
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
affects expression decreases expression
ISO EXP
Clozapine affects the expression of EGR2 mRNA Clozapine results in decreased expression of EGR2 protein
CTD
PMID:17028028 PMID:19401217
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Egr3
early growth response 3
affects response to substance
ISO
EGR3 protein affects the susceptibility to Clozapine
CTD
PMID:17637609
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Eif2s3
eukaryotic translation initiation factor 2 subunit gamma
increases expression
ISO
Clozapine results in increased expression of EIF2S3 protein
CTD
PMID:34122009
NCBI chr X:58,916,513...58,939,923
Ensembl chr X:58,917,490...58,940,686
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of EIF3C protein
CTD
PMID:34122009
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
G
Eif3j
eukaryotic translation initiation factor 3, subunit J
increases expression
ISO
Clozapine results in increased expression of EIF3J protein
CTD
PMID:34122009
NCBI chr 3:108,985,103...109,007,341
Ensembl chr 3:108,985,118...109,007,953
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of EIF3M protein
CTD
PMID:34122009
NCBI chr 3:91,424,754...91,442,358
Ensembl chr 3:91,416,325...91,442,392
G
Eif4a3
eukaryotic translation initiation factor 4A3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of EIF4A3 protein
CTD
PMID:34122009
NCBI chr10:104,549,038...104,559,032
Ensembl chr10:104,549,038...104,559,057
G
Eif4e
eukaryotic translation initiation factor 4E
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of EIF4E protein
CTD
PMID:34122009
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
G
Eif5b
eukaryotic translation initiation factor 5B
increases expression
ISO
Clozapine results in increased expression of EIF5B protein
CTD
PMID:34122009
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
G
Eif6
eukaryotic translation initiation factor 6
decreases expression
ISO
Clozapine results in decreased expression of EIF6 protein
CTD
PMID:34122009
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Elk1
ETS transcription factor ELK1
decreases phosphorylation
ISO
Clozapine results in decreased phosphorylation of ELK1 protein
CTD
PMID:12871586
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Eno1
enolase 1
increases expression
EXP
Clozapine results in increased expression of ENO1 mRNA
CTD
PMID:15860345
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Eno3
enolase 3
increases expression
ISO
Clozapine results in increased expression of ENO3 protein
CTD
PMID:34122009
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Epha7
Eph receptor A7
increases expression
ISO
Clozapine results in increased expression of EPHA7 mRNA
CTD
PMID:17266109
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
G
Ephb3
Eph receptor B3
increases expression
ISO
Clozapine results in increased expression of EPHB3 protein
CTD
PMID:34122009
NCBI chr11:79,840,668...79,859,345
Ensembl chr11:79,840,668...79,859,370
G
Erap1
endoplasmic reticulum aminopeptidase 1
decreases expression
ISO
Clozapine results in decreased expression of ERAP1 protein
CTD
PMID:34122009
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
G
Erbb2
erb-b2 receptor tyrosine kinase 2
affects phosphorylation
EXP
Clozapine affects the phosphorylation of ERBB2 protein
CTD
PMID:26961615
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
multiple interactions
EXP
Clozapine results in increased expression of and results in increased phosphorylation of ERBB4 protein
CTD
PMID:26961615
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Erh
ERH, mRNA splicing and mitosis factor
increases expression
ISO
Clozapine results in increased expression of ERH protein
CTD
PMID:34122009
NCBI chr 6:100,280,933...100,291,200
Ensembl chr 6:100,280,930...100,291,210
G
Erp44
endoplasmic reticulum protein 44
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of ERP44 protein
CTD
PMID:34122009
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
G
Ewsr1
EWS RNA-binding protein 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of EWSR1 protein
CTD
PMID:34122009
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
G
Exosc4
exosome component 4
increases expression
ISO
Clozapine results in increased expression of EXOSC4 protein
CTD
PMID:34122009
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
G
Ezr
ezrin
decreases expression
ISO
Clozapine results in decreased expression of EZR protein
CTD
PMID:34122009
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
Clozapine results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fan1
FANCD2 and FANCI associated nuclease 1
increases expression
ISO
Clozapine results in increased expression of FAN1 protein
CTD
PMID:34122009
NCBI chr 1:117,915,323...117,945,044
Ensembl chr 1:117,917,099...117,944,977
G
Farsa
phenylalanyl-tRNA synthetase subunit alpha
increases expression
ISO
Clozapine results in increased expression of FARSA protein
CTD
PMID:34122009
NCBI chr19:23,291,409...23,300,985
Ensembl chr19:23,268,869...23,300,980
G
Farsb
phenylalanyl-tRNA synthetase subunit beta
increases expression
ISO
Clozapine results in increased expression of FARSB protein
CTD
PMID:34122009
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
G
Fas
Fas cell surface death receptor
multiple interactions
ISO
[Clozapine co-treated with Berberine] results in decreased expression of FAS mRNA
CTD
PMID:20564506
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
multiple interactions
ISO
[Clozapine analog co-treated with Hydrogen Peroxide] results in increased expression of FASLG mRNA; [Clozapine co-treated with Hydrogen Peroxide co-treated with Tretinoin] results in increased expression of FASLG mRNA
CTD
PMID:16510162
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fasn
fatty acid synthase
increases expression
ISO
Clozapine results in increased expression of FASN mRNA
CTD
PMID:16027736 PMID:17052361
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fdps
farnesyl diphosphate synthase
increases expression
ISO
Clozapine results in increased expression of FDPS mRNA
CTD
PMID:17052361
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fen1
flap structure-specific endonuclease 1
increases expression
ISO
Clozapine results in increased expression of FEN1 protein
CTD
PMID:34122009
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fgf2
fibroblast growth factor 2
increases expression
EXP
Clozapine results in increased expression of FGF2 mRNA
CTD
PMID:11264663
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgl1
fibrinogen-like 1
increases expression
ISO
Clozapine results in increased expression of FGL1 protein
CTD
PMID:36482696
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
G
Fhod1
formin homology 2 domain containing 1
decreases expression
ISO
Clozapine results in decreased expression of FHOD1 protein
CTD
PMID:34122009
NCBI chr19:33,206,492...33,225,448
Ensembl chr19:33,206,492...33,225,356
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
Clozapine results in decreased expression of FKBP8 protein
CTD
PMID:34122009
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
G
Flot2
flotillin 2
increases expression
ISO
Clozapine results in increased expression of FLOT2 protein
CTD
PMID:34122009
NCBI chr10:62,926,047...62,947,759
Ensembl chr10:62,920,665...62,947,756
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
increases metabolic processing
ISO
FMO1 protein results in increased metabolism of Clozapine
CTD
PMID:18809730
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases metabolic processing
ISO
FMO3 protein results in increased metabolism of Clozapine
CTD
PMID:18809730 PMID:27320963
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Clozapine results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression decreases expression
EXP ISO
Clozapine affects the reaction [Haloperidol results in increased expression of FOS protein]; Cycloserine promotes the reaction [Clozapine results in increased expression of FOS mRNA] Clozapine results in increased expression of FOS protein Clozapine analog results in increased expression of FOS protein; Clozapine results in increased expression of FOS mRNA; Clozapine results in increased expression of FOS protein Clozapine results in decreased expression of FOS protein
CTD
PMID:10435392 PMID:11166331 PMID:11440804 PMID:11997696 PMID:12093589 PMID:12243769 PMID:12464447 PMID:17028028 PMID:18208916 PMID:18521575 PMID:19695244 PMID:28272498 More...
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions decreases expression
ISO EXP
Clozapine results in increased expression of FOSB protein alternative form Clozapine results in increased expression of FOSB mRNA; Clozapine results in increased expression of FOSB protein DRD3 protein affects the reaction [Clozapine results in increased expression of FOSB protein alternative form] Clozapine results in decreased expression of FOSB mRNA
CTD
PMID:11259127 PMID:12093589 PMID:12243769 PMID:15579174 PMID:19695244
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
Clozapine results in increased expression of FOSL1 mRNA
CTD
PMID:18208916
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
EXP
Clozapine results in increased expression of FOSL2 mRNA
CTD
PMID:12093589 PMID:12243769
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxp2
forkhead box P2
increases expression
ISO
Clozapine results in increased expression of FOXP2 mRNA
CTD
PMID:17266109
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
G
Fstl1
follistatin-like 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of FSTL1 protein
CTD
PMID:34122009
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
G
Fubp1
far upstream element binding protein 1
increases expression
ISO
Clozapine results in increased expression of FUBP1 protein
CTD
PMID:34122009
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
G6pd
glucose-6-phosphate dehydrogenase
decreases expression
ISO
Clozapine results in decreased expression of G6PD protein
CTD
PMID:34122009
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gabarapl2
GABA type A receptor associated protein like 2
increases expression
ISO
Clozapine results in increased expression of GABARAPL2 protein
CTD
PMID:36482696
NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628 Ensembl chr 8:39,910,534...39,924,628
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
decreases expression
ISO
Clozapine results in decreased expression of GABBR1 mRNA
CTD
PMID:17266109
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
increases expression
ISO
Clozapine results in increased expression of GABRA1 mRNA
CTD
PMID:17266109
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
increases expression
EXP
Clozapine results in increased expression of GABRB3 mRNA
CTD
PMID:18923069
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
G
Gad1
glutamate decarboxylase 1
increases expression decreases methylation multiple interactions
ISO EXP
Clozapine results in increased expression of GAD1 mRNA Clozapine results in decreased methylation of GAD1 promoter Clozapine promotes the reaction [KMT2A protein binds to GAD1 promoter]; Valproic Acid promotes the reaction [Clozapine results in decreased methylation of GAD1 promoter]
CTD
PMID:12887421 PMID:15061247 PMID:17942719 PMID:18757738 PMID:18923069
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
increases expression
ISO EXP
Clozapine results in increased expression of GAD2 mRNA
CTD
PMID:17266109 PMID:18923069
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
EXP ISO
Clozapine results in increased expression of GAPDH mRNA Clozapine results in increased expression of GAPDH protein
CTD
PMID:15860345 PMID:34122009
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
increases expression
ISO
Clozapine results in increased expression of GART protein
CTD
PMID:34122009
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gatm
glycine amidinotransferase
increases expression
ISO
Clozapine results in increased expression of GATM protein
CTD
PMID:34122009
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gcc2
GRIP and coiled-coil domain containing 2
decreases expression
ISO
Clozapine results in decreased expression of GCC2 protein
CTD
PMID:34122009
NCBI chr20:26,247,394...26,293,613
Ensembl chr20:26,247,404...26,293,613
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Clozapine results in increased expression of GDF15 protein
CTD
PMID:36482696
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Clozapine results in increased expression of GDPD3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
G
Gfap
glial fibrillary acidic protein
decreases expression increases expression
EXP
Clozapine results in decreased expression of GFAP protein Clozapine results in increased expression of GFAP mRNA
CTD
PMID:18585900 PMID:19441803
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Ghitm
growth hormone inducible transmembrane protein
increases expression
ISO
Clozapine results in increased expression of GHITM protein
CTD
PMID:34122009
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
G
Gimap5
GTPase, IMAP family member 5
decreases expression
EXP
Clozapine results in decreased expression of GIMAP5 mRNA
CTD
PMID:16715494
NCBI chr 4:77,693,417...77,701,025
Ensembl chr 4:77,687,564...77,703,086
G
Gip
gastric inhibitory polypeptide
increases expression
EXP
Clozapine results in increased expression of GIP mRNA; Clozapine results in increased expression of GIP protein
CTD
PMID:16402076
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
G
Gja1
gap junction protein, alpha 1
increases expression
EXP
Clozapine results in increased expression of GJA1 protein
CTD
PMID:18585900
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glp1r
glucagon-like peptide 1 receptor
multiple interactions decreases expression
EXP
PGRMC1 protein inhibits the reaction [Clozapine results in decreased expression of GLP1R protein]
CTD
PMID:37087062
NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,972,004...9,010,241
G
Glrx3
glutaredoxin 3
increases expression
ISO
Clozapine results in increased expression of GLRX3 protein
CTD
PMID:34122009
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
G
Glul
glutamate-ammonia ligase
decreases expression
ISO
Clozapine results in decreased expression of GLUL protein
CTD
PMID:36482696
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gna12
G protein subunit alpha 12
decreases expression increases expression
EXP ISO
Clozapine results in decreased expression of GNA12 mRNA Clozapine results in increased expression of GNA12 protein
CTD
PMID:15860345 PMID:34122009
NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255
G
Gnai1
G protein subunit alpha i1
decreases expression
EXP
Clozapine results in decreased expression of GNAI1 mRNA
CTD
PMID:15860345
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnai2
G protein subunit alpha i2
decreases expression
EXP
Clozapine results in decreased expression of GNAI2 mRNA
CTD
PMID:15860345
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
decreases expression
EXP
Clozapine results in decreased expression of GNAI3 mRNA
CTD
PMID:15860345
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gnas
GNAS complex locus
decreases expression multiple interactions increases expression
EXP ISO
Clozapine results in decreased expression of GNAS mRNA [Cuprizone co-treated with Clozapine] results in decreased expression of GNAS protein Clozapine results in increased expression of GNAS protein
CTD
PMID:15860345 PMID:34122009
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnb3
G protein subunit beta 3
decreases response to substance increases expression affects response to substance increases response to substance
ISO EXP
GNB3 gene polymorphism results in decreased susceptibility to Clozapine Clozapine results in increased expression of GNB3 protein GNB3 protein affects the susceptibility to Clozapine GNB3 gene polymorphism results in increased susceptibility to Clozapine
CTD
PMID:16139171 PMID:16141801 PMID:18855531
NCBI chr 4:157,639,468...157,645,171
Ensembl chr 4:157,639,469...157,645,173
G
Golga3
golgin A3
increases expression
ISO
Clozapine results in increased expression of GOLGA3 protein
CTD
PMID:34122009
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509
G
Golgb1
golgin B1
increases expression
ISO
Clozapine results in increased expression of GOLGB1 protein
CTD
PMID:34122009
NCBI chr11:63,843,179...63,900,665
Ensembl chr11:63,843,986...63,900,770
G
Got2
glutamic-oxaloacetic transaminase 2
increases expression multiple interactions
EXP ISO
Clozapine results in increased expression of GOT2 mRNA [Cuprizone co-treated with Clozapine] results in increased expression of GOT2 protein
CTD
PMID:15860345 PMID:34122009
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
decreases expression
ISO
Clozapine results in decreased expression of GPD2 protein
CTD
PMID:34122009
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
G
Gpi
glucose-6-phosphate isomerase
increases expression
ISO
Clozapine results in increased expression of GPI protein
CTD
PMID:34122009
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
[Chloroquine co-treated with Clozapine] results in increased secretion of GPT protein
CTD
PMID:36482696
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
Clozapine results in increased expression of GPX1 mRNA
CTD
PMID:14647396
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
increases expression
EXP
Clozapine results in increased expression of GRIK2 mRNA
CTD
PMID:18923069
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
affects expression decreases expression
ISO EXP
Clozapine affects the expression of GRIK5 mRNA Clozapine results in decreased expression of GRIK5 mRNA
CTD
PMID:14647396 PMID:18923069
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression increases expression
ISO EXP
Clozapine results in decreased expression of GRIN1 mRNA Clozapine results in increased expression of GRIN1 mRNA
CTD
PMID:12020038 PMID:12608697 PMID:17266109 PMID:18923069
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
decreases expression
EXP
Clozapine results in decreased expression of GRIN2A mRNA
CTD
PMID:12608697 PMID:18923069
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
decreases expression
EXP
Clozapine results in decreased expression of GRIN2B mRNA
CTD
PMID:18923069
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
decreases expression
EXP
Clozapine results in decreased expression of GRIN2C mRNA
CTD
PMID:18923069
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grk6
G protein-coupled receptor kinase 6
decreases expression
EXP
Clozapine results in decreased expression of GRK6 mRNA
CTD
PMID:16715494
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
G
Gsk3a
glycogen synthase kinase 3 alpha
increases expression multiple interactions
EXP
Clozapine results in increased expression of GSK3A protein DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3A protein]
CTD
PMID:16144542
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
G
Gsk3b
glycogen synthase kinase 3 beta
increases phosphorylation increases expression multiple interactions
ISO EXP
Clozapine results in increased phosphorylation of GSK3B protein Clozapine results in increased expression of GSK3B protein DRD2 protein affects the reaction [Clozapine results in increased expression of GSK3B protein]
CTD
PMID:16144542 PMID:19359144 PMID:19440698
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsta1
glutathione S-transferase alpha 1
decreases activity increases glutathionylation
ISO
GSTA1 protein results in decreased activity of Clozapine GSTA1 protein results in increased glutathionylation of Clozapine
CTD
PMID:20849150
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gstm1
glutathione S-transferase mu 1
decreases activity increases expression increases glutathionylation
ISO EXP
GSTM1 protein results in decreased activity of Clozapine Clozapine results in increased expression of GSTM1 mRNA GSTM1 protein results in increased glutathionylation of Clozapine
CTD
PMID:15860345 PMID:20849150
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
decreases expression
EXP
Clozapine results in decreased expression of GSTM2 mRNA
CTD
PMID:15860345
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
decreases activity affects metabolic processing increases glutathionylation affects binding
ISO
Clozapine metabolite results in decreased activity of GSTP1 protein; GSTP1 protein results in decreased activity of Clozapine GSTP1 protein affects the metabolism of Clozapine metabolite GSTP1 protein results in increased glutathionylation of Clozapine Clozapine metabolite binds to GSTP1 protein
CTD
PMID:20849150 PMID:21639118 PMID:24185126
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
Clozapine results in increased expression of H1-2 protein
CTD
PMID:34122009
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H2ac18
H2A clustered histone 18
increases expression
ISO
Clozapine results in increased expression of H2AC18 mRNA
CTD
PMID:14647396
NCBI chr 2:183,808,398...183,808,992
G
H2ac20
H2A clustered histone 20
increases expression
ISO
Clozapine results in increased expression of H2AC20 protein
CTD
PMID:34122009
NCBI chr 2:183,779,879...183,780,357
G
H2aj
H2A.J histone
increases expression
ISO
Clozapine results in increased expression of H2AJ protein
CTD
PMID:34122009
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
G
Haao
3-hydroxyanthranilate 3,4-dioxygenase
decreases expression
ISO
Clozapine results in decreased expression of HAAO protein
CTD
PMID:36482696
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
increases expression
ISO
Clozapine results in increased expression of HACD3 protein
CTD
PMID:34122009
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
ISO
Clozapine results in increased expression of HADHB protein
CTD
PMID:34122009
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hars1
histidyl-tRNA synthetase 1
increases expression
ISO
Clozapine results in increased expression of HARS1 protein
CTD
PMID:34122009
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
G
Hat1
histone acetyltransferase 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of HAT1 protein
CTD
PMID:34122009
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
G
Hcls1
hematopoietic cell specific Lyn substrate 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of HCLS1 protein
CTD
PMID:34122009
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
G
Hdgfl2
HDGF like 2
increases expression
ISO
Clozapine results in increased expression of HDGFRP2 protein
CTD
PMID:34122009
NCBI chr 9:909,581...929,195
Ensembl chr 9:909,614...929,186
G
Higd1a
HIG1 hypoxia inducible domain family, member 1A
increases expression
ISO
Clozapine results in increased expression of HIGD1A mRNA
CTD
PMID:14647396
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
G
Hmgb2
high mobility group box 2
increases expression
ISO
Clozapine results in increased expression of HMGB2 protein
CTD
PMID:34122009
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions increases expression increases activity
ISO
[Clozapine results in increased activity of HMGCR protein] which results in increased abundance of Cholesterol; [Clozapine results in increased activity of HMGCR protein] which results in increased abundance of Triglycerides Clozapine results in increased expression of HMGCR mRNA
CTD
PMID:16027736 PMID:17052361
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
Clozapine results in increased expression of HMGCS1 mRNA
CTD
PMID:16027736 PMID:17052361
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
increases expression
ISO
Clozapine results in increased expression of HMOX1 mRNA
CTD
PMID:18227147
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpd
heterogeneous nuclear ribonucleoprotein D
decreases expression
ISO
Clozapine results in decreased expression of HNRNPD protein
CTD
PMID:34122009
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
G
Hnrnph2
heterogeneous nuclear ribonucleoprotein H2
decreases expression
ISO
Clozapine results in decreased expression of HNRNPH2 protein
CTD
PMID:36482696
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
G
Homer1
homer scaffold protein 1
increases expression multiple interactions
EXP
Clozapine results in increased expression of HOMER1 mRNA Cycloserine inhibits the reaction [Clozapine results in increased expression of HOMER1 mRNA]
CTD
PMID:12464447 PMID:15860345
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Hpcal1
hippocalcin-like 1
decreases expression
EXP
Clozapine results in decreased expression of HPCAL1 mRNA
CTD
PMID:12437575
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
G
Hpcal4
hippocalcin-like 4
affects expression
EXP
Clozapine affects the expression of HPCAL4 mRNA
CTD
PMID:12437575
NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416
G
Hpn
hepsin
increases expression
ISO
Clozapine results in increased expression of HPN mRNA
CTD
PMID:15342952
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
G
Hrh1
histamine receptor H 1
affects binding
ISO
Clozapine binds to HRH1 protein
CTD
PMID:16983399
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Hrh3
histamine receptor H3
multiple interactions
EXP
Clozapine binds to Hrh3 protein; Clozapine inhibits the reaction [N-methylhistamine binds to Hrh3 protein]
RGD
PMID:10869375
RGD:632981
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
decreases expression
ISO
Clozapine results in decreased expression of HSD17B10 protein
CTD
PMID:34122009
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Hsd17b12
hydroxysteroid (17-beta) dehydrogenase 12
increases expression
ISO
Clozapine results in increased expression of HSD17B12 protein
CTD
PMID:34122009
NCBI chr 3:79,990,048...80,113,556
Ensembl chr 3:79,990,056...80,113,617
G
Hspa9
heat shock protein family A (Hsp70) member 9
decreases expression
ISO
Clozapine results in decreased expression of HSPA9 protein
CTD
PMID:34122009
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions affects binding
ISO EXP
Clozapine binds to and affects the activity of HTR1A protein Clozapine binds to HTR1A protein
CTD
PMID:9723970 PMID:15482641
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr1d
5-hydroxytryptamine receptor 1D
decreases expression
EXP
Clozapine results in decreased expression of HTR1D mRNA
CTD
PMID:16715494
NCBI chr 5:148,656,252...148,676,532
Ensembl chr 5:148,674,495...148,675,619
G
Htr2a
5-hydroxytryptamine receptor 2A
increases response to substance affects binding multiple interactions decreases expression decreases activity affects response to substance increases expression
ISO EXP
HTR2A gene SNP results in increased susceptibility to Clozapine Clozapine analog binds to HTR2A protein; Clozapine binds to HTR2A protein Clozapine binds to and results in decreased activity of HTR2A protein; Clozapine inhibits the reaction [Ketanserin binds to HTR2A protein] Clozapine results in decreased expression of HTR2A mRNA; Clozapine results in decreased expression of HTR2A protein Clozapine results in decreased activity of HTR2A protein [[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein; [Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein]; Clozapine binds to and results in decreased activity of HTR2A protein; Clozapine promotes the reaction [Phencyclidine results in decreased activity of HTR2A protein] HTR2A protein affects the susceptibility to Clozapine Clozapine results in increased expression of HTR2A mRNA
CTD
PMID:7520908 PMID:9723970 PMID:11997696 PMID:14751426 PMID:15380371 PMID:15542763 PMID:16314884 PMID:16983399 PMID:17868938 PMID:18976543 PMID:20521326 More...
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding decreases expression affects response to substance
ISO EXP
Clozapine binds to HTR2C protein Clozapine results in decreased expression of HTR2C mRNA HTR2C gene polymorphism affects the susceptibility to Clozapine; HTR2C gene SNP affects the susceptibility to Clozapine; HTR2C promoter SNP affects the susceptibility to Clozapine; HTR2C protein affects the susceptibility to Clozapine
CTD
PMID:9723970 PMID:12668355 PMID:15635667 PMID:16983399 PMID:17868938 PMID:19142101 PMID:19142110 More...
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Htr3a
5-hydroxytryptamine receptor 3A
multiple interactions affects response to substance
ISO
Clozapine binds to and results in decreased activity of HTR3A protein HTR3A protein affects the susceptibility to Clozapine
CTD
PMID:19696922 PMID:20168265
NCBI chr 8:49,242,018...49,254,475
Ensembl chr 8:49,242,020...49,254,389
G
Htr6
5-hydroxytryptamine receptor 6
multiple interactions affects binding
ISO
Clozapine binds to and results in decreased activity of HTR6 protein [Cuprizone co-treated with Clozapine] results in increased expression of HTR6 protein Clozapine binds to HTR6 protein
CTD
PMID:11406289 PMID:16983399 PMID:34122009
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
G
Htr7
5-hydroxytryptamine receptor 7
affects binding multiple interactions
ISO
Clozapine binds to HTR7 protein [Clozapine binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP]; Clozapine inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]
CTD
PMID:14578406 PMID:20827463
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Id2
inhibitor of DNA binding 2
increases expression
EXP
Clozapine results in increased expression of ID2 mRNA
CTD
PMID:12437575
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of IDH2 protein
CTD
PMID:34122009
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Idi1
isopentenyl-diphosphate delta isomerase 1
decreases expression
ISO
Clozapine results in decreased expression of IDI1 protein
CTD
PMID:34122009
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ifng
interferon gamma
affects expression decreases expression
ISO
Clozapine affects the expression of IFNG protein Clozapine results in decreased expression of IFNG mRNA
CTD
PMID:17346280
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
increases expression
ISO
Clozapine results in increased expression of IFNGR1 protein
CTD
PMID:36482696
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
Clozapine results in decreased expression of IGF1 protein
CTD
PMID:11769361
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
ISO
Clozapine results in increased expression of IGFBP1 protein
CTD
PMID:36482696
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Il10
interleukin 10
decreases expression
EXP
Clozapine results in decreased expression of IL10 protein
CTD
PMID:24709159
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
increases secretion multiple interactions
EXP
Clozapine results in increased secretion of IL1B protein belnacasan inhibits the reaction [Clozapine results in increased secretion of IL1B protein]
CTD
PMID:34935985
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il2ra
interleukin 2 receptor subunit alpha
increases secretion
ISO
Clozapine results in increased secretion of IL2RA protein
CTD
PMID:8067274
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il5
interleukin 5
affects expression
ISO
Clozapine affects the expression of IL5 protein
CTD
PMID:17346280
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Ilkap
ILK associated serine/threonine phosphatase
decreases expression
EXP
Clozapine results in decreased expression of ILKAP mRNA
CTD
PMID:15860345
NCBI chr 9:91,966,440...91,988,791
Ensembl chr 9:91,966,441...91,988,892
G
Inha
inhibin subunit alpha
decreases expression
EXP
Clozapine results in decreased expression of INHA mRNA
CTD
PMID:16715494
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Clozapine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Ins2
insulin 2
affects secretion increases expression
ISO
Clozapine affects the secretion of INS protein Clozapine results in increased expression of INS protein
CTD
PMID:11769361 PMID:16601995
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Itga6
integrin subunit alpha 6
increases expression
ISO
Clozapine results in increased expression of ITGA6 protein
CTD
PMID:34122009
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Jak1
Janus kinase 1
increases expression
ISO
Clozapine results in increased expression of JAK1 protein
CTD
PMID:36482696
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
multiple interactions
EXP
[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein; [Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein]
CTD
PMID:18976543
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression increases expression
EXP
Clozapine results in decreased expression of JUN mRNA Clozapine results in increased expression of JUN mRNA
CTD
PMID:12093589 PMID:15860345 PMID:18208916
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Clozapine results in increased expression of JUNB mRNA
CTD
PMID:12093589 PMID:19695244
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Clozapine results in decreased expression of JUND mRNA
CTD
PMID:12093589
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kcna1
potassium voltage-gated channel subfamily A member 1
increases expression
ISO
Clozapine results in increased expression of KCNA1 mRNA
CTD
PMID:18797397
NCBI chr 4:159,464,223...159,472,905
Ensembl chr 4:159,464,188...159,472,682
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
Clozapine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:21158687
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnip3
potassium voltage-gated channel interacting protein 3
decreases expression increases expression
ISO
Clozapine results in decreased expression of KCNIP3 mRNA Clozapine results in increased expression of KCNIP3 mRNA
CTD
PMID:17266109 PMID:18797397
NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556
G
Kcnk2
potassium two pore domain channel subfamily K member 2
decreases expression
ISO
Clozapine results in decreased expression of KCNK2 mRNA
CTD
PMID:15542763
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kctd12
potassium channel tetramerization domain containing 12
decreases expression
ISO
Clozapine results in decreased expression of KCTD12 protein
CTD
PMID:34122009
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
G
Kdr
kinase insert domain receptor
increases expression
ISO
Clozapine results in increased expression of KDR protein
CTD
PMID:34122009
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Khdrbs1
KH RNA binding domain containing, signal transduction associated 1
decreases expression
ISO
Clozapine results in decreased expression of KHDRBS1 protein
CTD
PMID:34122009
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
G
Kif13b
kinesin family member 13B
increases expression
ISO
Clozapine results in increased expression of KIF13B protein
CTD
PMID:34122009
NCBI chr15:38,908,257...39,066,021
Ensembl chr15:38,924,624...39,084,879
G
Kif5c
kinesin family member 5C
decreases expression
ISO
Clozapine results in decreased expression of KIF5C protein
CTD
PMID:34122009
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
G
Kiz
kizuna centrosomal protein
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of KIZ protein
CTD
PMID:34122009
NCBI chr 3:134,277,631...134,385,260
Ensembl chr 3:134,277,687...134,385,190
G
Klhdc2
kelch domain containing 2
decreases expression
ISO
Clozapine results in decreased expression of KLHDC2 protein
CTD
PMID:34122009
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
G
Kmt2a
lysine methyltransferase 2A
increases expression decreases expression multiple interactions
ISO
Clozapine results in increased expression of KMT2A mRNA Clozapine results in decreased expression of KMT2A mRNA Clozapine promotes the reaction [KMT2A protein binds to GAD1 promoter]
CTD
PMID:14647396 PMID:17942719
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Kpna4
karyopherin subunit alpha 4
multiple interactions increases expression
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of KPNA4 protein Clozapine results in increased expression of KPNA4 protein
CTD
PMID:34122009
NCBI chr 2:153,319,380...153,381,085
Ensembl chr 2:153,324,273...153,381,081
G
Kremen1
kringle containing transmembrane protein 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of KREMEN1 protein
CTD
PMID:34122009
NCBI chr14:80,081,870...80,147,489
Ensembl chr14:80,084,403...80,147,516
G
Lactb2
lactamase, beta 2
increases expression
ISO
Clozapine results in increased expression of LACTB2 protein
CTD
PMID:34122009
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Lamp1
lysosomal-associated membrane protein 1
increases expression
ISO
Clozapine results in increased expression of LAMP1 protein
CTD
PMID:34122009
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
G
Lamtor3
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
increases expression
ISO
Clozapine results in increased expression of LAMTOR3 mRNA
CTD
PMID:14647396
NCBI chr 2:226,411,389...226,423,612
Ensembl chr 2:226,411,400...226,423,607
G
Larp7
La ribonucleoprotein 7, transcriptional regulator
increases expression
ISO
Clozapine results in increased expression of LARP7 protein
CTD
PMID:34122009
NCBI chr 2:215,997,641...216,012,833
Ensembl chr 2:215,997,649...216,012,865
G
Lcn1
lipocalin 1
decreases expression
ISO
Clozapine results in decreased expression of LCN1 protein
CTD
PMID:34122009
NCBI chr 3:9,532,860...9,537,859
Ensembl chr 3:9,532,915...9,536,577
G
Ldhb
lactate dehydrogenase B
increases expression
EXP
Clozapine results in increased expression of LDHB mRNA
CTD
PMID:15860345
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
G
Ldlr
low density lipoprotein receptor
increases expression multiple interactions
ISO
Clozapine results in increased expression of LDLR mRNA Berberine inhibits the reaction [Clozapine results in increased expression of LDLR mRNA]
CTD
PMID:17052361 PMID:20564506
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Leap2
liver enriched antimicrobial peptide 2
increases expression
ISO
Clozapine results in increased expression of LEAP2 mRNA
CTD
PMID:17346280
NCBI chr10:37,580,172...37,581,244
Ensembl chr10:37,577,855...37,581,244
G
Lemd2
LEM domain nuclear envelope protein 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of LEMD2 protein
CTD
PMID:34122009
NCBI chr20:5,282,397...5,296,621
Ensembl chr20:5,282,397...5,296,626
G
Lep
leptin
affects response to substance increases expression
ISO EXP
LEP protein affects the susceptibility to Clozapine Clozapine results in increased expression of LEP protein
CTD
PMID:16402076 PMID:17502770
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals8
galectin 8
increases expression
ISO
Clozapine results in increased expression of LGALS8 protein
CTD
PMID:36482696
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
G
Lipa
lipase A, lysosomal acid type
increases expression
ISO
Clozapine results in increased expression of LIPA protein
CTD
PMID:34122009
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Lmod2
leiomodin 2
increases expression
ISO
Clozapine results in increased expression of LMOD2 protein
CTD
PMID:34122009
NCBI chr 4:53,067,428...53,075,124
Ensembl chr 4:53,067,428...53,075,120
G
Lpl
lipoprotein lipase
decreases expression increases expression
ISO
Clozapine results in decreased expression of LPL mRNA; Clozapine results in decreased expression of LPL protein Clozapine results in increased expression of LPL mRNA
CTD
PMID:17266109 PMID:19682446
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrp10
LDL receptor related protein 10
increases expression
ISO
Clozapine results in increased expression of LRP10 protein
CTD
PMID:36482696
NCBI chr15:27,921,335...27,927,507
Ensembl chr15:27,920,259...27,927,505
G
Lrpprc
leucine-rich pentatricopeptide repeat containing
increases expression
ISO
Clozapine results in increased expression of LRPPRC protein
CTD
PMID:34122009
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
G
Lrrk2
leucine-rich repeat kinase 2
increases expression
ISO
Clozapine results in increased expression of LRRK2 protein
CTD
PMID:34122009
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
G
Lss
lanosterol synthase
increases expression multiple interactions
ISO
Clozapine results in increased expression of LSS mRNA [Cuprizone co-treated with Clozapine] results in decreased expression of LSS protein
CTD
PMID:15342952 PMID:17175557 PMID:34122009
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Lta4h
leukotriene A4 hydrolase
decreases expression
ISO
Clozapine results in decreased expression of LTA4H protein
CTD
PMID:34122009
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
G
Magt1
magnesium transporter 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of MAGT1 protein
CTD
PMID:34122009
NCBI chr X:71,038,489...71,079,704
Ensembl chr X:71,038,489...71,079,699
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
Clozapine results in decreased expression of MAL mRNA
CTD
PMID:17266109 PMID:18797397
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Maob
monoamine oxidase B
increases expression
ISO
Clozapine results in increased expression of MAOB mRNA
CTD
PMID:17266109
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map1a
microtubule-associated protein 1A
increases expression decreases expression
EXP ISO
Clozapine results in increased expression of MAP1A mRNA Clozapine results in decreased expression of MAP1A protein
CTD
PMID:15860345 PMID:34122009
NCBI chr 3:108,263,217...108,283,936
Ensembl chr 3:108,263,151...108,282,899
G
Map1b
microtubule-associated protein 1B
decreases expression
ISO
Clozapine results in decreased expression of MAP1B protein
CTD
PMID:34122009
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases lipidation multiple interactions
ISO
Clozapine results in increased lipidation of MAP1LC3B protein [Chloroquine co-treated with Clozapine] results in increased lipidation of MAP1LC3B protein
CTD
PMID:36482696
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map1s
microtubule-associated protein 1S
increases expression
ISO
Clozapine results in increased expression of MAP1S protein
CTD
PMID:34122009
NCBI chr16:18,516,759...18,527,777
Ensembl chr16:18,517,574...18,527,988
G
Map2k1
mitogen activated protein kinase kinase 1
decreases expression
EXP
Clozapine results in decreased expression of MAP2K1 mRNA
CTD
PMID:15860345
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Map2k2
mitogen activated protein kinase kinase 2
increases expression decreases expression
ISO EXP
Clozapine results in increased expression of MAP2K2 mRNA Clozapine results in decreased expression of MAP2K2 mRNA
CTD
PMID:14647396 PMID:15860345
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
EXP
Clozapine results in decreased expression of MAP2K5 mRNA
CTD
PMID:15860345
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
increases expression
EXP
Clozapine results in increased expression of MAP3K1 mRNA
CTD
PMID:15860345
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k12
mitogen activated protein kinase kinase kinase 12
increases expression
EXP
Clozapine results in increased expression of MAP3K12 mRNA
CTD
PMID:15860345
NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases expression decreases phosphorylation
ISO EXP
Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein] Clozapine results in decreased expression of MAPK1 mRNA Clozapine results in decreased phosphorylation of MAPK1 protein
CTD
PMID:12871586 PMID:15860345
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
affects expression
EXP
Clozapine affects the expression of MAPK14 mRNA
CTD
PMID:15860345
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation multiple interactions
ISO
Clozapine results in decreased phosphorylation of MAPK3 protein Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK3 protein]
CTD
PMID:12871586
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk6
mitogen-activated protein kinase 6
affects expression
EXP
Clozapine affects the expression of MAPK6 mRNA
CTD
PMID:15860345
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
G
Mapk8ip1
mitogen-activated protein kinase 8 interacting protein 1
increases expression
ISO
Clozapine results in increased expression of MAPK8IP1 mRNA
CTD
PMID:17266109
NCBI chr 3:78,355,051...78,372,946
Ensembl chr 3:78,355,048...78,372,884
G
Mapk9
mitogen-activated protein kinase 9
affects expression
EXP
Clozapine affects the expression of MAPK9 mRNA
CTD
PMID:15860345
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
decreases expression multiple interactions
ISO
Clozapine results in decreased expression of MAPRE1 protein [Cuprizone co-treated with Clozapine] results in decreased expression of MAPRE1 protein
CTD
PMID:34122009
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
decreases expression
EXP
Clozapine results in decreased expression of MAS1 mRNA
CTD
PMID:16715494
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Mat2a
methionine adenosyltransferase 2A
decreases expression
ISO
Clozapine results in decreased expression of MAT2A protein
CTD
PMID:34122009
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
G
Mat2b
methionine adenosyltransferase 2 non-catalytic beta subunit
decreases expression
ISO
Clozapine results in decreased expression of MAT2B protein
CTD
PMID:34122009
NCBI chr10:25,106,928...25,122,982
Ensembl chr10:25,106,930...25,122,777
G
Mbp
myelin basic protein
increases expression
ISO
Clozapine results in increased expression of MBP mRNA
CTD
PMID:17266109 PMID:17346280
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mc1r
melanocortin 1 receptor
increases expression
ISO
Clozapine results in increased expression of MC1R mRNA
CTD
PMID:17346280
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mdc1
mediator of DNA damage checkpoint 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of MDC1 protein
CTD
PMID:34122009
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
G
Mdh1
malate dehydrogenase 1
decreases expression
ISO
Clozapine results in decreased expression of MDH1 protein
CTD
PMID:34122009
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Mfn2
mitofusin 2
decreases expression multiple interactions
EXP
Clozapine results in decreased expression of MFN2 protein PGRMC1 protein inhibits the reaction [Clozapine results in decreased expression of MFN2 protein]
CTD
PMID:37087062
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mlkl
mixed lineage kinase domain like pseudokinase
increases expression
ISO
Clozapine results in increased expression of MLKL protein
CTD
PMID:31220554
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
G
Mmp10
matrix metallopeptidase 10
decreases expression
ISO
Clozapine results in decreased expression of MMP10 mRNA
CTD
PMID:17346280
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp14
matrix metallopeptidase 14
increases expression
ISO
Clozapine results in increased expression of MMP14 protein
CTD
PMID:36482696
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp7
matrix metallopeptidase 7
decreases expression
ISO
Clozapine results in decreased expression of MMP7 mRNA
CTD
PMID:17346280
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mobp
myelin-associated oligodendrocyte basic protein
increases expression
ISO
Clozapine results in increased expression of MOBP mRNA
CTD
PMID:15542763 PMID:17266109
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
G
Mpo
myeloperoxidase
affects response to substance increases activity multiple interactions increases oxidation
ISO
MPO protein affects the susceptibility to Clozapine Clozapine results in increased activity of MPO protein Clozapine promotes the reaction [[MPO protein results in increased metabolism of chlorodimedone] which results in increased abundance of Hypochlorous Acid]; Clozapine promotes the reaction [MPO protein results in increased abundance of Hypochlorous Acid] MPO protein results in increased oxidation of Clozapine
CTD
PMID:24588327 PMID:35575633
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mpp3
MAGUK p55 scaffold protein 3
decreases expression
ISO
Clozapine results in decreased expression of MPP3 mRNA
CTD
PMID:17266109
NCBI chr10:86,945,705...86,975,261
Ensembl chr10:86,945,714...86,974,737
G
Mr1
major histocompatibility complex, class I-related
affects expression
ISO
Clozapine affects the expression of MR1 mRNA
CTD
PMID:25811541
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mta2
metastasis associated 1 family, member 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of MTA2 protein
CTD
PMID:34122009
NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946
G
Mtdh
metadherin
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of MTDH protein
CTD
PMID:34122009
NCBI chr 7:65,306,464...65,365,647
Ensembl chr 7:65,306,400...65,364,413
G
Mthfr
methylenetetrahydrofolate reductase
affects response to substance
ISO
MTHFR gene polymorphism affects the susceptibility to Clozapine; MTHFR protein affects the susceptibility to Clozapine
CTD
PMID:20547447
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Myadm
myeloid-associated differentiation marker
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of MYADM protein
CTD
PMID:34122009
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Mybbp1a
MYB binding protein 1a
increases expression
ISO
Clozapine results in increased expression of MYBBP1A protein
CTD
PMID:34122009
NCBI chr10:57,056,897...57,067,258
Ensembl chr10:57,056,874...57,067,255
G
Myh10
myosin heavy chain 10
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of MYH10 protein
CTD
PMID:34122009
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
G
Myh3
myosin heavy chain 3
increases expression
ISO
Clozapine results in increased expression of MYH3 protein
CTD
PMID:34122009
NCBI chr10:51,770,177...51,793,994
Ensembl chr10:51,770,177...51,793,992
G
Myl1
myosin, light chain 1
increases expression
ISO
Clozapine results in increased expression of MYL1 protein
CTD
PMID:34122009
NCBI chr 9:68,437,514...68,458,256
Ensembl chr 9:68,437,517...68,458,261
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
decreases expression
ISO
Clozapine results in decreased expression of NAA10 protein
CTD
PMID:34122009
NCBI chr X:151,656,056...151,661,304
Ensembl chr X:151,656,056...151,661,252
G
Nap1l4
nucleosome assembly protein 1-like 4
increases expression
ISO
Clozapine results in increased expression of NAP1L4 protein
CTD
PMID:34122009
NCBI chr 1:198,709,697...198,746,093
Ensembl chr 1:198,709,701...198,746,020
G
Nat10
N-acetyltransferase 10
decreases expression
ISO
Clozapine results in decreased expression of NAT10 protein
CTD
PMID:34122009
NCBI chr 3:90,111,643...90,149,891
Ensembl chr 3:90,111,645...90,149,927
G
Ncan
neurocan
decreases expression
ISO
Clozapine results in decreased expression of NCAN mRNA
CTD
PMID:18797397
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
G
Ncapg
non-SMC condensin I complex, subunit G
increases expression
ISO
Clozapine results in increased expression of NCAPG protein
CTD
PMID:34122009
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncaph
non-SMC condensin I complex, subunit H
decreases expression
ISO
Clozapine results in decreased expression of NCAPH protein
CTD
PMID:34122009 PMID:36482696
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ncbp1
nuclear cap binding protein subunit 1
decreases expression
ISO
Clozapine results in decreased expression of NCBP1 protein
CTD
PMID:34122009
NCBI chr 5:60,416,023...60,449,004
Ensembl chr 5:60,415,982...60,449,089
G
Ncl
nucleolin
increases expression
ISO
Clozapine results in increased expression of NCL mRNA
CTD
PMID:14647396
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Ncoa4
nuclear receptor coactivator 4
increases expression
ISO
Clozapine results in increased expression of NCOA4 protein
CTD
PMID:36482696
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
increases expression
EXP
Clozapine results in increased expression of NDUFV2 mRNA
CTD
PMID:19441803
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
G
Nectin2
nectin cell adhesion molecule 2
decreases expression
ISO
Clozapine results in decreased expression of NECTIN2 protein
CTD
PMID:34122009
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
decreases expression
ISO
Clozapine results in decreased expression of NEDD4 mRNA
CTD
PMID:18797397
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
G
Nes
nestin
decreases expression
ISO
Clozapine results in decreased expression of NES protein
CTD
PMID:34122009
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects response to substance
ISO
NFE2L2 protein affects the susceptibility to Clozapine
CTD
PMID:21540358
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
EXP
Clozapine results in decreased expression of NFKB1 protein
CTD
PMID:16500086
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Ngfr
nerve growth factor receptor
decreases expression
ISO EXP
Clozapine results in decreased expression of NGFR protein; Clozapine results in decreased expression of NGFR protein alternative form Clozapine results in decreased expression of NGFR mRNA
CTD
PMID:12111809 PMID:14598305 PMID:16513140
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nifk
nucleolar protein interacting with the FHA domain of MKI67
decreases expression
ISO
Clozapine results in decreased expression of NIFK protein
CTD
PMID:34122009
NCBI chr13:29,393,303...29,403,387
Ensembl chr13:29,393,286...29,405,896
G
Nnmt
nicotinamide N-methyltransferase
increases expression
ISO
Clozapine results in increased expression of NNMT protein
CTD
PMID:34122009
NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
Clozapine results in decreased expression of NNT protein
CTD
PMID:34122009
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Noc2l
NOC2-like nucleolar associated transcriptional repressor
increases expression
ISO
Clozapine results in increased expression of NOC2L protein
CTD
PMID:34122009
NCBI chr 5:166,820,150...166,831,949
Ensembl chr 5:166,820,161...166,831,949
G
Nomo1
Nodal modulator 1
increases expression
ISO
Clozapine results in increased expression of NOMO3 protein
CTD
PMID:34122009
NCBI chr 1:96,505,460...96,556,280
Ensembl chr 1:96,505,484...96,556,279
G
Nop53
NOP53 ribosome biogenesis factor
affects expression
ISO
Clozapine affects the expression of NOP53 mRNA
CTD
PMID:14647396
NCBI chr 1:76,629,084...76,636,902
Ensembl chr 1:76,629,069...76,636,902
G
Notch2
notch receptor 2
increases expression
ISO
Clozapine results in increased expression of NOTCH2 protein
CTD
PMID:36482696
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
G
Nploc4
NPL4 homolog, ubiquitin recognition factor
decreases expression
ISO
Clozapine results in decreased expression of NPLOC4 protein
CTD
PMID:34122009
NCBI chr10:105,654,395...105,709,958
Ensembl chr10:105,654,812...105,709,913
G
Nptn
neuroplastin
increases expression
ISO
Clozapine results in increased expression of NPTN mRNA
CTD
PMID:18797397
NCBI chr 8:58,996,873...59,063,402
Ensembl chr 8:58,996,887...59,063,401
G
Nptx2
neuronal pentraxin 2
decreases expression
EXP
Clozapine results in decreased expression of NPTX2 mRNA
CTD
PMID:18208916
NCBI chr12:10,037,435...10,048,345
Ensembl chr12:10,037,435...10,048,345
G
Npy
neuropeptide Y
decreases expression
EXP
Clozapine results in decreased expression of NPY mRNA
CTD
PMID:16516965
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
affects response to substance increases reduction multiple interactions
ISO
NQO2 gene SNP affects the susceptibility to Clozapine NQO2 protein results in increased reduction of Clozapine metabolite Clozapine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]
CTD
PMID:14617031 PMID:29281794
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Clozapine results in increased expression of NR0B2 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
Clozapine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Clozapine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]
CTD
PMID:21402137
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
Clozapine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]
CTD
PMID:16581232
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression decreases expression
EXP
Clozapine results in increased expression of NR4A1 mRNA Clozapine results in decreased expression of NR4A1 mRNA
CTD
PMID:10987852 PMID:11564422 PMID:19695244
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Clozapine results in increased expression of NR4A2 mRNA
CTD
PMID:17266109
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nrg1
neuregulin 1
increases expression affects expression affects response to substance
ISO EXP
Clozapine results in increased expression of NRG1 mRNA Clozapine affects the expression of NRG1 protein NRG1 protein affects the susceptibility to Clozapine
CTD
PMID:15706234 PMID:18184445 PMID:19502011
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
decreases expression
ISO
Clozapine results in decreased expression of NSF protein
CTD
PMID:34122009
NCBI chr10:88,727,912...88,857,375
Ensembl chr10:88,727,912...88,857,386
G
Ntng2
netrin G2
increases expression
EXP
Clozapine results in increased expression of NTNG2 mRNA
CTD
PMID:17507910
NCBI chr 3:12,492,574...12,551,104
Ensembl chr 3:12,492,639...12,545,890
G
Nts
neurotensin
increases expression
EXP
Clozapine results in increased expression of NTS mRNA
CTD
PMID:12887421
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Numa1
nuclear mitotic apparatus protein 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of NUMA1 protein
CTD
PMID:34122009
NCBI chr 1:156,297,907...156,372,855
Ensembl chr 1:156,326,259...156,372,855
G
Numbl
NUMB-like, endocytic adaptor protein
decreases expression
ISO
Clozapine results in decreased expression of NUMBL mRNA
CTD
PMID:18797397
NCBI chr 1:82,549,814...82,573,788
Ensembl chr 1:82,550,054...82,573,776
G
Nup160
nucleoporin 160
increases expression
ISO
Clozapine results in increased expression of NUP160 protein
CTD
PMID:34122009
NCBI chr 3:76,665,786...76,729,296
Ensembl chr 3:76,665,786...76,724,565
G
Nup50
nucleoporin 50
increases expression
ISO
Clozapine results in increased expression of NUP50 protein
CTD
PMID:34122009
NCBI chr 7:116,047,960...116,065,231
Ensembl chr 7:116,048,021...116,066,905
G
Nup54
nucleoporin 54
decreases expression
ISO
Clozapine results in decreased expression of NUP54 protein
CTD
PMID:34122009
NCBI chr14:15,617,630...15,636,029
Ensembl chr14:15,617,679...15,636,028
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Clozapine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Osbpl8
oxysterol binding protein-like 8
increases expression
ISO
Clozapine results in increased expression of OSBPL8 mRNA
CTD
PMID:14647396
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Oxt
oxytocin/neurophysin I prepropeptide
affects response to substance
ISO
OXT protein affects the susceptibility to Clozapine
CTD
PMID:20196918
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Pakap
paralemmin A kinase anchor protein
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of PALM2AKAP2 protein
CTD
PMID:34122009
NCBI chr 5:72,536,986...72,648,524 NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524
G
Pank3
pantothenate kinase 3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of PANK3 protein
CTD
PMID:34122009
NCBI chr10:20,229,129...20,252,955
Ensembl chr10:20,229,129...20,252,955
G
Park7
Parkinsonism associated deglycase
increases expression
ISO
Clozapine results in increased expression of PARK7 mRNA
CTD
PMID:14647396
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
G
Pcbp1
poly(rC) binding protein 1
increases expression
ISO
Clozapine results in increased expression of PCBP1 protein
CTD
PMID:34122009
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
decreases expression
ISO
Clozapine results in decreased expression of PCK2 protein
CTD
PMID:34122009
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
G
Pclo
piccolo (presynaptic cytomatrix protein)
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of PCLO protein
CTD
PMID:34122009
NCBI chr 4:19,691,439...20,050,015
Ensembl chr 4:19,695,315...20,049,885
G
Pcm1
pericentriolar material 1
decreases expression
ISO
Clozapine results in decreased expression of PCM1 mRNA
CTD
PMID:19048012
NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091
G
Pcnp
PEST proteolytic signal containing nuclear protein
increases expression
ISO
Clozapine results in increased expression of PCNP protein
CTD
PMID:34122009
NCBI chr11:44,592,766...44,607,372
Ensembl chr11:44,592,742...44,607,348
G
Pcsk1n
proprotein convertase subtilisin/kexin type 1 inhibitor
affects expression
ISO
Clozapine affects the expression of PCSK1N mRNA
CTD
PMID:14647396
NCBI chr X:14,580,036...14,583,478
Ensembl chr X:14,580,038...14,583,566
G
Pdcd11
programmed cell death 11
increases expression
ISO
Clozapine results in increased expression of PDCD11 protein
CTD
PMID:34122009
NCBI chr 1:245,980,840...246,021,999
Ensembl chr 1:245,980,880...246,021,999
G
Pde10a
phosphodiesterase 10A
increases expression
ISO EXP
Clozapine results in increased expression of PDE10A mRNA Clozapine results in increased expression of PDE10A mRNA; Clozapine results in increased expression of PDE10A protein
CTD
PMID:17266109 PMID:18222493
NCBI chr 1:51,765,743...52,218,086
Ensembl chr 1:51,770,132...52,216,563
G
Pde1b
phosphodiesterase 1B
increases expression
ISO
Clozapine results in increased expression of PDE1B mRNA
CTD
PMID:14647396
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580
G
Pde4a
phosphodiesterase 4A
decreases expression
EXP
Clozapine results in decreased expression of PDE4A protein
CTD
PMID:20222156
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
G
Pde4b
phosphodiesterase 4B
decreases expression increases expression
EXP
Clozapine results in decreased expression of PDE4B protein Clozapine results in increased expression of PDE4B mRNA; Clozapine results in increased expression of PDE4B protein
CTD
PMID:18222493 PMID:20222156
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pdia3
protein disulfide isomerase family A, member 3
decreases expression
ISO
Clozapine results in decreased expression of PDIA3 protein
CTD
PMID:34122009
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
Pdia4
protein disulfide isomerase family A, member 4
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of PDIA4 protein
CTD
PMID:34122009
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdlim5
PDZ and LIM domain 5
decreases expression
ISO
Clozapine results in decreased expression of PDLIM5 protein
CTD
PMID:34122009
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
G
Pebp1
phosphatidylethanolamine binding protein 1
decreases expression
ISO
Clozapine results in decreased expression of PEBP1 protein
CTD
PMID:34122009
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
G
Penk
proenkephalin
decreases expression increases expression
EXP
Clozapine results in decreased expression of PENK mRNA Clozapine results in increased expression of PENK mRNA
CTD
PMID:1635659 PMID:12887421
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Pfdn5
prefoldin subunit 5
increases expression
ISO
Clozapine results in increased expression of PFDN5 mRNA
CTD
PMID:14647396
NCBI chr 7:133,451,778...133,456,516
Ensembl chr 7:133,451,453...133,456,516
G
Pfkp
phosphofructokinase, platelet
increases expression
EXP
Clozapine results in increased expression of PFKP mRNA
CTD
PMID:15860345
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pgam5
PGAM family member 5, mitochondrial serine/threonine protein phosphatase
decreases expression
ISO
Clozapine results in decreased expression of PGAM5 protein
CTD
PMID:34122009
NCBI chr12:46,409,324...46,416,410
Ensembl chr12:46,409,369...46,416,420
G
Pgk1
phosphoglycerate kinase 1
increases expression
EXP
Clozapine results in increased expression of PGK1 mRNA
CTD
PMID:15860345
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgrmc1
progesterone receptor membrane component 1
multiple interactions
EXP
PGRMC1 protein inhibits the reaction [Clozapine results in decreased expression of GLP1R protein]; PGRMC1 protein inhibits the reaction [Clozapine results in decreased expression of MFN2 protein]
CTD
PMID:37087062
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
G
Phactr1
phosphatase and actin regulator 1
increases expression
ISO
Clozapine results in increased expression of PHACTR1 mRNA
CTD
PMID:14647396
NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831
G
Phf14
PHD finger protein 14
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of PHF14 protein
CTD
PMID:34122009
NCBI chr 4:40,009,691...40,195,877
Ensembl chr 4:40,009,264...40,195,885
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
EXP
Clozapine results in decreased expression of PIK3R3 mRNA
CTD
PMID:16715494
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Pitpnb
phosphatidylinositol transfer protein, beta
increases expression
ISO
Clozapine results in increased expression of PITPNB protein
CTD
PMID:34122009
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
G
Pkib
cAMP-dependent protein kinase inhibitor beta
decreases expression
EXP
Clozapine results in decreased expression of PKIB mRNA
CTD
PMID:15860345
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
G
Pkm
pyruvate kinase M1/2
increases expression
EXP
Clozapine results in increased expression of PKM mRNA
CTD
PMID:15860345
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plcb1
phospholipase C beta 1
increases expression
ISO
Clozapine results in increased expression of PLCB1 mRNA
CTD
PMID:16465460
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
G
Plp1
proteolipid protein 1
decreases expression increases expression
ISO
Clozapine results in decreased expression of PLP1 mRNA Clozapine results in increased expression of PLP1 mRNA
CTD
PMID:17266109 PMID:18797397
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Pls3
plastin 3
decreases expression
ISO
Clozapine results in decreased expression of PLS3 protein
CTD
PMID:34122009
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Pnma1
PNMA family member 1
increases expression
ISO
Clozapine results in increased expression of PNMA1 protein
CTD
PMID:34122009
NCBI chr 6:103,782,244...103,784,029
Ensembl chr 6:103,773,889...103,784,567
G
Pon3
paraoxonase 3
increases expression
ISO
Clozapine results in increased expression of PON3 protein
CTD
PMID:34122009
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Ppa1
inorganic pyrophosphatase 1
increases expression
ISO
Clozapine results in increased expression of PPA1 protein
CTD
PMID:34122009
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]; Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein] Clozapine results in increased expression of PPARG mRNA; Clozapine results in increased expression of PPARG protein
CTD
PMID:20564506
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppm1a
protein phosphatase, Mg2+/Mn2+ dependent, 1A
decreases expression
EXP
Clozapine results in decreased expression of PPM1A mRNA
CTD
PMID:15860345
NCBI chr 6:91,439,094...91,486,139
Ensembl chr 6:91,438,834...91,480,697
G
Ppm1b
protein phosphatase, Mg2+/Mn2+ dependent, 1B
decreases expression
EXP
Clozapine results in decreased expression of PPM1B mRNA
CTD
PMID:15860345
NCBI chr 6:9,646,695...9,707,471
Ensembl chr 6:9,655,765...9,707,974
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
decreases expression
EXP
Clozapine results in decreased expression of PPP1CB mRNA
CTD
PMID:15860345
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
decreases expression
EXP
Clozapine results in decreased expression of PPP1CC mRNA
CTD
PMID:15860345
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
decreases expression
ISO
Clozapine results in decreased expression of PPP1R14B protein
CTD
PMID:34122009
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
G
Ppp1r1a
protein phosphatase 1, regulatory (inhibitor) subunit 1A
decreases expression
EXP
Clozapine results in decreased expression of PPP1R1A mRNA
CTD
PMID:15860345
NCBI chr 7:134,654,578...134,662,236
Ensembl chr 7:134,654,579...134,662,230
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
multiple interactions increases phosphorylation
ISO
Clozapine inhibits the reaction [Serotonin results in decreased phosphorylation of PPP1R1B protein]; Clozapine inhibits the reaction [Serotonin results in increased phosphorylation of PPP1R1B protein] Clozapine results in increased phosphorylation of PPP1R1B protein
CTD
PMID:11880652 PMID:12871586
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Ppp1r2
protein phosphatase 1, regulatory (inhibitor) subunit 2
decreases expression
EXP
Clozapine results in decreased expression of PPP1R2 mRNA
CTD
PMID:15860345
NCBI chr11:69,472,676...69,494,468
Ensembl chr11:69,472,555...69,494,463
G
Ppp1r9b
protein phosphatase 1, regulatory subunit 9B
increases expression
EXP
Clozapine results in increased expression of PPP1R9B protein
CTD
PMID:16844384
NCBI chr10:79,938,055...79,954,085
Ensembl chr10:79,938,066...79,954,083
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
decreases expression
EXP
Clozapine results in decreased expression of PPP2CA mRNA
CTD
PMID:15860345
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
decreases expression
EXP
Clozapine results in decreased expression of PPP2CB mRNA
CTD
PMID:15860345
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
increases expression
EXP
Clozapine results in increased expression of PPP2R1A mRNA
CTD
PMID:15860345
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
G
Ppp2r2a
protein phosphatase 2, regulatory subunit B, alpha
decreases expression
EXP
Clozapine results in decreased expression of PPP2R2A mRNA
CTD
PMID:15860345
NCBI chr15:41,204,659...41,263,924
Ensembl chr15:41,204,200...41,263,924
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
multiple interactions increases expression decreases expression
EXP
[Clozapine binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein Clozapine results in increased expression of PPP3CA mRNA Clozapine results in decreased expression of PPP3CA mRNA; Clozapine results in decreased expression of PPP3CA protein
CTD
PMID:12437575 PMID:16033416
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Ppp4r2
protein phosphatase 4, regulatory subunit 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of PPP4R2 protein
CTD
PMID:34122009
NCBI chr 4:133,454,555...133,495,486
Ensembl chr 4:133,454,555...133,495,486
G
Ppp5c
protein phosphatase 5, catalytic subunit
affects expression
ISO
Clozapine affects the expression of PPP5C mRNA
CTD
PMID:14647396
NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:77,690,208...77,714,456
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of PRDX1 protein
CTD
PMID:34122009
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
increases expression
EXP
Clozapine results in increased expression of PRKACA mRNA
CTD
PMID:15860345
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
decreases expression increases expression
EXP
Clozapine results in decreased expression of PRKACB mRNA; Clozapine results in decreased expression of PRKACB protein Clozapine results in increased expression of PRKACB mRNA
CTD
PMID:11907174 PMID:15860345
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
G
Prkar2a
protein kinase cAMP-dependent type II regulatory subunit alpha
multiple interactions decreases expression
EXP ISO
Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2A protein] [Cuprizone co-treated with Clozapine] results in decreased expression of PRKAR2A protein Clozapine results in decreased expression of PRKAR2A mRNA; Clozapine results in decreased expression of PRKAR2A protein
CTD
PMID:11907174 PMID:34122009
NCBI chr 8:109,393,189...109,458,832
Ensembl chr 8:109,395,833...109,455,628
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
decreases expression multiple interactions
EXP
Clozapine results in decreased expression of PRKAR2B mRNA; Clozapine results in decreased expression of PRKAR2B protein Clozapine inhibits the reaction [Cyclic AMP binds to PRKAR2B protein]
CTD
PMID:11907174 PMID:15860345
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
G
Prkcb
protein kinase C, beta
affects expression increases expression
EXP
Clozapine affects the expression of PRKCB protein Clozapine results in increased expression of PRKCB mRNA
CTD
PMID:15860345 PMID:15967061
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkce
protein kinase C, epsilon
increases expression
EXP
Clozapine results in increased expression of PRKCE mRNA
CTD
PMID:15860345
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkcz
protein kinase C, zeta
increases expression
EXP
Clozapine results in increased expression of PRKCZ mRNA
CTD
PMID:15860345
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Prl
prolactin
increases secretion increases expression multiple interactions
ISO EXP
Clozapine results in increased secretion of PRL protein Clozapine analog results in increased expression of PRL protein [Clozapine co-treated with DRD2 gene polymorphism] results in increased secretion of PRL protein; [Risperidone co-treated with Clozapine] results in increased expression of PRL protein
CTD
PMID:11155212 PMID:11997696 PMID:15286066 PMID:18562423
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prmt1
protein arginine methyltransferase 1
decreases expression
ISO
Clozapine results in decreased expression of PRMT1 protein
CTD
PMID:34122009
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
increases expression
ISO
Clozapine results in increased expression of PROC protein
CTD
PMID:20126316
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Prpf38b
pre-mRNA processing factor 38B
decreases expression
ISO
Clozapine results in decreased expression of PRPF38B mRNA
CTD
PMID:14647396
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250
G
Prpf6
pre-mRNA processing factor 6
decreases expression multiple interactions
ISO
Clozapine results in decreased expression of PRPF6 protein [Cuprizone co-treated with Clozapine] results in decreased expression of PRPF6 protein
CTD
PMID:34122009
NCBI chr 3:168,706,952...168,771,191
Ensembl chr 3:168,704,299...168,774,991
G
Prrc2a
proline-rich coiled-coil 2A
decreases expression
ISO
Clozapine results in decreased expression of PRRC2A mRNA
CTD
PMID:18797397
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
G
Psmb5
proteasome 20S subunit beta 5
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of PSMB5 protein
CTD
PMID:34122009
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
G
Psmb7
proteasome 20S subunit beta 7
decreases expression
ISO
Clozapine results in decreased expression of PSMB7 protein
CTD
PMID:34122009
NCBI chr 3:22,357,777...22,417,748
Ensembl chr 3:22,354,698...22,417,937
G
Psmc3
proteasome 26S subunit, ATPase 3
increases expression
ISO
Clozapine results in increased expression of PSMC3 protein
CTD
PMID:34122009
NCBI chr 3:77,031,825...77,037,207
Ensembl chr 3:77,031,825...77,043,358
G
Psmc5
proteasome 26S subunit, ATPase 5
increases expression
ISO
Clozapine results in increased expression of PSMC5 protein
CTD
PMID:34122009
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
G
Psmd14
proteasome 26S subunit, non-ATPase 14
increases expression
ISO
Clozapine results in increased expression of PSMD14 protein
CTD
PMID:34122009
NCBI chr 3:46,254,338...46,347,076
Ensembl chr 3:46,254,330...46,347,076
G
Psmd7
proteasome 26S subunit, non-ATPase 7
increases expression
ISO
Clozapine results in increased expression of PSMD7 protein
CTD
PMID:34122009
NCBI chr19:35,494,317...35,501,605
Ensembl chr19:35,494,316...35,501,588
G
Ptcd3
Pentatricopeptide repeat domain 3
increases expression
ISO
Clozapine results in increased expression of PTCD3 protein
CTD
PMID:34122009
NCBI chr 4:103,922,440...103,957,445
Ensembl chr 4:103,920,566...103,957,538
G
Ptgds
prostaglandin D2 synthase
decreases expression increases expression
ISO
Clozapine results in decreased expression of PTGDS mRNA Clozapine results in increased expression of PTGDS mRNA
CTD
PMID:15542763 PMID:17266109
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
G
Ptk2
protein tyrosine kinase 2
increases expression
ISO
Clozapine results in increased expression of PTK2 protein
CTD
PMID:34122009
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptma
prothymosin alpha
increases expression
ISO
Clozapine results in increased expression of PTMA protein
CTD
PMID:34122009
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptms
parathymosin
increases expression
ISO
Clozapine results in increased expression of PTMS mRNA
CTD
PMID:14647396
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Pvalb
parvalbumin
multiple interactions
EXP
Clozapine inhibits the reaction [Phencyclidine results in decreased expression of PVALB mRNA]
CTD
PMID:12589379
NCBI chr 7:109,772,939...109,787,954
Ensembl chr 7:109,772,593...109,784,561
G
Pwp2
PWP2, small subunit processome component
increases expression
ISO
Clozapine results in increased expression of PWP2 protein
CTD
PMID:34122009
NCBI chr20:10,499,332...10,512,965
Ensembl chr20:10,499,363...10,513,640
G
Pycr1
pyrroline-5-carboxylate reductase 1
increases expression
ISO
Clozapine results in increased expression of PYCR1 protein
CTD
PMID:34122009
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Qdpr
quinoid dihydropteridine reductase
decreases expression
ISO
Clozapine results in decreased expression of QDPR protein
CTD
PMID:34122009
NCBI chr14:65,670,251...65,683,853
Ensembl chr14:65,670,131...65,683,854
G
Rab12
RAB12, member RAS oncogene family
decreases expression
EXP
Clozapine results in decreased expression of RAB12 mRNA
CTD
PMID:12437575
NCBI chr 9:106,480,301...106,506,895
Ensembl chr 9:106,480,301...106,506,910
G
Rac1
Rac family small GTPase 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of RAC1 protein
CTD
PMID:34122009
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Rack1
receptor for activated C kinase 1
decreases expression
ISO
Clozapine results in decreased expression of RACK1 protein
CTD
PMID:34122009
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Ralyl
RALY RNA binding protein-like
increases expression
ISO
Clozapine results in increased expression of RALYL protein
CTD
PMID:34122009
NCBI chr 2:87,482,747...88,274,329
Ensembl chr 2:87,482,755...88,274,452
G
Ran
RAN, member RAS oncogene family
decreases expression
ISO
Clozapine results in decreased expression of RAN protein
CTD
PMID:34122009
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rap1gds1
Rap1 GTPase-GDP dissociation stimulator 1
increases expression
ISO
Clozapine results in increased expression of RAP1GDS1 protein
CTD
PMID:34122009
NCBI chr 2:227,500,366...227,645,213
Ensembl chr 2:227,500,367...227,645,169
G
Rapgef4
Rap guanine nucleotide exchange factor 4
decreases expression
ISO
Clozapine results in decreased expression of RAPGEF4 mRNA
CTD
PMID:18797397
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
affects expression
EXP
Clozapine affects the expression of RASGRF1 mRNA
CTD
PMID:12437575
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
decreases expression
ISO
Clozapine results in decreased expression of RBBP4 protein
CTD
PMID:34122009
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases expression
EXP
Clozapine results in decreased expression of RELA protein
CTD
PMID:16500086
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Reln
reelin
decreases expression multiple interactions decreases methylation
ISO EXP
Clozapine results in decreased expression of RELN mRNA Clozapine results in decreased expression of RELN protein Valproic Acid promotes the reaction [Clozapine results in decreased methylation of RELN promoter]
CTD
PMID:17266109 PMID:18757738 PMID:19359144
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rfc5
replication factor C subunit 5
increases expression
ISO
Clozapine results in increased expression of RFC5 protein
CTD
PMID:34122009
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
G
Rgs4
regulator of G-protein signaling 4
increases expression
EXP ISO
Clozapine results in increased expression of RGS4 mRNA
CTD
PMID:15860345 PMID:17266109
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs7
regulator of G-protein signaling 7
multiple interactions increases expression
EXP
[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [[[Clozapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein] Clozapine results in increased expression of RGS7 mRNA
CTD
PMID:18976543
NCBI chr13:86,979,269...87,408,834
Ensembl chr13:86,979,279...87,408,888
G
Rgs8
regulator of G-protein signaling 8
increases expression
EXP
Clozapine results in increased expression of RGS8 mRNA
CTD
PMID:15860345
NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807
G
Rhob
ras homolog family member B
increases expression
ISO
Clozapine results in increased expression of RHOB protein
CTD
PMID:36482696
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Ric8a
RIC8 guanine nucleotide exchange factor A
decreases expression
ISO
Clozapine results in decreased expression of RIC8A protein
CTD
PMID:34122009
NCBI chr 1:195,935,162...195,941,469
Ensembl chr 1:195,935,349...195,941,467
G
Rnf13
ring finger protein 13
increases expression
ISO
Clozapine results in increased expression of RNF13 protein
CTD
PMID:36482696
NCBI chr 2:141,927,887...142,061,801
Ensembl chr 2:141,927,909...142,061,801
G
Rnf20
ring finger protein 20
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of RNF20 protein
CTD
PMID:34122009
NCBI chr 5:63,976,063...64,001,754
Ensembl chr 5:63,976,045...64,001,754
G
Rorb
RAR-related orphan receptor B
decreases expression
EXP
Clozapine results in decreased expression of RORB mRNA
CTD
PMID:11564422
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
G
Rpa1
replication protein A1
decreases expression
ISO
Clozapine results in decreased expression of RPA1 protein
CTD
PMID:34122009
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpl11
ribosomal protein L11
increases expression
ISO
Clozapine results in increased expression of RPL11 protein
CTD
PMID:34122009
NCBI chr 5:148,274,060...148,277,708
Ensembl chr 5:148,274,069...148,277,599
G
Rpl19
ribosomal protein L19
increases expression
ISO
Clozapine results in increased expression of RPL19 protein
CTD
PMID:34122009
NCBI chr10:83,022,503...83,026,030
Ensembl chr10:83,019,257...83,052,112
G
Rpl30
ribosomal protein L30
increases expression
ISO
Clozapine results in increased expression of RPL30 protein
CTD
PMID:34122009
NCBI chr 7:65,648,266...65,651,401
Ensembl chr 7:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363
G
Rpl5
ribosomal protein L5
increases expression
ISO
Clozapine results in increased expression of RPL5 protein
CTD
PMID:34122009
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rplp0l1
ribosomal protein lateral stalk subunit P0 like 1
decreases expression
ISO
Clozapine results in decreased expression of RPLP0P6 protein
CTD
PMID:34122009
NCBI chr 2:191,921,503...191,922,661
Ensembl chr 2:191,921,574...191,922,646
G
Rplp2
ribosomal protein lateral stalk subunit P2
increases expression
ISO
Clozapine results in increased expression of RPLP2 mRNA
CTD
PMID:14647396
NCBI chr 1:196,546,086...196,548,636
Ensembl chr 1:196,546,352...196,548,645
G
Rpn2
ribophorin II
decreases expression
ISO
Clozapine results in decreased expression of RPN2 protein
CTD
PMID:34122009
NCBI chr 3:145,941,787...145,989,271
Ensembl chr 3:145,941,839...145,989,543
G
Rps10
ribosomal protein S10
increases expression
ISO
Clozapine results in increased expression of RPS10 mRNA
CTD
PMID:14647396
NCBI chr20:5,694,313...5,698,922
Ensembl chr20:5,694,313...5,699,044 Ensembl chr 6:5,694,313...5,699,044
G
Rps11
ribosomal protein S11
decreases expression
ISO
Clozapine results in decreased expression of RPS11 protein
CTD
PMID:34122009
NCBI chr 1:95,605,690...95,607,798
Ensembl chr 1:95,605,692...95,607,874
G
Rps3
ribosomal protein S3
decreases expression
ISO
Clozapine results in decreased expression of RPS3 protein
CTD
PMID:34122009
NCBI chr 1:153,778,363...153,783,663
Ensembl chr 1:153,777,472...153,783,680
G
Rrbp1
ribosome binding protein 1
decreases expression
ISO
Clozapine results in decreased expression of RRBP1 protein
CTD
PMID:34122009
NCBI chr 3:131,314,996...131,376,930
Ensembl chr 3:131,314,998...131,376,981
G
Rsf1
remodeling and spacing factor 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of RSF1 protein
CTD
PMID:34122009
NCBI chr 1:151,892,055...152,015,089
Ensembl chr 1:151,892,434...152,009,051
G
Rspry1
ring finger and SPRY domain containing 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of RSPRY1 protein
CTD
PMID:34122009
NCBI chr19:10,352,449...10,403,015
Ensembl chr19:10,353,821...10,401,102
G
RT1-A2
RT1 class Ia, locus A2
increases expression
ISO
Clozapine results in increased expression of HLA-E protein
CTD
PMID:36482696
NCBI chr20:4,870,939...4,910,183
G
Rtcb
RNA 2',3'-cyclic phosphate and 5'-OH ligase
increases expression
ISO
Clozapine results in increased expression of RTCB protein
CTD
PMID:34122009
NCBI chr 7:17,907,668...17,927,136
Ensembl chr 7:17,907,705...17,927,132
G
Rtn4
reticulon 4
increases expression
ISO
Clozapine results in increased expression of RTN4 mRNA
CTD
PMID:17266109
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Rxrg
retinoid X receptor gamma
decreases expression
EXP
Clozapine results in decreased expression of RXRG mRNA alternative form
CTD
PMID:11564422
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
S100a9
S100 calcium binding protein A9
decreases expression
ISO
Clozapine results in decreased expression of S100A9 mRNA
CTD
PMID:18797397
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Safb
scaffold attachment factor B
increases expression
ISO
Clozapine results in increased expression of SAFB protein
CTD
PMID:34122009
NCBI chr 9:1,417,449...1,438,408
Ensembl chr 9:1,417,525...1,438,644
G
Sars1
seryl-tRNA synthetase 1
decreases expression
ISO
Clozapine results in decreased expression of SARS1 protein
CTD
PMID:34122009
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Satb2
SATB homeobox 2
increases expression
ISO
Clozapine results in increased expression of SATB2 protein
CTD
PMID:34122009
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
Clozapine results in increased expression of SC5D mRNA
CTD
PMID:17052361
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Scd
stearoyl-CoA desaturase
increases expression
ISO
Clozapine results in increased expression of SCD mRNA
CTD
PMID:16027736 PMID:17052361
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sdcbp
syndecan binding protein
decreases expression increases expression
ISO
Clozapine results in decreased expression of SDCBP protein Clozapine results in increased expression of SDCBP protein
CTD
PMID:34122009 PMID:36482696
NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:19,489,961...19,527,572
G
Sec31a
SEC31 homolog A, COPII coat complex component
increases expression
ISO
Clozapine results in increased expression of SEC31A protein
CTD
PMID:34122009
NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273
G
Sec61b
SEC61 translocon subunit beta
increases expression
ISO
Clozapine results in increased expression of SEC61B protein
CTD
PMID:34122009
NCBI chr 5:61,773,594...61,781,804
Ensembl chr 5:61,773,594...61,781,804
G
Sec63
SEC63 homolog, protein translocation regulator
increases expression
ISO
Clozapine results in increased expression of SEC63 protein
CTD
PMID:34122009
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
G
Septin14
septin 14
decreases expression
ISO
Clozapine results in decreased expression of SEPTIN14 protein
CTD
PMID:34122009
NCBI chr12:26,975,283...27,005,588
Ensembl chr12:26,975,344...26,998,299
G
Serinc1
serine incorporator 1
increases expression
ISO
Clozapine results in increased expression of SERINC1 protein
CTD
PMID:36482696
NCBI chr20:36,850,062...36,868,999
Ensembl chr20:36,850,076...36,896,691
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
Clozapine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpine2
serpin family E member 2
increases expression
EXP
Clozapine results in increased expression of SERPINE2 mRNA; Clozapine results in increased expression of SERPINE2 protein
CTD
PMID:15354176
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Set
Set nuclear proto-oncogene
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of SET protein
CTD
PMID:34122009
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
G
Setx
senataxin
increases expression
ISO
Clozapine results in increased expression of SETX protein
CTD
PMID:34122009
NCBI chr 3:12,428,091...12,480,801
Ensembl chr 3:12,427,635...12,480,803
G
Sf3b3
splicing factor 3b, subunit 3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of SF3B3 protein
CTD
PMID:34122009
NCBI chr19:38,782,749...38,820,271
Ensembl chr19:38,783,040...38,820,245
G
Sfpq
splicing factor proline and glutamine rich
decreases expression
ISO
Clozapine results in decreased expression of SFPQ protein
CTD
PMID:34122009
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sfxn1
sideroflexin 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of SFXN1 protein
CTD
PMID:34122009
NCBI chr17:10,486,250...10,522,640
Ensembl chr17:10,486,271...10,522,529
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO EXP
Clozapine results in increased expression of SGK1 mRNA
CTD
PMID:17266109 PMID:18208916
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sh3gl1
SH3 domain containing GRB2 like 1, endophilin A2
increases expression
ISO
Clozapine results in increased expression of SH3GL1 protein
CTD
PMID:34122009
NCBI chr 9:842,285...869,753
Ensembl chr 9:842,288...869,716
G
Sh3kbp1
SH3 domain-containing kinase-binding protein 1
increases expression
ISO
Clozapine results in increased expression of SH3KBP1 protein
CTD
PMID:34122009
NCBI chr X:34,877,862...35,223,013
Ensembl chr X:34,877,866...35,222,747
G
Sh3pxd2b
SH3 and PX domains 2B
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of SH3PXD2B protein
CTD
PMID:34122009
NCBI chr10:16,918,611...17,027,499
Ensembl chr10:16,918,679...17,005,170
G
Sim2
SIM bHLH transcription factor 2
decreases expression
ISO
Clozapine results in decreased expression of SIM2 protein
CTD
PMID:34122009
NCBI chr11:33,414,218...33,453,663
Ensembl chr11:33,414,218...33,453,663
G
Sirt2
sirtuin 2
increases expression
ISO
Clozapine results in increased expression of SIRT2 protein
CTD
PMID:36482696
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
G
Skp1
S-phase kinase-associated protein 1
decreases expression
ISO
Clozapine results in decreased expression of SKP1 protein
CTD
PMID:34122009
NCBI chr10:36,401,987...36,417,066
Ensembl chr10:36,402,153...36,417,388
G
Slc17a6
solute carrier family 17 member 6
increases expression
ISO
Clozapine results in increased expression of SLC17A6 mRNA; Clozapine results in increased expression of SLC17A6 protein
CTD
PMID:17266109 PMID:18155072
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Slc17a7
solute carrier family 17 member 7
increases expression
ISO
Clozapine results in increased expression of SLC17A7 mRNA; Clozapine results in increased expression of SLC17A7 protein
CTD
PMID:16111724
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc18a2
solute carrier family 18 member A2
increases expression
EXP
Clozapine results in increased expression of SLC18A2 mRNA; Clozapine results in increased expression of SLC18A2 protein
CTD
PMID:12007678
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc1a1
solute carrier family 1 member 1
decreases expression
EXP
Clozapine results in decreased expression of SLC1A1 mRNA
CTD
PMID:12873733
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a2
solute carrier family 1 member 2
decreases activity decreases expression
EXP
Clozapine results in decreased activity of SLC1A2 protein Clozapine results in decreased expression of SLC1A2 mRNA; Clozapine results in decreased expression of SLC1A2 protein
CTD
PMID:11443521 PMID:12873733
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Clozapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO
Clozapine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:30465787
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc25a13
solute carrier family 25 member 13
increases expression
ISO
Clozapine results in increased expression of SLC25A13 protein
CTD
PMID:34122009
NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902
G
Slc25a24
solute carrier family 25 member 24
increases expression
ISO
Clozapine results in increased expression of SLC25A24 protein
CTD
PMID:34122009
NCBI chr 2:196,761,076...196,799,236
Ensembl chr 2:196,761,274...196,799,231
G
Slc25a6
solute carrier family 25 member 6
increases expression
ISO
Clozapine results in increased expression of SLC25A6 protein
CTD
PMID:34122009
NCBI chr18:68,571,222...68,572,461
Ensembl chr18:68,571,300...68,572,199
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Clozapine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc39a7
solute carrier family 39 member 7
increases expression
ISO
Clozapine results in increased expression of SLC39A7 mRNA
CTD
PMID:14647396
NCBI chr20:4,823,166...4,826,538
Ensembl chr20:4,822,012...4,826,537
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
Clozapine results in increased expression of SLC3A2 protein
CTD
PMID:36482696
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc6a2
solute carrier family 6 member 2
decreases expression
EXP
Clozapine results in decreased expression of SLC6A2 mRNA
CTD
PMID:18923069
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
G
Slc6a3
solute carrier family 6 member 3
affects response to substance
ISO
SLC6A3 5' UTR affects the susceptibility to Clozapine
CTD
PMID:20580759
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
multiple interactions increases expression affects response to substance
ISO EXP
[SLC6A4 gene polymorphism results in decreased uptake of Serotonin] which results in decreased susceptibility to Clozapine Clozapine results in increased expression of SLC6A4 SLC6A4 protein affects the susceptibility to Clozapine
CTD
PMID:12007678 PMID:20452607
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Smarcb1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
decreases expression
ISO
Clozapine results in decreased expression of SMARCB1 protein
CTD
PMID:34122009
NCBI chr20:12,741,164...12,763,616
Ensembl chr20:12,741,477...12,763,620
G
Smarcc2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of SMARCC2 protein
CTD
PMID:34122009
NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978
G
Smc2
structural maintenance of chromosomes 2
decreases expression
ISO
Clozapine results in decreased expression of SMC2 protein
CTD
PMID:34122009
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
G
Smc3
structural maintenance of chromosomes 3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of SMC3 protein
CTD
PMID:34122009
NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522
G
Snap25
synaptosome associated protein 25
increases expression affects response to substance
EXP ISO
Clozapine results in increased expression of SNAP25 mRNA SNAP25 gene SNP affects the susceptibility to Clozapine
CTD
PMID:15823421 PMID:15860345
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
G
Snrnp200
small nuclear ribonucleoprotein U5 subunit 200
increases expression
ISO
Clozapine results in increased expression of SNRNP200 protein
CTD
PMID:34122009
NCBI chr 3:114,428,854...114,458,194
Ensembl chr 3:114,428,854...114,458,182
G
Snrpb
small nuclear ribonucleoprotein polypeptides B and B1
increases expression
ISO
Clozapine results in increased expression of SNRPB protein
CTD
PMID:34122009
NCBI chr 3:117,369,816...117,379,344
Ensembl chr 3:117,370,100...117,379,339
G
Snrpd2
small nuclear ribonucleoprotein D2 polypeptide
increases expression
ISO
Clozapine results in increased expression of SNRPD2 mRNA
CTD
PMID:14647396
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
G
Snx1
sorting nexin 1
decreases expression
ISO
Clozapine results in decreased expression of SNX1 protein
CTD
PMID:34122009
NCBI chr 8:66,630,086...66,670,418
Ensembl chr 8:66,630,086...66,670,360
G
Snx6
sorting nexin 6
increases expression
ISO
Clozapine results in increased expression of SNX6 protein
CTD
PMID:34122009
NCBI chr 6:72,230,950...72,274,157
Ensembl chr 6:72,229,870...72,315,911
G
Sod1
superoxide dismutase 1
increases expression decreases expression multiple interactions
EXP ISO
Clozapine results in increased expression of SOD1 mRNA Clozapine results in decreased expression of SOD1 protein Clozapine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA]; Clozapine inhibits the reaction [Haloperidol results in decreased expression of SOD1 protein]
CTD
PMID:12111809 PMID:12752374 PMID:16564057 PMID:34122009
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases expression
EXP
Clozapine results in decreased expression of SOD2 mRNA
CTD
PMID:15860345
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
EXP
Clozapine results in increased expression of SOD3 mRNA
CTD
PMID:15860345
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
decreases expression increases expression
EXP
Clozapine results in decreased expression of SOS1 mRNA Clozapine results in increased expression of SOS1 mRNA
CTD
PMID:12437575
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
G
Spp1
secreted phosphoprotein 1
decreases expression
ISO
Clozapine results in decreased expression of SPP1 mRNA
CTD
PMID:17346280
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sptlc1
serine palmitoyltransferase, long chain base subunit 1
decreases expression
ISO
Clozapine results in decreased expression of SPTLC1 protein
CTD
PMID:34122009
NCBI chr17:11,877,249...11,916,295
Ensembl chr17:11,877,249...11,916,295
G
Sqstm1
sequestosome 1
increases expression
ISO
Clozapine results in increased expression of SQSTM1 protein
CTD
PMID:36482696
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression multiple interactions
ISO
Clozapine results in increased expression of SREBF1 mRNA Clozapine results in increased expression of SREBF1 mRNA; Clozapine results in increased expression of SREBF1 protein Berberine inhibits the reaction [Clozapine results in increased expression of SREBF1 mRNA]; Berberine inhibits the reaction [Clozapine results in increased expression of SREBF1 protein]
CTD
PMID:17052361 PMID:19682446 PMID:20564506
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions increases expression
ISO
Clozapine inhibits the reaction [25-hydroxycholesterol results in decreased activity of SREBF2 protein]; Clozapine results in increased cleavage of and results in increased activity of SREBF2 protein Clozapine results in increased expression of SREBF2 mRNA
CTD
PMID:17052361
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Srrm2
serine/arginine repetitive matrix 2
decreases expression
ISO
Clozapine results in decreased expression of SRRM2 protein
CTD
PMID:34122009
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
G
Srsf2
serine and arginine rich splicing factor 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of SRSF2 protein
CTD
PMID:34122009
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Srsf5
serine and arginine rich splicing factor 5
multiple interactions increases expression
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of SRSF5 protein Clozapine results in increased expression of SRSF5 protein
CTD
PMID:34122009
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
Srsf7
serine and arginine rich splicing factor 7
decreases expression
ISO
Clozapine results in decreased expression of SRSF7 protein
CTD
PMID:34122009
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
G
Ssr3
signal sequence receptor subunit 3
decreases expression
ISO
Clozapine results in decreased expression of SSR3 protein
CTD
PMID:34122009
NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:149,605,005...149,625,132
G
Sst
somatostatin
multiple interactions
EXP
Clozapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of SST mRNA]; Clozapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of SST protein]
CTD
PMID:16567023
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
G
Stim1
stromal interaction molecule 1
decreases expression
ISO
Clozapine results in decreased expression of STIM1 protein
CTD
PMID:34122009
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
G
Stip1
stress-induced phosphoprotein 1
decreases expression
ISO
Clozapine results in decreased expression of STIP1 protein
CTD
PMID:34122009
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Strap
serine/threonine kinase receptor associated protein
decreases expression
ISO
Clozapine results in decreased expression of STRAP protein
CTD
PMID:34122009
NCBI chr 4:170,646,042...170,660,291
Ensembl chr 4:170,646,001...170,660,828
G
Strn4
striatin 4
increases expression
ISO
Clozapine results in increased expression of STRN4 mRNA
CTD
PMID:14647396
NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858
G
Stx1a
syntaxin 1A
increases expression
EXP
Clozapine results in increased expression of STX1A mRNA
CTD
PMID:15860345
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
G
Stx1b
syntaxin 1B
increases expression
EXP
Clozapine results in increased expression of STX1B mRNA
CTD
PMID:15860345
NCBI chr 1:182,415,544...182,434,385
Ensembl chr 1:182,415,546...182,441,280
G
Stx4
syntaxin 4
increases expression
EXP
Clozapine results in increased expression of STX4 mRNA
CTD
PMID:15860345
NCBI chr 1:182,451,108...182,459,701
Ensembl chr 1:182,451,117...182,459,979
G
Stx8
syntaxin 8
affects expression
EXP
Clozapine affects the expression of STX8 mRNA
CTD
PMID:15860345
NCBI chr10:52,655,643...52,900,048
Ensembl chr10:52,654,990...52,894,993
G
Stxbp1
syntaxin binding protein 1
affects expression
EXP
Clozapine affects the expression of STXBP1 mRNA
CTD
PMID:12437575
NCBI chr 3:16,076,725...16,138,431
Ensembl chr 3:16,076,391...16,138,369
G
Sucla2
succinate-CoA ligase ADP-forming subunit beta
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of SUCLA2 protein
CTD
PMID:34122009
NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138
G
Suclg1
succinate-CoA ligase GDP/ADP-forming subunit alpha
decreases expression
ISO
Clozapine results in decreased expression of SUCLG1 protein
CTD
PMID:34122009
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
G
Supt3h
SPT3 homolog, SAGA and STAGA complex component
increases expression
EXP
Clozapine results in increased expression of SUPT3H mRNA
CTD
PMID:16715494
NCBI chr 9:15,878,296...16,206,768
Ensembl chr 9:15,868,287...16,206,706
G
Syn2
synapsin II
decreases expression increases expression
ISO EXP
Clozapine results in decreased expression of SYN2 mRNA Clozapine results in increased expression of SYN2 mRNA
CTD
PMID:15860345 PMID:17266109
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Clozapine results in decreased expression of SYNCRIP protein
CTD
PMID:34122009
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
G
Syt11
synaptotagmin 11
increases expression
EXP
Clozapine results in increased expression of SYT11 mRNA
CTD
PMID:15860345
NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964
G
Syt2
synaptotagmin 2
increases expression
ISO
Clozapine results in increased expression of SYT2 mRNA
CTD
PMID:17266109
NCBI chr13:46,088,046...46,197,976
Ensembl chr13:46,185,282...46,193,859
G
Syt4
synaptotagmin 4
increases expression
EXP
Clozapine results in increased expression of SYT4 mRNA
CTD
PMID:15860345
NCBI chr18:23,036,973...23,046,380
Ensembl chr18:23,038,378...23,046,332
G
Syt5
synaptotagmin 5
decreases expression
EXP
Clozapine results in decreased expression of SYT5 mRNA
CTD
PMID:12437575
NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067
G
Tac1
tachykinin, precursor 1
decreases expression
ISO EXP
Clozapine results in decreased expression of TAC1 mRNA
CTD
PMID:10974607 PMID:17266109
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tagln
transgelin
decreases expression
ISO
Clozapine results in decreased expression of TAGLN mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tagln2
transgelin 2
decreases expression
ISO
Clozapine results in decreased expression of TAGLN2 protein
CTD
PMID:34122009
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Taok2
TAO kinase 2
increases expression
ISO
Clozapine results in increased expression of TAOK2 protein
CTD
PMID:34122009
NCBI chr 1:181,475,708...181,494,738
Ensembl chr 1:181,475,711...181,494,613
G
Tatdn1
TatD DNase domain containing 1
increases expression
ISO
Clozapine results in increased expression of TATDN1 mRNA
CTD
PMID:14647396
NCBI chr 7:90,449,979...90,481,000
Ensembl chr 7:90,441,079...90,481,133
G
Tbc1d15
TBC1 domain family, member 15
increases expression
ISO
Clozapine results in increased expression of TBC1D15 protein
CTD
PMID:36482696
NCBI chr 7:50,804,553...50,860,272
Ensembl chr 7:50,804,012...50,860,175
G
Tbc1d8b
TBC1 domain family member 8B
increases expression
ISO
Clozapine results in increased expression of TBC1D8B protein
CTD
PMID:34122009
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbcb
tubulin folding cofactor B
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of TBCB protein
CTD
PMID:34122009
NCBI chr 1:85,477,639...85,483,488
Ensembl chr 1:85,477,640...85,483,488
G
Tbl3
transducin (beta)-like 3
increases expression
ISO
Clozapine results in increased expression of TBL3 protein
CTD
PMID:34122009
NCBI chr10:13,726,127...13,731,340
Ensembl chr10:13,726,129...13,731,372
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
Clozapine results in decreased expression of TCAF1 protein
CTD
PMID:34122009
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tes
testin LIM domain protein
decreases expression
ISO
Clozapine results in decreased expression of TES protein
CTD
PMID:34122009
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
G
Tgoln2
trans-golgi network protein 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of TGOLN2 protein
CTD
PMID:34122009
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Th
tyrosine hydroxylase
decreases activity multiple interactions increases expression decreases expression increases activity
EXP ISO
Clozapine results in decreased activity of TH protein Ethylmaleimide inhibits the reaction [Clozapine results in decreased expression of TH protein] Clozapine results in increased expression of TH protein Clozapine results in decreased expression of TH mRNA; Clozapine results in decreased expression of TH protein Clozapine results in increased activity of TH protein 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine promotes the reaction [[Clozapine results in increased activity of TH protein] which results in increased metabolism of Dopamine]; [Clozapine results in increased activity of TH protein] which results in increased metabolism of Dopamine
CTD
PMID:12645084 PMID:15983997 PMID:16402076 PMID:16415089 PMID:17028028
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Thra
thyroid hormone receptor alpha
decreases expression increases expression
EXP
Clozapine results in decreased expression of THRA mRNA alternative form Clozapine results in increased expression of THRA mRNA alternative form
CTD
PMID:11564422
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Thrap3
thyroid hormone receptor associated protein 3
decreases expression
ISO
Clozapine results in decreased expression of THRAP3 protein
CTD
PMID:34122009
NCBI chr 5:138,445,284...138,487,544
Ensembl chr 5:138,445,295...138,487,477
G
Thrb
thyroid hormone receptor beta
decreases expression
EXP
Clozapine results in decreased expression of THRB mRNA alternative form
CTD
PMID:11564422
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Tln2
talin 2
decreases expression
ISO
Clozapine results in decreased expression of TLN2 protein
CTD
PMID:34122009
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tm9sf2
transmembrane 9 superfamily member 2
decreases expression
ISO
Clozapine results in decreased expression of TM9SF2 protein
CTD
PMID:34122009
NCBI chr15:99,201,556...99,254,054
Ensembl chr15:99,201,489...99,254,049
G
Tmed10
transmembrane p24 trafficking protein 10
decreases expression
ISO
Clozapine results in decreased expression of TMED10 protein
CTD
PMID:34122009
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmem109
transmembrane protein 109
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of TMEM109 protein
CTD
PMID:34122009
NCBI chr 1:207,519,628...207,530,245
Ensembl chr 1:207,519,624...207,530,215
G
Tmpo
thymopoietin
decreases expression
ISO
Clozapine results in decreased expression of TMPO protein
CTD
PMID:34122009
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tnf
tumor necrosis factor
affects response to substance increases secretion multiple interactions increases expression
ISO EXP
TNF protein affects the susceptibility to Clozapine Clozapine results in increased secretion of TNF protein belnacasan inhibits the reaction [Clozapine results in increased secretion of TNF protein] Clozapine results in increased expression of TNF protein
CTD
PMID:20521320 PMID:24709159 PMID:34935985
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf15
TNF superfamily member 15
decreases expression
ISO
Clozapine results in decreased expression of TNFSF15 mRNA
CTD
PMID:17346280
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnik
TRAF2 and NCK interacting kinase
decreases expression
ISO
Clozapine results in decreased expression of TNIK mRNA
CTD
PMID:14647396
NCBI chr 2:111,184,352...111,587,993
Ensembl chr 2:111,184,387...111,580,750
G
Top1mt
DNA topoisomerase I mitochondrial
increases expression
ISO
Clozapine results in increased expression of TOP1MT protein
CTD
PMID:34122009
NCBI chr 7:107,338,092...107,368,125
Ensembl chr 7:107,342,527...107,366,049
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
Clozapine results in increased expression of TP53 mRNA CSF3 protein inhibits the reaction [Clozapine results in increased expression of TP53 mRNA]
CTD
PMID:16160616
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpi1
triosephosphate isomerase 1
increases expression
EXP
Clozapine results in increased expression of TPI1 mRNA
CTD
PMID:15860345
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Tpm2
tropomyosin 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of TPM2 protein
CTD
PMID:34122009
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
G
Tpm3
tropomyosin 3
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of TPM3 protein
CTD
PMID:34122009
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Tpm4
tropomyosin 4
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of TPM4 protein
CTD
PMID:34122009
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tpr
translocated promoter region, nuclear basket protein
decreases expression
ISO
Clozapine results in decreased expression of TPR protein
CTD
PMID:34122009
NCBI chr13:62,424,312...62,487,502
Ensembl chr13:62,424,312...62,487,496
G
Tra2b
transformer 2 beta
decreases expression
ISO
Clozapine results in decreased expression of TRA2B protein
CTD
PMID:34122009
NCBI chr11:78,788,880...78,807,252
Ensembl chr11:78,788,884...78,807,249
G
Trim2
tripartite motif-containing 2
decreases expression
ISO
Clozapine results in decreased expression of TRIM2 mRNA
CTD
PMID:14647396
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim28
tripartite motif-containing 28
decreases expression
ISO
Clozapine results in decreased expression of TRIM28 protein
CTD
PMID:34122009
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
G
Tspan3
tetraspanin 3
decreases expression increases expression
ISO
Clozapine results in decreased expression of TSPAN3 protein Clozapine results in increased expression of TSPAN3 protein
CTD
PMID:34122009 PMID:36482696
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
G
Ttbk1
tau tubulin kinase 1
increases expression
ISO
Clozapine results in increased expression of TTBK1 protein
CTD
PMID:34122009
NCBI chr 9:14,493,166...14,538,372
Ensembl chr 9:14,493,389...14,535,774
G
Ttr
transthyretin
decreases expression increases expression
ISO EXP
Clozapine results in decreased expression of TTR mRNA Clozapine results in increased expression of TTR mRNA; Clozapine results in increased expression of TTR protein
CTD
PMID:15927202 PMID:17266109
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Ttyh2
tweety family member 2
increases expression
ISO
Clozapine results in increased expression of TTYH2 protein
CTD
PMID:34122009
NCBI chr10:99,709,063...99,753,449
Ensembl chr10:99,709,007...99,753,444
G
Tubal3
tubulin, alpha-like 3
increases expression
ISO
Clozapine results in increased expression of TUBAL3 protein
CTD
PMID:34122009
NCBI chr17:66,323,733...66,332,423
Ensembl chr17:66,323,733...66,335,355
G
Tubb4b
tubulin, beta 4B class IVb
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of TUBB4B protein
CTD
PMID:34122009
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
increases expression
ISO
Clozapine results in increased expression of TUBB protein
CTD
PMID:34122009
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubb6
tubulin, beta 6 class V
decreases expression
ISO
Clozapine results in decreased expression of TUBB6 protein
CTD
PMID:34122009
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Uap1l1
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
increases expression
ISO
Clozapine results in increased expression of UAP1L1 protein
CTD
PMID:34122009
NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443
G
Uba2
ubiquitin-like modifier activating enzyme 2
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in increased expression of UBA2 protein
CTD
PMID:34122009
NCBI chr 1:86,775,239...86,802,685
Ensembl chr 1:86,775,244...86,802,682
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
increases expression
ISO
Clozapine results in increased expression of UBA52 mRNA
CTD
PMID:14647396
NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807
G
Ube2r2
ubiquitin-conjugating enzyme E2R 2
affects expression
ISO
Clozapine affects the expression of UBE2R2 mRNA
CTD
PMID:14647396
NCBI chr 5:56,286,604...56,345,160
Ensembl chr 5:56,286,725...56,345,513
G
Ubtf
upstream binding transcription factor
decreases expression
ISO
Clozapine results in decreased expression of UBTF protein
CTD
PMID:34122009
NCBI chr10:87,258,217...87,274,291
Ensembl chr10:87,258,217...87,272,969
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
Clozapine results in increased expression of UGT1A1 mRNA
CTD
PMID:18227147
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
increases glucuronidation
ISO
UGT1A4 protein SNP results in increased glucuronidation of Clozapine
CTD
PMID:15708967
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Unc13a
unc-13 homolog A
decreases expression
EXP
Clozapine results in decreased expression of UNC13A mRNA
CTD
PMID:15860345
NCBI chr16:18,333,910...18,381,813
Ensembl chr16:18,336,229...18,381,872
G
Unc45b
unc-45 myosin chaperone B
increases expression
ISO
Clozapine results in increased expression of UNC45B protein
CTD
PMID:34122009
NCBI chr10:67,845,464...67,873,143
Ensembl chr10:67,845,462...67,873,389
G
Uqcr11
ubiquinol-cytochrome c reductase, complex III subunit XI
affects expression
ISO
Clozapine affects the expression of UQCR11 mRNA
CTD
PMID:14647396
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
G
Usp34
ubiquitin specific peptidase 34
increases expression
ISO
Clozapine results in increased expression of USP34 protein
CTD
PMID:34122009
NCBI chr14:97,285,799...97,476,376
Ensembl chr14:97,286,018...97,476,376
G
Usp5
ubiquitin specific peptidase 5
increases expression
ISO
Clozapine results in increased expression of USP5 protein
CTD
PMID:34122009
NCBI chr 4:157,619,663...157,634,681
Ensembl chr 4:157,619,643...157,634,711
G
Utp18
UTP18 small subunit processome component
increases expression
ISO
Clozapine results in increased expression of UTP18 protein
CTD
PMID:34122009
NCBI chr10:78,811,879...78,839,338
Ensembl chr10:78,811,880...78,839,627
G
Vamp1
vesicle-associated membrane protein 1
increases expression
EXP
Clozapine results in increased expression of VAMP1 mRNA
CTD
PMID:15860345
NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349
G
Vamp2
vesicle-associated membrane protein 2
increases expression
EXP
Clozapine results in increased expression of VAMP2 mRNA
CTD
PMID:15860345
NCBI chr10:53,793,581...53,797,815
Ensembl chr10:53,793,923...53,797,809
G
Vapa
VAMP associated protein A
increases expression
ISO
Clozapine results in increased expression of VAPA protein
CTD
PMID:34122009
NCBI chr 9:105,177,904...105,208,400
Ensembl chr 9:105,177,907...105,207,847
G
Vapb
VAMP associated protein B and C
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of VAPB protein
CTD
PMID:34122009
NCBI chr 3:162,535,974...162,578,747
Ensembl chr 3:162,535,905...162,573,763
G
Vcl
vinculin
increases expression
ISO
Clozapine results in increased expression of VCL protein
CTD
PMID:34122009
NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606
G
Vdac1
voltage-dependent anion channel 1
decreases expression
ISO
Clozapine results in decreased expression of VDAC1 protein
CTD
PMID:34122009
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vsnl1
visinin-like 1
decreases expression
EXP
Clozapine results in decreased expression of VSNL1 mRNA
CTD
PMID:12437575
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Wars1
tryptophanyl-tRNA synthetase 1
multiple interactions
ISO
[Cuprizone co-treated with Clozapine] results in decreased expression of WARS1 protein
CTD
PMID:34122009
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Wbp1l
WW domain binding protein 1-like
decreases expression
ISO
Clozapine results in decreased expression of WBP1L mRNA
CTD
PMID:14647396
NCBI chr 1:245,472,292...245,528,627
Ensembl chr 1:245,472,296...245,528,627
G
Wdr12
WD repeat domain 12
decreases expression
ISO
Clozapine results in decreased expression of WDR12 protein
CTD
PMID:34122009
NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Clozapine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
decreases expression
ISO
Clozapine results in decreased expression of YWHAB mRNA
CTD
PMID:17266109
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
increases expression
ISO
Clozapine results in increased expression of YWHAQ protein
CTD
PMID:34122009
NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:40,935,949...40,966,273
G
Zc3hav1
zinc finger CCCH-type containing, antiviral 1
decreases expression
ISO
Clozapine results in decreased expression of ZC3HAV1 protein
CTD
PMID:34122009
NCBI chr 4:67,012,129...67,062,428
Ensembl chr 4:67,012,185...67,062,428
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
ISO
Droperidol results in decreased activity of KCNH2 protein Droperidol inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:16757186 PMID:21158687 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Droperidol inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Il13
interleukin 13
decreases expression decreases secretion
ISO
Etazolate results in decreased expression of IL13 mRNA Etazolate results in decreased secretion of IL13 protein
CTD
PMID:16083514
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Ltc4s
leukotriene C4 synthase
decreases secretion
ISO
Etazolate results in decreased secretion of LTC4S protein
CTD
PMID:16083514
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions decreases activity
ISO
Flupenthixol analog inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Flupenthixol analog inhibits the reaction [ABCB1 protein results in decreased susceptibility to Vincristine] Flupenthixol analog results in decreased activity of ABCB1 protein; Flupenthixol analog results in decreased activity of ABCB1 protein mutant form
CTD
PMID:7905786 PMID:12711602
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Drd1
dopamine receptor D1
affects binding
ISO
Flupenthixol binds to DRD1 protein
CTD
PMID:1352677
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Flupenthixol results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
Flupenthixol results in decreased expression of PTGS1 protein
CTD
PMID:8897462
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Flupenthixol results in decreased expression of PTGS2 protein
CTD
PMID:8897462
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Alad
aminolevulinate dehydratase
multiple interactions decreases activity
EXP
[Fluphenazine co-treated with diphenyldiselenide] results in decreased activity of ALAD protein Fluphenazine results in decreased activity of ALAD protein
CTD
PMID:19486337
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Ar
androgen receptor
multiple interactions
ISO
Fluphenazine binds to and results in decreased activity of AR protein
CTD
PMID:17606915
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Cat
catalase
multiple interactions increases activity
EXP
diphenyldiselenide inhibits the reaction [Fluphenazine results in increased activity of CAT protein]
CTD
PMID:19486337
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
Fluphenazine results in decreased activity of CYP2C19 protein
CTD
PMID:15135088
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
Fluphenazine results in decreased activity of CYP2E1 protein
CTD
PMID:15135088
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
Fluphenazine results in decreased activity of CYP3A4 protein
CTD
PMID:15135088
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Drd2
dopamine receptor D2
affects binding
ISO
Fluphenazine binds to DRD2 protein
CTD
PMID:17606915
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Htr2a
5-hydroxytryptamine receptor 2A
affects binding
ISO
Fluphenazine binds to HTR2A protein
CTD
PMID:17606915
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding
ISO
Fluphenazine binds to HTR2C protein
CTD
PMID:17606915
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Ngf
nerve growth factor
multiple interactions
EXP
Fluphenazine inhibits the reaction [NGF protein results in increased uptake of Calcium]
CTD
PMID:1374475
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Prl
prolactin
increases secretion
ISO
Fluphenazine results in increased secretion of PRL protein
CTD
PMID:9989566
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Fluphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Tac1
tachykinin, precursor 1
decreases expression
ISO
Fluphenazine results in decreased expression of TAC1 mRNA
CTD
PMID:15845098
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tfeb
transcription factor EB
affects localization
ISO
Fluphenazine affects the localization of TFEB protein
CTD
PMID:28366621
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
G
Tmprss2
transmembrane serine protease 2
increases expression
EXP
Fluphenazine results in increased expression of TMPRSS2 mRNA
CTD
PMID:32808185
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions decreases expression decreases activity
ISO
Haloperidol inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin] Haloperidol results in decreased expression of ABCB1 mRNA Haloperidol results in decreased activity of ABCB1 protein
CTD
PMID:15946544 PMID:16810505
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
multiple interactions decreases expression
ISO
Haloperidol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] Haloperidol results in decreased expression of ABCC1 mRNA
CTD
PMID:15946544
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Haloperidol inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acadvl
acyl-CoA dehydrogenase, very long chain
decreases expression
ISO
Haloperidol results in decreased expression of ACADVL protein
CTD
PMID:34122009
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
G
Acat1
acetyl-CoA acetyltransferase 1
decreases expression
ISO
Haloperidol results in decreased expression of ACAT1 protein
CTD
PMID:34122009
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
G
Acsl3
acyl-CoA synthetase long-chain family member 3
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of ACSL3 protein
CTD
PMID:34122009
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Adam1a
ADAM metallopeptidase domain 1a
decreases expression
EXP
Haloperidol results in decreased expression of ADAM1A mRNA
CTD
PMID:16715494
NCBI chr12:35,017,433...35,020,300
Ensembl chr12:35,017,315...35,020,311
G
Adcy5
adenylate cyclase 5
affects response to substance multiple interactions
ISO
ADCY5 protein affects the susceptibility to Haloperidol SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Haloperidol]
CTD
PMID:12223546
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
G
Adcyap1r1
ADCYAP receptor type I
affects expression
ISO
Haloperidol affects the expression of ADCYAP1R1 mRNA
CTD
PMID:27900577
NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700
G
Adora2a
adenosine A2a receptor
affects response to substance
ISO
ADORA2A protein affects the susceptibility to Haloperidol
CTD
PMID:11172060
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adsl
adenylosuccinate lyase
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of ADSL protein
CTD
PMID:34122009
NCBI chr 7:112,479,256...112,503,439
Ensembl chr 7:112,479,271...112,503,760
G
Agpat1
1-acylglycerol-3-phosphate O-acyltransferase 1
decreases expression
ISO
Haloperidol results in decreased expression of AGPAT1 mRNA
CTD
PMID:14647396
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
G
Agps
alkylglycerone phosphate synthase
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of AGPS protein
CTD
PMID:34122009
NCBI chr 3:60,747,323...60,845,831
Ensembl chr 3:60,747,323...60,845,830
G
Ak4
adenylate kinase 4
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of AK4 protein
CTD
PMID:34122009
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akt1
AKT serine/threonine kinase 1
decreases expression
EXP
Haloperidol results in decreased expression of AKT1 mRNA
CTD
PMID:15860345
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
increases expression
EXP
Haloperidol results in increased expression of AKT2 mRNA
CTD
PMID:15860345
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
decreases expression
ISO
Haloperidol results in decreased expression of ALDH18A1 protein
CTD
PMID:34122009
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
Haloperidol results in increased expression of ALDOA mRNA
CTD
PMID:15860345
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
EXP
Haloperidol results in increased expression of ALDOC mRNA
CTD
PMID:15860345
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Ankhd1
ankyrin repeat and KH domain containing 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of ANKHD1 protein
CTD
PMID:34122009
NCBI chr18:28,161,882...28,260,917
Ensembl chr18:28,162,311...28,268,024
G
Ap2a2
adaptor related protein complex 2 subunit alpha 2
decreases expression
EXP
Haloperidol results in decreased expression of AP2A2 mRNA
CTD
PMID:15860345
NCBI chr 1:196,652,315...196,725,609
Ensembl chr 1:196,652,337...196,725,603
G
Ap2b1
adaptor related protein complex 2 subunit beta 1
affects expression
EXP
Haloperidol affects the expression of AP2B1 mRNA
CTD
PMID:15860345
NCBI chr10:68,099,397...68,205,023
Ensembl chr10:68,099,547...68,205,013
G
Ap2m1
adaptor related protein complex 2 subunit mu 1
increases expression
ISO
Haloperidol results in increased expression of AP2M1 protein
CTD
PMID:34122009
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
G
Ap3b1
adaptor related protein complex 3 subunit beta 1
increases expression
ISO
Haloperidol results in increased expression of AP3B1 protein
CTD
PMID:34122009
NCBI chr 2:25,600,069...25,800,937
Ensembl chr 2:25,600,040...25,800,935
G
Apod
apolipoprotein D
increases expression
ISO
Haloperidol results in increased expression of APOD mRNA
CTD
PMID:14647396
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
Appl1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of APPL1 protein
CTD
PMID:34122009
NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692
G
Arc
activity-regulated cytoskeleton-associated protein
increases expression multiple interactions
EXP
Haloperidol results in increased expression of ARC mRNA 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of ARC mRNA]
CTD
PMID:18208916 PMID:19695244
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Arf1
ADP-ribosylation factor 1
decreases expression
EXP
Haloperidol results in decreased expression of ARF1 mRNA
CTD
PMID:15860345
NCBI chr10:43,997,983...44,014,461
Ensembl chr10:43,997,986...44,014,434
G
Arf3
ADP-ribosylation factor 3
decreases expression
EXP
Haloperidol results in decreased expression of ARF3 mRNA
CTD
PMID:15860345
NCBI chr 7:129,886,082...129,912,022
Ensembl chr 7:129,886,082...129,912,002
G
Arl3
ADP ribosylation factor like GTPase 3
decreases expression
EXP
Haloperidol results in decreased expression of ARL3 mRNA
CTD
PMID:15860345
NCBI chr 1:245,400,659...245,446,673
Ensembl chr 1:245,400,550...245,446,820
G
Arl5a
ADP-ribosylation factor like GTPase 5A
decreases expression
EXP
Haloperidol results in decreased expression of ARL5A mRNA
CTD
PMID:15860345
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
G
Arpc4
actin related protein 2/3 complex, subunit 4
increases expression
ISO
Haloperidol results in increased expression of ARPC4 mRNA
CTD
PMID:14647396
NCBI chr 4:146,522,255...146,532,784
Ensembl chr 4:146,522,176...146,532,785
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
Haloperidol results in decreased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Asph
aspartate-beta-hydroxylase
increases expression
ISO
Haloperidol results in increased expression of ASPH protein
CTD
PMID:34122009
NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
decreases expression
EXP
Haloperidol results in decreased expression of ATP1A1 mRNA
CTD
PMID:15860345
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
decreases expression
EXP
Haloperidol results in decreased expression of ATP1A3 mRNA
CTD
PMID:15860345
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
increases expression
EXP
Haloperidol results in increased expression of ATP1B1 mRNA
CTD
PMID:15860345
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Atp1b2
ATPase Na+/K+ transporting subunit beta 2
decreases expression
EXP
Haloperidol results in decreased expression of ATP1B2 mRNA
CTD
PMID:15860345
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
G
Atp1b3
ATPase Na+/K+ transporting subunit beta 3
increases expression
EXP
Haloperidol results in increased expression of ATP1B3 mRNA
CTD
PMID:15860345
NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of ATP2A3 protein
CTD
PMID:34122009
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp6v1b1
ATPase H+ transporting V1 subunit B1
decreases expression
ISO
Haloperidol results in decreased expression of ATP6V1B1 protein
CTD
PMID:34122009
NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475
G
Atp6v1b2
ATPase H+ transporting V1 subunit B2
decreases expression
ISO
Haloperidol results in decreased expression of ATP6V1B2 mRNA
CTD
PMID:16465460
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
G
Axin2
axin 2
decreases expression
EXP
Haloperidol results in decreased expression of AXIN2 mRNA
CTD
PMID:16715494
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression increases expression
EXP
Haloperidol results in decreased expression of BAX protein Haloperidol results in increased expression of BAX mRNA; Haloperidol results in increased expression of BAX protein
CTD
PMID:16462815 PMID:17069804
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcat2
branched chain amino acid transaminase 2
decreases expression
ISO
Haloperidol results in decreased expression of BCAT2 protein
CTD
PMID:34122009
NCBI chr 1:96,040,407...96,060,008
Ensembl chr 1:96,042,625...96,060,007
G
Bcl2
BCL2, apoptosis regulator
increases expression
EXP
Haloperidol results in increased expression of BCL2 protein
CTD
PMID:17069804
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions increases expression decreases expression
EXP
EPO protein inhibits the reaction [Haloperidol results in decreased expression of BCL2L1 protein] Haloperidol results in increased expression of BCL2L1 protein
CTD
PMID:16462815 PMID:17805306
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
multiple interactions increases expression decreases expression
EXP ISO
BDNF protein inhibits the reaction [Haloperidol results in increased activity of CASP3 protein]; EPO protein inhibits the reaction [Haloperidol results in decreased expression of BDNF protein]; Haloperidol inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA] Haloperidol results in increased expression of BDNF mRNA Haloperidol results in increased expression of BDNF protein Haloperidol inhibits the reaction [Cocaine results in decreased expression of BDNF protein] Haloperidol results in decreased expression of BDNF mRNA; Haloperidol results in decreased expression of BDNF protein
CTD
PMID:11488957 PMID:12393228 PMID:12478621 PMID:15168214 PMID:17442543 PMID:17805306 PMID:18208916 PMID:20554863 PMID:29182611 More...
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
affects expression
EXP
Haloperidol affects the expression of BET1L mRNA
CTD
PMID:15860345
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
G
Bop1
BOP1 ribosomal biogenesis factor
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of BOP1 protein
CTD
PMID:34122009
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
G
Bptf
bromodomain PHD finger transcription factor
decreases expression
ISO
Haloperidol results in decreased expression of BPTF mRNA
CTD
PMID:14647396
NCBI chr10:91,980,279...92,082,731
Ensembl chr10:91,982,758...92,082,769
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
decreases expression
EXP ISO
Haloperidol results in decreased expression of CACNA1A mRNA
CTD
PMID:14647396 PMID:16715494
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
G
Calca
calcitonin-related polypeptide alpha
affects activity
EXP
Haloperidol affects the activity of CALCA protein
CTD
PMID:10075105
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Calm2
calmodulin 2
increases expression
EXP
Haloperidol results in increased expression of CALM2 mRNA
CTD
PMID:19289156
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions increases expression decreases expression
EXP
Haloperidol results in decreased expression of and results in decreased phosphorylation of CAMK2A protein Haloperidol results in increased expression of CAMK2A mRNA Haloperidol results in decreased expression of CAMK2A protein
CTD
PMID:15860345 PMID:18061412 PMID:19289156
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
decreases expression
EXP
Haloperidol results in decreased expression of CAMK2B mRNA
CTD
PMID:15860345
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
decreases expression
EXP
Haloperidol results in decreased expression of CAMK2D mRNA
CTD
PMID:15860345
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases expression increases expression
EXP
Haloperidol results in decreased expression of CAMK4 protein Haloperidol results in increased expression of CAMK4 mRNA
CTD
PMID:15860345 PMID:19289156
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
G
Camkk1
calcium/calmodulin-dependent protein kinase kinase 1
decreases expression
EXP
Haloperidol results in decreased expression of CAMKK1 protein
CTD
PMID:19289156
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
decreases expression
EXP
Haloperidol results in decreased expression of CAMKK2 protein
CTD
PMID:19289156
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of CAP1 protein
CTD
PMID:34122009
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
G
Casp3
caspase 3
multiple interactions increases expression increases activity
EXP
BDNF protein inhibits the reaction [Haloperidol results in increased activity of CASP3 protein]; EPO protein inhibits the reaction [Haloperidol results in increased expression of CASP3 protein]
CTD
PMID:15168214 PMID:17805306 PMID:18590723
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions decreases activity decreases expression
EXP ISO
Carvedilol inhibits the reaction [Haloperidol results in decreased expression of CAT protein]; Haloperidol results in decreased activity of and results in decreased expression of CAT protein; Zolpidem inhibits the reaction [Haloperidol results in decreased activity of CAT] Haloperidol results in decreased activity of CAT protein Cannabidiol inhibits the reaction [Haloperidol results in decreased activity of CAT protein]
CTD
PMID:12010767 PMID:12482469 PMID:16564057 PMID:17513028 PMID:30217539
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbx5
chromobox 5
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of CBX5 protein
CTD
PMID:34122009
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
G
Ccdc121
coiled-coil domain containing 121
increases expression
ISO
Haloperidol results in increased expression of CCDC121 protein
CTD
PMID:34122009
NCBI chr 6:24,970,845...24,973,451
Ensembl chr 6:24,970,833...24,973,478
G
Cck
cholecystokinin
increases expression
EXP
Haloperidol results in increased expression of CCK mRNA
CTD
PMID:10974607
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Ccnd1
cyclin D1
decreases expression
EXP
Haloperidol results in decreased expression of CCND1 mRNA
CTD
PMID:15860345
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
increases expression
EXP
Haloperidol results in increased expression of CCND3 mRNA
CTD
PMID:15860345
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccnl1
cyclin L1
increases expression
EXP
Haloperidol results in increased expression of CCNL1 mRNA
CTD
PMID:15860345
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Cct8
chaperonin containing TCP1 subunit 8
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of CCT8 protein
CTD
PMID:34122009
NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
G
Cdc42
cell division cycle 42
increases expression
EXP
Haloperidol results in increased expression of CDC42 mRNA
CTD
PMID:15860345
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdk4
cyclin-dependent kinase 4
increases expression
EXP
Haloperidol results in increased expression of CDK4 mRNA
CTD
PMID:15860345
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk5
cyclin-dependent kinase 5
increases expression
EXP
Haloperidol results in increased expression of CDK5 mRNA
CTD
PMID:15860345
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cfap161
cilia and flagella associated protein 161
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of CFAP161 protein
CTD
PMID:34122009
NCBI chr 1:137,743,783...137,768,685
Ensembl chr 1:137,743,784...137,768,730
G
Cfdp1
craniofacial development protein 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of CFDP1 protein
CTD
PMID:34122009
NCBI chr19:39,718,313...39,823,824
Ensembl chr19:39,718,347...39,823,824
G
Cfl1
cofilin 1
increases expression
ISO
Haloperidol results in increased expression of CFL1 protein
CTD
PMID:34122009
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Chl1
cell adhesion molecule L1-like
decreases expression
ISO
Haloperidol results in decreased expression of CHL1 mRNA
CTD
PMID:14647396
NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265
G
Chn1
chimerin 1
decreases expression
ISO
Haloperidol results in decreased expression of CHN1 mRNA
CTD
PMID:14647396
NCBI chr 3:58,509,822...58,676,462
Ensembl chr 3:58,510,536...58,676,490
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
ISO
Haloperidol results in increased expression of CHORDC1 protein
CTD
PMID:34122009
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
G
Chrm4
cholinergic receptor, muscarinic 4
affects response to substance
ISO
CHRM4 affects the susceptibility to Haloperidol
CTD
PMID:21269601
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
G
Cldn11
claudin 11
decreases expression
ISO
Haloperidol results in decreased expression of CLDN11 mRNA
CTD
PMID:17177202
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
G
Clta
clathrin, light chain A
affects expression
EXP
Haloperidol affects the expression of CLTA mRNA
CTD
PMID:15860345
NCBI chr 5:58,244,253...58,263,480
Ensembl chr 5:58,245,442...58,263,472
G
Cltb
clathrin, light chain B
decreases expression
EXP
Haloperidol results in decreased expression of CLTB mRNA
CTD
PMID:15860345
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
G
Cmya5
cardiomyopathy associated 5
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of CMYA5 protein
CTD
PMID:34122009
NCBI chr 2:24,279,520...24,378,253
Ensembl chr 2:24,279,528...24,378,364
G
Cnot3
CCR4-NOT transcription complex, subunit 3
decreases expression
ISO
Haloperidol results in decreased expression of CNOT3 protein
CTD
PMID:34122009
NCBI chr 1:65,555,924...65,572,167
Ensembl chr 1:65,555,924...65,572,167
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
decreases expression
ISO
Haloperidol results in decreased expression of CNP mRNA
CTD
PMID:17177202
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Cnr1
cannabinoid receptor 1
multiple interactions increases methylation
ISO EXP
CNR1 protein affects the reaction [[potassium perchlorate co-treated with 2-mercapto-1-methylimidazole] inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein]]; CNR1 protein affects the reaction [[potassium perchlorate co-treated with 2-mercapto-1-methylimidazole] inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK3 protein]] Haloperidol results in increased methylation of CNR1 promoter Haloperidol inhibits the reaction [Methylazoxymethanol Acetate results in decreased methylation of CNR1 promoter]
CTD
PMID:28017790 PMID:30496751
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Coil
coilin
increases expression
EXP
Haloperidol results in increased expression of COIL mRNA
CTD
PMID:16715494
NCBI chr10:73,789,077...73,810,378
Ensembl chr10:73,789,488...73,810,393
G
Cops3
COP9 signalosome subunit 3
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of COPS3 protein
CTD
PMID:34122009
NCBI chr10:44,618,115...44,652,807
Ensembl chr10:44,618,115...44,641,597
G
Cops4
COP9 signalosome subunit 4
decreases expression
ISO
Haloperidol results in decreased expression of COPS4 protein
CTD
PMID:34122009
NCBI chr14:9,078,579...9,108,788
Ensembl chr14:9,078,576...9,108,887
G
Cpn1
carboxypeptidase N subunit 1
increases expression
EXP
Haloperidol results in increased expression of CPN1 mRNA
CTD
PMID:16715494
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
G
Cpne3
copine 3
decreases expression
ISO
Haloperidol results in decreased expression of CPNE3 protein
CTD
PMID:34122009
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
G
Creb1
cAMP responsive element binding protein 1
multiple interactions increases activity increases phosphorylation
ISO EXP
Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of CREB1 protein] Amphetamine affects the reaction [Haloperidol results in increased activity of CREB1 protein modified form]
CTD
PMID:12125044 PMID:12871586
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Haloperidol results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crhbp
corticotropin releasing hormone binding protein
decreases expression
EXP
Haloperidol results in decreased expression of CRHBP mRNA
CTD
PMID:16715494
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
G
Cry1
cryptochrome circadian regulator 1
decreases expression
ISO
Haloperidol results in decreased expression of CRY1 mRNA
CTD
PMID:27746588
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
G
Csnk2a1
casein kinase 2 alpha 1
decreases expression
EXP
Haloperidol results in decreased expression of CSNK2A1 mRNA
CTD
PMID:16715494
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
G
Cst3
cystatin C
increases expression
ISO
Haloperidol results in increased expression of CST3 mRNA
CTD
PMID:14647396
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Ctnnb1
catenin beta 1
decreases expression increases expression multiple interactions
ISO EXP
Haloperidol results in decreased expression of CTNNB1 mRNA Haloperidol results in increased expression of CTNNB1 protein DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein]
CTD
PMID:16144542 PMID:18797397
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctrl
chymotrypsin-like
increases expression
EXP
Haloperidol results in increased expression of CTRL mRNA
CTD
PMID:16715494
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
G
Ctsk
cathepsin K
increases expression
EXP
Haloperidol results in increased expression of CTSK mRNA
CTD
PMID:16715494
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cyb5r1
cytochrome b5 reductase 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of CYB5R1 protein
CTD
PMID:34122009
NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects response to substance
ISO
CYP2D6 protein polymorphism affects the susceptibility to Haloperidol
CTD
PMID:15538130
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol; Fluoxetine inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]; Fluvoxamine inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]; nefazodone inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]; norfluoxetine inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]; Trazodone inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol]
CTD
PMID:12584149
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions
ISO
CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol; Fluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol]; Fluvoxamine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol]; nefazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol]; norfluoxetine inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol]; Trazodone inhibits the reaction [CYP3A5 protein results in increased oxidation of and results in increased activity of Haloperidol]
CTD
PMID:12584149
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Dcaf6
DDB1 and CUL4 associated factor 6
decreases expression
ISO
Haloperidol results in decreased expression of DCAF6 mRNA
CTD
PMID:14647396
NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512
G
Dclk1
doublecortin-like kinase 1
increases expression
ISO EXP
Haloperidol results in increased expression of DCLK1 mRNA
CTD
PMID:15860345 PMID:18797397
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Ddx27
DEAD-box helicase 27
increases expression
ISO
Haloperidol results in increased expression of DDX27 protein
CTD
PMID:34122009
NCBI chr 3:155,744,182...155,763,380
Ensembl chr 3:155,744,150...155,763,372
G
Ddx46
DEAD-box helicase 46
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of DDX46 protein
CTD
PMID:34122009
NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439
G
Ddx5
DEAD-box helicase 5
decreases expression
ISO
Haloperidol results in decreased expression of DDX5 protein
CTD
PMID:34122009
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
G
Dennd10
DENN domain containing 10
increases expression
EXP
Haloperidol results in increased expression of DENND10 mRNA
CTD
PMID:16715494
NCBI chr 1:259,950,955...259,974,459
Ensembl chr 1:259,950,866...259,974,455
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Haloperidol results in increased expression of DEPP1 mRNA
CTD
PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Dgka
diacylglycerol kinase, alpha
decreases expression
EXP
Haloperidol results in decreased expression of DGKA mRNA
CTD
PMID:15860345
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
G
Dhx36
DEAH-box helicase 36
decreases expression
ISO
Haloperidol results in decreased expression of DHX36 protein
CTD
PMID:34122009
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
G
Dhx38
DEAH-box helicase 38
decreases expression
ISO
Haloperidol results in decreased expression of DHX38 protein
CTD
PMID:34122009
NCBI chr19:37,512,893...37,530,135
Ensembl chr19:37,512,891...37,530,140
G
Dlat
dihydrolipoamide S-acetyltransferase
decreases expression
EXP
Haloperidol results in decreased expression of DLAT mRNA
CTD
PMID:15860345
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
G
Dlg2
discs large MAGUK scaffold protein 2
increases expression
ISO
Haloperidol results in increased expression of DLG2 protein
CTD
PMID:34122009
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
G
Dnah1
dynein, axonemal, heavy chain 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of DNAH1 protein
CTD
PMID:34122009
NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350
G
Dnah3
dynein, axonemal, heavy chain 3
increases expression
ISO
Haloperidol results in increased expression of DNAH3 protein
CTD
PMID:34122009
NCBI chr 1:174,305,929...174,479,490
Ensembl chr 1:174,306,644...174,479,474
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of DNAJB1 protein
CTD
PMID:34122009
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
multiple interactions increases expression
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of DNAJB11 protein Haloperidol results in increased expression of DNAJB11 protein
CTD
PMID:34122009
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dpf1
double PHD fingers 1
increases expression
ISO
Haloperidol results in increased expression of DPF1 mRNA
CTD
PMID:14647396
NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950
G
Dr1
down-regulator of transcription 1
decreases expression
ISO
Haloperidol results in decreased expression of DR1 protein
CTD
PMID:34122009
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
G
Drd1
dopamine receptor D1
affects binding increases expression decreases expression affects activity
ISO EXP
Haloperidol binds to DRD1 protein Haloperidol results in increased expression of DRD1 protein Haloperidol results in decreased expression of DRD1 mRNA Haloperidol affects the activity of DRD1 protein
CTD
PMID:8750706 PMID:8794996 PMID:12887421 PMID:16983399 PMID:23611293
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
affects binding affects activity multiple interactions increases expression affects response to substance
ISO EXP
DRD2 protein binds to Haloperidol; DRD2 protein binds to Haloperidol analog; Haloperidol binds to DRD2 protein Haloperidol affects the activity of DRD2 protein [Haloperidol binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein; cyclo(leucylglycine) inhibits the reaction [Haloperidol results in increased expression of DRD2 protein]; DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein]; DRD2 protein affects the reaction [Haloperidol results in increased expression of DVL3 protein]; DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3A protein]; DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3B protein]; felbamate inhibits the reaction [Haloperidol affects the activity of DRD2 protein]; Haloperidol binds to and results in decreased activity of DRD2 protein; Haloperidol inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; Haloperidol inhibits the reaction [iodosulpride binds to DRD2 protein]; Haloperidol inhibits the reaction [Spiperone binds to DRD2 protein]; Haloperidol promotes the reaction [Dopamine binds to DRD2 protein]; zinc chloride inhibits the reaction [Haloperidol binds to DRD2 protein] Haloperidol results in increased expression of DRD2; Haloperidol results in increased expression of DRD2 mRNA; Haloperidol results in increased expression of DRD2 protein Haloperidol binds to DRD2; Haloperidol binds to DRD2 protein; Haloperidol binds to DRD2 protein alternative form [Haloperidol binds to and results in decreased activity of DRD2 protein] which results in decreased susceptibility to Ethanol; [Haloperidol results in increased expression of DRD2 protein] which results in decreased susceptibility to Pentobarbital; Haloperidol binds to and results in decreased activity of DRD2 protein DRD2 affects the susceptibility to Haloperidol; DRD2 protein affects the susceptibility to Haloperidol Thioctic Acid inhibits the reaction [Haloperidol results in increased expression of DRD2 mRNA]; Thioctic Acid inhibits the reaction [Haloperidol results in increased expression of DRD2 protein]
CTD
PMID:1351265 PMID:1361536 PMID:1380082 PMID:2945998 PMID:7845605 PMID:7878047 PMID:8115415 PMID:8200438 PMID:8794996 PMID:9109525 PMID:9808703 PMID:10720636 PMID:10936494 PMID:11172060 PMID:11927170 PMID:11997696 PMID:12191584 PMID:12476322 PMID:14552778 PMID:15716360 PMID:16033416 PMID:16144542 PMID:18295747 PMID:19120057 PMID:20361897 PMID:20730801 PMID:23611293 More...
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
affects binding multiple interactions
ISO EXP
DRD3 protein binds to Haloperidol analog Haloperidol affects the reaction [Methylazoxymethanol Acetate results in increased expression of DRD3 mRNA]
CTD
PMID:14552778 PMID:32360362
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Drd4
dopamine receptor D4
affects activity affects binding
ISO EXP
Haloperidol affects the activity of DRD4 protein Haloperidol binds to Drd4 protein
CTD RGD
PMID:23611293 PMID:8078498
RGD:7248459
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
G
Drp2
dystrophin related protein 2
increases expression
EXP
Haloperidol results in increased expression of DRP2 mRNA alternative form
CTD
PMID:16715494
NCBI chr X:97,607,577...97,658,117
Ensembl chr X:97,607,719...97,655,684
G
Dtnbp1
dystrobrevin binding protein 1
increases response to substance affects response to substance
ISO
DTNBP1 gene polymorphism results in increased susceptibility to Haloperidol DTNBP1 protein affects the susceptibility to Haloperidol
CTD
PMID:19369910
NCBI chr17:19,685,218...19,776,668
Ensembl chr17:19,685,215...19,776,661
G
Dusp1
dual specificity phosphatase 1
decreases expression
EXP
Haloperidol results in decreased expression of DUSP1 mRNA
CTD
PMID:15860345
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
decreases expression
EXP
Haloperidol results in decreased expression of DUSP6 mRNA
CTD
PMID:15860345
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dvl3
dishevelled segment polarity protein 3
multiple interactions increases expression
EXP
DRD2 protein affects the reaction [Haloperidol results in increased expression of DVL3 protein]
CTD
PMID:16144542
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
G
Eef1g
eukaryotic translation elongation factor 1 gamma
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of EEF1G protein
CTD
PMID:34122009
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
G
Egr1
early growth response 1
affects expression multiple interactions increases expression
EXP ISO
Haloperidol affects the expression of EGR1 protein Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]; OPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]] Haloperidol results in increased expression of EGR1 mRNA; Haloperidol results in increased expression of EGR1 protein
CTD
PMID:12243769 PMID:16452686 PMID:17028028 PMID:17913375 PMID:18208916 PMID:19695244 PMID:20184921 More...
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
affects expression increases expression decreases expression
ISO EXP
Haloperidol affects the expression of EGR2 mRNA Haloperidol results in increased expression of EGR2 mRNA Haloperidol results in decreased expression of EGR2 protein
CTD
PMID:17028028 PMID:18208916 PMID:19401217
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Eif2b5
eukaryotic translation initiation factor 2B subunit epsilon
increases expression
ISO
Haloperidol results in increased expression of EIF2B5 protein
CTD
PMID:34122009
NCBI chr11:80,394,433...80,404,468
Ensembl chr11:80,394,433...80,404,419
G
Eif5a
eukaryotic translation initiation factor 5A
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of EIF5A protein
CTD
PMID:34122009
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
G
Elk1
ETS transcription factor ELK1
increases phosphorylation multiple interactions
ISO EXP
Haloperidol results in increased phosphorylation of ELK1 protein Nifedipine affects the reaction [Haloperidol results in increased phosphorylation of ELK1 protein] SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of ELK1 protein]
CTD
PMID:12871586 PMID:17913375
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Eno1
enolase 1
increases expression
EXP
Haloperidol results in increased expression of ENO1 mRNA
CTD
PMID:15860345
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Epo
erythropoietin
multiple interactions
EXP
EPO protein inhibits the reaction [Haloperidol results in decreased expression of BCL2L1 protein]; EPO protein inhibits the reaction [Haloperidol results in decreased expression of BDNF protein]; EPO protein inhibits the reaction [Haloperidol results in increased expression of CASP3 protein]
CTD
PMID:17805306
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Erap1
endoplasmic reticulum aminopeptidase 1
decreases expression
ISO
Haloperidol results in decreased expression of ERAP1 protein
CTD
PMID:34122009
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions
EXP
Haloperidol results in increased expression of and results in increased phosphorylation of ERBB2 protein
CTD
PMID:26961615
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
increases expression multiple interactions
EXP
Haloperidol results in increased expression of ERBB4 protein Haloperidol results in increased expression of and results in increased phosphorylation of ERBB4 protein
CTD
PMID:18184445 PMID:26961615
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Ergic1
endoplasmic reticulum-golgi intermediate compartment 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of ERGIC1 protein
CTD
PMID:34122009
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
G
Ezr
ezrin
decreases expression
ISO
Haloperidol results in decreased expression of EZR protein
CTD
PMID:34122009
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
Fabp3
fatty acid binding protein 3
affects response to substance increases expression
ISO
FABP3 affects the susceptibility to Haloperidol Haloperidol results in increased expression of FABP3 protein
CTD
PMID:20181611 PMID:34122009
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
G
Fasn
fatty acid synthase
increases expression
ISO
Haloperidol results in increased expression of FASN mRNA
CTD
PMID:16027736
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Flt1
Fms related receptor tyrosine kinase 1
decreases expression
ISO
Haloperidol results in decreased expression of FLT1 protein
CTD
PMID:34122009
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Haloperidol results in increased expression of FNDC4 mRNA
CTD
PMID:17175557
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression decreases expression
ISO EXP
8-Hydroxy-2-(di-n-propylamino)tetralin affects the reaction [Haloperidol results in increased expression of FOS protein]; Dizocilpine Maleate inhibits the reaction [Haloperidol results in increased expression of FOS protein]; ifenprodil inhibits the reaction [Haloperidol results in increased expression of FOS protein]; tandospirone inhibits the reaction [Haloperidol results in increased expression of FOS protein]; traxoprodil mesylate inhibits the reaction [Haloperidol results in increased expression of FOS protein]; WAY 100135 inhibits the reaction [tandospirone inhibits the reaction [Haloperidol results in increased expression of FOS protein]] Haloperidol results in increased expression of FOS mRNA; Haloperidol results in increased expression of FOS protein Haloperidol results in decreased expression of FOS mRNA; Haloperidol results in decreased expression of FOS protein 8-(3-chlorostyryl)caffeine inhibits the reaction [Haloperidol results in increased expression of FOS mRNA]; 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of FOS mRNA]; Clozapine affects the reaction [Haloperidol results in increased expression of FOS protein]; Dronabinol promotes the reaction [Haloperidol results in increased expression of FOS protein]; Nifedipine affects the reaction [Haloperidol results in increased expression of FOS protein]; Nimodipine affects the reaction [Haloperidol results in increased expression of FOS protein]; Propranolol inhibits the reaction [Haloperidol results in increased expression of FOS protein]; Scopolamine inhibits the reaction [Haloperidol results in increased expression of FOS protein]; Theophylline inhibits the reaction [Haloperidol results in increased expression of FOS mRNA]
CTD
PMID:1393566 PMID:9571656 PMID:9748542 PMID:10199625 PMID:10435392 PMID:11166331 PMID:11409749 PMID:11440804 PMID:11516571 PMID:11602683 PMID:11997696 PMID:12093589 PMID:12125044 PMID:12243769 PMID:12464447 PMID:15120589 PMID:15140647 PMID:17028028 PMID:17913375 PMID:18208916 PMID:18295747 PMID:18521575 PMID:18585397 PMID:18789920 PMID:19352073 PMID:19695244 More...
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO EXP
Haloperidol results in increased expression of FOSB protein alternative form Haloperidol results in increased expression of FOSB modified form; Haloperidol results in increased expression of FOSB mRNA; Haloperidol results in increased expression of FOSB protein 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of FOSB mRNA]
CTD
PMID:8714707 PMID:11180499 PMID:12243769 PMID:15579174 PMID:19695244 PMID:24067299 More...
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
Amphetamine affects the reaction [Haloperidol results in increased expression of FOSL1 protein] Haloperidol results in increased expression of FOSL1 mRNA; Haloperidol results in increased expression of FOSL1 protein
CTD
PMID:12125044 PMID:18208916
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
increases expression
EXP
Haloperidol results in increased expression of FOSL2 mRNA
CTD
PMID:12243769
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
multiple interactions increases phosphorylation affects response to substance
ISO
FYN gene mutant form inhibits the reaction [Haloperidol results in increased phosphorylation of GRIN2B protein] Haloperidol results in increased phosphorylation of FYN protein FYN protein affects the susceptibility to Haloperidol
CTD
PMID:16407246
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
decreases expression
ISO
Haloperidol results in decreased expression of GABRA1 mRNA
CTD
PMID:18797397
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
increases expression
EXP
Haloperidol results in increased expression of GABRB3 mRNA
CTD
PMID:18923069
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
G
Gad1
glutamate decarboxylase 1
multiple interactions increases expression decreases expression
EXP
[Haloperidol co-treated with Fluvoxamine] affects the expression of GAD1 protein Haloperidol results in increased expression of GAD1 mRNA Haloperidol results in decreased expression of GAD1 mRNA; Haloperidol results in decreased expression of GAD1 protein
CTD
PMID:12887421 PMID:14519413 PMID:15061247 PMID:15967061 PMID:18923069 PMID:19359144 More...
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
decreases expression increases expression
EXP
Haloperidol results in decreased expression of GAD2 mRNA; Haloperidol results in decreased expression of GAD2 protein Haloperidol results in increased expression of GAD2 mRNA
CTD
PMID:18923069 PMID:19359144
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Galnt2
polypeptide N-acetylgalactosaminyltransferase 2
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of GALNT2 protein
CTD
PMID:34122009
NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
EXP
Haloperidol results in increased expression of GAPDH mRNA
CTD
PMID:15860345
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gda
guanine deaminase
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of GDA protein
CTD
PMID:34122009
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Haloperidol results in increased expression of GDPD3 mRNA
CTD
PMID:17175557
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
G
Gfap
glial fibrillary acidic protein
decreases expression
ISO
Haloperidol results in decreased expression of GFAP protein
CTD
PMID:34122009
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gimap5
GTPase, IMAP family member 5
decreases expression
EXP
Haloperidol results in decreased expression of GIMAP5 mRNA
CTD
PMID:16715494
NCBI chr 4:77,693,417...77,701,025
Ensembl chr 4:77,687,564...77,703,086
G
Gja1
gap junction protein, alpha 1
decreases expression
EXP
Haloperidol results in decreased expression of GJA1 protein
CTD
PMID:18585900
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glo1
glyoxalase 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of GLO1 protein
CTD
PMID:34122009
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
G
Glul
glutamate-ammonia ligase
decreases expression
EXP
Haloperidol results in decreased expression of GLUL mRNA
CTD
PMID:15860345
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gna12
G protein subunit alpha 12
decreases expression
EXP
Haloperidol results in decreased expression of GNA12 mRNA
CTD
PMID:15860345
NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255
G
Gnai1
G protein subunit alpha i1
decreases expression
EXP
Haloperidol results in decreased expression of GNAI1 mRNA
CTD
PMID:15860345
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnai2
G protein subunit alpha i2
decreases expression
EXP
Haloperidol results in decreased expression of GNAI2 mRNA
CTD
PMID:15860345
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
decreases expression
EXP
Haloperidol results in decreased expression of GNAI3 mRNA
CTD
PMID:15860345
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gnao1
G protein subunit alpha o1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of GNAO1 protein
CTD
PMID:34122009
NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
G
Gnas
GNAS complex locus
decreases expression
EXP
Haloperidol results in decreased expression of GNAS mRNA
CTD
PMID:15860345
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnrh1
gonadotropin releasing hormone 1
multiple interactions
EXP
Haloperidol inhibits the reaction [manganese chloride results in increased secretion of GNRH1 protein]
CTD
PMID:18603625
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
G
Got2
glutamic-oxaloacetic transaminase 2
affects expression multiple interactions
EXP ISO
Haloperidol affects the expression of GOT2 mRNA [Cuprizone co-treated with Haloperidol] results in increased expression of GOT2 protein
CTD
PMID:15860345 PMID:34122009
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
Haloperidol results in increased expression of GPX1 mRNA
CTD
PMID:14647396
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
decreases expression
EXP
Haloperidol results in decreased expression of GRIA1 mRNA
CTD
PMID:15860345
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
increases expression
EXP
Haloperidol results in increased expression of GRIK2 mRNA
CTD
PMID:18923069
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
G
Grik4
glutamate ionotropic receptor kainate type subunit 4
increases expression
EXP
Haloperidol results in increased expression of GRIK4 mRNA
CTD
PMID:15860345
NCBI chr 8:42,903,043...43,331,990
Ensembl chr 8:42,905,056...43,193,751
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
increases expression
ISO EXP
Haloperidol results in increased expression of GRIK5 mRNA
CTD
PMID:14647396 PMID:15860345
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression increases expression
EXP
Haloperidol results in decreased expression of GRIN1 mRNA Haloperidol results in increased expression of GRIN1 mRNA
CTD
PMID:12020038
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
decreases expression
EXP
Haloperidol results in decreased expression of GRIN2A mRNA; Haloperidol results in decreased expression of GRIN2A protein
CTD
PMID:12608697 PMID:15860345 PMID:18061412
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
multiple interactions increases phosphorylation
ISO
FYN gene mutant form inhibits the reaction [Haloperidol results in increased phosphorylation of GRIN2B protein]
CTD
PMID:16407246
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
EXP
Haloperidol results in increased expression of GRIN2C mRNA
CTD
PMID:15860345
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grin2d
glutamate ionotropic receptor NMDA type subunit 2D
decreases expression
EXP
Haloperidol results in decreased expression of GRIN2D mRNA
CTD
PMID:18923069
NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
G
Grin3b
glutamate ionotropic receptor NMDA type subunit 3B
increases expression
EXP
Haloperidol results in increased expression of GRIN3B mRNA
CTD
PMID:15860345
NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183
G
Grk6
G protein-coupled receptor kinase 6
decreases expression
EXP
Haloperidol results in decreased expression of GRK6 mRNA
CTD
PMID:16715494
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
G
Grm1
glutamate metabotropic receptor 1
increases expression
EXP
Haloperidol results in increased expression of GRM1 mRNA
CTD
PMID:15860345
NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170
G
Grm2
glutamate metabotropic receptor 2
increases expression
EXP
Haloperidol results in increased expression of GRM2 mRNA
CTD
PMID:18923069
NCBI chr 8:107,280,099...107,293,159
Ensembl chr 8:107,280,099...107,293,146
G
Gsk3a
glycogen synthase kinase 3 alpha
increases expression multiple interactions
EXP
Haloperidol results in increased expression of GSK3A protein DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3A protein]
CTD
PMID:16144542
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions increases expression
EXP
DRD2 protein affects the reaction [Haloperidol results in increased expression of GSK3B protein] Haloperidol results in increased expression of GSK3B mRNA; Haloperidol results in increased expression of GSK3B protein
CTD
PMID:16144542 PMID:19359144
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP
Haloperidol results in increased expression of GSTM1 mRNA
CTD
PMID:15860345
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
decreases expression
EXP
Haloperidol results in decreased expression of GSTM2 mRNA
CTD
PMID:15860345
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
multiple interactions decreases expression
ISO
Haloperidol inhibits the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] Haloperidol results in decreased expression of GSTP1 mRNA
CTD
PMID:15946544
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gtf2e1
general transcription factor IIE subunit 1
decreases expression
ISO
Haloperidol results in decreased expression of GTF2E1 protein
CTD
PMID:34122009
NCBI chr11:63,182,073...63,215,349
Ensembl chr11:63,182,349...63,213,942
G
H2ac18
H2A clustered histone 18
increases expression
ISO
Haloperidol results in increased expression of H2AC18 mRNA
CTD
PMID:14647396
NCBI chr 2:183,808,398...183,808,992
G
H2ac20
H2A clustered histone 20
increases expression
ISO
Haloperidol results in increased expression of H2AC20 protein
CTD
PMID:34122009
NCBI chr 2:183,779,879...183,780,357
G
H2aj
H2A.J histone
increases expression
ISO
Haloperidol results in increased expression of H2AJ protein
CTD
PMID:34122009
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of HADHB protein
CTD
PMID:34122009
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
G
Hars1
histidyl-tRNA synthetase 1
increases expression
ISO
Haloperidol results in increased expression of HARS1 protein
CTD
PMID:34122009
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
G
Hcfc1
host cell factor C1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of HCFC1 protein
CTD
PMID:34122009
NCBI chr X:151,687,779...151,712,688
Ensembl chr X:151,687,779...151,712,638
G
Higd1a
HIG1 hypoxia inducible domain family, member 1A
increases expression
ISO
Haloperidol results in increased expression of HIGD1A mRNA
CTD
PMID:14647396
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases activity increases expression multiple interactions
ISO
Haloperidol results in increased activity of HMGCR protein Haloperidol results in increased expression of HMGCR mRNA [Haloperidol results in increased activity of HMGCR protein] which results in increased abundance of Cholesterol; [Haloperidol results in increased activity of HMGCR protein] which results in increased abundance of Triglycerides
CTD
PMID:16027736 PMID:17052361
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
Haloperidol results in increased expression of HMGCS1 mRNA
CTD
PMID:16027736 PMID:17052361
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hnrnpc
heterogeneous nuclear ribonucleoprotein C
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of HNRNPC protein
CTD
PMID:34122009
NCBI chr15:24,779,593...24,809,213
Ensembl chr15:24,779,450...24,809,183
G
Hnrnpk
heterogeneous nuclear ribonucleoprotein K
decreases expression
ISO
Haloperidol results in decreased expression of HNRNPK protein
CTD
PMID:34122009
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
G
Homer1
homer scaffold protein 1
multiple interactions increases expression
EXP
Cycloserine inhibits the reaction [Haloperidol results in increased expression of HOMER1 mRNA]
CTD
PMID:12464447 PMID:15860345 PMID:20147574
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Hpcal4
hippocalcin-like 4
decreases expression
EXP
Haloperidol results in decreased expression of HPCAL4 mRNA
CTD
PMID:12437575
NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
decreases expression
ISO
Haloperidol results in decreased expression of HSD17B4 protein
CTD
PMID:34122009
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
G
Hspg2
heparan sulfate proteoglycan 2
decreases expression multiple interactions
ISO
Haloperidol results in decreased expression of HSPG2 mRNA HSPG2 gene results in increased susceptibility to [Haloperidol co-treated with Reserpine]
CTD
PMID:20072119
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
G
Hsph1
heat shock protein family H (Hsp110) member 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of HSPH1 protein
CTD
PMID:34122009
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htr1d
5-hydroxytryptamine receptor 1D
decreases expression
EXP
Haloperidol results in decreased expression of HTR1D mRNA
CTD
PMID:16715494
NCBI chr 5:148,656,252...148,676,532
Ensembl chr 5:148,674,495...148,675,619
G
Htr2a
5-hydroxytryptamine receptor 2A
affects binding multiple interactions
EXP ISO
Haloperidol binds to HTR2A protein [Phencyclidine co-treated with Haloperidol] affects the activity of HTR2A protein
CTD
PMID:7520908 PMID:12191584 PMID:15380371
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
decreases expression
EXP
Haloperidol results in decreased expression of HTR2C mRNA
CTD
PMID:17868938
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Id2
inhibitor of DNA binding 2
decreases expression increases expression
EXP
Haloperidol results in decreased expression of ID2 mRNA Haloperidol results in increased expression of ID2 mRNA
CTD
PMID:12437575
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ikbip
IKBKB interacting protein
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of IKBIP protein
CTD
PMID:34122009
NCBI chr 7:25,579,865...25,598,548
Ensembl chr 7:25,579,832...25,605,162
G
Il10
interleukin 10
multiple interactions
ISO
[Cannabidiol co-treated with Haloperidol] results in increased expression of IL10 protein
CTD
PMID:30217539
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO
Cannabidiol inhibits the reaction [Haloperidol results in increased expression of IL1B protein]
CTD
PMID:30217539
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
increases expression multiple interactions
ISO
Haloperidol results in increased expression of IL6 mRNA Cannabidiol inhibits the reaction [Haloperidol results in increased expression of IL6 mRNA]
CTD
PMID:30217539
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ilkap
ILK associated serine/threonine phosphatase
decreases expression
EXP
Haloperidol results in decreased expression of ILKAP mRNA
CTD
PMID:15860345
NCBI chr 9:91,966,440...91,988,791
Ensembl chr 9:91,966,441...91,988,892
G
Impdh1
inosine monophosphate dehydrogenase 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of IMPDH1 protein
CTD
PMID:34122009
NCBI chr 4:57,801,842...57,817,434
Ensembl chr 4:57,801,831...57,819,076
G
Inha
inhibin subunit alpha
decreases expression
EXP
Haloperidol results in decreased expression of INHA mRNA
CTD
PMID:16715494
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Haloperidol results in increased expression of INHBE mRNA
CTD
PMID:17175557
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression decreases expression
EXP
Haloperidol results in increased expression of JUN mRNA; Haloperidol results in increased expression of JUN protein Haloperidol results in decreased expression of JUN mRNA
CTD
PMID:12093589 PMID:12125044 PMID:15860345 PMID:18208916
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression decreases expression
EXP
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of JUNB mRNA] Haloperidol results in decreased expression of JUNB mRNA
CTD
PMID:12093589 PMID:19695244
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kcna1
potassium voltage-gated channel subfamily A member 1
increases expression
ISO
Haloperidol results in increased expression of KCNA1 mRNA; Haloperidol results in increased expression of KCNA1 protein
CTD
PMID:18797397
NCBI chr 4:159,464,223...159,472,905
Ensembl chr 4:159,464,188...159,472,682
G
Kcnab1
potassium voltage-gated channel subfamily A regulatory beta subunit 1
decreases expression
ISO
Haloperidol results in decreased expression of KCNAB1 mRNA
CTD
PMID:18797397
NCBI chr 2:149,137,025...149,603,540
Ensembl chr 2:149,137,041...149,603,534
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Haloperidol inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Haloperidol results in decreased activity of KCNH2 protein
CTD
PMID:15671647 PMID:16278312 PMID:16494862 PMID:19583963 PMID:21158687
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnip3
potassium voltage-gated channel interacting protein 3
decreases expression
ISO
Haloperidol results in decreased expression of KCNIP3 mRNA; Haloperidol results in decreased expression of KCNIP3 protein
CTD
PMID:18797397
NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556
G
Kdm1a
lysine demethylase 1A
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of KDM1A protein
CTD
PMID:34122009
NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
G
Kdr
kinase insert domain receptor
increases expression
ISO
Haloperidol results in increased expression of KDR protein
CTD
PMID:34122009
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kif5c
kinesin family member 5C
decreases expression
ISO
Haloperidol results in decreased expression of KIF5C protein
CTD
PMID:34122009
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
G
Kiz
kizuna centrosomal protein
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of KIZ protein
CTD
PMID:34122009
NCBI chr 3:134,277,631...134,385,260
Ensembl chr 3:134,277,687...134,385,190
G
Klc1
kinesin light chain 1
decreases expression
ISO
Haloperidol results in decreased expression of KLC1 mRNA
CTD
PMID:18797397
NCBI chr 6:130,823,416...130,866,729
Ensembl chr 6:130,823,419...130,867,031
G
Klc4
kinesin light chain 4
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of KLC4 protein
CTD
PMID:34122009
NCBI chr 9:14,337,164...14,351,075
Ensembl chr 9:14,337,534...14,351,066
G
Klhdc2
kelch domain containing 2
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of KLHDC2 protein
CTD
PMID:34122009
NCBI chr 6:87,777,183...87,791,609
Ensembl chr 6:87,777,183...87,804,187
G
Kmt2a
lysine methyltransferase 2A
decreases expression
ISO
Haloperidol results in decreased expression of KMT2A mRNA
CTD
PMID:14647396
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Kpna4
karyopherin subunit alpha 4
increases expression
ISO
Haloperidol results in increased expression of KPNA4 protein
CTD
PMID:34122009
NCBI chr 2:153,319,380...153,381,085
Ensembl chr 2:153,324,273...153,381,081
G
Kras
KRAS proto-oncogene, GTPase
increases expression
EXP
Haloperidol results in increased expression of KRAS mRNA
CTD
PMID:15860345
NCBI chr 4:178,185,418...178,218,484
G
Kremen1
kringle containing transmembrane protein 1
multiple interactions increases expression
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of KREMEN1 protein Haloperidol results in increased expression of KREMEN1 protein
CTD
PMID:34122009
NCBI chr14:80,081,870...80,147,489
Ensembl chr14:80,084,403...80,147,516
G
Lamtor3
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
increases expression
ISO
Haloperidol results in increased expression of LAMTOR3 mRNA
CTD
PMID:14647396
NCBI chr 2:226,411,389...226,423,612
Ensembl chr 2:226,411,400...226,423,607
G
Ldhb
lactate dehydrogenase B
decreases expression increases expression
ISO EXP
Haloperidol results in decreased expression of LDHB mRNA Haloperidol results in increased expression of LDHB mRNA
CTD
PMID:15860345 PMID:16465460
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Haloperidol results in increased expression of LDLR mRNA
CTD
PMID:17052361
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lgals1
galectin 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of LGALS1 protein
CTD
PMID:34122009
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lipa
lipase A, lysosomal acid type
increases expression
ISO
Haloperidol results in increased expression of LIPA protein
CTD
PMID:34122009
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Mag
myelin-associated glycoprotein
decreases expression
ISO
Haloperidol results in decreased expression of MAG mRNA
CTD
PMID:17177202
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
G
Map1a
microtubule-associated protein 1A
increases expression decreases expression
EXP ISO
Haloperidol results in increased expression of MAP1A mRNA Haloperidol results in decreased expression of MAP1A protein
CTD
PMID:15860345 PMID:34122009
NCBI chr 3:108,263,217...108,283,936
Ensembl chr 3:108,263,151...108,282,899
G
Map2
microtubule-associated protein 2
increases expression
EXP
Haloperidol results in increased expression of MAP2 mRNA
CTD
PMID:15079866
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Map2k1
mitogen activated protein kinase kinase 1
decreases expression
EXP
Haloperidol results in decreased expression of MAP2K1 mRNA
CTD
PMID:15860345
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Map2k2
mitogen activated protein kinase kinase 2
decreases expression increases expression
EXP ISO
Haloperidol results in decreased expression of MAP2K2 mRNA Haloperidol results in increased expression of MAP2K2 mRNA
CTD
PMID:14647396 PMID:15860345
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
EXP
Haloperidol results in decreased expression of MAP2K5 mRNA
CTD
PMID:15860345
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
increases expression
EXP
Haloperidol results in increased expression of MAP3K1 mRNA
CTD
PMID:15860345
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
G
Map3k12
mitogen activated protein kinase kinase kinase 12
increases expression
EXP
Haloperidol results in increased expression of MAP3K12 mRNA
CTD
PMID:15860345
NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation decreases expression multiple interactions
ISO EXP
Haloperidol results in increased phosphorylation of MAPK1 protein Haloperidol results in decreased expression of MAPK1 mRNA [potassium perchlorate co-treated with 2-mercapto-1-methylimidazole] inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein]; Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein]; CNR1 protein affects the reaction [[potassium perchlorate co-treated with 2-mercapto-1-methylimidazole] inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein]]; SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK1 protein]
CTD
PMID:12871586 PMID:15860345 PMID:28017790
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
affects expression
EXP
Haloperidol affects the expression of MAPK14 mRNA
CTD
PMID:15860345
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions
ISO
Haloperidol results in increased phosphorylation of MAPK3 protein [potassium perchlorate co-treated with 2-mercapto-1-methylimidazole] inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK3 protein]; Clozapine inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK3 protein]; CNR1 protein affects the reaction [[potassium perchlorate co-treated with 2-mercapto-1-methylimidazole] inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK3 protein]]; SL 327 inhibits the reaction [Haloperidol results in increased phosphorylation of MAPK3 protein]
CTD
PMID:12871586 PMID:28017790
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk6
mitogen-activated protein kinase 6
affects expression
EXP
Haloperidol affects the expression of MAPK6 mRNA
CTD
PMID:15860345
NCBI chr 8:76,146,650...76,169,767
Ensembl chr 8:76,146,690...76,169,720
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
EXP
Haloperidol results in increased phosphorylation of MAPK8 protein
CTD
PMID:17092607
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
affects expression
EXP
Haloperidol affects the expression of MAPK9 mRNA
CTD
PMID:15860345
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of MAPRE1 protein
CTD
PMID:34122009
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
decreases expression
EXP
Haloperidol results in decreased expression of MAS1 mRNA
CTD
PMID:16715494
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Mbp
myelin basic protein
decreases expression
ISO
Haloperidol results in decreased expression of MBP mRNA
CTD
PMID:17177202
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mcam
melanoma cell adhesion molecule
increases expression
ISO
Haloperidol results in increased expression of MCAM protein
CTD
PMID:34122009
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mchr1
melanin-concentrating hormone receptor 1
affects binding
ISO
Haloperidol binds to MCHR1 protein
CTD
PMID:16983399
NCBI chr 7:112,761,554...112,764,746
Ensembl chr 7:112,761,554...112,764,032
G
Mmp10
matrix metallopeptidase 10
decreases expression
ISO
Haloperidol results in decreased expression of MMP10 protein
CTD
PMID:34122009
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mog
myelin oligodendrocyte glycoprotein
decreases expression
ISO
Haloperidol results in decreased expression of MOG mRNA
CTD
PMID:17177202
NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474
G
Mrps31
mitochondrial ribosomal protein S31
increases expression
ISO
Haloperidol results in increased expression of MRPS31 protein
CTD
PMID:34122009
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
G
Myadm
myeloid-associated differentiation marker
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of MYADM protein
CTD
PMID:34122009
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Myo5b
myosin Vb
decreases expression
ISO
Haloperidol results in decreased expression of MYO5B protein
CTD
PMID:34122009
NCBI chr18:68,038,759...68,341,568
Ensembl chr18:68,038,759...68,338,745
G
Nap1l3
nucleosome assembly protein 1-like 3
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of NAP1L3 protein
CTD
PMID:34122009
NCBI chr X:88,347,595...88,350,393
Ensembl chr X:88,347,598...88,350,393
G
Ncan
neurocan
decreases expression
ISO
Haloperidol results in decreased expression of NCAN mRNA
CTD
PMID:18797397
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
G
Ncaph
non-SMC condensin I complex, subunit H
decreases expression
ISO
Haloperidol results in decreased expression of NCAPH protein
CTD
PMID:34122009
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ncl
nucleolin
increases expression
ISO
Haloperidol results in increased expression of NCL mRNA
CTD
PMID:14647396
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Ndufv1
NADH:ubiquinone oxidoreductase core subunit V1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of NDUFV1 protein
CTD
PMID:34122009
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
decreases expression
ISO
Haloperidol results in decreased expression of NEDD4 mRNA
CTD
PMID:18797397
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
EXP
Haloperidol results in decreased expression of NFKB1 protein
CTD
PMID:16500086
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Ngfr
nerve growth factor receptor
decreases expression
EXP
Haloperidol results in decreased expression of NGFR mRNA
CTD
PMID:16513140
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nifk
nucleolar protein interacting with the FHA domain of MKI67
decreases expression
ISO
Haloperidol results in decreased expression of NIFK protein
CTD
PMID:34122009
NCBI chr13:29,393,303...29,403,387
Ensembl chr13:29,393,286...29,405,896
G
Nop14
NOP14 nucleolar protein
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of NOP14 protein
CTD
PMID:34122009
NCBI chr14:76,081,313...76,102,454
Ensembl chr14:76,080,793...76,102,453
G
Nop53
NOP53 ribosome biogenesis factor
increases expression
ISO
Haloperidol results in increased expression of NOP53 mRNA
CTD
PMID:14647396
NCBI chr 1:76,629,084...76,636,902
Ensembl chr 1:76,629,069...76,636,902
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression
ISO
Cannabidiol inhibits the reaction [Haloperidol results in increased expression of NOS2 mRNA]
CTD
PMID:30217539
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nppa
natriuretic peptide A
affects activity
EXP
Haloperidol affects the activity of NPPA protein modified form
CTD
PMID:1363893
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nptx2
neuronal pentraxin 2
decreases expression
EXP
Haloperidol results in decreased expression of NPTX2 mRNA
CTD
PMID:18208916
NCBI chr12:10,037,435...10,048,345
Ensembl chr12:10,037,435...10,048,345
G
Npy
neuropeptide Y
multiple interactions increases expression decreases expression
EXP
Haloperidol promotes the reaction [Amphetamine results in decreased expression of NPY protein] Haloperidol results in increased expression of NPY protein Haloperidol results in decreased expression of NPY mRNA
CTD
PMID:7644023 PMID:15985714 PMID:16516965
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of NQO1 protein
CTD
PMID:34122009
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Haloperidol results in increased expression of NR0B2 mRNA
CTD
PMID:17175557
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
EXP
Haloperidol results in increased expression of NR1D1 mRNA
CTD
PMID:11564422
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
affects response to substance multiple interactions increases expression decreases expression
ISO EXP
NR4A1 affects the susceptibility to Haloperidol 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of NR4A1 mRNA] Haloperidol results in decreased expression of NR4A1 mRNA
CTD
PMID:10987852 PMID:11564422 PMID:14603264 PMID:19695244
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
increases expression
EXP
Haloperidol results in increased expression of NR4A3 mRNA
CTD
PMID:19695244
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Nrg1
neuregulin 1
increases expression
EXP
Haloperidol results in increased expression of NRG1 protein
CTD
PMID:18184445 PMID:26961615
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
decreases expression
EXP ISO
Haloperidol results in decreased expression of NSF mRNA Haloperidol results in decreased expression of NSF protein
CTD
PMID:15860345 PMID:34122009
NCBI chr10:88,727,912...88,857,375
Ensembl chr10:88,727,912...88,857,386
G
Nts
neurotensin
multiple interactions increases expression
ISO EXP
SLC6A3 protein promotes the reaction [Haloperidol results in increased expression of NTS mRNA] Haloperidol results in increased expression of NTS mRNA; Haloperidol results in increased expression of NTS protein 8-(3-chlorostyryl)caffeine inhibits the reaction [Haloperidol results in increased expression of NTS mRNA]; Theophylline inhibits the reaction [Haloperidol results in increased expression of NTS mRNA]
CTD
PMID:10199625 PMID:11120399 PMID:11602683 PMID:12887421 PMID:14603264 PMID:14698760 More...
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Numbl
NUMB-like, endocytic adaptor protein
decreases expression
ISO
Haloperidol results in decreased expression of NUMBL mRNA
CTD
PMID:18797397
NCBI chr 1:82,549,814...82,573,788
Ensembl chr 1:82,550,054...82,573,776
G
Nup54
nucleoporin 54
decreases expression
ISO
Haloperidol results in decreased expression of NUP54 protein
CTD
PMID:34122009
NCBI chr14:15,617,630...15,636,029
Ensembl chr14:15,617,679...15,636,028
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Haloperidol results in increased expression of NUPR1 mRNA
CTD
PMID:17175557
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Oat
ornithine aminotransferase
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of OAT protein
CTD
PMID:34122009
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Oprl1
opioid related nociceptin receptor 1
affects response to substance
ISO
OPRL1 affects the susceptibility to Haloperidol
CTD
PMID:16237164
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
multiple interactions
ISO
OPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]]
CTD
PMID:20184921
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Osbpl8
oxysterol binding protein-like 8
increases expression
ISO
Haloperidol results in increased expression of OSBPL8 mRNA
CTD
PMID:14647396
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
G
Park7
Parkinsonism associated deglycase
increases expression
ISO
Haloperidol results in increased expression of PARK7 mRNA
CTD
PMID:14647396
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
G
Pcmt1
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
decreases expression
ISO
Haloperidol results in decreased expression of PCMT1 protein
CTD
PMID:34122009
NCBI chr 1:2,111,756...2,160,354
Ensembl chr 1:2,111,763...2,159,201
G
Pcsk1n
proprotein convertase subtilisin/kexin type 1 inhibitor
increases expression
ISO
Haloperidol results in increased expression of PCSK1N mRNA
CTD
PMID:14647396
NCBI chr X:14,580,036...14,583,478
Ensembl chr X:14,580,038...14,583,566
G
Pde10a
phosphodiesterase 10A
increases expression
EXP
Haloperidol results in increased expression of PDE10A mRNA; Haloperidol results in increased expression of PDE10A protein
CTD
PMID:18222493
NCBI chr 1:51,765,743...52,218,086
Ensembl chr 1:51,770,132...52,216,563
G
Pde1b
phosphodiesterase 1B
increases expression
EXP ISO
Haloperidol results in increased expression of PDE1B mRNA; Haloperidol results in increased expression of PDE1B protein
CTD
PMID:14647396 PMID:18222493
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580
G
Pde4a
phosphodiesterase 4A
decreases expression
EXP
Haloperidol results in decreased expression of PDE4A protein
CTD
PMID:20222156
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
G
Pdlim5
PDZ and LIM domain 5
decreases expression
ISO
Haloperidol results in decreased expression of PDLIM5 protein
CTD
PMID:34122009
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
G
Pdzrn3
PDZ domain containing RING finger 3
decreases expression
ISO
Haloperidol results in decreased expression of PDZRN3 protein
CTD
PMID:34122009
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
G
Penk
proenkephalin
multiple interactions increases expression
ISO EXP
3,4-dicarboxyphenylglycine promotes the reaction [Haloperidol results in increased expression of PENK mRNA]; Docosahexaenoic Acids inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]; Tretinoin inhibits the reaction [Haloperidol results in increased expression of PENK mRNA] Haloperidol results in increased expression of PENK mRNA; Haloperidol results in increased expression of PENK protein 1-aminocyclopentane-1,2,4-tricarboxylic acid inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]; 1-aminoindan-1,5-dicarboxylic acid inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]; 2-(2,3-dicarboxycyclopropyl)glycine promotes the reaction [Haloperidol results in increased expression of PENK mRNA]; 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]; 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]; Memantine inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]; Scopolamine inhibits the reaction [Haloperidol results in increased expression of PENK mRNA]
CTD
PMID:3838946 PMID:7637876 PMID:12373537 PMID:12727308 PMID:12834887 PMID:12887421 PMID:14603264 PMID:14642644 PMID:15215559 PMID:17224239 More...
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Per1
period circadian regulator 1
increases expression
ISO
Haloperidol results in increased expression of PER1 mRNA
CTD
PMID:27746588
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
G
Pfdn5
prefoldin subunit 5
increases expression
ISO
Haloperidol results in increased expression of PFDN5 mRNA
CTD
PMID:14647396
NCBI chr 7:133,451,778...133,456,516
Ensembl chr 7:133,451,453...133,456,516
G
Pfkp
phosphofructokinase, platelet
increases expression multiple interactions
EXP ISO
Haloperidol results in increased expression of PFKP mRNA [Cuprizone co-treated with Haloperidol] results in increased expression of PFKP protein
CTD
PMID:15860345 PMID:34122009
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pfn1
profilin 1
increases expression
ISO
Haloperidol results in increased expression of PFN1 protein
CTD
PMID:34122009
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pgk1
phosphoglycerate kinase 1
increases expression
EXP
Haloperidol results in increased expression of PGK1 mRNA
CTD
PMID:15860345
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Phactr1
phosphatase and actin regulator 1
increases expression
ISO
Haloperidol results in increased expression of PHACTR1 mRNA
CTD
PMID:14647396
NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831
G
Picalm
phosphatidylinositol binding clathrin assembly protein
decreases expression
EXP
Haloperidol results in decreased expression of PICALM mRNA
CTD
PMID:15860345
NCBI chr 1:144,056,415...144,138,045
Ensembl chr 1:144,056,721...144,137,557
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
EXP
Haloperidol results in decreased expression of PIK3R3 mRNA
CTD
PMID:16715494
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Pkib
cAMP-dependent protein kinase inhibitor beta
decreases expression
EXP
Haloperidol results in decreased expression of PKIB mRNA
CTD
PMID:15860345
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
G
Pkm
pyruvate kinase M1/2
increases expression
EXP
Haloperidol results in increased expression of PKM mRNA
CTD
PMID:15860345
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plp1
proteolipid protein 1
decreases expression
ISO
Haloperidol results in decreased expression of PLP1 mRNA
CTD
PMID:17177202 PMID:18797397
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Plpbp
pyridoxal phosphate binding protein
increases expression
ISO
Haloperidol results in increased expression of PLPBP protein
CTD
PMID:34122009
NCBI chr16:65,003,292...65,014,886
Ensembl chr16:65,002,223...65,014,886
G
Pls3
plastin 3
decreases expression
ISO
Haloperidol results in decreased expression of PLS3 protein
CTD
PMID:34122009
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Pmpca
peptidase, mitochondrial processing subunit alpha
increases expression
ISO
Haloperidol results in increased expression of PMPCA protein
CTD
PMID:34122009
NCBI chr 3:9,207,731...9,216,846
Ensembl chr 3:9,207,717...9,216,844
G
Ppa1
inorganic pyrophosphatase 1
increases expression
ISO
Haloperidol results in increased expression of PPA1 protein
CTD
PMID:34122009
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO
[Cannabidiol co-treated with Haloperidol] results in increased expression of PPARGC1A protein
CTD
PMID:30217539
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppm1a
protein phosphatase, Mg2+/Mn2+ dependent, 1A
decreases expression
EXP
Haloperidol results in decreased expression of PPM1A mRNA
CTD
PMID:15860345
NCBI chr 6:91,439,094...91,486,139
Ensembl chr 6:91,438,834...91,480,697
G
Ppm1b
protein phosphatase, Mg2+/Mn2+ dependent, 1B
decreases expression
EXP
Haloperidol results in decreased expression of PPM1B mRNA
CTD
PMID:15860345
NCBI chr 6:9,646,695...9,707,471
Ensembl chr 6:9,655,765...9,707,974
G
Ppm1f
protein phosphatase, Mg2+/Mn2+ dependent, 1F
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of PPM1F protein
CTD
PMID:34122009
NCBI chr11:84,064,422...84,094,410
Ensembl chr11:84,064,420...84,094,340
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
decreases expression
EXP
Haloperidol results in decreased expression of PPP1CB mRNA
CTD
PMID:15860345
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
decreases expression
EXP
Haloperidol results in decreased expression of PPP1CC mRNA
CTD
PMID:15860345
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of PPP1R14B protein
CTD
PMID:34122009
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
G
Ppp1r1a
protein phosphatase 1, regulatory (inhibitor) subunit 1A
decreases expression
EXP
Haloperidol results in decreased expression of PPP1R1A mRNA
CTD
PMID:15860345
NCBI chr 7:134,654,578...134,662,236
Ensembl chr 7:134,654,579...134,662,230
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
increases phosphorylation
ISO
Haloperidol results in increased phosphorylation of PPP1R1B protein
CTD
PMID:12871586
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Ppp1r2
protein phosphatase 1, regulatory (inhibitor) subunit 2
decreases expression
EXP
Haloperidol results in decreased expression of PPP1R2 mRNA
CTD
PMID:15860345
NCBI chr11:69,472,676...69,494,468
Ensembl chr11:69,472,555...69,494,463
G
Ppp1r9b
protein phosphatase 1, regulatory subunit 9B
decreases expression
EXP
Haloperidol results in decreased expression of PPP1R9B protein
CTD
PMID:16844384
NCBI chr10:79,938,055...79,954,085
Ensembl chr10:79,938,066...79,954,083
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
decreases expression
EXP
Haloperidol results in decreased expression of PPP2CA mRNA
CTD
PMID:15860345
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
decreases expression
EXP
Haloperidol results in decreased expression of PPP2CB mRNA
CTD
PMID:15860345
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
increases expression
EXP
Haloperidol results in increased expression of PPP2R1A mRNA
CTD
PMID:15860345
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
G
Ppp2r2a
protein phosphatase 2, regulatory subunit B, alpha
decreases expression
EXP
Haloperidol results in decreased expression of PPP2R2A mRNA
CTD
PMID:15860345
NCBI chr15:41,204,659...41,263,924
Ensembl chr15:41,204,200...41,263,924
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
multiple interactions decreases expression
EXP
[Haloperidol binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein Haloperidol results in decreased expression of PPP3CA mRNA; Haloperidol results in decreased expression of PPP3CA protein
CTD
PMID:16033416
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Ppp5c
protein phosphatase 5, catalytic subunit
decreases expression multiple interactions
ISO
Haloperidol results in decreased expression of PPP5C mRNA [Cuprizone co-treated with Haloperidol] results in decreased expression of PPP5C protein
CTD
PMID:14647396 PMID:34122009
NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:77,690,208...77,714,456
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
increases expression
EXP
Haloperidol results in increased expression of PRKACA mRNA
CTD
PMID:15860345
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
increases expression
EXP
Haloperidol results in increased expression of PRKACB mRNA
CTD
PMID:15860345
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
G
Prkar2a
protein kinase cAMP-dependent type II regulatory subunit alpha
multiple interactions increases expression
EXP ISO
Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2A protein] [Cuprizone co-treated with Haloperidol] results in decreased expression of PRKAR2A protein Haloperidol results in increased expression of PRKAR2A mRNA; Haloperidol results in increased expression of PRKAR2A protein
CTD
PMID:11907174 PMID:34122009
NCBI chr 8:109,393,189...109,458,832
Ensembl chr 8:109,395,833...109,455,628
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
multiple interactions increases expression decreases expression
EXP
Haloperidol promotes the reaction [Cyclic AMP binds to PRKAR2B protein] Haloperidol results in increased expression of PRKAR2B mRNA; Haloperidol results in increased expression of PRKAR2B protein Haloperidol results in decreased expression of PRKAR2B mRNA
CTD
PMID:11907174 PMID:15860345
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
G
Prkcb
protein kinase C, beta
multiple interactions increases expression
EXP
[Haloperidol co-treated with Fluvoxamine] affects the expression of PRKCB protein Haloperidol results in increased expression of PRKCB mRNA
CTD
PMID:15860345 PMID:15967061
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Prkce
protein kinase C, epsilon
increases expression
EXP
Haloperidol results in increased expression of PRKCE mRNA
CTD
PMID:15860345
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkcsh
PRKCSH beta subunit of glucosidase II
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of PRKCSH protein
CTD
PMID:34122009
NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492
G
Prkcz
protein kinase C, zeta
increases expression
EXP
Haloperidol results in increased expression of PRKCZ mRNA
CTD
PMID:15860345
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Prl
prolactin
affects expression increases secretion multiple interactions increases expression
ISO EXP
Haloperidol affects the expression of PRL protein Haloperidol results in increased secretion of PRL protein Haloperidol inhibits the reaction [Aripiprazole results in decreased secretion of PRL protein]; Haloperidol inhibits the reaction [Bromocriptine results in decreased secretion of PRL protein]; Haloperidol inhibits the reaction [cabergoline results in decreased secretion of PRL protein]; Haloperidol inhibits the reaction [Dopamine results in decreased secretion of PRL protein]; Haloperidol inhibits the reaction [talipexole results in decreased secretion of PRL protein]; LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)- inhibits the reaction [Haloperidol results in increased expression of PRL protein]; Triptorelin Pamoate inhibits the reaction [Haloperidol results in increased expression of PRL protein]
CTD
PMID:1304992 PMID:1380082 PMID:2136057 PMID:3019639 PMID:3158510 PMID:3883215 PMID:3906589 PMID:7018927 PMID:7214106 PMID:7348089 PMID:7670571 PMID:8613910 PMID:8915564 PMID:9090331 PMID:9128918 PMID:9265911 PMID:9265916 PMID:9376336 PMID:9572212 PMID:10661492 PMID:11048906 PMID:11071396 PMID:11997696 PMID:15289996 PMID:15638391 PMID:16282852 PMID:18521575 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prpf19
pre-mRNA processing factor 19
increases expression
ISO
Haloperidol results in increased expression of PRPF19 protein
CTD
PMID:34122009
NCBI chr 1:207,541,582...207,552,664
Ensembl chr 1:207,541,595...207,552,662
G
Prpf38b
pre-mRNA processing factor 38B
decreases expression
ISO
Haloperidol results in decreased expression of PRPF38B mRNA
CTD
PMID:14647396
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250
G
Prrc2a
proline-rich coiled-coil 2A
decreases expression
ISO
Haloperidol results in decreased expression of PRRC2A mRNA
CTD
PMID:18797397
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
G
Prxl2a
peroxiredoxin like 2A
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of PRXL2A protein
CTD
PMID:34122009
NCBI chr16:16,866,601...16,886,378
Ensembl chr16:16,866,603...16,886,433
G
Psmb9
proteasome 20S subunit beta 9
decreases expression
EXP
Haloperidol results in decreased expression of PSMB9 mRNA
CTD
PMID:16452686
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Psmd12
proteasome 26S subunit, non-ATPase 12
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of PSMD12 protein
CTD
PMID:34122009
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Haloperidol results in increased expression of PTGS2 mRNA
CTD
PMID:30217539
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptma
prothymosin alpha
increases expression
ISO
Haloperidol results in increased expression of PTMA protein
CTD
PMID:34122009
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptms
parathymosin
increases expression
ISO
Haloperidol results in increased expression of PTMS mRNA
CTD
PMID:14647396
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
G
Pura
purine rich element binding protein A
increases expression
ISO
Haloperidol results in increased expression of PURA protein
CTD
PMID:34122009
NCBI chr18:27,885,071...27,905,509
Ensembl chr18:27,884,556...27,905,513
G
Purb
purine rich element binding protein B
decreases expression
ISO
Haloperidol results in decreased expression of PURB protein
CTD
PMID:34122009
NCBI chr14:81,342,374...81,344,857
Ensembl chr14:81,336,448...81,351,432
G
Pvalb
parvalbumin
multiple interactions
EXP
Haloperidol inhibits the reaction [Phencyclidine results in decreased expression of PVALB mRNA]
CTD
PMID:12589379
NCBI chr 7:109,772,939...109,787,954
Ensembl chr 7:109,772,593...109,784,561
G
Pycr1
pyrroline-5-carboxylate reductase 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of PYCR1 protein
CTD
PMID:34122009
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Pygm
glycogen phosphorylase, muscle associated
decreases expression
ISO
Haloperidol results in decreased expression of PYGM protein
CTD
PMID:34122009
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
G
Qki
QKI, KH domain containing RNA binding
increases expression
ISO
Haloperidol results in increased expression of QKI mRNA alternative form
CTD
PMID:19335891
NCBI chr 1:50,387,716...50,501,568
Ensembl chr 1:50,387,698...50,498,831
G
Rab10
RAB10, member RAS oncogene family
increases expression
EXP
Haloperidol results in increased expression of RAB10 mRNA
CTD
PMID:15860345
NCBI chr 6:26,267,081...26,319,739
Ensembl chr 6:26,266,859...26,320,193
G
Rab11a
RAB11a, member RAS oncogene family
increases expression
EXP
Haloperidol results in increased expression of RAB11A mRNA
CTD
PMID:15860345
NCBI chr 8:65,223,698...65,246,461
Ensembl chr 8:65,222,949...65,246,525
G
Rab12
RAB12, member RAS oncogene family
increases expression
EXP
Haloperidol results in increased expression of RAB12 mRNA
CTD
PMID:12437575
NCBI chr 9:106,480,301...106,506,895
Ensembl chr 9:106,480,301...106,506,910
G
Rab28
RAB28, member RAS oncogene family
increases expression
EXP
Haloperidol results in increased expression of RAB28 mRNA
CTD
PMID:15860345
NCBI chr14:69,245,846...69,322,968
Ensembl chr14:69,245,854...69,322,967
G
Rab4a
RAB4A, member RAS oncogene family
decreases expression
EXP
Haloperidol results in decreased expression of RAB4A mRNA
CTD
PMID:15860345
NCBI chr19:51,795,613...51,822,706
Ensembl chr19:51,795,613...51,822,703
G
Rab5a
RAB5A, member RAS oncogene family
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RAB5A protein
CTD
PMID:34122009
NCBI chr 9:6,483,906...6,512,877
Ensembl chr 9:6,484,469...6,512,873
G
Rab6a
RAB6A, member RAS oncogene family
increases expression
EXP
Haloperidol results in increased expression of RAB6A mRNA
CTD
PMID:15860345
NCBI chr 1:154,957,870...155,008,922
Ensembl chr 1:154,958,189...154,996,715
G
Rab7a
RAB7A, member RAS oncogene family
decreases expression
EXP
Haloperidol results in decreased expression of RAB7A mRNA
CTD
PMID:15860345
NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889
G
Rab8a
RAB8A, member RAS oncogene family
decreases expression
EXP
Haloperidol results in decreased expression of RAB8A mRNA
CTD
PMID:15860345
NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678
G
Rac1
Rac family small GTPase 1
increases expression
EXP
Haloperidol results in increased expression of RAC1 mRNA
CTD
PMID:15860345
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Rala
RAS like proto-oncogene A
increases expression
EXP
Haloperidol results in increased expression of RALA mRNA
CTD
PMID:15860345
NCBI chr17:47,092,163...47,145,192
Ensembl chr17:47,092,207...47,144,063
G
Ralb
RAS like proto-oncogene B
increases expression
EXP
Haloperidol results in increased expression of RALB mRNA
CTD
PMID:15860345
NCBI chr13:30,588,036...30,624,199
Ensembl chr13:30,588,033...30,624,202
G
Ranbp3
RAN binding protein 3
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of RANBP3 protein
CTD
PMID:34122009
NCBI chr 9:1,507,233...1,544,460
Ensembl chr 9:1,507,361...1,544,460
G
Rap1b
RAP1B, member of RAS oncogene family
increases expression
EXP
Haloperidol results in increased expression of RAP1B mRNA
CTD
PMID:15860345
NCBI chr 7:53,423,039...53,456,349
Ensembl chr 7:53,423,130...53,456,370
G
Rapgef4
Rap guanine nucleotide exchange factor 4
decreases expression
ISO
Haloperidol results in decreased expression of RAPGEF4 mRNA
CTD
PMID:18797397
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
G
Rarb
retinoic acid receptor, beta
increases expression
EXP
Haloperidol results in increased expression of RARB mRNA alternative form
CTD
PMID:11564422
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
affects localization
EXP
Haloperidol affects the localization of RASGRF1 protein
CTD
PMID:17092607
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rasgrp1
RAS guanyl releasing protein 1
decreases expression
EXP
Haloperidol results in decreased expression of RASGRP1 mRNA
CTD
PMID:15860345
NCBI chr 3:104,168,549...104,230,107
Ensembl chr 3:104,170,013...104,230,056
G
Rcn1
reticulocalbin 1
multiple interactions decreases expression
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RCN1 protein Haloperidol results in decreased expression of RCN1 protein
CTD
PMID:34122009
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rdh11
retinol dehydrogenase 11
decreases expression
ISO
Haloperidol results in decreased expression of RDH11 protein
CTD
PMID:34122009
NCBI chr 6:97,979,377...97,995,252
Ensembl chr 6:97,979,378...97,995,252
G
Rdx
radixin
decreases expression
ISO
Haloperidol results in decreased expression of RDX protein
CTD
PMID:34122009
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
G
Rela
RELA proto-oncogene, NF-kB subunit
increases expression
EXP
Haloperidol results in increased expression of RELA protein
CTD
PMID:18554768 PMID:18590723
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Reln
reelin
decreases expression
EXP
Haloperidol results in decreased expression of RELN mRNA; Haloperidol results in decreased expression of RELN protein
CTD
PMID:19359144
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rgs2
regulator of G-protein signaling 2
increases expression
EXP
Haloperidol results in increased expression of RGS2 mRNA
CTD
PMID:11409749 PMID:11516571
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs4
regulator of G-protein signaling 4
increases expression
EXP
Haloperidol results in increased expression of RGS4 mRNA
CTD
PMID:15860345
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs8
regulator of G-protein signaling 8
increases expression
EXP
Haloperidol results in increased expression of RGS8 mRNA
CTD
PMID:15860345
NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807
G
Rgs9
regulator of G-protein signaling 9
affects response to substance
ISO
RGS9 affects the susceptibility to Haloperidol
CTD
PMID:15728856
NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892
G
Rhoa
ras homolog family member A
decreases expression
EXP
Haloperidol results in decreased expression of RHOA mRNA
CTD
PMID:15860345
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rims1
regulating synaptic membrane exocytosis 1
decreases expression
EXP
Haloperidol results in decreased expression of RIMS1 mRNA
CTD
PMID:15860345
NCBI chr 9:24,696,959...25,196,404
Ensembl chr 9:24,698,854...25,196,631
G
Rorb
RAR-related orphan receptor B
decreases expression
EXP
Haloperidol results in decreased expression of RORB mRNA
CTD
PMID:11564422
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
G
Rpl13
ribosomal protein L13
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RPL13 protein
CTD
PMID:34122009
NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014
G
Rpl18a
ribosomal protein L18A
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RPL18A protein
CTD
PMID:34122009
NCBI chr16:18,542,555...18,544,578
Ensembl chr16:18,542,566...18,545,546
G
Rpl19
ribosomal protein L19
decreases expression multiple interactions
ISO
Haloperidol results in decreased expression of RPL19 protein [Cuprizone co-treated with Haloperidol] results in increased expression of RPL19 protein
CTD
PMID:34122009
NCBI chr10:83,022,503...83,026,030
Ensembl chr10:83,019,257...83,052,112
G
Rpl30
ribosomal protein L30
increases expression
ISO
Haloperidol results in increased expression of RPL30 protein
CTD
PMID:34122009
NCBI chr 7:65,648,266...65,651,401
Ensembl chr 7:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363
G
Rpl6
ribosomal protein L6
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RPL6 protein
CTD
PMID:34122009
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
G
Rpl8
ribosomal protein L8
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RPL8 protein
CTD
PMID:34122009
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
G
Rplp0l1
ribosomal protein lateral stalk subunit P0 like 1
decreases expression
ISO
Haloperidol results in decreased expression of RPLP0P6 protein
CTD
PMID:34122009
NCBI chr 2:191,921,503...191,922,661
Ensembl chr 2:191,921,574...191,922,646
G
Rplp2
ribosomal protein lateral stalk subunit P2
increases expression
ISO
Haloperidol results in increased expression of RPLP2 mRNA
CTD
PMID:14647396
NCBI chr 1:196,546,086...196,548,636
Ensembl chr 1:196,546,352...196,548,645
G
Rps10
ribosomal protein S10
increases expression
ISO
Haloperidol results in increased expression of RPS10 mRNA
CTD
PMID:14647396
NCBI chr20:5,694,313...5,698,922
Ensembl chr20:5,694,313...5,699,044 Ensembl chr 6:5,694,313...5,699,044
G
Rps16
ribosomal protein S16
decreases expression
ISO
Haloperidol results in decreased expression of RPS16 protein
CTD
PMID:34122009
NCBI chr 1:83,643,066...83,646,056
Ensembl chr 1:83,643,130...83,646,206
G
Rps27
ribosomal protein S27
increases expression
ISO
Haloperidol results in increased expression of RPS27 protein
CTD
PMID:34122009
NCBI chr 2:175,665,858...175,666,963
Ensembl chr 2:175,665,853...175,666,964
G
Rps27a
ribosomal protein S27a
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RPS27A protein
CTD
PMID:34122009
NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011
G
Rps9
ribosomal protein S9
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of RPS9 protein
CTD
PMID:34122009
NCBI chr 1:65,511,723...65,515,076
Ensembl chr 1:65,511,723...65,515,123
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
EXP
Haloperidol results in increased expression of RRAD mRNA
CTD
PMID:15860345
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rrbp1
ribosome binding protein 1
decreases expression
ISO
Haloperidol results in decreased expression of RRBP1 protein
CTD
PMID:34122009
NCBI chr 3:131,314,996...131,376,930
Ensembl chr 3:131,314,998...131,376,981
G
Rsf1
remodeling and spacing factor 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of RSF1 protein
CTD
PMID:34122009
NCBI chr 1:151,892,055...152,015,089
Ensembl chr 1:151,892,434...152,009,051
G
Rtn4
reticulon 4
decreases expression
ISO
Haloperidol results in decreased expression of RTN4 mRNA
CTD
PMID:18797397
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Rxrg
retinoid X receptor gamma
affects response to substance increases expression
ISO EXP
RXRG protein affects the susceptibility to Haloperidol Haloperidol results in increased expression of RXRG mRNA alternative form
CTD
PMID:10336693 PMID:11564422
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
S100a9
S100 calcium binding protein A9
decreases expression
ISO
Haloperidol results in decreased expression of S100A9 mRNA
CTD
PMID:18797397
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Sae1
SUMO1 activating enzyme subunit 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SAE1 protein
CTD
PMID:34122009
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
G
Sars1
seryl-tRNA synthetase 1
decreases expression
ISO
Haloperidol results in decreased expression of SARS1 protein
CTD
PMID:34122009
NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277
G
Satb2
SATB homeobox 2
decreases expression
ISO
Haloperidol results in decreased expression of SATB2 protein
CTD
PMID:34122009
NCBI chr 9:58,348,027...58,534,256
Ensembl chr 9:58,350,246...58,530,707
G
Sbds
Sbds, ribosome maturation factor
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of SBDS protein
CTD
PMID:34122009
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
Haloperidol results in increased expression of SC5D mRNA
CTD
PMID:17052361
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Scd
stearoyl-CoA desaturase
increases expression
ISO
Haloperidol results in increased expression of SCD mRNA
CTD
PMID:16027736
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sec61a1
SEC61 translocon subunit alpha 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SEC61A1 protein
CTD
PMID:34122009
NCBI chr 4:120,973,519...120,987,871
Ensembl chr 4:120,960,626...120,987,925
G
Sec63
SEC63 homolog, protein translocation regulator
increases expression
ISO
Haloperidol results in increased expression of SEC63 protein
CTD
PMID:34122009
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
Haloperidol results in increased expression of SERPINA3 mRNA; Haloperidol results in increased expression of SERPINA3 protein
CTD
PMID:17175557 PMID:34122009
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpini1
serpin family I member 1
decreases expression
ISO
Haloperidol results in decreased expression of SERPINI1 mRNA
CTD
PMID:18797397
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sf3b4
splicing factor 3B subunit 4
decreases expression
ISO
Haloperidol results in decreased expression of SF3B4 protein
CTD
PMID:34122009
NCBI chr 2:183,732,791...183,737,545
Ensembl chr 2:183,732,754...183,737,959
G
Sgcd
sarcoglycan, delta
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SGCD protein
CTD
PMID:34122009
NCBI chr10:31,346,480...32,328,364
Ensembl chr10:31,280,511...31,724,840
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
EXP
Haloperidol results in increased expression of SGK1 mRNA
CTD
PMID:16452686
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sh3kbp1
SH3 domain-containing kinase-binding protein 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SH3KBP1 protein
CTD
PMID:34122009
NCBI chr X:34,877,862...35,223,013
Ensembl chr X:34,877,866...35,222,747
G
Sh3pxd2b
SH3 and PX domains 2B
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of SH3PXD2B protein
CTD
PMID:34122009
NCBI chr10:16,918,611...17,027,499
Ensembl chr10:16,918,679...17,005,170
G
Slc17a6
solute carrier family 17 member 6
increases expression
ISO
Haloperidol results in increased expression of SLC17A6 mRNA; Haloperidol results in increased expression of SLC17A6 protein
CTD
PMID:18155072
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Slc17a8
solute carrier family 17 member 8
affects response to substance
ISO
SLC17A8 protein affects the susceptibility to Haloperidol
CTD
PMID:18278042
NCBI chr 7:23,994,212...24,049,498
Ensembl chr 7:23,994,217...24,048,079
G
Slc18a2
solute carrier family 18 member A2
affects binding
ISO
Haloperidol binds to SLC18A2 protein
CTD
PMID:7912402
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc1a1
solute carrier family 1 member 1
decreases expression
EXP
Haloperidol results in decreased expression of SLC1A1 mRNA
CTD
PMID:12873733
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a2
solute carrier family 1 member 2
decreases expression
EXP
Haloperidol results in decreased expression of SLC1A2 mRNA
CTD
PMID:12873733
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
G
Slc1a3
solute carrier family 1 member 3
decreases expression
EXP
Haloperidol results in decreased expression of SLC1A3 mRNA
CTD
PMID:15860345
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Haloperidol inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium]
CTD
PMID:23770354
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc25a3
solute carrier family 25 member 3
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SLC25A3 protein
CTD
PMID:34122009
NCBI chr 7:25,611,937...25,619,401
Ensembl chr 7:25,586,725...25,667,727
G
Slc2a4
solute carrier family 2 member 4
increases expression
ISO
Haloperidol results in increased expression of SLC2A4 mRNA
CTD
PMID:16002093
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc39a7
solute carrier family 39 member 7
increases expression
ISO
Haloperidol results in increased expression of SLC39A7 mRNA
CTD
PMID:14647396
NCBI chr20:4,823,166...4,826,538
Ensembl chr20:4,822,012...4,826,537
G
Slc6a3
solute carrier family 6 member 3
multiple interactions increases expression
ISO EXP
SLC6A3 protein promotes the reaction [Haloperidol results in increased expression of NTS mRNA] Haloperidol results in increased expression of SLC6A3 protein
CTD
PMID:14698760 PMID:17069804
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
increases expression
EXP
Haloperidol results in increased expression of SLC6A4
CTD
PMID:12007678
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Snap25
synaptosome associated protein 25
affects response to substance affects expression
ISO EXP
SNAP25 gene SNP affects the susceptibility to Haloperidol Haloperidol affects the expression of SNAP25 mRNA
CTD
PMID:15823421 PMID:15860345
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
G
Snrpd2
small nuclear ribonucleoprotein D2 polypeptide
increases expression
ISO
Haloperidol results in increased expression of SNRPD2 mRNA
CTD
PMID:14647396
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
G
Sod1
superoxide dismutase 1
increases expression decreases expression multiple interactions
EXP
Haloperidol results in increased expression of SOD1 mRNA Haloperidol results in decreased expression of SOD1 protein Clozapine inhibits the reaction [Haloperidol results in decreased expression of SOD1 protein]; Haloperidol results in decreased activity of and results in decreased expression of SOD1 protein; olanzapine inhibits the reaction [Haloperidol results in decreased expression of SOD1 protein]; Risperidone inhibits the reaction [Haloperidol results in decreased expression of SOD1 protein]
CTD
PMID:12482469 PMID:12752374 PMID:16564057
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases expression multiple interactions
EXP
Haloperidol results in decreased expression of SOD2 mRNA; Haloperidol results in decreased expression of SOD2 protein Haloperidol results in decreased activity of and results in decreased expression of SOD2 protein
CTD
PMID:12482469 PMID:15860345 PMID:16564057
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
EXP
Haloperidol results in increased expression of SOD3 mRNA
CTD
PMID:15860345
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Speg
striated muscle enriched protein kinase
increases expression
ISO
Haloperidol results in increased expression of SPEG protein
CTD
PMID:34122009
NCBI chr 9:76,865,714...76,923,170
Ensembl chr 9:76,865,754...76,923,144
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
Haloperidol results in increased cleavage of and results in increased activity of SREBF2 protein
CTD
PMID:17052361
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Srpra
SRP receptor subunit alpha
decreases expression
ISO
Haloperidol results in decreased expression of SRPRA protein
CTD
PMID:34122009
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srsf2
serine and arginine rich splicing factor 2
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SRSF2 protein
CTD
PMID:34122009
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Srsf5
serine and arginine rich splicing factor 5
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of SRSF5 protein
CTD
PMID:34122009
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
Stip1
stress-induced phosphoprotein 1
decreases expression
ISO
Haloperidol results in decreased expression of STIP1 protein
CTD
PMID:34122009
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
G
Strn4
striatin 4
increases expression
ISO
Haloperidol results in increased expression of STRN4 mRNA
CTD
PMID:14647396
NCBI chr 1:77,482,267...77,511,862
Ensembl chr 1:77,482,094...77,511,858
G
Stt3a
STT3 oligosaccharyltransferase complex catalytic subunit A
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of STT3A protein
CTD
PMID:34122009
NCBI chr 8:36,443,623...36,483,111
Ensembl chr 8:36,446,788...36,483,293
G
Stx1a
syntaxin 1A
increases expression
EXP
Haloperidol results in increased expression of STX1A mRNA
CTD
PMID:15860345
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
G
Stx1b
syntaxin 1B
affects expression
EXP
Haloperidol affects the expression of STX1B mRNA
CTD
PMID:15860345
NCBI chr 1:182,415,544...182,434,385
Ensembl chr 1:182,415,546...182,441,280
G
Stx4
syntaxin 4
increases expression
EXP
Haloperidol results in increased expression of STX4 mRNA
CTD
PMID:15860345
NCBI chr 1:182,451,108...182,459,701
Ensembl chr 1:182,451,117...182,459,979
G
Stx5
syntaxin 5
decreases expression
EXP
Haloperidol results in decreased expression of STX5 mRNA
CTD
PMID:15860345
NCBI chr 1:205,637,401...205,653,563
Ensembl chr 1:205,637,413...205,653,563
G
Stx7
syntaxin 7
decreases expression
EXP
Haloperidol results in decreased expression of STX7 mRNA
CTD
PMID:15860345
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Stx8
syntaxin 8
affects expression
EXP
Haloperidol affects the expression of STX8 mRNA
CTD
PMID:15860345
NCBI chr10:52,655,643...52,900,048
Ensembl chr10:52,654,990...52,894,993
G
Supt3h
SPT3 homolog, SAGA and STAGA complex component
increases expression
EXP
Haloperidol results in increased expression of SUPT3H mRNA
CTD
PMID:16715494
NCBI chr 9:15,878,296...16,206,768
Ensembl chr 9:15,868,287...16,206,706
G
Syn2
synapsin II
increases expression
EXP
Haloperidol results in increased expression of SYN2 mRNA
CTD
PMID:15860345
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
G
Sypl1
synaptophysin-like 1
decreases expression
ISO
Haloperidol results in decreased expression of SYPL1 mRNA
CTD
PMID:18797397
NCBI chr 6:49,565,111...49,585,205
Ensembl chr 6:49,565,154...49,585,330
G
Syt11
synaptotagmin 11
increases expression
EXP
Haloperidol results in increased expression of SYT11 mRNA
CTD
PMID:15860345
NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964
G
Syt3
synaptotagmin 3
decreases expression
EXP
Haloperidol results in decreased expression of SYT3 mRNA
CTD
PMID:15860345
NCBI chr 1:94,880,835...94,895,518
Ensembl chr 1:94,881,247...94,895,246
G
Syt4
synaptotagmin 4
affects expression
EXP
Haloperidol affects the expression of SYT4 mRNA
CTD
PMID:15860345
NCBI chr18:23,036,973...23,046,380
Ensembl chr18:23,038,378...23,046,332
G
Tac1
tachykinin, precursor 1
increases expression
EXP
Haloperidol results in increased expression of TAC1 mRNA
CTD
PMID:10974607
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tagln
transgelin
decreases expression
ISO
Haloperidol results in decreased expression of TAGLN mRNA
CTD
PMID:17175557
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tagln2
transgelin 2
decreases expression
ISO
Haloperidol results in decreased expression of TAGLN2 protein
CTD
PMID:34122009
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Tap1
transporter 1, ATP binding cassette subfamily B member
decreases expression
EXP
Haloperidol results in decreased expression of TAP1 mRNA
CTD
PMID:16452686
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tatdn1
TatD DNase domain containing 1
increases expression
ISO
Haloperidol results in increased expression of TATDN1 mRNA
CTD
PMID:14647396
NCBI chr 7:90,449,979...90,481,000
Ensembl chr 7:90,441,079...90,481,133
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
Haloperidol results in decreased expression of TCAF1 protein
CTD
PMID:34122009
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tcerg1
transcription elongation regulator 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of TCERG1 protein
CTD
PMID:34122009
NCBI chr18:34,505,708...34,566,470
Ensembl chr18:34,505,751...34,566,470
G
Tf
transferrin
decreases expression
ISO
Haloperidol results in decreased expression of TRF mRNA
CTD
PMID:17177202
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgoln2
trans-golgi network protein 2
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of TGOLN2 protein
CTD
PMID:34122009
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Th
tyrosine hydroxylase
increases expression
EXP
Haloperidol results in increased expression of TH protein
CTD
PMID:17028028
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Thra
thyroid hormone receptor alpha
decreases expression increases expression
EXP
Haloperidol results in decreased expression of THRA mRNA alternative form Haloperidol results in increased expression of THRA mRNA alternative form
CTD
PMID:11564422
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tln2
talin 2
decreases expression
ISO
Haloperidol results in decreased expression of TLN2 protein
CTD
PMID:34122009
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tm9sf2
transmembrane 9 superfamily member 2
decreases expression
ISO
Haloperidol results in decreased expression of TM9SF2 protein
CTD
PMID:34122009
NCBI chr15:99,201,556...99,254,054
Ensembl chr15:99,201,489...99,254,049
G
Tmem109
transmembrane protein 109
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of TMEM109 protein
CTD
PMID:34122009
NCBI chr 1:207,519,628...207,530,245
Ensembl chr 1:207,519,624...207,530,215
G
Tmod3
tropomodulin 3
decreases expression
ISO
Haloperidol results in decreased expression of TMOD3 protein
CTD
PMID:34122009
NCBI chr 8:76,248,978...76,310,855
Ensembl chr 8:76,248,979...76,310,977
G
Tmprss2
transmembrane serine protease 2
increases expression
EXP
Haloperidol results in increased expression of TMPRSS2 mRNA
CTD
PMID:32808185
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
G
Tnf
tumor necrosis factor
multiple interactions increases expression
EXP ISO
Haloperidol affects the reaction [Phencyclidine affects the expression of TNF mRNA] Cannabidiol inhibits the reaction [Haloperidol results in increased expression of TNF mRNA] Haloperidol results in increased expression of TNF protein
CTD
PMID:16478754 PMID:18554768 PMID:18590723 PMID:30217539
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnik
TRAF2 and NCK interacting kinase
decreases expression
ISO
Haloperidol results in decreased expression of TNIK mRNA
CTD
PMID:14647396
NCBI chr 2:111,184,352...111,587,993
Ensembl chr 2:111,184,387...111,580,750
G
Tor1a
torsin family 1, member A
affects response to substance
ISO
TOR1A gene mutant form affects the susceptibility to Haloperidol
CTD
PMID:20227500
NCBI chr 3:14,250,667...14,257,704
Ensembl chr 3:14,250,676...14,257,691
G
Tp53
tumor protein p53
increases expression
EXP
Haloperidol results in increased expression of TP53 mRNA; Haloperidol results in increased expression of TP53 protein
CTD
PMID:16462815
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpi1
triosephosphate isomerase 1
increases expression
EXP
Haloperidol results in increased expression of TPI1 mRNA
CTD
PMID:15860345
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Trim2
tripartite motif-containing 2
decreases expression
ISO
Haloperidol results in decreased expression of TRIM2 mRNA
CTD
PMID:14647396
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim23
tripartite motif-containing 23
decreases expression
EXP
Haloperidol results in decreased expression of TRIM23 mRNA
CTD
PMID:15860345
NCBI chr 2:35,302,405...35,335,746
Ensembl chr 2:35,302,409...35,335,743
G
Trim28
tripartite motif-containing 28
decreases expression
ISO
Haloperidol results in decreased expression of TRIM28 protein
CTD
PMID:34122009
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
G
Trmt13
tRNA methyltransferase 13 homolog
decreases expression
ISO
Haloperidol results in decreased expression of TRMT13 protein
CTD
PMID:34122009
NCBI chr 2:204,533,630...204,547,711
Ensembl chr 2:204,533,632...204,546,843
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of TRPV5 protein
CTD
PMID:34122009
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
G
Ttbk1
tau tubulin kinase 1
increases expression
ISO
Haloperidol results in increased expression of TTBK1 protein
CTD
PMID:34122009
NCBI chr 9:14,493,166...14,538,372
Ensembl chr 9:14,493,389...14,535,774
G
Tubb4b
tubulin, beta 4B class IVb
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of TUBB4B protein
CTD
PMID:34122009
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Txlna
taxilin alpha
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of TXLNA protein
CTD
PMID:34122009
NCBI chr 5:141,969,337...141,985,054
Ensembl chr 5:141,969,346...141,984,583
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
increases expression
ISO
Haloperidol results in increased expression of UBA52 mRNA
CTD
PMID:14647396
NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807
G
Ubc
ubiquitin C
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of UBC protein
CTD
PMID:34122009
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Ube2r2
ubiquitin-conjugating enzyme E2R 2
increases expression
ISO
Haloperidol results in increased expression of UBE2R2 mRNA
CTD
PMID:14647396
NCBI chr 5:56,286,604...56,345,160
Ensembl chr 5:56,286,725...56,345,513
G
Ubqln4
ubiquilin 4
decreases expression
ISO
Haloperidol results in decreased expression of UBQLN4 protein
CTD
PMID:34122009
NCBI chr 2:174,012,726...174,028,062
Ensembl chr 2:174,012,777...174,028,059
G
Ubtf
upstream binding transcription factor
decreases expression
ISO
Haloperidol results in decreased expression of UBTF protein
CTD
PMID:34122009
NCBI chr10:87,258,217...87,274,291
Ensembl chr10:87,258,217...87,272,969
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
Haloperidol results in increased expression of UGP2 protein
CTD
PMID:34122009
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Ugt8
UDP glycosyltransferase 8
decreases expression
ISO
Haloperidol results in decreased expression of UGT8A mRNA
CTD
PMID:17177202
NCBI chr 2:214,264,483...214,332,769
Ensembl chr 2:214,264,483...214,332,660
G
Unc13a
unc-13 homolog A
decreases expression
EXP
Haloperidol results in decreased expression of UNC13A mRNA
CTD
PMID:15860345
NCBI chr16:18,333,910...18,381,813
Ensembl chr16:18,336,229...18,381,872
G
Uqcr11
ubiquinol-cytochrome c reductase, complex III subunit XI
increases expression
ISO
Haloperidol results in increased expression of UQCR11 mRNA
CTD
PMID:14647396
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
G
Uso1
USO1 vesicle transport factor
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of USO1 protein
CTD
PMID:34122009
NCBI chr14:15,866,638...15,932,185
Ensembl chr14:15,866,638...15,932,171
G
Usp5
ubiquitin specific peptidase 5
multiple interactions increases expression
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of USP5 protein Haloperidol results in increased expression of USP5 protein
CTD
PMID:34122009
NCBI chr 4:157,619,663...157,634,681
Ensembl chr 4:157,619,643...157,634,711
G
Usp7
ubiquitin specific peptidase 7
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in increased expression of USP7 protein
CTD
PMID:34122009
NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355
G
Vamp1
vesicle-associated membrane protein 1
decreases expression increases expression
EXP
Haloperidol results in decreased expression of VAMP1 mRNA Haloperidol results in increased expression of VAMP1 mRNA
CTD
PMID:15860345
NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349
G
Vamp2
vesicle-associated membrane protein 2
decreases expression increases expression
EXP
Haloperidol results in decreased expression of VAMP2 mRNA Haloperidol results in increased expression of VAMP2 mRNA
CTD
PMID:15860345
NCBI chr10:53,793,581...53,797,815
Ensembl chr10:53,793,923...53,797,809
G
Vipr2
vasoactive intestinal peptide receptor 2
decreases expression
ISO
Haloperidol results in decreased expression of VIPR2 mRNA
CTD
PMID:27900577
NCBI chr 6:136,996,664...137,070,599
Ensembl chr 6:137,001,511...137,070,597
G
Vldlr
very low density lipoprotein receptor
increases expression
EXP
Haloperidol results in increased expression of VLDLR protein
CTD
PMID:19359144
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vsnl1
visinin-like 1
decreases expression
EXP
Haloperidol results in decreased expression of VSNL1 mRNA
CTD
PMID:12437575
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Wars1
tryptophanyl-tRNA synthetase 1
multiple interactions
ISO
[Cuprizone co-treated with Haloperidol] results in decreased expression of WARS1 protein
CTD
PMID:34122009
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
G
Wbp1l
WW domain binding protein 1-like
decreases expression
ISO
Haloperidol results in decreased expression of WBP1L mRNA
CTD
PMID:14647396
NCBI chr 1:245,472,292...245,528,627
Ensembl chr 1:245,472,296...245,528,627
G
Wdr12
WD repeat domain 12
decreases expression
ISO
Haloperidol results in decreased expression of WDR12 protein
CTD
PMID:34122009
NCBI chr 9:61,475,498...61,502,762
Ensembl chr 9:61,475,517...61,502,469
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Haloperidol results in increased expression of WIPI1 mRNA
CTD
PMID:17175557
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Wwc3
WWC family member 3
decreases expression
ISO
Haloperidol results in decreased expression of WWC3 protein
CTD
PMID:34122009
NCBI chr X:23,584,204...23,701,864
Ensembl chr X:23,584,424...23,700,513
G
Xirp2
xin actin-binding repeat containing 2
decreases expression
ISO
Haloperidol results in decreased expression of XIRP2 protein
CTD
PMID:34122009
NCBI chr 3:52,126,213...52,213,094
Ensembl chr 3:51,870,092...52,213,091
G
Xpnpep1
X-prolyl aminopeptidase 1
increases expression
ISO
Haloperidol results in increased expression of XPNPEP1 protein
CTD
PMID:34122009
NCBI chr 1:252,001,366...252,052,077
Ensembl chr 1:252,001,367...252,051,479
G
Zfr
zinc finger RNA binding protein
decreases expression
ISO
Haloperidol results in decreased expression of ZFR protein
CTD
PMID:34122009
NCBI chr 2:61,137,611...61,200,322
Ensembl chr 2:61,137,611...61,200,322
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
iloperidone results in decreased activity of ABCB11 protein
CTD
PMID:23956101
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity decreases expression
ISO
iloperidone results in decreased activity of CYP3A4 protein iloperidone results in decreased expression of CYP3A4 mRNA
CTD
PMID:32941854
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases metabolic processing
ISO
CYP1A2 results in increased metabolism of Loxapine
CTD
PMID:21826677
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases metabolic processing
ISO
CYP2D6 results in increased metabolism of Loxapine
CTD
PMID:21826677
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases metabolic processing
ISO
CYP3A4 results in increased metabolism of Loxapine
CTD
PMID:21826677
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Drd1
dopamine receptor D1
affects binding
EXP
Loxapine analog binds to DRD1 protein; Loxapine binds to DRD1 protein
CTD
PMID:9723970
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
affects binding
EXP
Loxapine analog binds to DRD2 protein; Loxapine binds to DRD2 protein
CTD
PMID:9723970
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Htr1a
5-hydroxytryptamine receptor 1A
affects binding
EXP
Loxapine analog binds to HTR1A protein; Loxapine binds to HTR1A protein
CTD
PMID:9723970
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
affects binding
EXP
Loxapine analog binds to HTR2A protein; Loxapine binds to HTR2A protein
CTD
PMID:9723970
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
affects binding
EXP
Loxapine analog binds to HTR2C protein; Loxapine binds to HTR2C protein
CTD
PMID:9723970
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Loxapine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Drd2
dopamine receptor D2
multiple interactions
ISO
Lurasidone Hydrochloride binds to and results in decreased activity of DRD2 protein
CTD
PMID:20404009
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO
Lurasidone Hydrochloride binds to and results in increased activity of HTR1A protein
CTD
PMID:20404009
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
Lurasidone Hydrochloride binds to and results in decreased activity of HTR7 protein
CTD
PMID:20404009
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
EXP
LY 379268 inhibits the reaction [bisphenol A results in decreased expression of NR3C1 mRNA]
CTD
PMID:25812946
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Mesoridazine results in decreased activity of KCNH2 protein
CTD
PMID:17042915
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Methiothepin binds to and results in decreased activity of ADRA1A protein
CTD
PMID:16545797
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
ISO EXP
Methiothepin binds to and results in decreased activity of HTR1A protein
CTD
PMID:2207497 PMID:15482641
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
affects binding
EXP
Methiothepin binds to HTR1B protein
CTD
PMID:11888550
NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions
ISO
[Methiothepin binds to and results in decreased activity of HTR2A protein] which results in decreased susceptibility to Cocaine
CTD
PMID:10764922
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr5b
5-hydroxytryptamine (serotonin) receptor 5B
multiple interactions
EXP
methiothepin binds to protein 5-Htr5b; inhibits the reaction[5-carboxamidotryptamine binds to 5-Htr5b]
RGD
PMID:8224165
RGD:2303647
NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Methiothepin binds to and results in decreased activity of HTR7 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; [Methiothepin binds to and results in decreased activity of HTR7 protein] which results in decreased abundance of Cyclic AMP; Methiothepin binds to and results in decreased activity of HTR7 protein
CTD
PMID:14578406 PMID:18996971 PMID:19509219
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Methiothepin results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Sigmar1
sigma non-opioid intracellular receptor 1
multiple interactions
EXP
[N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride binds to and results in decreased activity of SIGMAR1 protein] inhibits the reaction [1-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-3,4-dihydro-5-methoxy-2(1H)-quinolinone results in increased secretion of Acetylcholine]
CTD
PMID:11907181
NCBI chr 5:56,904,155...56,907,012
Ensembl chr 5:56,904,159...56,907,017
G
A1bg
alpha-1-B glycoprotein
affects phosphorylation
ISO
olanzapine affects the phosphorylation of A1BG protein
CTD
PMID:25821032
NCBI chr 7:92,493,934...92,498,460
Ensembl chr 7:92,494,372...92,498,097
G
A2m
alpha-2-macroglobulin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of A2M protein
CTD
PMID:25821032
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
olanzapine results in decreased activity of ABCB11 protein
CTD
PMID:22646477
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases activity multiple interactions
ISO EXP
olanzapine results in decreased activity of ABCB1 protein [[ABCB1A gene mutant form co-treated with ABCB1B gene mutant form] affects the susceptibility to Fluoxetine] which affects the abundance of Olanzapine; [[ABCB1A gene mutant form co-treated with ABCB1B gene mutant form] affects the susceptibility to Fluoxetine] which results in increased uptake of Olanzapine; [ABCB1A gene mutant form co-treated with ABCB1B gene mutant form] results in increased abundance of and results in decreased uptake of Olanzapine
CTD
PMID:16810505 PMID:34610281
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
multiple interactions
EXP
[[ABCB1A gene mutant form co-treated with ABCB1B gene mutant form] affects the susceptibility to Fluoxetine] which affects the abundance of Olanzapine; [[ABCB1A gene mutant form co-treated with ABCB1B gene mutant form] affects the susceptibility to Fluoxetine] which results in increased uptake of Olanzapine; [ABCB1A gene mutant form co-treated with ABCB1B gene mutant form] results in increased abundance of and results in decreased uptake of Olanzapine
CTD
PMID:34610281
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
olanzapine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acaca
acetyl-CoA carboxylase alpha
decreases expression multiple interactions
ISO
Olanzapine results in decreased expression of ACACA mRNA capsazepine inhibits the reaction [Olanzapine results in decreased expression of ACACA mRNA]; Metformin inhibits the reaction [Olanzapine results in decreased expression of ACACA mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of ACACA mRNA]
CTD
PMID:32652086
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acox1
acyl-CoA oxidase 1
multiple interactions
EXP
[olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased activity of ACOX1 protein; [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased expression of ACOX1 mRNA
CTD
PMID:23226405
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
G
Adcyap1r1
ADCYAP receptor type I
affects expression
ISO
olanzapine affects the expression of ADCYAP1R1 mRNA
CTD
PMID:27900577
NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression decreases expression multiple interactions
ISO
olanzapine results in increased expression of ADIPOQ mRNA Olanzapine results in decreased expression of ADIPOQ protein capsazepine inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein]; Metformin inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein]; Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein]
CTD
PMID:17651982 PMID:32652086
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Afm
afamin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of AFM protein
CTD
PMID:25821032
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
G
Agrp
agouti related neuropeptide
increases expression multiple interactions
EXP ISO
olanzapine results in increased expression of AGRP protein Metformin inhibits the reaction [Olanzapine results in increased expression of AGRP mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of AGRP mRNA]
CTD
PMID:21695181 PMID:32652086
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
G
Akt1
AKT serine/threonine kinase 1
increases expression decreases expression multiple interactions increases response to substance increases phosphorylation
ISO
Olanzapine results in increased expression of AKT1 mRNA; Olanzapine results in increased expression of AKT1 protein Olanzapine results in decreased expression of AKT1 mRNA capsazepine inhibits the reaction [Olanzapine results in decreased expression of AKT1 mRNA]; Metformin inhibits the reaction [Olanzapine results in decreased expression of AKT1 mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of AKT1 mRNA] AKT1 gene SNP results in increased susceptibility to olanzapine olanzapine results in increased phosphorylation of AKT1 protein
CTD
PMID:19440698 PMID:21187413 PMID:32652086
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of ALB protein
CTD
PMID:25821032
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Apoa1
apolipoprotein A1
increases phosphorylation
ISO
olanzapine results in increased phosphorylation of APOA1 protein
CTD
PMID:25821032
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoa4
apolipoprotein A4
affects phosphorylation
ISO
olanzapine affects the phosphorylation of APOA4 protein
CTD
PMID:25821032
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
increases phosphorylation
ISO
olanzapine results in increased phosphorylation of APOB protein
CTD
PMID:25821032
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc3
apolipoprotein C3
affects response to substance
EXP
APOC3 gene polymorphism affects the susceptibility to olanzapine
CTD
PMID:17726453
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Apoh
apolipoprotein H
affects phosphorylation
ISO
olanzapine affects the phosphorylation of APOH protein
CTD
PMID:25821032
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
G
App
amyloid beta precursor protein
multiple interactions
EXP
olanzapine inhibits the reaction [APP protein modified form affects the activity of CAT protein]; olanzapine inhibits the reaction [APP protein modified form results in increased abundance of Reactive Oxygen Species]
CTD
PMID:15948179
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Aqp4
aquaporin 4
affects response to substance increases response to substance
ISO
AQP4 gene polymorphism affects the susceptibility to olanzapine AQP4 protein results in increased susceptibility to olanzapine
CTD
PMID:22544010
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
olanzapine results in increased expression of BAX protein
CTD
PMID:16462815
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression
EXP
olanzapine inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] olanzapine results in increased expression of BCL2 mRNA; olanzapine results in increased expression of BCL2 protein
CTD
PMID:15126120 PMID:15276877
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
increases expression
EXP ISO
olanzapine results in increased expression of BDNF mRNA; olanzapine results in increased expression of BDNF protein Olanzapine results in increased expression of BDNF mRNA; Olanzapine results in increased expression of BDNF protein
CTD
PMID:12478621 PMID:17442489 PMID:29182611
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bik
BCL2-interacting killer
increases expression
ISO
olanzapine results in increased expression of BIK mRNA
CTD
PMID:16160616
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
C3
complement C3
affects phosphorylation
ISO
olanzapine affects the phosphorylation of C3 protein
CTD
PMID:25821032
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4a
complement C4A
decreases phosphorylation
ISO
olanzapine results in decreased phosphorylation of C4A protein
CTD
PMID:25821032
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
G
C4b
complement C4B
affects phosphorylation
ISO
olanzapine affects the phosphorylation of C4B protein
CTD
PMID:25821032
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
C5
complement C5
affects phosphorylation
ISO
olanzapine affects the phosphorylation of C5 protein
CTD
PMID:25821032
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C6
complement C6
affects phosphorylation
ISO
olanzapine affects the phosphorylation of C6 protein
CTD
PMID:25821032
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
G
C9
complement C9
affects phosphorylation
ISO
olanzapine affects the phosphorylation of C9 protein
CTD
PMID:25821032
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
EXP
olanzapine results in decreased expression of and results in decreased phosphorylation of CAMK2A protein
CTD
PMID:18061412
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Cat
catalase
multiple interactions
EXP
olanzapine inhibits the reaction [APP protein modified form affects the activity of CAT protein]
CTD
PMID:15948179
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cfb
complement factor B
affects phosphorylation
ISO
olanzapine affects the phosphorylation of CFB protein
CTD
PMID:25821032
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfh
complement factor H
decreases phosphorylation
ISO
olanzapine results in decreased phosphorylation of CFH protein
CTD
PMID:25821032
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Chrm1
cholinergic receptor, muscarinic 1
affects binding
ISO
olanzapine binds to CHRM1 protein
CTD
PMID:16983399
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Clu
clusterin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of CLU protein
CTD
PMID:25821032
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Col1a1
collagen type I alpha 1 chain
decreases phosphorylation
ISO
olanzapine results in decreased phosphorylation of COL1A1 protein
CTD
PMID:25821032
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Comt
catechol-O-methyltransferase
increases expression
EXP
olanzapine results in increased expression of COMT mRNA
CTD
PMID:15964593
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cp
ceruloplasmin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of CP protein
CTD
PMID:25821032
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpt2
carnitine palmitoyltransferase 2
multiple interactions
EXP
[olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in decreased expression of CPT2 mRNA; [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased activity of CPT2 protein; [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in increased expression of CPT2 mRNA
CTD
PMID:23226405
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
[Fluoxetine co-treated with olanzapine] results in decreased phosphorylation of CREB1 protein
CTD
PMID:14556240
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Ctnnb1
catenin beta 1
decreases expression increases expression multiple interactions
ISO
olanzapine results in decreased expression of CTNNB1 mRNA Olanzapine results in increased expression of CTNNB1 mRNA Olanzapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA]
CTD
PMID:18797397 PMID:31563592
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects metabolic processing multiple interactions
ISO
CYP1A2 protein affects the metabolism of olanzapine Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine]
CTD
PMID:15545309 PMID:15883149
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Dab1
DAB adaptor protein 1
decreases expression
EXP
olanzapine results in decreased expression of DAB1 protein
CTD
PMID:19359144
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
G
Dclk1
doublecortin-like kinase 1
increases expression
ISO
olanzapine results in increased expression of DCLK1 mRNA
CTD
PMID:18797397
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
G
Drd1
dopamine receptor D1
affects binding
ISO
olanzapine binds to DRD1 protein
CTD
PMID:24389121
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
increases response to substance affects binding multiple interactions decreases activity affects activity
ISO EXP
DRD2 gene SNP results in increased susceptibility to olanzapine; DRD2 intron SNP results in increased susceptibility to olanzapine olanzapine binds to DRD2 protein olanzapine promotes the reaction [Dopamine binds to DRD2 protein] olanzapine results in decreased activity of DRD2 protein olanzapine affects the activity of DRD2 protein
CTD
PMID:10482380 PMID:10831489 PMID:11198054 PMID:15716360 PMID:20361897 PMID:20375926 PMID:21187413 PMID:24389121 More...
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
multiple interactions
ISO
DRD3 protein results in increased susceptibility to [olanzapine co-treated with Fluoxetine]
CTD
PMID:20021991
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
F2
coagulation factor II, thrombin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of F2 protein
CTD
PMID:25821032
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
Olanzapine results in increased expression of FABP1 mRNA
CTD
PMID:31437515
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fasn
fatty acid synthase
increases expression
ISO
olanzapine results in increased expression of FASN mRNA
CTD
PMID:17651982
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fgf2
fibroblast growth factor 2
multiple interactions
EXP
[Fluoxetine co-treated with olanzapine] results in increased expression of FGF2 mRNA
CTD
PMID:15158429
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fn1
fibronectin 1
affects phosphorylation
ISO
olanzapine affects the phosphorylation of FN1 protein
CTD
PMID:25821032
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[Fluoxetine co-treated with olanzapine] results in decreased expression of FOS protein
CTD
PMID:14556240
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
multiple interactions
EXP
olanzapine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased expression of FOSL1 protein]
CTD
PMID:11425506
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Gad1
glutamate decarboxylase 1
decreases expression
EXP
olanzapine results in decreased expression of GAD1 mRNA; olanzapine results in decreased expression of GAD1 protein
CTD
PMID:14519413 PMID:19359144
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
decreases expression
EXP
olanzapine results in decreased expression of GAD2 protein
CTD
PMID:19359144
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
G
Gc
GC, vitamin D binding protein
affects phosphorylation
ISO
olanzapine affects the phosphorylation of GC protein
CTD
PMID:25821032
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Olanzapine results in increased expression of GCLC mRNA
CTD
PMID:37005277
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gfap
glial fibrillary acidic protein
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA]; Metformin inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GFAP mRNA]
CTD
PMID:32652086
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Ghrl
ghrelin and obestatin prepropeptide
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in increased expression of GHRL protein]; Metformin inhibits the reaction [Olanzapine results in increased expression of GHRL protein]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GHRL protein]
CTD
PMID:32652086
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Ghsr
growth hormone secretagogue receptor
increases expression multiple interactions
ISO
Olanzapine results in increased expression of GHSR mRNA capsazepine inhibits the reaction [Olanzapine results in increased expression of GHSR mRNA]; Metformin inhibits the reaction [Olanzapine results in increased expression of GHSR mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of GHSR mRNA]
CTD
PMID:32652086
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases expression
ISO
Dietary Fats promotes the reaction [Olanzapine results in increased expression of GPT protein]
CTD
PMID:37019375
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
increases expression
EXP
olanzapine results in increased expression of GRIA2 mRNA
CTD
PMID:11526992
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
increases expression
EXP
olanzapine results in increased expression of GRIA3 mRNA
CTD
PMID:11526992
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Gsk3b
glycogen synthase kinase 3 beta
increases phosphorylation multiple interactions decreases expression
ISO
olanzapine results in increased phosphorylation of GSK3B protein Olanzapine inhibits the reaction [Dizocilpine Maleate results in increased expression of GSK3B mRNA] Olanzapine results in decreased expression of GSK3B mRNA
CTD
PMID:19440698 PMID:31563592
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression decreases expression multiple interactions
ISO EXP
olanzapine results in increased expression of HMGCR mRNA olanzapine results in decreased expression of HMGCR mRNA 1-(carboxymethylthio)tetradecane promotes the reaction [olanzapine results in decreased expression of HMGCR mRNA]; olanzapine promotes the reaction [1-(carboxymethylthio)tetradecane results in decreased expression of HMGCR mRNA]
CTD
PMID:17052361 PMID:23226405
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
olanzapine results in increased expression of HMGCS1 mRNA
CTD
PMID:17052361
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
increases expression
ISO
Olanzapine results in increased expression of HMOX1 mRNA
CTD
PMID:37005277
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpx
hemopexin
affects phosphorylation
ISO
olanzapine affects the phosphorylation of HPX protein
CTD
PMID:25821032
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Hrg
histidine-rich glycoprotein
affects phosphorylation
ISO
olanzapine affects the phosphorylation of HRG protein
CTD
PMID:25821032
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
G
Hrh1
histamine receptor H 1
affects binding multiple interactions
ISO
olanzapine binds to HRH1 protein HRH1 protein results in increased susceptibility to [olanzapine co-treated with Fluoxetine]
CTD
PMID:16983399 PMID:20021991 PMID:24389121
NCBI chr 4:147,564,963...147,649,353
Ensembl chr 4:147,645,995...147,647,455
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions affects binding decreases activity
ISO EXP
olanzapine binds to and results in decreased activity of HTR2A protein olanzapine binds to HTR2A protein olanzapine results in decreased activity of HTR2A protein [[olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [olanzapine results in decreased activity of HTR2A protein]; [olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein; olanzapine binds to and results in decreased activity of HTR2A protein
CTD
PMID:16983399 PMID:18976543 PMID:19304867 PMID:20521326 PMID:24389121
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
increases response to substance affects binding affects response to substance
ISO
HTR2C gene polymorphism results in increased susceptibility to olanzapine olanzapine binds to HTR2C protein HTR2C gene polymorphism affects the susceptibility to Olanzapine; HTR2C gene SNP affects the susceptibility to Olanzapine; HTR2C protein affects the susceptibility to Olanzapine
CTD
PMID:15666332 PMID:16983399 PMID:19142110 PMID:19434072 PMID:24389121
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Htr6
5-hydroxytryptamine receptor 6
affects binding
ISO
olanzapine binds to HTR6 protein
CTD
PMID:16983399
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
G
Il10
interleukin 10
increases expression decreases expression multiple interactions
ISO
Olanzapine results in increased expression of IL10 mRNA Olanzapine results in decreased expression of IL10 protein Lithium inhibits the reaction [Olanzapine results in decreased expression of IL10 protein]
CTD
PMID:30695037
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO
Lithium inhibits the reaction [Olanzapine results in increased expression of IL1B mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of IL1B protein] Olanzapine results in increased expression of IL1B mRNA; Olanzapine results in increased expression of IL1B protein
CTD
PMID:30695037
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in increased expression of IL6 protein]; Lithium inhibits the reaction [Olanzapine results in increased expression of IL6 mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of IL6 protein]; Metformin inhibits the reaction [Olanzapine results in increased expression of IL6 protein]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of IL6 protein] Olanzapine results in increased expression of IL6 mRNA; Olanzapine results in increased expression of IL6 protein
CTD
PMID:30695037 PMID:32652086
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins2
insulin 2
increases secretion increases expression
ISO
olanzapine results in increased secretion of INS protein olanzapine results in increased expression of INS protein
CTD
PMID:11769361 PMID:11927762 PMID:16601995 PMID:19512971
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Itih2
inter-alpha-trypsin inhibitor heavy chain 2
affects phosphorylation
ISO
olanzapine affects the phosphorylation of ITIH2 protein
CTD
PMID:25821032
NCBI chr17:68,375,574...68,411,849
Ensembl chr17:68,375,567...68,411,841
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
affects phosphorylation
ISO
olanzapine affects the phosphorylation of ITIH4 protein
CTD
PMID:25821032
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
G
Jak2
Janus kinase 2
multiple interactions increases activity
EXP
[[olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [olanzapine results in decreased activity of HTR2A protein]; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [olanzapine results in increased expression of RGS7 mRNA]; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [olanzapine results in increased expression of RGS7 protein]; [olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein olanzapine results in increased activity of JAK2 protein
CTD
PMID:18976543 PMID:19304867
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kcna1
potassium voltage-gated channel subfamily A member 1
increases expression
ISO
olanzapine results in increased expression of KCNA1 mRNA
CTD
PMID:18797397
NCBI chr 4:159,464,223...159,472,905
Ensembl chr 4:159,464,188...159,472,682
G
Kcnab1
potassium voltage-gated channel subfamily A regulatory beta subunit 1
decreases expression
ISO
olanzapine results in decreased expression of KCNAB1 mRNA
CTD
PMID:18797397
NCBI chr 2:149,137,025...149,603,540
Ensembl chr 2:149,137,041...149,603,534
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
ISO
olanzapine results in decreased activity of KCNH2 protein olanzapine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:16494862 PMID:21158687
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnip3
potassium voltage-gated channel interacting protein 3
decreases expression
ISO
olanzapine results in decreased expression of KCNIP3 mRNA; olanzapine results in decreased expression of KCNIP3 protein
CTD
PMID:18797397
NCBI chr 3:114,677,027...114,742,923
Ensembl chr 3:114,677,030...114,743,556
G
Klc1
kinesin light chain 1
decreases expression
ISO
olanzapine results in decreased expression of KLC1 mRNA
CTD
PMID:18797397
NCBI chr 6:130,823,416...130,866,729
Ensembl chr 6:130,823,419...130,867,031
G
Kng1
kininogen 1
affects phosphorylation
ISO
Olanzapine affects the phosphorylation of KNG1 protein
CTD
PMID:25821032
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Ldlr
low density lipoprotein receptor
increases expression multiple interactions
ISO
olanzapine results in increased expression of LDLR mRNA olanzapine promotes the reaction [SREBF1 protein results in increased expression of LDLR mRNA]
CTD
PMID:17052361 PMID:17651982
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
increases expression multiple interactions
ISO
olanzapine results in increased expression of LEP protein Olanzapine results in increased expression of LEP protein capsazepine inhibits the reaction [Olanzapine results in increased expression of LEP protein]; Metformin inhibits the reaction [Olanzapine results in increased expression of LEP protein]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of LEP protein]
CTD
PMID:11927762 PMID:19512971 PMID:32652086
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
olanzapine results in decreased expression of MAL mRNA
CTD
PMID:18797397
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Maoa
monoamine oxidase A
increases expression
EXP
olanzapine results in increased expression of MAOA mRNA
CTD
PMID:15964593
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Maob
monoamine oxidase B
increases expression
EXP
olanzapine results in increased expression of MAOB mRNA
CTD
PMID:15964593
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map2
microtubule-associated protein 2
increases expression
EXP
olanzapine results in increased expression of MAP2 mRNA
CTD
PMID:15079866
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mthfr
methylenetetrahydrofolate reductase
affects response to substance
ISO
MTHFR gene polymorphism affects the susceptibility to olanzapine; MTHFR protein affects the susceptibility to olanzapine
CTD
PMID:20547447
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Ncan
neurocan
decreases expression
ISO
olanzapine results in decreased expression of NCAN mRNA
CTD
PMID:18797397
NCBI chr16:19,301,969...19,328,436
Ensembl chr16:19,301,969...19,328,436
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
decreases expression
ISO
olanzapine results in decreased expression of NEDD4 mRNA; olanzapine results in decreased expression of NEDD4 protein
CTD
PMID:18797397
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases expression
ISO
Olanzapine results in decreased expression of NFE2L2 protein
CTD
PMID:37019375
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in increased expression of NFKB1 mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of NFKB1 mRNA]
CTD
PMID:32652086
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nptn
neuroplastin
increases expression
ISO
olanzapine results in increased expression of NPTN mRNA
CTD
PMID:18797397
NCBI chr 8:58,996,873...59,063,402
Ensembl chr 8:58,996,887...59,063,401
G
Npy
neuropeptide Y
decreases expression increases expression multiple interactions
EXP ISO
olanzapine results in decreased expression of NPY mRNA Olanzapine results in increased expression of NPY mRNA capsazepine inhibits the reaction [Olanzapine results in increased expression of NPY mRNA]; Metformin inhibits the reaction [Olanzapine results in increased expression of NPY mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of NPY mRNA] olanzapine results in increased expression of NPY protein
CTD
PMID:16516965 PMID:21695181 PMID:32652086
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Numbl
NUMB-like, endocytic adaptor protein
decreases expression
ISO
olanzapine results in decreased expression of NUMBL mRNA
CTD
PMID:18797397
NCBI chr 1:82,549,814...82,573,788
Ensembl chr 1:82,550,054...82,573,776
G
Pde1a
phosphodiesterase 1A
increases expression
EXP
olanzapine results in increased expression of PDE1A mRNA
CTD
PMID:20222156
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pde8b
phosphodiesterase 8B
increases expression
EXP
olanzapine results in increased expression of PDE8B mRNA
CTD
PMID:20222156
NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions decreases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in decreased expression of PIK3R1 mRNA]; Metformin inhibits the reaction [Olanzapine results in decreased expression of PIK3R1 mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of PIK3R1 mRNA]
CTD
PMID:32652086
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Plac8
placenta associated 8
affects phosphorylation
ISO
olanzapine affects the phosphorylation of C15 protein
CTD
PMID:25821032
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Plp1
proteolipid protein 1
decreases expression
ISO
olanzapine results in decreased expression of PLP1 mRNA
CTD
PMID:18797397
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Pnpla2
patatin-like phospholipase domain containing 2
affects expression
EXP
olanzapine affects the expression of PNPLA2 mRNA
CTD
PMID:23226405
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
G
Pomc
proopiomelanocortin
decreases expression multiple interactions
EXP ISO
olanzapine results in decreased expression of POMC protein Olanzapine results in decreased expression of POMC mRNA capsazepine inhibits the reaction [Olanzapine results in decreased expression of POMC mRNA]; Metformin inhibits the reaction [Olanzapine results in decreased expression of POMC mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of POMC mRNA]
CTD
PMID:21695181 PMID:32652086
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
olanzapine results in increased expression of PPARG protein alternative form
CTD
PMID:17651982
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
decreases expression multiple interactions
EXP
olanzapine results in decreased expression of PPARGC1A mRNA [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in decreased expression of PPARGC1A mRNA; olanzapine promotes the reaction [1-(carboxymethylthio)tetradecane results in decreased expression of PPARGC1A mRNA]
CTD
PMID:23226405
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
increases expression multiple interactions
ISO
Olanzapine results in increased expression of PRKAG2 mRNA capsazepine inhibits the reaction [Olanzapine results in increased expression of PRKAG2 mRNA]; Metformin inhibits the reaction [Olanzapine results in increased expression of PRKAG2 mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of PRKAG2 mRNA]
CTD
PMID:32652086
NCBI chr 4:10,010,890...10,252,155
Ensembl chr 4:10,010,890...10,252,142
G
Prl
prolactin
multiple interactions increases secretion increases expression
ISO
[olanzapine co-treated with Fluoxetine] results in increased expression of PRL protein olanzapine results in increased secretion of PRL protein olanzapine results in increased expression of PRL protein
CTD
PMID:9090331 PMID:9265911 PMID:9376336 PMID:10831029 PMID:11048906 PMID:11442886 PMID:12447030 PMID:15286066 PMID:15960571 PMID:18063941 PMID:19896213 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prrc2a
proline-rich coiled-coil 2A
decreases expression
ISO
olanzapine results in decreased expression of PRRC2A mRNA
CTD
PMID:18797397
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
G
Rapgef4
Rap guanine nucleotide exchange factor 4
decreases expression
ISO
olanzapine results in decreased expression of RAPGEF4 mRNA
CTD
PMID:18797397
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
G
Reln
reelin
increases expression
EXP
olanzapine results in increased expression of RELN mRNA; olanzapine results in increased expression of RELN protein
CTD
PMID:19359144
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rgs7
regulator of G-protein signaling 7
multiple interactions increases expression
EXP
[[Olanzapine binds to and results in decreased activity of HTR2A protein] which results in increased phosphorylation of JAK2 protein] which results in increased expression of RGS7 protein; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [Olanzapine results in increased expression of RGS7 mRNA]; [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [Olanzapine results in increased expression of RGS7 protein]; Olanzapine promotes the reaction [[STAT3 protein binds to RGS7 promoter] which results in increased expression of RGS7 mRNA]; Olanzapine promotes the reaction [STAT3 protein binds to RGS7 promoter] olanzapine results in increased expression of RGS7 mRNA; olanzapine results in increased expression of RGS7 protein
CTD
PMID:18976543 PMID:19304867
NCBI chr13:86,979,269...87,408,834
Ensembl chr13:86,979,279...87,408,888
G
Rtn4
reticulon 4
decreases expression
ISO
olanzapine results in decreased expression of RTN4 mRNA
CTD
PMID:18797397
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
S100a9
S100 calcium binding protein A9
decreases expression
ISO
olanzapine results in decreased expression of S100A9 mRNA
CTD
PMID:18797397
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
olanzapine results in increased expression of SC5D mRNA
CTD
PMID:17052361
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases phosphorylation
ISO
Olanzapine results in increased phosphorylation of SERPINA3 protein
CTD
PMID:25821032
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serping1
serpin family G member 1
affects phosphorylation
ISO
olanzapine affects the phosphorylation of SERPING1 protein
CTD
PMID:25821032
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Serpini1
serpin family I member 1
decreases expression
ISO
olanzapine results in decreased expression of SERPINI1 mRNA
CTD
PMID:18797397
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Shbg
sex hormone binding globulin
decreases expression
ISO
olanzapine results in decreased expression of SHBG protein
CTD
PMID:19512971
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
olanzapine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a5
solute carrier family 22 member 5
decreases expression multiple interactions
ISO
Olanzapine results in decreased expression of SLC22A5 mRNA; Olanzapine results in decreased expression of SLC22A5 protein Olanzapine inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine analog]
CTD
PMID:31437515
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc27a2
solute carrier family 27 member 2
increases expression
ISO
Olanzapine results in increased expression of SLC27A2 mRNA
CTD
PMID:31437515
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc27a5
solute carrier family 27 member 5
increases expression
ISO
Olanzapine results in increased expression of SLC27A5 mRNA
CTD
PMID:31437515
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc2a4
solute carrier family 2 member 4
increases expression
ISO
olanzapine results in increased expression of SLC2A4 mRNA
CTD
PMID:16002093
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
Olanzapine results in decreased expression of SLC7A11 mRNA
CTD
PMID:37005277
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Snap25
synaptosome associated protein 25
affects response to substance
ISO
SNAP25 gene SNP affects the susceptibility to olanzapine
CTD
PMID:15823421
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
G
Sod1
superoxide dismutase 1
multiple interactions decreases activity increases expression
EXP ISO
olanzapine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA]; olanzapine inhibits the reaction [Haloperidol results in decreased expression of SOD1 protein]; olanzapine inhibits the reaction [Hydrogen Peroxide results in decreased expression of SOD1 mRNA] Olanzapine results in decreased activity of SOD1 protein Dietary Fats promotes the reaction [Olanzapine results in decreased activity of SOD1 protein] olanzapine results in increased expression of SOD1 mRNA
CTD
PMID:12752374 PMID:12868070 PMID:16564057 PMID:37019375
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions increases expression
ISO
olanzapine promotes the reaction [SREBF1 protein results in increased expression of LDLR mRNA]; olanzapine results in increased activity of and results in increased expression of SREBF1 protein olanzapine results in increased expression of SREBF1 mRNA
CTD
PMID:17651982
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO EXP
olanzapine results in increased cleavage of and results in increased activity of SREBF2 protein [olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in decreased expression of SREBF2 mRNA
CTD
PMID:17052361 PMID:23226405
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
EXP
olanzapine promotes the reaction [[STAT3 protein binds to RGS7 promoter] which results in increased expression of RGS7 mRNA]; olanzapine promotes the reaction [STAT3 protein binds to RGS7 promoter]
CTD
PMID:18976543
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Sypl1
synaptophysin-like 1
decreases expression
ISO
Olanzapine results in decreased expression of SYPL1 mRNA
CTD
PMID:18797397
NCBI chr 6:49,565,111...49,585,205
Ensembl chr 6:49,565,154...49,585,330
G
Th
tyrosine hydroxylase
multiple interactions
EXP
olanzapine inhibits the reaction [Methamphetamine results in decreased expression of TH protein]
CTD
PMID:15276877
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in increased expression of TNF protein]; Dietary Fats promotes the reaction [Olanzapine results in increased expression of TNF protein]; Lithium inhibits the reaction [Olanzapine results in increased expression of TNF mRNA]; Lithium inhibits the reaction [Olanzapine results in increased expression of TNF protein]; Metformin inhibits the reaction [Olanzapine results in increased expression of TNF protein]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of TNF protein] Olanzapine results in increased expression of TNF mRNA; Olanzapine results in increased expression of TNF protein
CTD
PMID:30695037 PMID:32652086 PMID:37019375
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases expression
ISO
olanzapine results in increased expression of TP53 mRNA
CTD
PMID:16160616
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
multiple interactions increases expression
ISO
capsazepine inhibits the reaction [Olanzapine results in increased expression of TRPV1 mRNA]; Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of TRPV1 mRNA]
CTD
PMID:32652086
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
multiple interactions increases expression
ISO
Ruthenium Red inhibits the reaction [Olanzapine results in increased expression of TRPV3 mRNA]
CTD
PMID:32652086
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Ttr
transthyretin
increases expression
EXP
olanzapine results in increased expression of TTR mRNA
CTD
PMID:15927202
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Ucp1
uncoupling protein 1
multiple interactions
EXP
[olanzapine co-treated with 1-(carboxymethylthio)tetradecane] results in decreased expression of UCP1 mRNA
CTD
PMID:23226405
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Vipr2
vasoactive intestinal peptide receptor 2
affects expression
ISO
olanzapine affects the expression of VIPR2 mRNA
CTD
PMID:27900577
NCBI chr 6:136,996,664...137,070,599
Ensembl chr 6:137,001,511...137,070,597
G
Vldlr
very low density lipoprotein receptor
increases expression
EXP
olanzapine results in increased expression of VLDLR protein
CTD
PMID:19359144
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects abundance multiple interactions increases export increases transport affects response to substance decreases activity
ISO EXP
ABCB1 gene polymorphism affects the abundance of Paliperidone Palmitate; ABCB1 protein affects the abundance of Paliperidone Palmitate Cyclosporine inhibits the reaction [ABCB1A protein results in increased export of Paliperidone Palmitate] ABCB1A protein results in increased transport of Paliperidone Palmitate ABCB1A protein affects the susceptibility to Paliperidone Palmitate Paliperidone Palmitate results in decreased activity of ABCB1 protein Paliperidone Palmitate inhibits the reaction [ABCB1 protein results in decreased export of Doxorubicin] ABCB1 protein results in increased transport of Paliperidone Palmitate
CTD
PMID:15502009 PMID:16118767 PMID:16810505 PMID:16936711 PMID:17541883 PMID:22691713 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects response to substance
ISO
ABCB1B protein affects the susceptibility to Paliperidone Palmitate
CTD
PMID:15502009
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcb4
ATP binding cassette subfamily B member 4
decreases activity
ISO
Paliperidone Palmitate results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Paliperidone Palmitate inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Bdnf
brain-derived neurotrophic factor
increases expression
EXP
Paliperidone Palmitate results in increased expression of BDNF mRNA
CTD
PMID:21220416
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects abundance
ISO
CYP2D6 gene polymorphism affects the abundance of Paliperidone Palmitate; CYP2D6 protein affects the abundance of Paliperidone Palmitate
CTD
PMID:10639689 PMID:15089809 PMID:17541883
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Drd2
dopamine receptor D2
multiple interactions affects binding
ISO EXP
Paliperidone Palmitate binds to and results in decreased activity of DRD2 protein Paliperidone Palmitate binds to DRD2 protein
CTD
PMID:19713555 PMID:22437487
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Fads2
fatty acid desaturase 2
increases expression multiple interactions
EXP
Paliperidone Palmitate results in increased expression of FADS2 mRNA [Paliperidone Palmitate results in increased expression of FADS2 mRNA] which results in increased abundance of Fatty Acids, Unsaturated
CTD
PMID:21458237
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Htr2a
5-hydroxytryptamine receptor 2A
affects binding multiple interactions
ISO EXP
Paliperidone Palmitate binds to HTR2A protein Paliperidone Palmitate binds to and results in decreased activity of HTR2A protein
CTD
PMID:7520908 PMID:19713555 PMID:22437487
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Paliperidone Palmitate binds to and results in decreased activity of HTR7 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; Paliperidone Palmitate binds to and results in decreased activity of HTR7 protein
CTD
PMID:18996971 PMID:19509219 PMID:20827463
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Il1a
interleukin 1 alpha
increases expression
ISO
Paliperidone Palmitate results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
ISO
Paliperidone Palmitate results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il24
interleukin 24
increases expression
ISO
Paliperidone Palmitate results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Paliperidone Palmitate results in decreased activity of KCNH2 protein
CTD
PMID:21394035
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Prl
prolactin
increases expression
ISO
Paliperidone Palmitate results in increased expression of PRL protein
CTD
PMID:17460786 PMID:19825908
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases methylation
ISO
CYP3A4 protein results in decreased methylation of Perazine
CTD
PMID:11026737
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
increases oxidation
ISO
FMO3 protein results in increased oxidation of Perazine
CTD
PMID:11026737
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Ar
androgen receptor
multiple interactions
ISO
periciazine binds to and results in decreased activity of AR protein
CTD
PMID:17606915
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
periciazine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]
CTD
PMID:20097249
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO EXP
Perphenazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
CTD
PMID:18493746
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Fshb
follicle stimulating hormone subunit beta
decreases expression
EXP
Perphenazine results in decreased expression of FSHB protein
CTD
PMID:6770916
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Perphenazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Perphenazine results in decreased activity of KCNH2 protein
CTD
PMID:21158687 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Lhb
luteinizing hormone subunit beta
decreases expression
EXP
Perphenazine results in decreased expression of LHB protein
CTD
PMID:6770916
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Prl
prolactin
increases expression
ISO EXP
Perphenazine results in increased expression of PRL protein
CTD
PMID:6770916 PMID:7262630 PMID:17335319
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Perphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Tnni3
troponin I3, cardiac type
increases expression
ISO
Perphenazine results in increased expression of TNNI3 protein
CTD
PMID:14742781
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Pimozide results in decreased expression of BCL2 mRNA
CTD
PMID:12130671
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
istradefylline inhibits the reaction [Pimozide results in increased expression of FOS protein]; Tropicamide promotes the reaction [Pimozide results in increased expression of FOS protein]
CTD
PMID:19467297
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Kcna10
potassium voltage-gated channel subfamily A member 10
multiple interactions
ISO
Pimozide inhibits the reaction [KCNA10 protein results in increased transport of Potassium]
CTD
PMID:10836990
NCBI chr 2:194,786,500...194,798,575
Ensembl chr 2:194,786,500...194,798,575
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Pimozide inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Pimozide results in decreased activity of KCNH2 protein
CTD
PMID:15671647 PMID:19583963 PMID:21158687 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
Pimozide results in decreased secretion of and results in decreased glycosylation of LHB protein
CTD
PMID:3896764
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Prl
prolactin
increases expression
ISO
Pimozide results in increased expression of PRL protein
CTD
PMID:8915564
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ache
acetylcholinesterase
increases activity
ISO
Prochlorperazine results in increased activity of ACHE protein
CTD
PMID:29614332
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Esr1
estrogen receptor 1
multiple interactions
ISO
Prochlorperazine binds to and results in increased activity of ESR1 protein
CTD
PMID:25752796
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Tfeb
transcription factor EB
affects localization
ISO
Prochlorperazine affects the localization of TFEB protein
CTD
PMID:28366621
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
G
Bche
butyrylcholinesterase
decreases activity
ISO
Promazine results in decreased activity of BCHE protein
CTD
PMID:236606
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Promazine results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Promazine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Promazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases activity
ISO
Quetiapine Fumarate results in decreased activity of ABCB1 protein
CTD
PMID:16810505
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Quetiapine Fumarate inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
App
amyloid beta precursor protein
multiple interactions
EXP
Quetiapine Fumarate inhibits the reaction [APP protein modified form affects the activity of CAT protein]; Quetiapine Fumarate inhibits the reaction [APP protein modified form results in increased abundance of Reactive Oxygen Species]
CTD
PMID:15948179
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
Quetiapine Fumarate results in increased expression of BAX protein
CTD
PMID:16462815
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bdnf
brain-derived neurotrophic factor
increases expression
EXP
Quetiapine Fumarate results in increased expression of BDNF protein
CTD
PMID:17442489
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Cat
catalase
multiple interactions
EXP
Quetiapine Fumarate inhibits the reaction [APP protein modified form affects the activity of CAT protein]
CTD
PMID:15948179
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cnr1
cannabinoid receptor 1
decreases expression
ISO
Quetiapine Fumarate results in decreased expression of CNR1 protein
CTD
PMID:31220554
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cnr2
cannabinoid receptor 2
increases expression
ISO
Quetiapine Fumarate results in increased expression of CNR2 protein
CTD
PMID:31220554
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
Carbamazepine promotes the reaction [CYP3A4 protein results in increased metabolism of and results in decreased abundance of Quetiapine Fumarate]; CYP3A4 protein results in increased metabolism of and results in decreased abundance of Quetiapine Fumarate; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of and results in decreased abundance of Quetiapine Fumarate]
CTD
PMID:16390352
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Drd2
dopamine receptor D2
multiple interactions
EXP
Quetiapine Fumarate promotes the reaction [Dopamine binds to DRD2 protein]
CTD
PMID:15716360
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions
ISO
Quetiapine Fumarate inhibits the reaction [Ketanserin binds to HTR2A protein]
CTD
PMID:16314884
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Quetiapine Fumarate inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Quetiapine Fumarate results in decreased activity of KCNH2 protein
CTD
PMID:21158687 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
decreases metabolic processing
ISO
Quetiapine Fumarate results in decreased metabolism of MAP1LC3B protein
CTD
PMID:31220554
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Mbp
myelin basic protein
multiple interactions
ISO
Quetiapine Fumarate inhibits the reaction [Cuprizone results in decreased activity of MBP protein]
CTD
PMID:18938062
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mlkl
mixed lineage kinase domain like pseudokinase
multiple interactions
ISO
1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Quetiapine Fumarate affects the localization of MLKL protein]; 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Quetiapine Fumarate results in increased expression of and results in increased phosphorylation of MLKL protein]; AM 1241 inhibits the reaction [Quetiapine Fumarate affects the localization of MLKL protein]; AM 1241 inhibits the reaction [Quetiapine Fumarate results in increased expression of and results in increased phosphorylation of MLKL protein]; AM 281 inhibits the reaction [Quetiapine Fumarate affects the localization of MLKL protein]; AM 281 inhibits the reaction [Quetiapine Fumarate results in increased phosphorylation of MLKL protein]; Quetiapine Fumarate results in increased expression of and affects the localization of MLKL protein; Quetiapine Fumarate results in increased expression of and results in increased phosphorylation of MLKL protein; Rimonabant inhibits the reaction [Quetiapine Fumarate affects the localization of MLKL protein]; Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of and results in increased phosphorylation of MLKL protein]
CTD
PMID:31220554
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
G
Mpo
myeloperoxidase
multiple interactions decreases activity affects oxidation
ISO
Quetiapine Fumarate inhibits the reaction [[MPO protein results in increased metabolism of chlorodimedone] which results in increased abundance of Hypochlorous Acid]; Quetiapine Fumarate inhibits the reaction [MPO protein results in increased abundance of Hypochlorous Acid] Quetiapine Fumarate results in decreased activity of MPO protein MPO protein affects the oxidation of Quetiapine Fumarate
CTD
PMID:35575633
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
increases expression
EXP
Quetiapine Fumarate results in increased expression of NDUFV2 mRNA
CTD
PMID:19441803
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
G
Ngfr
nerve growth factor receptor
decreases expression
EXP
Quetiapine Fumarate results in decreased expression of NGFR mRNA
CTD
PMID:12111809 PMID:16513140
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Prl
prolactin
decreases expression increases secretion
ISO
Quetiapine Fumarate results in decreased expression of PRL protein Quetiapine Fumarate results in increased secretion of PRL protein
CTD
PMID:16379509 PMID:18063941
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ripk1
receptor interacting serine/threonine kinase 1
multiple interactions increases expression
ISO
AM 281 inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK1 protein]; Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK1 protein]
CTD
PMID:31220554
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
G
Ripk3
receptor-interacting serine-threonine kinase 3
multiple interactions increases expression
ISO
Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of RIPK3 protein]
CTD
PMID:31220554
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO
Quetiapine Fumarate inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:30465787
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Sod1
superoxide dismutase 1
multiple interactions increases expression
ISO EXP
Quetiapine Fumarate inhibits the reaction [Cuprizone results in decreased activity of SOD1 protein] Quetiapine Fumarate results in increased expression of SOD1 mRNA Quetiapine Fumarate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA]
CTD
PMID:12111809 PMID:12752374 PMID:18938062
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
Reserpine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Reserpine results in decreased activity of ABCB11 protein
CTD
PMID:20829430 PMID:23956101 PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases expression decreases activity
ISO
Cycloheximide promotes the reaction [Reserpine results in increased expression of ABCB1 mRNA]; Reserpine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of Vinblastine] Reserpine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon] Reserpine results in increased expression of ABCB1 mRNA; Reserpine results in increased expression of ABCB1 protein Reserpine results in decreased activity of ABCB1 protein
CTD
PMID:7476894 PMID:8632764 PMID:10617675 PMID:12235267 PMID:19528478
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Reserpine inhibits the reaction [ABCG2 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]; Reserpine inhibits the reaction [ABCG2 protein results in increased transport of Irinotecan]
CTD
PMID:12869632
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ache
acetylcholinesterase
multiple interactions affects activity
EXP
[Plant Extracts results in increased abundance of Dronabinol] inhibits the reaction [Reserpine affects the activity of ACHE protein]
CTD
PMID:28212939
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Adra1d
adrenoceptor alpha 1D
increases response to substance increases expression
EXP
ADRA1D protein results in increased susceptibility to Reserpine Reserpine results in increased expression of ADRA1D mRNA
CTD
PMID:15159276 PMID:17676312
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Adra2a
adrenoceptor alpha 2A
increases expression
EXP
Reserpine results in increased expression of ADRA2A mRNA
CTD
PMID:11264240
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Adrb1
adrenoceptor beta 1
increases expression increases stability
EXP
Reserpine results in increased expression of ADRB1 mRNA; Reserpine results in increased expression of ADRB1 protein Reserpine results in increased stability of ADRB1 mRNA
CTD
PMID:1336118
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
increases expression
EXP
Reserpine results in increased expression of ADRB2 mRNA
CTD
PMID:1664493
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agtr2
angiotensin II receptor, type 2
increases expression
EXP
Reserpine results in increased expression of AGTR2 mRNA; Reserpine results in increased expression of AGTR2 protein
CTD
PMID:20964730
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Reserpine results in increased expression of AKR1B10 mRNA
CTD
PMID:26198647
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
Reserpine results in decreased phosphorylation of AKT1 protein arsenic trioxide promotes the reaction [Reserpine results in decreased phosphorylation of AKT1 protein]
CTD
PMID:26114099
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Amd1
adenosylmethionine decarboxylase 1
multiple interactions
ISO
Reserpine inhibits the reaction [Folic Acid results in increased activity of AMD1 protein]
CTD
PMID:17371283
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Ar
androgen receptor
multiple interactions
ISO
Reserpine inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]
CTD
PMID:29162470
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arc
activity-regulated cytoskeleton-associated protein
multiple interactions
EXP
Reserpine inhibits the reaction [Cocaine results in increased expression of ARC mRNA]
CTD
PMID:7722525
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
EXP
IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein]
CTD
PMID:19463876
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
EXP
IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein]
CTD
PMID:19463876
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
decreases expression multiple interactions
ISO EXP
Reserpine results in decreased expression of BDNF protein cerebrolysin inhibits the reaction [Reserpine results in decreased expression of BDNF protein]; Fluoxetine inhibits the reaction [Reserpine results in decreased expression of BDNF protein] arsenic trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein]
CTD
PMID:26114099 PMID:33279466
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Birc5
baculoviral IAP repeat-containing 5
affects binding
ISO
Reserpine binds to BIRC5 promoter
CTD
PMID:17968851
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
C3
complement C3
affects expression
EXP
Reserpine affects the expression of C3 mRNA
CTD
PMID:18363858
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Casp3
caspase 3
multiple interactions increases activity
EXP
IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP3 protein]
CTD
PMID:19463876
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases activity
EXP
IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein]
CTD
PMID:19463876
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
multiple interactions decreases expression increases expression
EXP
Plant Extracts inhibits the reaction [Reserpine results in decreased expression of CAT protein]; Quercetin inhibits the reaction [Reserpine results in decreased expression of CAT protein] Reserpine results in increased expression of CAT protein
CTD
PMID:14685008 PMID:16444668 PMID:19109989 PMID:19761039 PMID:20628966
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccnd1
cyclin D1
decreases expression
ISO
Reserpine results in decreased expression of CCND1 mRNA; Reserpine results in decreased expression of CCND1 protein
CTD
PMID:19607803
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
EXP
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein
CTD
PMID:11318962
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
multiple interactions
EXP
[Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA]
CTD
PMID:18504326
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Chga
chromogranin A
multiple interactions increases expression increases activity
ISO EXP
CHGA protein alternative form inhibits the reaction [Reserpine results in increased activity of CHGA promoter]; Chlorisondamine inhibits the reaction [Reserpine results in increased activity of CHGA promoter] Reserpine results in increased expression of CHGA mRNA
CTD
PMID:1907749 PMID:8189248 PMID:12799369
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Chgb
chromogranin B
increases expression
EXP
Reserpine results in increased expression of CHGB mRNA; Reserpine results in increased expression of CHGB protein
CTD
PMID:1907749 PMID:8189248 PMID:8361347
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
G
Chrm1
cholinergic receptor, muscarinic 1
increases expression decreases expression
EXP
Reserpine results in increased expression of CHRM1 mRNA Reserpine results in decreased expression of CHRM1 protein
CTD
PMID:1506860
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
G
Cnr1
cannabinoid receptor 1
decreases expression
EXP
Reserpine results in decreased expression of CNR1 mRNA
CTD
PMID:11358453
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cpe
carboxypeptidase E
increases expression
EXP
Reserpine results in increased expression of CPE mRNA
CTD
PMID:8189248
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Crem
cAMP responsive element modulator
multiple interactions increases expression
EXP
Reserpine promotes the reaction [CREM protein binds to TH promoter] Reserpine results in increased expression of CREM mRNA alternative form; Reserpine results in increased expression of CREM protein; Reserpine results in increased expression of CREM protein alternative form
CTD
PMID:8810303 PMID:11438978
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Crh
corticotropin releasing hormone
increases expression
EXP
Reserpine results in increased expression of CRH mRNA; Reserpine results in increased expression of CRH protein
CTD
PMID:1850078
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
Reserpine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
CTD
PMID:15627480 PMID:18493746
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]
CTD
PMID:16510159
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA
CTD
PMID:17041008
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression multiple interactions
ISO
Reserpine results in increased expression of CYP3A4 mRNA; Reserpine results in increased expression of CYP3A4 protein [Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Reserpine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein]
CTD
PMID:8632764 PMID:16837568 PMID:17041008 PMID:29782822
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
ISO
Reserpine results in increased expression of CYP3A5 protein
CTD
PMID:8632764
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyss
cystatin S
multiple interactions
EXP
Reserpine inhibits the reaction [Isoproterenol results in increased expression of CYSS mRNA]
CTD
PMID:9447264
NCBI chr 3:137,432,049...137,436,654
Ensembl chr 3:137,432,049...137,436,610
G
Dbh
dopamine beta-hydroxylase
decreases activity increases expression increases stability increases activity
EXP
Reserpine results in decreased activity of DBH protein Reserpine results in increased expression of DBH mRNA Reserpine results in increased stability of DBH protein Reserpine results in increased activity of DBH protein
CTD
PMID:1359376 PMID:2325165 PMID:7984052 PMID:8189248
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
G
Ddc
dopa decarboxylase
increases expression
EXP
Reserpine results in increased expression of DDC mRNA
CTD
PMID:1359376
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Drd1
dopamine receptor D1
increases expression
EXP
Reserpine results in increased expression of DRD1 mRNA
CTD
PMID:8419537
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions increases expression
ISO EXP
DRD2 protein affects the susceptibility to [8-(3-chlorostyryl)caffeine co-treated with Reserpine] Reserpine results in increased expression of DRD2 mRNA; Reserpine results in increased expression of DRD2 mRNA alternative form
CTD
PMID:1331675 PMID:8419537 PMID:11172060
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Egr1
early growth response 1
multiple interactions increases expression
EXP
[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA; eticlopride inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; Quinpirole inhibits the reaction [Reserpine results in increased expression of EGR1 mRNA]; Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; SCH 23390 inhibits the reaction [Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]] Reserpine results in increased expression of EGR1 mRNA; Reserpine results in increased expression of EGR1 protein
CTD
PMID:1347779 PMID:8063705 PMID:9729266 PMID:9890435
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Erbb2
erb-b2 receptor tyrosine kinase 2
increases response to substance
EXP
ERBB2 protein results in increased susceptibility to Reserpine
CTD
PMID:8093862
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Fabp7
fatty acid binding protein 7
affects expression
EXP
Reserpine affects the expression of FABP7 mRNA
CTD
PMID:18363858
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression increases phosphorylation
EXP
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine promotes the reaction [Reserpine results in increased expression of FOS protein]; 3,7-dimethyl-1-propargylxanthine inhibits the reaction [Reserpine results in increased expression of FOS protein]; 8-(3-chlorostyryl)caffeine promotes the reaction [Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]]; Quinpirole inhibits the reaction [Reserpine results in increased expression of FOS protein]; Quinpirole promotes the reaction [Reserpine results in increased expression of FOS protein]; Reserpine inhibits the reaction [[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Quinpirole] results in increased expression of FOS protein]; Reserpine inhibits the reaction [Cocaine results in increased expression of FOS protein]; Reserpine promotes the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased expression of FOS protein]; Reserpine promotes the reaction [Amphetamine results in increased expression of FOS protein]; Reserpine promotes the reaction [Quinpirole results in increased expression of FOS protein]; Theophylline inhibits the reaction [Reserpine results in increased expression of FOS protein] Reserpine results in increased expression of FOS mRNA; Reserpine results in increased expression of FOS protein Reserpine results in increased phosphorylation of FOS protein
CTD
PMID:1359376 PMID:1686849 PMID:2118661 PMID:7845612 PMID:7914358 PMID:8100600 PMID:8102797 PMID:8577368 PMID:8864302 PMID:9210518 More...
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gad1
glutamate decarboxylase 1
increases expression multiple interactions
EXP
Reserpine results in increased expression of GAD1 mRNA Clenbuterol inhibits the reaction [Reserpine results in increased expression of GAD1 mRNA]
CTD
PMID:8774452
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gal
galanin and GMAP prepropeptide
decreases expression increases expression multiple interactions
EXP
Reserpine results in decreased expression of GAL mRNA Reserpine results in increased expression of GAL mRNA Desipramine inhibits the reaction [Reserpine results in increased expression of GAL mRNA]
CTD
PMID:1279347 PMID:1698642 PMID:1705056 PMID:1717808 PMID:9512271 PMID:19598284 More...
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gast
gastrin
multiple interactions
EXP
Reserpine inhibits the reaction [Levodopa results in decreased cleavage of GAST protein]
CTD
PMID:10332097
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
G
Gch1
GTP cyclohydrolase 1
increases expression
EXP
Reserpine results in increased expression of GCH1 mRNA; Reserpine results in increased expression of GCH1 mRNA alternative form
CTD
PMID:8103077
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
Reserpine results in increased expression of GCNT3 mRNA
CTD
PMID:26198647
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gnai1
G protein subunit alpha i1
increases expression
EXP
Reserpine results in increased expression of GNAI1 protein
CTD
PMID:11264240
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnai2
G protein subunit alpha i2
increases expression
EXP
Reserpine results in increased expression of GNAI2 mRNA; Reserpine results in increased expression of GNAI2 protein
CTD
PMID:8419537 PMID:11264240
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
increases expression
EXP
Reserpine results in increased expression of GNAI3 protein
CTD
PMID:11264240
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gnao1
G protein subunit alpha o1
increases expression
EXP
Reserpine results in increased expression of GNAO1 mRNA; Reserpine results in increased expression of GNAO1 protein
CTD
PMID:8419537 PMID:11264240
NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
G
Gnas
GNAS complex locus
increases expression decreases expression
EXP
Reserpine results in increased expression of GNAS mRNA; Reserpine results in increased expression of GNAS protein Reserpine results in decreased expression of GNAS protein alternative form
CTD
PMID:1336118 PMID:8419537 PMID:11264240
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Grm5
glutamate metabotropic receptor 5
decreases expression increases expression
EXP
Reserpine results in decreased expression of GRM5 mRNA Reserpine results in increased expression of GRM5 protein
CTD
PMID:16890937
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
G
Hgf
hepatocyte growth factor
increases expression
EXP
Reserpine results in increased expression of HGF protein
CTD
PMID:16081063
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hspg2
heparan sulfate proteoglycan 2
multiple interactions
ISO
HSPG2 gene results in increased susceptibility to [Haloperidol co-treated with Reserpine]
CTD
PMID:20072119
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
G
Htr1a
5-hydroxytryptamine receptor 1A
decreases expression
ISO
Reserpine results in decreased expression of HTR1A protein
CTD
PMID:26114099
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Iapp
islet amyloid polypeptide
multiple interactions
EXP
IAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein]; IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP3 protein]; IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein]; IAPP protein inhibits the reaction [Reserpine results in increased expression of BAX protein]; IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein]
CTD
PMID:19463876
NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920
G
Il10
interleukin 10
decreases expression multiple interactions
ISO
Reserpine results in decreased expression of IL10 mRNA; Reserpine results in decreased expression of IL10 protein SCH 23390 inhibits the reaction [Reserpine results in decreased expression of IL10 mRNA]; SCH 23390 inhibits the reaction [Reserpine results in decreased expression of IL10 protein]
CTD
PMID:16985181
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
increases expression
EXP
Reserpine results in increased expression of IL18 mRNA
CTD
PMID:8999896
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
Reserpine results in increased expression of JUN mRNA
CTD
PMID:1359376
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
Reserpine promotes the reaction [Dextroamphetamine results in increased expression of JUNB mRNA]; SCH 23390 inhibits the reaction [Reserpine promotes the reaction [Dextroamphetamine results in increased expression of JUNB mRNA]]
CTD
PMID:1347779
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Kcna3
potassium voltage-gated channel subfamily A member 3
decreases activity multiple interactions
ISO
Reserpine results in decreased activity of KCNA3 protein [Reserpine results in decreased activity of KCNA3 protein] which results in decreased import of Thallium
CTD
PMID:21362439
NCBI chr 2:194,632,106...194,634,059
Ensembl chr 2:194,632,196...194,650,138
G
Kcna5
potassium voltage-gated channel subfamily A member 5
increases expression
EXP
Reserpine results in increased expression of KCNA5 mRNA
CTD
PMID:12606256
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
G
Kcnd2
potassium voltage-gated channel subfamily D member 2
decreases expression
EXP
Reserpine results in decreased expression of KCND2 mRNA
CTD
PMID:12606256
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
G
Kcnd3
potassium voltage-gated channel subfamily D member 3
decreases expression
EXP
Reserpine results in decreased expression of KCND3 mRNA
CTD
PMID:12606256
NCBI chr 2:192,937,950...193,155,345
Ensembl chr 2:192,937,950...193,155,345
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
ISO
Reserpine results in decreased activity of KCNH2 protein [Reserpine results in decreased activity of KCNH2 protein] which results in decreased import of Thallium
CTD
PMID:21362439 PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Lep
leptin
increases expression
ISO
Reserpine results in increased expression of LEP mRNA
CTD
PMID:10050748
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases response to substance decreases expression
ISO
MYC protein results in increased susceptibility to Reserpine Reserpine results in decreased expression of MYC protein
CTD
PMID:8093862 PMID:19607803
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncf1
neutrophil cytosolic factor 1
increases expression
EXP
Reserpine results in increased expression of NCF1 mRNA; Reserpine results in increased expression of NCF1 protein
CTD
PMID:20964730
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity
ISO
Reserpine results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ngf
nerve growth factor
increases expression
EXP
Reserpine results in increased expression of NGF mRNA; Reserpine results in increased expression of NGF protein
CTD
PMID:1996081 PMID:8593794
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nos1
nitric oxide synthase 1
increases expression
EXP
Reserpine results in increased expression of NOS1 mRNA; Reserpine results in increased expression of NOS1 protein
CTD
PMID:7533141
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Npy
neuropeptide Y
multiple interactions increases expression decreases expression
EXP
Chlorisondamine inhibits the reaction [Reserpine results in increased expression of NPY mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of NPY mRNA]; Dexamethasone inhibits the reaction [Reserpine results in increased expression of NPY mRNA] Reserpine results in increased expression of NPY mRNA; Reserpine results in increased expression of NPY protein Reserpine results in decreased expression of NPY mRNA; Reserpine results in decreased expression of NPY protein
CTD
PMID:1671012 PMID:1676830 PMID:1687976 PMID:1698642 PMID:1713314 PMID:1714554 PMID:1878751 PMID:1907749 PMID:2233698 PMID:2897091 PMID:2903502 PMID:3215285 PMID:3805164 PMID:7644023 PMID:7911764 PMID:8189248 PMID:20504635 More...
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD
PMID:17041008
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions decreases activity
ISO
[Reserpine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA Reserpine results in decreased activity of NR1I3 protein
CTD
PMID:17041008 PMID:30203046
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
increases expression
EXP
Reserpine results in increased expression of NR3C1 mRNA
CTD
PMID:7984052
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
multiple interactions decreases expression
ISO
arsenic trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein]
CTD
PMID:26114099
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Nts
neurotensin
increases expression
EXP
Reserpine results in increased expression of NTS mRNA
CTD
PMID:1850078
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Odc1
ornithine decarboxylase 1
decreases expression multiple interactions
EXP ISO
Reserpine results in decreased expression of ODC1 protein Reserpine inhibits the reaction [CB 3717 results in increased activity of ODC1 protein]; Reserpine inhibits the reaction [CB 3717 results in increased expression of ODC1 mRNA]; Reserpine inhibits the reaction [Testosterone results in increased activity of ODC1 protein]; Reserpine inhibits the reaction [Testosterone results in increased expression of ODC1 mRNA]
CTD
PMID:6519379 PMID:9194572 PMID:10354516 PMID:17371283
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Pam
peptidylglycine alpha-amidating monooxygenase
increases expression
EXP
Reserpine results in increased expression of PAM mRNA
CTD
PMID:8189248
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein
CTD
PMID:11318962
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
increases expression
EXP
Reserpine results in increased expression of PCSK2 mRNA
CTD
PMID:8189248
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
G
Penk
proenkephalin
multiple interactions increases expression decreases expression
EXP
Apomorphine inhibits the reaction [Reserpine results in increased expression of PENK mRNA] Reserpine results in increased expression of PENK mRNA; Reserpine results in increased expression of PENK protein Reserpine results in decreased expression of PENK mRNA
CTD
PMID:1331675 PMID:1850078 PMID:3188958 PMID:3838946 PMID:4078631 PMID:7494455 PMID:17719177 More...
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Pnmt
phenylethanolamine-N-methyltransferase
multiple interactions increases expression decreases expression
EXP
Chlorisondamine inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; Dexamethasone inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; POMC protein alternative form inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]; Reserpine results in increased expression of and results in increased activity of PNMT protein Reserpine results in increased expression of PNMT mRNA
CTD
PMID:1359376 PMID:1687976 PMID:1714554 PMID:2903502 PMID:8063705 PMID:8479280 PMID:20504635 More...
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
G
Pomc
proopiomelanocortin
increases expression multiple interactions
EXP
Reserpine results in increased expression of POMC mRNA; Reserpine results in increased expression of POMC protein alternative form POMC protein alternative form inhibits the reaction [Reserpine results in decreased expression of PNMT mRNA]
CTD
PMID:8479280 PMID:20504635
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
decreases expression
ISO
Reserpine results in decreased expression of PRKACA protein
CTD
PMID:26114099
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
G
Prl
prolactin
increases expression
EXP
Reserpine results in increased expression of PRL protein
CTD
PMID:11071396
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prss1
serine protease 1
decreases expression increases expression
EXP
Reserpine results in decreased expression of PRSS1 protein Reserpine results in increased expression of PRSS1 protein
CTD
PMID:8625754
NCBI chr 4:70,364,589...70,367,792
Ensembl chr 4:70,364,586...70,367,792
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Reserpine results in increased expression of PTGS2 protein
CTD
PMID:16081063
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pts
6-pyruvoyl-tetrahydropterin synthase
increases expression
EXP
Reserpine results in increased expression of PTS mRNA
CTD
PMID:7545485
NCBI chr 8:50,870,838...50,877,869
Ensembl chr 8:50,870,841...50,877,869
G
Rasd2
RASD family, member 2
decreases expression
EXP
Reserpine results in decreased expression of RASD2 mRNA
CTD
PMID:16352400
NCBI chr19:13,594,291...13,605,016
Ensembl chr19:13,594,291...13,605,016
G
Rgs10
regulator of G-protein signaling 10
decreases expression
EXP
Reserpine results in decreased expression of RGS10 mRNA
CTD
PMID:14505795
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
decreases expression
EXP
Reserpine results in decreased expression of RGS2 mRNA
CTD
PMID:14505795
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs4
regulator of G-protein signaling 4
decreases expression
EXP
Reserpine results in decreased expression of RGS4 mRNA
CTD
PMID:14505795
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs5
regulator of G-protein signaling 5
decreases expression
EXP
Reserpine results in decreased expression of RGS5 mRNA
CTD
PMID:14505795
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
G
Rgs8
regulator of G-protein signaling 8
decreases expression
EXP
Reserpine results in decreased expression of RGS8 mRNA
CTD
PMID:14505795
NCBI chr13:65,804,703...65,848,955
Ensembl chr13:65,804,797...65,846,807
G
Rgs9
regulator of G-protein signaling 9
affects response to substance decreases expression
ISO EXP
RGS9 affects the susceptibility to Reserpine Reserpine results in decreased expression of RGS9 mRNA
CTD
PMID:14505795 PMID:15728856
NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892
G
Scg2
secretogranin II
increases expression
EXP
Reserpine results in increased expression of SCG2 mRNA
CTD
PMID:1907749 PMID:8189248 PMID:8361347
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
G
Serpine1
serpin family E member 1
multiple interactions
EXP
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein
CTD
PMID:11318962
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Siah1
siah E3 ubiquitin protein ligase 1
increases expression
ISO
Reserpine results in increased expression of SIAH1 mRNA
CTD
PMID:19607803
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Slc18a1
solute carrier family 18 member A1
decreases activity multiple interactions
ISO
Reserpine results in decreased activity of SLC18A1 protein Reserpine inhibits the reaction [SLC18A1 protein results in increased uptake of Serotonin]
CTD
PMID:8245983 PMID:21712771
NCBI chr16:20,653,268...20,687,051
Ensembl chr16:20,653,508...20,687,051
G
Slc18a2
solute carrier family 18 member A2
affects binding multiple interactions decreases activity increases expression affects response to substance decreases response to substance
ISO EXP
Reserpine binds to SLC18A2 protein Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] Reserpine results in decreased activity of SLC18A2 protein SLC18A2 protein binds to Reserpine Reserpine results in increased expression of SLC18A2 mRNA SLC18A2 affects the susceptibility to Reserpine Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin]; Serotonin inhibits the reaction [SLC18A2 protein binds to Reserpine] SLC18A2 gene SNP results in decreased susceptibility to Reserpine
CTD
PMID:1438304 PMID:7912402 PMID:8189248 PMID:9038139 PMID:15475732 PMID:17664021 PMID:18287335 PMID:29908239 PMID:33378168 More...
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc6a2
solute carrier family 6 member 2
decreases expression
EXP
Reserpine results in decreased expression of SLC6A2 mRNA
CTD
PMID:7478180 PMID:7616203
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
G
Slc6a3
solute carrier family 6 member 3
decreases activity affects response to substance
ISO
Reserpine results in decreased activity of SLC6A3 protein SLC6A3 gene mutant form affects the susceptibility to Reserpine
CTD
PMID:17664021 PMID:19615345
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
decreases expression
EXP
Reserpine results in decreased expression of SLC6A4 mRNA
CTD
PMID:10027743
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Snca
synuclein alpha
affects response to substance
ISO
SNCA protein mutant form affects the susceptibility to Reserpine
CTD
PMID:18622040
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Sqstm1
sequestosome 1
increases expression
ISO
Reserpine results in increased expression of SQSTM1 mRNA
CTD
PMID:26198647
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Syt7
synaptotagmin 7
multiple interactions
EXP
[Reserpine co-treated with Apomorphine] results in increased expression of SYT7 mRNA
CTD
PMID:17719177
NCBI chr 1:207,031,359...207,093,787
Ensembl chr 1:207,031,592...207,089,026
G
Tac1
tachykinin, precursor 1
multiple interactions increases expression
EXP
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine co-treated with Quinpirole] results in increased expression of TAC1 mRNA; [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine co-treated with Reserpine] results in increased expression of TAC1 mRNA; Apomorphine promotes the reaction [Reserpine results in increased expression of TAC1 mRNA]
CTD
PMID:9751140 PMID:17719177
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tff1
trefoil factor 1
increases expression
ISO
Reserpine results in increased expression of TFF1 mRNA
CTD
PMID:35307500
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Th
tyrosine hydroxylase
increases expression increases activity decreases expression affects activity increases stability multiple interactions
ISO EXP
Reserpine results in increased expression of TH mRNA Reserpine results in increased activity of TH protein Reserpine results in increased expression of TH mRNA; Reserpine results in increased expression of TH protein Reserpine results in decreased expression of TH mRNA Reserpine affects the activity of TH protein Reserpine results in increased stability of TH mRNA Bicuculline promotes the reaction [Reserpine affects the activity of TH protein]; Bicuculline promotes the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Chlorisondamine promotes the reaction [Reserpine results in increased expression of TH mRNA]; Desipramine inhibits the reaction [Reserpine results in increased expression of TH mRNA]; Reserpine promotes the reaction [CREM protein binds to TH promoter]; Reserpine results in increased expression of and results in increased activity of TH protein
CTD
PMID:1350653 PMID:1359376 PMID:1676830 PMID:1687822 PMID:1687976 PMID:1698642 PMID:1705056 PMID:1714554 PMID:1717808 PMID:1970845 PMID:1976760 PMID:1978789 PMID:1981253 PMID:2568627 PMID:2862954 PMID:2863328 PMID:2872048 PMID:2881815 PMID:2882513 PMID:2883324 PMID:2903502 PMID:7478180 PMID:7532593 PMID:7545485 PMID:7616203 PMID:7911764 PMID:8369965 PMID:8666980 PMID:9210518 PMID:9691425 PMID:11161478 PMID:11438978 PMID:20504635 More...
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
increases expression multiple interactions
EXP
Reserpine results in increased expression of TNF protein cerebrolysin inhibits the reaction [Reserpine results in increased expression of TNF protein]; Fluoxetine inhibits the reaction [Reserpine results in increased expression of TNF protein]
CTD
PMID:33279466
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
multiple interactions increases expression
EXP
IAPP protein inhibits the reaction [Reserpine results in increased expression of TNFSF10 protein]
CTD
PMID:19463876
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tph1
tryptophan hydroxylase 1
increases activity decreases activity
EXP
Reserpine results in increased activity of TPH1 protein Reserpine results in decreased activity of TPH1 protein
CTD
PMID:8369965
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
G
Vgf
VGF nerve growth factor inducible
increases expression
EXP
Reserpine results in increased expression of VGF mRNA
CTD
PMID:8189248
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
G
Vip
vasoactive intestinal peptide
increases expression
EXP
Reserpine results in increased expression of VIP mRNA
CTD
PMID:1850078
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects abundance multiple interactions increases export increases transport decreases activity affects response to substance increases response to substance
ISO EXP
ABCB1 gene polymorphism affects the abundance of Risperidone; ABCB1 protein affects the abundance of Risperidone Cyclosporine inhibits the reaction [ABCB1A protein results in increased export of Risperidone] ABCB1A protein results in increased transport of Risperidone Risperidone results in decreased activity of ABCB1 protein ABCB1A protein affects the susceptibility to Risperidone ABCB1 protein results in increased transport of Risperidone Risperidone inhibits the reaction [ABCB1 protein results in decreased export of Doxorubicin] ABCB1 protein results in increased susceptibility to Risperidone ABCB1 gene polymorphism affects the susceptibility to Risperidone; ABCB1 protein affects the susceptibility to Risperidone
CTD
PMID:15502009 PMID:16118767 PMID:16810505 PMID:16936711 PMID:17054409 PMID:17541883 PMID:18708991 PMID:19997080 PMID:20563569 PMID:21449914 PMID:22623266 PMID:22691713 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
affects response to substance
ISO
ABCB1B protein affects the susceptibility to Risperidone
CTD
PMID:15502009
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
Risperidone inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Risperidone inhibits the reaction [ABCG2 protein results in increased uptake of estrone sulfate]
CTD
PMID:18834354
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Risperidone results in increased expression of ADIPOQ mRNA]
CTD
PMID:20564506
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Bdnf
brain-derived neurotrophic factor
decreases expression multiple interactions
EXP ISO
Risperidone results in decreased expression of BDNF mRNA BDNF gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein] Risperidone inhibits the reaction [Rotenone results in decreased expression of BDNF mRNA]
CTD
PMID:12393228 PMID:17442543 PMID:19997080
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Calm2
calmodulin 2
increases expression
EXP
Risperidone results in increased expression of CALM2 mRNA
CTD
PMID:19289156
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
decreases expression
EXP
Risperidone results in decreased expression of CAMK2A protein
CTD
PMID:19289156
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Camk4
calcium/calmodulin-dependent protein kinase IV
decreases expression
EXP
Risperidone results in decreased expression of CAMK4 protein
CTD
PMID:19289156
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
G
Camkk1
calcium/calmodulin-dependent protein kinase kinase 1
decreases expression
EXP
Risperidone results in decreased expression of CAMKK1 protein
CTD
PMID:19289156
NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498
G
Camkk2
calcium/calmodulin-dependent protein kinase kinase 2
decreases expression
EXP
Risperidone results in decreased expression of CAMKK2 protein
CTD
PMID:19289156
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
G
Casp3
caspase 3
multiple interactions increases activity
ISO
Palmitic Acid promotes the reaction [Risperidone results in increased activity of CASP3 protein]
CTD
PMID:22700542
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions increases activity
ISO
Palmitic Acid promotes the reaction [Risperidone results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA protein] Risperidone results in increased expression of CEBPA mRNA; Risperidone results in increased expression of CEBPA protein
CTD
PMID:20564506
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Chrm4
cholinergic receptor, muscarinic 4
affects response to substance
ISO
CHRM4 affects the susceptibility to Risperidone
CTD
PMID:21269601
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
G
Comt
catechol-O-methyltransferase
increases expression
EXP
Risperidone results in increased expression of COMT mRNA
CTD
PMID:15964593
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Risperidone results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Ctnnb1
catenin beta 1
multiple interactions increases expression
EXP
DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein]
CTD
PMID:16144542
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects metabolic processing increases metabolic processing increases response to substance affects response to substance decreases hydroxylation decreases metabolic processing affects abundance multiple interactions
ISO
CYP2D6 gene polymorphism affects the metabolism of Risperidone; CYP2D6 protein affects the metabolism of Risperidone CYP2D6 protein results in increased metabolism of Risperidone CYP2D6 protein results in increased susceptibility to Risperidone CYP2D6 gene polymorphism affects the susceptibility to Risperidone; CYP2D6 protein polymorphism affects the susceptibility to Risperidone CYP2D6 gene polymorphism results in decreased hydroxylation of Risperidone CYP2D6 gene polymorphism results in decreased metabolism of Risperidone CYP2D6 gene polymorphism affects the abundance of Risperidone; CYP2D6 protein affects the abundance of Risperidone CYP2D6 gene polymorphism affects the metabolism of and affects the abundance of Risperidone; CYP2D6 protein affects the metabolism of and affects the abundance of Risperidone
CTD
PMID:10639689 PMID:15089809 PMID:15260906 PMID:15565299 PMID:15669884 PMID:16044105 PMID:17224713 PMID:17541883 PMID:18708991 PMID:19387994 PMID:20332423 PMID:20563569 PMID:21449914 PMID:22623266 PMID:22745940 PMID:23609392 More...
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions affects response to substance
ISO
N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Risperidone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Risperidone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA] CYP3A4 gene polymorphism affects the susceptibility to Risperidone; CYP3A4 protein affects the susceptibility to Risperidone
CTD
PMID:19395426 PMID:21402137
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
affects abundance increases metabolic processing
ISO
CYP3A5 gene polymorphism affects the abundance of Risperidone; CYP3A5 protein affects the abundance of Risperidone CYP3A5 protein results in increased metabolism of Risperidone
CTD
PMID:18708991 PMID:20332423
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Drd2
dopamine receptor D2
multiple interactions affects binding increases response to substance affects response to substance
ISO EXP
Risperidone binds to and results in decreased activity of DRD2 protein Risperidone binds to DRD2 protein [Risperidone binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein; DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein]; DRD2 protein affects the reaction [Risperidone results in increased expression of DVL3 protein]; DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3A protein]; DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3B protein]; Risperidone binds to and results in decreased activity of DRD2 protein; Risperidone inhibits the reaction [Apomorphine binds to and results in increased activity of DRD2 protein]; Risperidone promotes the reaction [Dopamine binds to DRD2 protein] DRD2 gene polymorphism results in increased susceptibility to Risperidone; DRD2 gene SNP results in increased susceptibility to Risperidone; DRD2 protein results in increased susceptibility to Risperidone DRD2 gene polymorphism affects the susceptibility to Risperidone
CTD
PMID:1380082 PMID:7520908 PMID:8804920 PMID:10831489 PMID:12191584 PMID:15710053 PMID:15716360 PMID:16033416 PMID:16144542 PMID:16513859 PMID:18058087 PMID:19339912 PMID:19640686 PMID:19910723 PMID:20361897 PMID:20375926 PMID:21869689 PMID:22437487 PMID:22967779 More...
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
increases response to substance
ISO
DRD3 gene SNP results in increased susceptibility to Risperidone; DRD3 protein results in increased susceptibility to Risperidone
CTD
PMID:19506579 PMID:19997080
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Dvl3
dishevelled segment polarity protein 3
multiple interactions increases expression
EXP
DRD2 protein affects the reaction [Risperidone results in increased expression of DVL3 protein]
CTD
PMID:16144542
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
G
Egr1
early growth response 1
decreases expression
EXP
Risperidone results in decreased expression of EGR1 protein
CTD
PMID:17028028
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
decreases expression multiple interactions
EXP ISO
Risperidone results in decreased expression of EGR2 protein Risperidone inhibits the reaction [Toluene promotes the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased expression of EGR2 protein]]
CTD
PMID:17028028 PMID:32980479
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Erbb2
erb-b2 receptor tyrosine kinase 2
increases phosphorylation
EXP
Risperidone results in increased phosphorylation of ERBB2 protein
CTD
PMID:26961615
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
multiple interactions
EXP
Risperidone results in increased expression of and results in increased phosphorylation of ERBB4 protein
CTD
PMID:26961615
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Fads2
fatty acid desaturase 2
increases expression multiple interactions
EXP
Risperidone results in increased expression of FADS2 mRNA [Risperidone results in increased expression of FADS2 mRNA] which results in increased abundance of Fatty Acids, Unsaturated
CTD
PMID:21458237
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Fas
Fas cell surface death receptor
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Risperidone results in increased expression of FAS mRNA]
CTD
PMID:20564506
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP ISO
Risperidone promotes the reaction [Rotenone results in increased expression of FOS mRNA] Dronabinol inhibits the reaction [Risperidone results in increased expression of FOS protein]; Risperidone inhibits the reaction [Toluene promotes the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased expression of FOS protein]] Risperidone results in increased expression of FOS mRNA
CTD
PMID:11516571 PMID:17442543 PMID:28272498 PMID:32980479
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fshb
follicle stimulating hormone subunit beta
affects expression
ISO
Risperidone affects the expression of FSHB protein
CTD
PMID:18838228
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GGT1 protein]; coenzyme Q10 inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GGT1 protein]; Risperidone results in increased expression of and results in increased secretion of GGT1 protein
CTD
PMID:27387968
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GOT1 protein]; coenzyme Q10 inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GOT1 protein]; Risperidone results in increased expression of and results in increased secretion of GOT1 protein
CTD
PMID:27387968
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
Acetylcysteine inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GPT protein]; coenzyme Q10 inhibits the reaction [Risperidone results in increased expression of and results in increased secretion of GPT protein]; Risperidone results in increased expression of and results in increased secretion of GPT protein
CTD
PMID:27387968
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsk3a
glycogen synthase kinase 3 alpha
increases expression multiple interactions
EXP
Risperidone results in increased expression of GSK3A protein DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3A protein]
CTD
PMID:16144542
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions increases expression
EXP
DRD2 protein affects the reaction [Risperidone results in increased expression of GSK3B protein]
CTD
PMID:16144542
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
Risperidone results in increased expression of HMGCR mRNA
CTD
PMID:17052361
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Homer1
homer scaffold protein 1
increases expression
EXP
Risperidone results in increased expression of HOMER1 mRNA
CTD
PMID:20147574
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Htr1a
5-hydroxytryptamine receptor 1A
increases response to substance multiple interactions
EXP
HTR1A protein results in increased susceptibility to Risperidone N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [HTR1A protein results in increased susceptibility to Risperidone]
CTD
PMID:17530476
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
increases response to substance affects binding multiple interactions affects response to substance
ISO EXP
HTR2A gene SNP results in increased susceptibility to Risperidone; HTR2A protein results in increased susceptibility to Risperidone Risperidone binds to HTR2A protein Risperidone binds to and results in decreased activity of HTR2A protein; Risperidone inhibits the reaction [Ketanserin binds to HTR2A protein] HTR2A gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein]; Risperidone binds to and results in decreased activity of HTR2A protein HTR2A protein affects the susceptibility to Risperidone
CTD
PMID:7520908 PMID:11927170 PMID:12191584 PMID:16314884 PMID:16948927 PMID:19997080 PMID:22437487 More...
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
affects response to substance multiple interactions increases response to substance
ISO
HTR2C gene polymorphism affects the susceptibility to Risperidone; HTR2C protein affects the susceptibility to Risperidone HTR2C gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein] HTR2C protein results in increased susceptibility to Risperidone
CTD
PMID:19142101 PMID:19997080
NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287
G
Htr6
5-hydroxytryptamine receptor 6
multiple interactions
ISO
HTR6 gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein]
CTD
PMID:19997080
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]; [Risperidone binds to and results in decreased activity of HTR7 protein] inhibits the reaction [Colforsin results in increased abundance of Cyclic AMP]; Clozapine inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]; Cyproheptadine inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]; mesulergine inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]; Mianserin inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]; Risperidone binds to and results in decreased activity of HTR7 protein; SB 269970 inhibits the reaction [Risperidone binds to and results in decreased activity of HTR7 protein]
CTD
PMID:18996971 PMID:19509219 PMID:20827463
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Inha
inhibin subunit alpha
multiple interactions
ISO
Risperidone results in increased expression of [INHA protein binds to INHBB protein]
CTD
PMID:18838228
NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
G
Inhbb
inhibin subunit beta B
multiple interactions
ISO
Risperidone results in increased expression of [INHA protein binds to INHBB protein]
CTD
PMID:18838228
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Ins2
insulin 2
increases expression
ISO
Risperidone results in increased expression of INS protein
CTD
PMID:11927762 PMID:16601995
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
Risperidone inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:21158687
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Ldlr
low density lipoprotein receptor
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Risperidone results in increased expression of LDLR mRNA]
CTD
PMID:20564506
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Maoa
monoamine oxidase A
affects response to substance increases response to substance
ISO
MAOA gene polymorphism affects the susceptibility to Risperidone MAOA protein results in increased susceptibility to Risperidone
CTD
PMID:22544010
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
G
Maob
monoamine oxidase B
increases expression
EXP
Risperidone results in increased expression of MAOB mRNA
CTD
PMID:15964593
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map2
microtubule-associated protein 2
increases expression
EXP
Risperidone results in increased expression of MAP2 mRNA
CTD
PMID:15079866
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Ngfr
nerve growth factor receptor
decreases expression
EXP
Risperidone results in decreased expression of NGFR mRNA
CTD
PMID:12111809 PMID:16513140
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Risperidone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Risperidone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]
CTD
PMID:21402137
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nrg1
neuregulin 1
increases expression
EXP
Risperidone results in increased expression of NRG1 protein
CTD
PMID:26961615
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression multiple interactions
ISO
Risperidone results in increased expression of PPARG mRNA; Risperidone results in increased expression of PPARG protein Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein]
CTD
PMID:20564506
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
multiple interactions decreases expression
EXP
[Risperidone binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein Risperidone results in decreased expression of PPP3CA mRNA; Risperidone results in decreased expression of PPP3CA protein
CTD
PMID:16033416
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Prl
prolactin
multiple interactions increases secretion increases expression
ISO EXP
[Risperidone co-treated with Clozapine] results in increased expression of PRL protein; Aripiprazole inhibits the reaction [Risperidone results in increased secretion of PRL protein]; BDNF gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein]; HTR2A gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein]; HTR2C gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein]; HTR6 gene polymorphism affects the reaction [Risperidone results in increased expression of PRL protein] Risperidone inhibits the reaction [Dopamine results in decreased secretion of PRL protein]
CTD
PMID:1380082 PMID:9696519 PMID:9989566 PMID:10084644 PMID:11048906 PMID:11155212 PMID:11561931 PMID:11927762 PMID:12902212 PMID:12974991 PMID:15206663 PMID:15286066 PMID:15289996 PMID:15669890 PMID:15960571 PMID:16379509 PMID:16730335 PMID:17224713 PMID:18063941 PMID:18080171 PMID:18466271 PMID:18562423 PMID:18759643 PMID:18838228 PMID:19653986 PMID:19825908 PMID:19906340 PMID:19997080 PMID:20373475 PMID:20661022 PMID:20814333 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Rgs2
regulator of G-protein signaling 2
increases expression
EXP
Risperidone results in increased expression of RGS2 mRNA
CTD
PMID:11516571
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
S100b
S100 calcium binding protein B
increases secretion
EXP
Risperidone results in increased secretion of S100B protein
CTD
PMID:18421423
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Slc17a6
solute carrier family 17 member 6
increases expression
ISO
Risperidone results in increased expression of SLC17A6 mRNA; Risperidone results in increased expression of SLC17A6 protein
CTD
PMID:18155072
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Snap25
synaptosome associated protein 25
affects response to substance
ISO
SNAP25 gene SNP affects the susceptibility to Risperidone
CTD
PMID:15823421
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
G
Sod1
superoxide dismutase 1
multiple interactions increases expression
EXP
Risperidone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA]; Risperidone inhibits the reaction [Haloperidol results in decreased expression of SOD1 protein] Risperidone results in increased expression of SOD1 mRNA
CTD
PMID:12111809 PMID:12752374 PMID:16564057
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions increases expression
ISO
Berberine inhibits the reaction [Risperidone results in increased expression of SREBF1 mRNA]; Berberine inhibits the reaction [Risperidone results in increased expression of SREBF1 protein] Risperidone results in increased expression of SREBF1 mRNA; Risperidone results in increased expression of SREBF1 protein
CTD
PMID:20564506
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
EXP
Risperidone inhibits the reaction [Rotenone results in decreased expression of STAT3 mRNA]
CTD
PMID:17442543
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Th
tyrosine hydroxylase
increases expression
EXP
Risperidone results in increased expression of TH protein
CTD
PMID:17028028
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Bdnf
brain-derived neurotrophic factor
increases expression
EXP
Ritanserin results in increased expression of BDNF mRNA
CTD
PMID:12393228
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions affects binding
ISO EXP
Ritanserin binds to and results in decreased activity of HTR2A protein Ritanserin binds to HTR2A protein
CTD
PMID:8937629 PMID:17031071
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr2b
5-hydroxytryptamine receptor 2B
multiple interactions
ISO
Ritanserin binds to and results in decreased activity of HTR2B protein
CTD
PMID:10978843
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Ritanserin binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP]
CTD
PMID:14578406
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
Ritanserin inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:19583963
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Pdyn
prodynorphin
increases expression
EXP
Ritanserin results in increased expression of PDYN mRNA
CTD
PMID:9526047
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Sox17
SRY-box transcription factor 17
decreases localization
ISO
Ritanserin results in decreased localization of SOX17 protein
CTD
PMID:24154490
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity multiple interactions
ISO
sertindole results in decreased activity of KCNH2 protein sertindole inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:16278312 PMID:21158687 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
EXP
Spiperone inhibits the reaction [Bromocriptine results in increased expression of ABCB1 protein]; Spiperone inhibits the reaction [N-n-propylnorapomorphine results in increased expression of ABCB1 protein]; Spiperone inhibits the reaction [Quinpirole results in increased expression of ABCB1 protein]
CTD
PMID:9111066
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
multiple interactions
EXP
Spiperone inhibits the reaction [Bromocriptine results in increased activity of ABCB1B promoter]; Spiperone inhibits the reaction [N-n-propylnorapomorphine results in increased activity of ABCB1B promoter]; Spiperone inhibits the reaction [Quinpirole results in increased activity of ABCB1B promoter]
CTD
PMID:9111066
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Adra1a
adrenoceptor alpha 1A
multiple interactions
EXP
Spiperone inhibits the reaction [Norepinephrine results in increased activity of ADRA1A protein]
CTD
PMID:10416824
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
G
Drd1
dopamine receptor D1
multiple interactions
EXP
Spiperone inhibits the reaction [A 86929 promotes the reaction [DRD1 protein results in increased chemical synthesis of Cyclic AMP]]
CTD
PMID:8558425
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
multiple interactions affects binding
ISO EXP
amitraz inhibits the reaction [Spiperone binds to DRD2 protein]; demethylchlordimeform inhibits the reaction [Spiperone binds to DRD2 protein]; NR3C1 protein promotes the reaction [Spiperone binds to DRD2 protein] Melitten inhibits the reaction [Spiperone binds to DRD2 protein] 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine inhibits the reaction [Spiperone binds to DRD2 protein]; Amphetamine inhibits the reaction [Spiperone binds to DRD2 protein]; Caffeine inhibits the reaction [N-Methyl-3,4-methylenedioxyamphetamine promotes the reaction [Spiperone binds to DRD2 protein]]; Cocaine affects the reaction [Spiperone binds to DRD2 protein]; Haloperidol inhibits the reaction [Spiperone binds to DRD2 protein]; manganese chloride inhibits the reaction [DRD2 protein binds to Spiperone]; N-Methyl-3,4-methylenedioxyamphetamine promotes the reaction [Spiperone binds to DRD2 protein]; perospirone inhibits the reaction [Spiperone binds to DRD2 protein]; Pilocarpine inhibits the reaction [Spiperone binds to DRD2 protein]; Pilocarpine promotes the reaction [Spiperone binds to DRD2 protein]; Remoxipride inhibits the reaction [Spiperone binds to DRD2 protein]; Spiperone inhibits the reaction [Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of Dopamine]]
CTD
PMID:1975278 PMID:2018630 PMID:2833825 PMID:6149133 PMID:8804920 PMID:8829135 PMID:11226678 PMID:11927170 PMID:14559291 PMID:16137708 PMID:16889759 PMID:17161392 PMID:18457824 PMID:20729865 PMID:20969853 PMID:21484877 PMID:21999579 PMID:25522657 More...
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
affects binding multiple interactions
ISO
Spiperone binds to DRD3 protein N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Spiperone binds to DRD3 protein]
CTD
PMID:21999579 PMID:29458138
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Drd4
dopamine receptor D4
affects binding multiple interactions
ISO EXP
Spiperone binds to DRD4 protein Spiperone binds to Drd4 protein N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Spiperone binds to DRD4 protein]
CTD RGD
PMID:21999579 PMID:29458138 PMID:8078498
RGD:7248459
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
EXP ISO
Spiperone binds to and results in decreased activity of HTR1A protein
CTD
PMID:2207497 PMID:15482641
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions
ISO
Spiperone inhibits the reaction [Ketanserin binds to HTR2A protein]
CTD
PMID:2891550
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Htr7
5-hydroxytryptamine receptor 7
multiple interactions
ISO
[Spiperone binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP]
CTD
PMID:14578406
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
NR3C1 protein promotes the reaction [Spiperone binds to DRD2 protein]
CTD
PMID:11226678
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Spiperone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Th
tyrosine hydroxylase
multiple interactions
EXP
Spiperone inhibits the reaction [Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of Dopamine]]
CTD
PMID:20729865
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases transport
ISO
Verapamil inhibits the reaction [ABCB1 protein results in increased transport of Sulpiride]
CTD
PMID:28597291
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions increases transport
ISO
Elacridar inhibits the reaction [ABCG2 protein results in increased transport of Sulpiride]
CTD
PMID:28597291
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Adcy5
adenylate cyclase 5
increases response to substance
ISO
ADCY5 protein results in increased susceptibility to Sulpiride
CTD
PMID:12223546
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
G
Ahr
aryl hydrocarbon receptor
multiple interactions decreases expression
EXP
Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR mRNA] Sulpiride results in decreased expression of AHR mRNA
CTD
PMID:26466350
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ahrr
aryl-hydrocarbon receptor repressor
multiple interactions
EXP
Sulpiride promotes the reaction [Benzo(a)pyrene results in increased expression of AHRR mRNA]
CTD
PMID:26466350
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
G
Aif1
allograft inflammatory factor 1
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of AIF1 protein]
CTD
PMID:30922767
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases expression
EXP
Sulpiride results in decreased expression of AKR1C3 mRNA
CTD
PMID:21427058
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
EXP
Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of ARNT mRNA]
CTD
PMID:26466350
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of BAX protein]
CTD
PMID:30922767
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of BCL2 protein]
CTD
PMID:30922767
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
multiple interactions
ISO
Sulpiride inhibits the reaction [Methamphetamine results in increased expression of CACNA2D1 mRNA]; Sulpiride inhibits the reaction [Methamphetamine results in increased expression of CACNA2D1 protein]
CTD
PMID:20340177
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
G
Car2
carbonic anhydrase 2
multiple interactions
ISO
Sulpiride binds to and results in decreased activity of CA2 protein
CTD
PMID:17826101
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Car3
carbonic anhydrase 3
multiple interactions
ISO
Sulpiride binds to and results in decreased activity of CA3 protein
CTD
PMID:17826101
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Casp3
caspase 3
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased cleavage of CASP3 protein]
CTD
PMID:30922767
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
ISO
Sulpiride promotes the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]]
CTD
PMID:14730115
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cckbr
cholecystokinin B receptor
affects response to substance
ISO
CCKBR protein affects the susceptibility to Sulpiride
CTD
PMID:11403953
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Cd86
CD86 molecule
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of CD86 mRNA]
CTD
PMID:30922767
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cish
cytokine inducible SH2-containing protein
increases expression multiple interactions
EXP
Sulpiride results in increased expression of CISH mRNA Estradiol promotes the reaction [Sulpiride results in increased expression of CISH mRNA]
CTD
PMID:18162529
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
increases expression
EXP
Sulpiride results in increased expression of CYP11A1 mRNA; Sulpiride results in increased expression of CYP11A1 protein
CTD
PMID:21427058
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression multiple interactions
EXP
Sulpiride results in decreased expression of CYP1A1 mRNA Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
CTD
PMID:26466350
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases expression multiple interactions
EXP
Sulpiride results in decreased expression of CYP1A2 mRNA Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]
CTD
PMID:26466350
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Drd2
dopamine receptor D2
affects binding decreases activity multiple interactions increases expression
ISO EXP
Sulpiride binds to DRD2 protein Sulpiride results in decreased activity of DRD2 protein [Sulpiride binds to and results in decreased activity of DRD2 protein] which results in decreased susceptibility to Methamphetamine Sulpiride results in increased expression of DRD2 Sulpiride inhibits the reaction [[Norepinephrine binds to and results in increased activity of DRD2 protein alternative form] which results in decreased transport of Calcium]; Sulpiride inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein alternative form] which results in decreased transport of Calcium] Methamphetamine inhibits the reaction [Sulpiride binds to DRD2 protein]; Sulpiride binds to and results in decreased activity of DRD2 protein; Sulpiride inhibits the reaction [Tacrolimus affects the activity of DRD2 protein]
CTD
PMID:1351265 PMID:2891082 PMID:2901473 PMID:7644023 PMID:8032591 PMID:8774428 PMID:15332494 PMID:20340177 PMID:20361897 More...
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Fcgr2a
Fc gamma receptor 2A
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of FCGR3 mRNA]
CTD
PMID:30922767
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr2b
Fc gamma receptor 2B
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of FCGR2B mRNA]
CTD
PMID:30922767
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Foxo1
forkhead box O1
affects localization
EXP
Sulpiride affects the localization of FOXO1 protein modified form
CTD
PMID:26466350
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Gad1
glutamate decarboxylase 1
decreases methylation multiple interactions
ISO
Sulpiride results in decreased methylation of GAD1 promoter Valproic Acid promotes the reaction [Sulpiride results in decreased methylation of GAD1 promoter]
CTD
PMID:18757738
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gh1
growth hormone 1
decreases expression multiple interactions
EXP
Sulpiride results in decreased expression of GH1 protein Benzo(a)pyrene affects the reaction [Sulpiride results in decreased expression of GH1 protein]
CTD
PMID:26466350
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
multiple interactions increases expression
EXP
Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of HSP90AA1 mRNA] Sulpiride results in increased expression of HSP90AA1 mRNA
CTD
PMID:26466350
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Ins1
insulin 1
multiple interactions decreases expression
EXP
[Sulpiride co-treated with Benzo(a)pyrene] results in decreased expression of INS1 protein Sulpiride results in decreased expression of INS1 protein
CTD
PMID:26466350
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Ins2
insulin 2
increases expression
ISO
Sulpiride results in increased expression of INS protein
CTD
PMID:16601995
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Irs1
insulin receptor substrate 1
multiple interactions decreases expression
EXP
Sulpiride results in decreased expression of and results in increased phosphorylation of IRS1 protein Sulpiride results in decreased expression of IRS1 mRNA
CTD
PMID:29551354
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
G
Kcnh1
potassium voltage-gated channel subfamily H member 1
multiple interactions
ISO
Sulpiride binds to and results in decreased activity of KCNH1 protein
CTD
PMID:17982510
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
G
Lhb
luteinizing hormone subunit beta
affects secretion
EXP
Sulpiride affects the secretion of LHB protein
CTD
PMID:18162529
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
increases expression
EXP
Sulpiride results in increased expression of NR5A2 mRNA
CTD
PMID:21427058
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Prl
prolactin
increases abundance increases expression increases secretion multiple interactions
ISO EXP
Sulpiride results in increased abundance of PRL protein Sulpiride results in increased expression of PRL mRNA; Sulpiride results in increased expression of PRL protein Sulpiride results in increased secretion of PRL protein Benzo(a)pyrene promotes the reaction [Sulpiride results in increased expression of PRL protein]; Sulpiride inhibits the reaction [Bromocriptine results in decreased secretion of PRL protein]; Sulpiride inhibits the reaction [Cabergoline results in decreased secretion of PRL protein] Triptorelin Pamoate inhibits the reaction [Sulpiride results in increased abundance of PRL protein]; Verapamil inhibits the reaction [Sulpiride results in increased secretion of PRL protein]
CTD
PMID:956353 PMID:2948424 PMID:2954994 PMID:3137082 PMID:3891423 PMID:4001434 PMID:7106173 PMID:7243090 PMID:7670571 PMID:7851873 PMID:18978642 PMID:21427058 PMID:26466350 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prlr
prolactin receptor
increases expression
EXP
Sulpiride results in increased expression of PRLR mRNA alternative form
CTD
PMID:18162529
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Reln
reelin
multiple interactions decreases methylation
ISO
Valproic Acid promotes the reaction [Sulpiride results in decreased methylation of RELN promoter]
CTD
PMID:18757738 PMID:19110320
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Scarb1
scavenger receptor class B, member 1
increases expression
EXP
Sulpiride results in increased expression of SCARB1 mRNA; Sulpiride results in increased expression of SCARB1 protein
CTD
PMID:21427058
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Slc18a2
solute carrier family 18 member A2
multiple interactions
ISO
Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of SLC18A2 protein]
CTD
PMID:30922767
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Slc22a23
solute carrier family 22, member 23
multiple interactions
ISO
Sulpiride inhibits the reaction [SLC22A23 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog]
CTD
PMID:28597291
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc22a3
solute carrier family 22 member 3
increases uptake
ISO
SLC22A3 protein results in increased uptake of Sulpiride
CTD
PMID:28597291
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc6a3
solute carrier family 6 member 3
multiple interactions
ISO
Sulpiride inhibits the reaction [Dopamine affects the localization of SLC6A3 protein]; Sulpiride inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of SLC6A3 protein]
CTD
PMID:20875051 PMID:30922767
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Socs1
suppressor of cytokine signaling 1
increases expression
EXP
Sulpiride results in increased expression of SOCS1 mRNA
CTD
PMID:18162529
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
increases expression multiple interactions
EXP
Sulpiride results in increased expression of SOCS3 mRNA Estradiol promotes the reaction [Sulpiride results in increased expression of SOCS3 mRNA]
CTD
PMID:18162529
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Srd5a1
steroid 5 alpha-reductase 1
increases expression
EXP
Sulpiride results in increased expression of SRD5A1 mRNA
CTD
PMID:18978642
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srd5a2
steroid 5 alpha-reductase 2
increases expression
EXP
Sulpiride results in increased expression of SRD5A2 mRNA
CTD
PMID:18978642
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
G
Star
steroidogenic acute regulatory protein
increases expression
EXP
Sulpiride results in increased expression of STAR mRNA; Sulpiride results in increased expression of STAR protein
CTD
PMID:21427058
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Th
tyrosine hydroxylase
multiple interactions increases activity
EXP ISO
Sulpiride inhibits the reaction [Dopamine results in decreased activity of TH protein]; Sulpiride inhibits the reaction [Rotenone results in decreased expression of TH protein] Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of TH protein] Sulpiride results in increased activity of TH protein
CTD
PMID:2884129 PMID:18289173 PMID:30922767
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Slc18a1
solute carrier family 18 member A1
multiple interactions
ISO
Tetrabenazine inhibits the reaction [SLC18A1 protein results in increased uptake of Serotonin]
CTD
PMID:8245983
NCBI chr16:20,653,268...20,687,051
Ensembl chr16:20,653,508...20,687,051
G
Slc18a2
solute carrier family 18 member A2
affects binding decreases activity multiple interactions
ISO EXP
Tetrabenazine binds to SLC18A2 protein Tetrabenazine binds to Slc8a2 protein Tetrabenazine results in decreased activity of SLC18A2 protein Tetrabenazine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin]
CTD RGD
PMID:1438304 PMID:7912402 PMID:15475732 PMID:19616025 PMID:33378168 PMID:20007701 More...
RGD:5130957
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Abcc1
ATP binding cassette subfamily C member 1
multiple interactions
ISO
[Thiethylperazine results in increased activity of ABCC1 protein] which results in increased export of APP protein
CTD
PMID:21881209
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
App
amyloid beta precursor protein
multiple interactions
ISO
[Thiethylperazine results in increased activity of ABCC1 protein] which results in increased export of APP protein
CTD
PMID:21881209
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Ap1s1
adaptor related protein complex 1 subunit sigma 1
decreases expression
ISO
Thioridazine results in decreased expression of AP1S1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Thioridazine results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Thioridazine results in increased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Casp3
caspase 3
increases activity
ISO
Thioridazine results in increased activity of CASP3 protein
CTD
PMID:21035837
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccnd1
cyclin D1
decreases expression
ISO
Thioridazine results in decreased expression of CCND1 protein
CTD
PMID:21035837
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdc25a
cell division cycle 25A
increases phosphorylation
ISO
Thioridazine results in increased phosphorylation of CDC25A protein
CTD
PMID:21035837
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Thioridazine results in decreased expression of CDK4 protein
CTD
PMID:21035837
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Thioridazine results in increased expression of CDKN1A protein
CTD
PMID:21035837
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
Thioridazine results in increased expression of CDKN2A protein
CTD
PMID:21035837
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]
CTD
PMID:20097249
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Thioridazine results in decreased expression of CRH mRNA
CTD
PMID:16205782
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine
CTD
PMID:19482014 PMID:23397584
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions decreases activity
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP2C19 protein
CTD
PMID:15135088 PMID:23397584
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP2D6 protein results in increased metabolism of and results in increased activity of Thioridazine
CTD
PMID:19482014 PMID:23397584
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
Thioridazine results in decreased activity of CYP2E1 protein
CTD
PMID:15135088
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions decreases activity
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP3A4 protein
CTD
PMID:15135088 PMID:23397584
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Thioridazine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases phosphorylation
ISO
Thioridazine results in decreased phosphorylation of EIF4EBP1 protein
CTD
PMID:21035837
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
Thioridazine results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Thioridazine results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Thioridazine results in increased expression of GDPD3 mRNA
CTD
PMID:17175557
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
G
Hpn
hepsin
increases expression
ISO
Thioridazine results in increased expression of HPN mRNA
CTD
PMID:15342952
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
G
Inhbe
inhibin subunit beta E
increases expression
ISO
Thioridazine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity
ISO
Thioridazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Thioridazine results in decreased activity of KCNH2 protein
CTD
PMID:15671647 PMID:16278312 PMID:21158687 PMID:24052561
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Lss
lanosterol synthase
increases expression
ISO
Thioridazine results in increased expression of LSS mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Thioridazine results in increased expression of NR0B2 mRNA
CTD
PMID:17175557
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Thioridazine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Phyh
phytanoyl-CoA 2-hydroxylase
increases expression
ISO
Thioridazine results in increased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Prl
prolactin
increases expression
ISO
Thioridazine results in increased expression of PRL protein
CTD
PMID:4065553
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
Thioridazine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Thioridazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Thioridazine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Tagln
transgelin
decreases expression
ISO
Thioridazine results in decreased expression of TAGLN mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tp53
tumor protein p53
affects activity
ISO
Thioridazine affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Thioridazine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
EXP
tianeptine results in increased expression of ABCC2 mRNA
CTD
PMID:27765674
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
EXP
tianeptine results in increased expression of ABCG5 mRNA
CTD
PMID:27765674
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
increases expression
EXP
tianeptine results in increased expression of ABCG8 mRNA
CTD
PMID:27765674
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Angptl3
angiopoietin-like 3
decreases expression
ISO
tianeptine results in decreased expression of ANGPTL3 mRNA
CTD
PMID:27089845
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Cat
catalase
multiple interactions
EXP
tianeptine inhibits the reaction [Indomethacin results in increased activity of CAT protein]
CTD
PMID:19497431
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cnr2
cannabinoid receptor 2
increases expression
EXP
tianeptine results in increased expression of CNR2 protein
CTD
PMID:28866072
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
G
Drd2
dopamine receptor D2
decreases expression
EXP
tianeptine results in decreased expression of DRD2 mRNA
CTD
PMID:11981225
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
ISO
tianeptine results in increased expression of IGFBP1 mRNA
CTD
PMID:27089845
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Mpo
myeloperoxidase
multiple interactions
EXP
tianeptine inhibits the reaction [Indomethacin results in increased activity of MPO protein]
CTD
PMID:19497431
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Oprm1
opioid receptor, mu 1
increases activity
ISO
tianeptine results in increased activity of OPRM1 protein
CTD
PMID:32734307
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Slc10a1
solute carrier family 10 member 1
decreases expression
EXP
tianeptine results in decreased expression of SLC10A1 mRNA
CTD
PMID:27765674
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc6a4
solute carrier family 6 member 4
multiple interactions
ISO
tianeptine binds to and results in decreased activity of SLC6A4 protein
CTD
PMID:16272152
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression
ISO
tianeptine results in increased expression of SREBF1 mRNA
CTD
PMID:27089845
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases activity
ISO
Trifluoperazine results in increased activity of ABCB1 protein
CTD
PMID:2900677
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Ache
acetylcholinesterase
multiple interactions increases activity decreases expression
EXP ISO
energostim inhibits the reaction [Trifluoperazine results in decreased expression of ACHE protein] Trifluoperazine results in increased activity of ACHE protein
CTD
PMID:15232633 PMID:29614332
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of AKT1 protein]
CTD
PMID:19233221 PMID:21544200
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Atp6v1h
ATPase H+ transporting V1 subunit H
multiple interactions
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA
CTD
PMID:28366621
NCBI chr 5:14,379,029...14,484,703
Ensembl chr 5:14,378,257...14,537,962
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Trifluoperazine results in increased expression of BAX protein
CTD
PMID:21475906
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Trifluoperazine results in decreased expression of BCL2 protein
CTD
PMID:21475906
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
multiple interactions
EXP
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of CAMK2A protein]
CTD
PMID:19233221
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein]
CTD
PMID:21544200
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cd44
CD44 molecule
multiple interactions
ISO
Trifluoperazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein]
CTD
PMID:9929743
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein]
CTD
PMID:21544200
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Fmo2
flavin containing dimethylaniline monoxygenase 2
increases oxidation
ISO
FMO2 protein results in increased oxidation of Trifluoperazine
CTD
PMID:26062974
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
multiple interactions
ISO
Trifluoperazine inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]]
CTD
PMID:15627515
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
multiple interactions
ISO
Trifluoperazine inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]]
CTD
PMID:15627515
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
G
Hif1a
hypoxia inducible factor 1 subunit alpha
decreases expression
ISO
Trifluoperazine results in decreased expression of HIF1A protein
CTD
PMID:18822394
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Il12b
interleukin 12B
multiple interactions
ISO
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IL12B protein]
CTD
PMID:16249388
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
Trifluoperazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:21158687
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
decreases activity
EXP
Trifluoperazine results in decreased activity of KCNN2 protein
CTD
PMID:10915830
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Lamp1
lysosomal-associated membrane protein 1
multiple interactions
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA
CTD
PMID:28366621
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK1 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Trifluoperazine inhibits the reaction [Dinoprost results in increased activity of MAPK1 protein]
CTD
PMID:11914123 PMID:21544200
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO EXP
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein]
CTD
PMID:21544200
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK3 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Trifluoperazine inhibits the reaction [Dinoprost results in increased activity of MAPK3 protein]
CTD
PMID:11914123 PMID:21544200
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO EXP
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein]
CTD
PMID:21544200
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions
ISO EXP
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein]
CTD
PMID:21544200
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mt1
metallothionein 1
increases expression
EXP
Trifluoperazine results in increased expression of MT1A mRNA
CTD
PMID:8128501
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions decreases phosphorylation
EXP ISO
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] Trifluoperazine analog results in decreased phosphorylation of MTOR protein STON2 protein inhibits the reaction [Trifluoperazine analog results in decreased phosphorylation of MTOR protein]
CTD
PMID:21544200 PMID:36702439
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Myl9
myosin light chain 9
multiple interactions
EXP
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MYL9 protein]; Trifluoperazine inhibits the reaction [Ionomycin results in increased phosphorylation of MYL9 protein]
CTD
PMID:19233221
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
G
Nefl
neurofilament light chain
multiple interactions
EXP
Trifluoperazine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA]
CTD
PMID:31969611
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases activity
ISO
Trifluoperazine results in decreased activity of NR3C1 protein
CTD
PMID:7887964
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein]
CTD
PMID:21544200
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pink1
PTEN induced kinase 1
multiple interactions
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]
CTD
PMID:28366621
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Prkn
parkin RBR E3 ubiquitin protein ligase
affects localization multiple interactions
ISO
Trifluoperazine affects the localization of PRKN protein PRKN protein affects the reaction [Trifluoperazine affects the localization of PRKN protein]
CTD
PMID:28366621
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Prl
prolactin
increases expression
ISO
Trifluoperazine results in increased expression of PRL protein
CTD
PMID:2136057
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Rel
REL proto-oncogene, NF-kB subunit
multiple interactions
ISO
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased localization of REL protein]
CTD
PMID:16249388
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
EXP ISO
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:21544200
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Slc5a6
solute carrier family 5 member 6
multiple interactions
ISO
Trifluoperazine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]
CTD
PMID:15561972
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
G
Ston2
stonin 2
decreases expression multiple interactions
ISO
Trifluoperazine analog results in decreased expression of STON2 protein STON2 protein inhibits the reaction [Trifluoperazine analog results in decreased phosphorylation of MTOR protein]
CTD
PMID:36702439
NCBI chr 6:110,567,485...110,676,376
Ensembl chr 6:110,567,485...110,676,376
G
Tfeb
transcription factor EB
multiple interactions
ISO
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]
CTD
PMID:28366621
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
G
Tnfsf11
TNF superfamily member 11
decreases activity
ISO
Trifluoperazine results in decreased activity of TNFSF11
CTD
PMID:21869564
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
increases glucuronidation multiple interactions increases activity
ISO
UGT1A4 protein results in increased glucuronidation of Trifluoperazine Finasteride inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Trifluoperazine]; hecogenin inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Trifluoperazine]; licochalcone A inhibits the reaction [Trifluoperazine results in increased activity of UGT1A4 protein]; Trifluoperazine inhibits the reaction [UGT1A4 protein results in increased glucuronidation of afloqualone]
CTD
PMID:15135306 PMID:15475412 PMID:25393417 PMID:25448279 PMID:26875642 PMID:33290829 More...
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
Triflupromazine results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Alb
albumin
multiple interactions affects binding
EXP ISO
ziprasidone results in decreased expression of and results in increased reduction of ALB protein ziprasidone binds to ALB protein [ziprasidone results in increased reduction of Cysteine] which results in increased activity of ALB protein; stearic acid inhibits the reaction [ziprasidone binds to ALB protein]
CTD
PMID:31400341
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Cat
catalase
increases expression
EXP
ziprasidone results in increased expression of CAT mRNA
CTD
PMID:32937854
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
ziprasidone results in increased expression of HMGCR mRNA
CTD
PMID:17052361
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
ziprasidone results in increased expression of HMGCS1 mRNA
CTD
PMID:17052361
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
increases expression
EXP
ziprasidone results in increased expression of HMOX1 mRNA
CTD
PMID:32937854
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Htr1a
5-hydroxytryptamine receptor 1A
multiple interactions
EXP
[N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide binds to and results in decreased activity of HTR1A protein] which results in increased susceptibility to ziprasidone
CTD
PMID:15996562
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
multiple interactions
ISO
ziprasidone inhibits the reaction [Ketanserin binds to HTR2A protein]
CTD
PMID:16314884
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
ziprasidone results in decreased activity of KCNH2 protein
CTD
PMID:28551711
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
ziprasidone results in increased expression of NQO1 mRNA
CTD
PMID:32937854
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
ziprasidone results in increased expression of SC5D mRNA
CTD
PMID:17052361
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO
ziprasidone inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:30465787
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Sox17
SRY-box transcription factor 17
decreases localization
ISO
ziprasidone results in decreased localization of SOX17 protein
CTD
PMID:24154490
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
G
Prl
prolactin
decreases expression
ISO
zotepine results in decreased expression of PRL protein
CTD
PMID:18063941
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all